Proguanil PDF

2014 Edition
INTERNATIONAL DRUG PRICE

INDICATOR GUIDE
GUIA INTERNACIONAL DE INDICADORES DE

PRECIOS DE MEDICAMENTOS
INDICATEUR DE PRIX INTERNATIONAUX

DES MEDICAMENTS
2014
Edited by
Julie E. Frye
Copyright © 2015 Management Sciences for Health, Inc.
Management Sciences for Health Phone: 617.250.9500

200 Rivers Edge Drive Fax: 617.250.9090
Medford, MA 02155 USA URL: www.msh.org
Center for Pharmaceutical Management Phone: 703.524.6575

Management Sciences for Health Fax: 703.524.7898
4301 N. Fairfax Drive, Suite 400 E-mail: cpm@msh.org
Arlington, VA 22203 USA
Recommended citation: MSH (Management Sciences for Health). 2015. International Drug Price Indicator Guide, 2014
Edition. (Updated annually.) Medford, Mass.: MSH.
Cover design by Joe Meiring
This publication was developed by Management Sciences for Health’s Center for Pharmaceutical Management,
Arlington, Virginia. The Guide is updated annually. The explanatory notes are in English, French, and Spanish and
the products and prices are in English. Comments and questions should be e-mailed to cpm@msh.org.
Note: All rights reserved. MSH has made every effort to ensure the accuracy of price, supplier, procurement agency
and other information presented in this publication. However, the reader’s attention is drawn to the introduction,
which describes the specific sources and limitations of information provided in this publication.
The reader’s attention is also drawn to the importance of quality assurance for pharmaceutical products. Licensing
authorities in the respective countries of manufacture are responsible for the review and approval of the detailed
composition and formulation when authorizing a pharmaceutical product to be marketed, including the specifica-
tions of its ingredients, as submitted by the manufacturer of the dosage form, and to oversee compliance with Good
Manufacturing Practice requirements as recommended by WHO.
MSH does not warrant that the products mentioned are in accordance with the national laws and regulations of any
country, including but not limited to patent laws. It is recommended that readers intending to use this publication
familiarize themselves with issues such as quality, safety and efficacy as well as quantification, patents, financial
stability and standing of the supplier, ability to supply the required quantities, delivery time, and other related
aspects.
This publication does not constitute an endorsement or warranty of the fitness of any product for a particular
purpose. This publication is not based on an active assessment of, and does not therefore constitute an acceptance or
recommendation in regard to, any product’s quality, safety, or efficacy.
This list may not be used by manufacturers and suppliers for commercial or promotional purposes. The mention of
specific companies and certain of their products does not imply that they are recommended by MSH in preference to
others of a similar nature that are not mentioned. Errors or omissions excepted, the names of propriety products are
distinguished by initial capital letters.
Bearing in mind that the data and information provided for a product depend largely on the supplier or procure-
ment agency, these data and information are being provided as is, and MSH makes no representations or warranties,
either express or implied, as to their accuracy, completeness, or fitness for a particular purpose. MSH accepts no
responsibility or liability for the reliance on, or use of, such data and information.
Nota: Todos los derechos reservados. MSH ha realizado todos los esfuerzos necesarios para asegurar la exactitud de
los precios, proveedores, agencias de adquisiciones y otra información presentada en esta publicación. Sin embargo,
se llama la atención del lector a la introducción que describe las fuentes específicas y las limitaciones de la información
proporcionada en esta publicación.
También se llama la atención del lector a la importancia del aseguramiento de la calidad para los productos
farmacéuticos. Las autoridades responsables de otorgar licencias en los respectivos países de fabricación son
responsables de la revisión y aprobación de la composición y formulación detallada al autorizar un producto
farmacéutico para su comercialización, incluyendo las especificaciones de los ingredientes, de acuerdo con la
información suministrada por el fabricante, así como de supervisar el cumplimiento con los requisitos de las Buenas
Prácticas de Fabricación recomendadas por la OMS.
MSH no garantiza que los productos mencionados están de acuerdo con las leyes y regulaciones nacionales de
ningún país, incluyendo pero no limitándose a las leyes de patentes. Se recomienda que los lectores que tengan la
intención de utilizar esta publicación se familiaricen con los aspectos relativos a la calidad, seguridad y eficacia así
como la cuantificación, los patentes, la estabilidad financiera y la situación del proveedor, su habilidad para
suministrar las cantidades requeridas, el tiempo de entrega y otros aspectos relacionados.
Esta publicación no constituye un respaldo o garantía con respecto a la idoneidad de cualquier producto para un fin
en particular. Esta publicación no está basada en una evaluación activa y por lo tanto no constituye una aceptación o
recomendación con respecto a la calidad, seguridad o eficacia de cualquier producto.
Esta lista no puede ser utilizada por los fabricantes y proveedores para fines comerciales o promocionales. La
mención de empresas específicas así como ciertos de sus productos no implica que estos están recomendados por
MSH con preferencia sobre otros productos de naturaleza similar que no hubieran sido mencionados. Salvo por
errores u omisiones, los nombres de los productos comerciales se distinguen con una letra mayúscula inicial.
Teniendo en mente que los datos y la información dados para un producto dependen en gran medida del proveedor
o de la agencia de adquisiciones, estos datos e información se suministran tal cuál están, y MSH no realiza ninguna
declación o garantía, ya sea expresa o implícita con respecto a la exactitud, integridad o idoneidad para un propósito
en particular. MSH no acepta responsabilidad alguna por la confianza depositada o el uso de dichos datos e
información.
Note: Tous droits réservés. MSH a cherché dans la mesure du possible à vérifier l’exactitude des données sur les prix,
les fournisseurs, les organismes d’achat et des autres informations présentées dans cette publication. Le lecteur n’en
est pas moins prié de se rapporter à l’introduction qui décrit les sources spécifiques et les limitations de l’information
donnée dans cette publication.
Le lecteur doit également prêter attention à l’importance de l’assurance de qualité pour les produits
pharmaceutiques. Les organismes chargés de la délivrance des autorisations dans les pays respectifs des fabricants
sont responsables de l’examen et de l’approbation de la composition et formulation détaillées avant d’autoriser la
mise sur le marché d’un produit donnée, notamment des spécifications des composants, tel qu’indiqué par le
fabricant dans la présentation et doivent par ailleurs s’assurer que sont observées les Bonnes pratiques de fabrication
recommandées par l’OMS.
MSH ne garantisse pas que les produits mentionnés soient conformes aux lois et réglementations nationales d’un
pays donné, notamment les lois relatives aux brevets. On recommande au lecteur qui souhaite utiliser cette publica-
tion de se mettre au courant des divers aspects tels que la qualité, l’innocuité et l’efficacité ainsi que la quantifications,
brevets, situation financière et réputation du fournisseur ainsi que sa capacité à fournir les quantités demandées dans
les bons délais.
La présente publication ne constitue pas une approbation ou recommandation de l’efficacité d’un produit dans un but
précis. Cette publication ne se fonde pas sur une évaluation active et ne constitue donc pas une acceptation ou
recommandation de la qualité, innocuité ou efficacité d’un produit.
Cette liste ne peut pas être utilisée par des fabricants ou fournisseurs à des fins commerciales ou promotionnelles. Si
certaines sociétés ou certains produits sont mentionnés, cela ne veut nullement dire qu’ils sont recommandés par
MSH de préférence à d’autres de nature analogue qui ne sont pas recommandés. Sauf erreur ou omission, les
marques déposées sont indiquées par des initiales en majuscule.
Sachant que les données et informations fournies sur un produit dépendent largement du fournisseur ou de
l’organisme chargé des achats, lesdites informations sont donc données telles quelles, sans que MSH ne fasse aucune
recommandation ou garantie, explicite ou implicite, quant à leur exactitude, intégralité ou adéquation dans tel but
donné. MSH n’accepte aucune responsabilité concernant la fiabilité ou l’utilisation des dites données et informations.
Editor
Julie E. Frye, Management Sciences for Health
Consulting Editor
Keith Johnson, Management Sciences for Health
Contributors
We thank MSH and WHO staff for their assistance with the International Drug Price Indicator
Guide. We also very much appreciate the information and cooperation we receive from the
suppliers included in the Guide. Finally, the tender data provided by government agencies
around the world greatly enhances the usefulness of the International Drug Price Indicator Guide,
and we thank the staff of the following organizations for their time and effort.
• Botswana Public Procurement and Asset Disposal Board
• La División Médica, la Gerencia de Operaciones y el Departamento de Farmacoterapia de la
Caja Costarricense de Seguro Social (“Costa Rica Social Security”)
• Clinton Health Access Initiative
• Democratic Republic of Congo Integrated Health Project (IHP)
• Dominican Republic PROMESE/CAL (“Central Support Unit for the Essential Medicines
Program”)
• Mission for Essential Medical Supplies (MEMS), Tanzania
• Namibia Ministry of Health and Social Services
• Organisation of Eastern Caribbean States Pharmaceutical Procurement Service, St. Lucia
• Ministerio de Salud del Perú (“Ministry of Health, Peru”)
• El Sistema de Integración Centroamericana (SICA) ("System of Central American Integra-
tion")
• South Africa Department of Health
• Sudan National Health Insurance Fund
Contents
PLEASE NOTE: Explanatory FAVOR DE NOTAR: Notas NOTE: Le texte explicatif

notes are presented in three explicativas están presenta- est disponible en trois
languages, each displayed das en tres idiomas, cada uno langues, chacune avec une
with its own pagination: con su propia paginación: numérotation différente :
English - E-1 Inglés - E-1 Anglais - E-1
Spanish - S-1 Español - S-1 Espagnol - S-1
French - F-1 Francés - F-1 Français - F-1
ACRONYMS/ABREVIATURAS/SIGLES ................................................................................................................ ix
PREFACE .................................................................................................................................................................... E-3
Prólogo ............................................................................................................................................ S-3
Préface ............................................................................................................................................ F-3
HOW TO USE THE GUIDE ................................................................................................................................................ E-5

Cómo Usar la Guía ........................................................................................................................ S-5
Comment Utiliser le Guide .......................................................................................................... F-5
INFORMATION YOU SHOULD KNOW ......................................................................................................... E-6

Información que Usted Debe Saber ............................................................................................ S-6
Information que Vous Devriez Connaître ................................................................................ F-6
LIST OF PRICE SOURCES ...................................................................................................................................... E-9

Fuentes de las Listas de Precios ................................................................................................ S-10
Liste des Sources des Prix ........................................................................................................... F-9
CONTACT INFORMATION............................................................................................................................ E-15

Información del Contacto ......................................................................................................... S-16
Information de Contact ............................................................................................................. F-15
FORMAT OF THE PRICE LISTS ....................................................................................................................... E-23

Formato de las Listas de Precios ............................................................................................... S-23
Format des Listes de Prix ........................................................................................................... F-22
HOW TO ANALYZE AND COMPARE YOUR PRICES.......................................................................... E-33

Cómo Analizar y Comparar sus Precios ................................................................................. S-35
Comment Analyser et Comparer vos Prix ............................................................................. F-34
Contents/Contenido/Table des Matières vii

LIST I: PRODUCTS SORTED ALPHABETICALLY ........................................................ A-1
Lista I: Productos Clasificados por Orden Alfabético
Liste I : Produits Pharmaceutiques Classés par Ordre Alphabétique
LIST II: PRODUCTS SORTED BY THERAPEUTIC CATEGORY ................................... T-1

Lista II: Productos Clasificados por Categoría Terapéutica
Liste II : Produits Pharmaceutiques Classés par Classe Thérapeutique
LIST III: PRICE COMPARISON FORM (SUPPLIER PRICES ONLY) ............................ SP-1
Lista III: Formulario para la Comparación de Precios (Precios de Proveedores Solamente)
Liste III : Formulaire pour la Comparaison des Prix (Prix des Fournisseurs Seulement)
LIST III: PRICE COMPARISON FORM (BUYER PRICES ONLY) .................................. BP-1
Lista III: Formulario para la Comparación de Precios (Precios de Compradores Solamente)
Liste III : Formulaire pour la Comparaison des Prix (Prix des Acheteurs Seulement)
ANNEXES
List of Synonyms
WHO Essential Medicines List Therapeutic Categories
OMS Lista Modelo de Medicamentos Esenciales Categorías Terapéuticas
OMS Liste Modèle des Médicaments Essentiels Catégories Thérapeutiques
ABOUT MANAGEMENT SCIENCES FOR HEALTH

ABOUT THE MSH CENTER FOR PHARMACEUTICAL MANAGEMENT
viii International Drug Price Indicator Guide 2014

Acronyms/Abreviaturas/Sigles
AIDS acquired immunodeficiency syndrome
ARV antiretroviral
ATC anatomical therapeutic chemical
anatómica terapéutica química
anatomique thérapeutique chimique
BP British Pharmacopoeia
Farmacopea Británica
Pharmacopée britannique
BPF Bonnes Pratiques de Fabrication
CIF cost, insurance, and freight [Incoterm]
costo, seguro y flete
coût, assurance et fret
CPM Center for Pharmaceutical Management
Centro de Gestión Farmacéutica
Centre pour la Gestion des Médicaments
DDD defined daily dose
dosis diaria definida
dose journalière définie
DDP delivered duty paid [Incoterm]
entregada derechos pagados
délivré dédouané
DMP Drug Management Program [part of Management Sciences for Health]
DOTS directly observed treatment, short-course
tratamiento directamente observado, a corto plazo
stratégie de traitement sous surveillance directe
DURG Drug Utilization Research Group
Grupo de Investigación sobre la Utilización de Medicamentos
Groupe de Recherche de l’Utilisation des Médicaments
EEUU estadounidense
EML Essential Medicines List [WHO]
EP European Pharmacopoeia
Farmacopea Europea
Pharmacopée européenne
EXW ex-works [Incoterm]
franco en almacén sin transporte
départ usine
FCA free carrier [Incoterm]
franco transportista [Incoterm]
franco transporteur [Incoterm]
FNUAP Fonds des Nations Unies pour la Population
FOB free on board [Incoterm]
franco a bordo
franco à bord
Acronyms/Abreviaturas/Sigles ix
GDF Global TB Drug Facility
GMP good manufacturing practices
buenas prácticas de manufactura
HIV human immunodeficiency virus
IC international (narcotics) control
control internacional de narcóticos
contrôle international (narcotiques)
INN international nonproprietary name
denominación común internacional
dénomination internationale
LME Lista de Medicamentos Esenciales [OMS]
Liste de Médicaments essentiels [OMS]
MOH Ministry of Health
MS ministère de la santé
MSH Management Sciences for Health
MSP ministerios de salud pública
N/D no disponible
NGO nongovernmental organization
OECS Organisation of Eastern Caribbean States
Organización de Estados del Caribe Oriental
Organisation des Etats de la Caraïbe de l’Est
OMS Organización Mundial de la Salud
Organisation mondiale de la Santé
ONG organizaciones no gubernamentales
organisations nongouvernementales
OPB organisations bénévoles privées
OVP organizaciones voluntarias privadas
P/D pas disponible
PPS Pharmaceutical Procurement Service
Servicio de Abastecimiento Farmacéutico
Service d’Approvisionnement pharmaceutique
SIDA síndrome de inmunodeficiencia adquirida
syndrome d’immunodéficience acquise
TU thousand units
miles de unidades
mille unités
UNFPA United Nations Population Fund
Fonds des Nations Unies pour la Population
USP United States Pharmacopeia
Farmacopea de los Estados Unidos
Pharmacopée des Etats Unis
VIH virus de la inmunodeficiencia humana
virus d’immunodéficience humaine
WHO World Health Organization
x International Drug Price Indicator Guide 2014

INTERNATIONAL DRUG PRICE
INDICATOR GUIDE
Preface
The International Drug Price Indicator Guide provides what the name implies—an indication of
drug prices on the international market. This Guide has been published by MSH since 1986, and
in collaboration with WHO since 2000. It provides a spectrum of prices from nonprofit drug
suppliers and commercial procurement agencies, based on their current catalogs or price lists. It
also contains prices obtained from international development agencies and from government
agencies.
MSH, in collaboration with WHO, is working with partners to make existing drug price infor-
mation more widely available in order to improve procurement of medicines of assured quality
for the lowest possible price. This will contribute to equitable access to health services and
commodities, including essential medicines, that are necessary for the prevention and treatment
of prevalent diseases.
Because the potential cost of providing a full range of treatments for common diseases is high,
prices and financing are inescapable factors in determining access to essential medicines. Lower
prices can be obtained through bulk purchasing, competition, skillful negotiation, and sound
supply management. Comparative price information is important for getting the best price.
Such information helps in price negotiations, in locating new supply sources, and in assessing
the efficiency of local procurement systems.
The International Drug Price Indicator Guide helps supply officers determine the probable cost
of pharmaceutical products for their programs. It can be used as a reference list to compare
current prices paid to prices for products available on the international market; it can also be
used to assess the potential financial impact of changes to a drug list.
The database of prices is maintained by the Center for Pharmaceutical Management of Manage-
ment Sciences for Health, a nonprofit organization, as a contribution towards making essential
medicines available to all the world’s citizens. The Guide may be copied for in-service educa-
tion or other nonprofit use.
Additional information on international drug prices can be found on the Web at:
• “Medicines Price Information” (http://www.who.int/medicines/areas/access/ecofin/
en/index.html), a page maintained by WHO. It includes prices of international price
information services on starting materials, finished products, and selected HIV-related
medicines. In addition, it reports on disease-specific price information and individual
country price information services.
Please note that an electronic version of the International Drug Price Indicator Guide can be
found on MSH’s Electronic Resource Center at http://erc.msh.org/priceguide.
For more information or to provide comments or suggestions on the format or the contents of
this publication, please contact us at:
Preface E-3
Center for Pharmaceutical Management Policy, Access and Use Unit
Management Sciences for Health Department of Essential Medicines and Health
4301 North Fairfax Drive, Suite 400 Products
Arlington, VA 22203-1627 USA World Health Organization
Telephone: 1.703.524.6575 Avenue Appia 20
Fax: 1.703.524.7898 CH-1211 Geneva 27
E-mail: cpm@msh.org Switzerland
E-mail: forteg@who.int
E-4 International Drug Price Indicator Guide 2014

How to Use the Guide
The Guide begins with “Information You Should Know” to better understand the data pre-
sented here. A list of the suppliers and buyers in this edition follows that section and includes
details on shipping terms and restrictions. Supplier and buyer addresses appear next. After that,
the Guide explains the format of the comparative price information reports, as well as the terms
used on the price listings and the codes and abbreviations used.
The price data are provided in three formats in this Guide. Each format includes supplier prices
and buyer prices. The buyer prices are usually government agency international competitive
bidding (or tender) prices.
• List I: The products are in alphabetical order by generic name, and the list includes the
price details for each supplier and buyer. This format is intended for procurement refer-
ence and allows a quick search for a particular medicine.
• List II: The products are in alphabetical order within the WHO Essential Medicines List
(EML) classification system. This format assists with, for example, formulary develop-
ment and allows a convenient comparison of medicines within classes. Items in a class
cannot necessarily directly substitute for each other.
• List III: The products are in alphabetical order with only the median price for an item
displayed. This format is meant to facilitate comparison of a user’s prices with Guide
prices. The supplier and buyer prices appear on separate lists.
If you need information on how to use these prices for comparison purposes, please see the
section called “How to Analyze and Compare Your Prices.” A list of synonyms and the WHO
therapeutic class categories are included in the Annexes for reference.
This Guide is intended as a comparative reference only; it is not suitable for actually ordering
products. To place orders, the vendor must be contacted directly. No guarantees are implied as
to availability of prices listed, quality of products, or specific sales conditions. The vendors
included are not intended to be a comprehensive list of potential suppliers. Prices from buyers
are listed for comparison purposes only.
How to Use the Guide E-5

Information You Should Know
Products Included
The International Drug Price Indicator Guide primarily focuses on essential medicines, but
includes other products as well. Medicines from the WHO Essential Medicines Lists are always
included, as are medicines and products important for the treatment or prevention of tuberculo-
sis, malaria, and HIV/AIDS. Vaccines, immunologic agents, disinfectants, fluids and electro-
lytes, and diagnostic tests and agents are also typically covered. Increasingly, medicines re-
quired for cancer treatment and chronic disease care, and strengths and dosage forms required
for pediatric care are being added to the database. New products are added to the Guide each
year, as the information reported to us changes.
Price Conversion
Prices in the International Drug Price Indicator Guide are listed in ascending order according to
unit price. All prices for the organizations listed below have been converted to U.S. dollars
(USD). The exchange rates used are for 1 July 2014 (http://www.oanda.com). Other catalogue
prices were listed originally in U.S. dollars and were not converted.
Currency (Organization Code) Exchange Rate (to USD)
British pound (DURBIN) 1.7126
Dominican Republic pesos (DOMREPUB) 0.0228
Euro (IDA, MEDEOR/EU) 1.3687
Ghanian New Cedi (CHAI) 0.3099
Indian Rupee (CHAI) 0.0166
Kenya shilling (MEDS) 0.0112
Namibian dollar (NAMIBIA) 0.0942
Nigerian Naira (CHAI) 0.0061
Peruvian nuevo sol (PERU) 0.3532
South African rand (SAFRICA) 0.0942
Sudanese pound (SUDANNHIF) 0.1746
Tanzanian shilling (MEDEOR/TZ, MEMS) 0.0006
Changes in exchange rates can cause costs to vary widely. The most current rate at the time of
your analysis should always be used when calculating drug costs.
Price Terms
The supplier prices and buyer prices in this Guide are based on different price terms, and so
must not be directly compared. The following incoterms are used to define the price types:
• CIF (cost, insurance, and freight): includes insurance and transport charges up to the port of
destination (sea shipments only)

• CIP (carriage and insurance paid to): includes cost of carriage and insurance to the carrier at
the agreed place
• DDP (delivered duty paid): includes delivery and import duties and unloading costs
• DDU (delivered duty unpaid): includes delivery, but not import duties or unloading costs
• EXW (ex works): does not include loading, insurance, or freight
• FCA (free carrier): includes transport and insurance until the goods are delivered to the
carrier
Some suppliers and agencies charge a standard handling fee. The handling fees shown in the
List of Price Sources have been added to the prices listed in this Guide.
Calculating Prices
When calculating and projecting real costs, it is important to consider factors such as financing,
delivery times, modes of transportation (air/sea/inland), and handling charges. An analysis of
these factors is beyond the scope and intent of this Guide. However, it is reasonable, for estima-
tion purposes, to add 10% for shipping costs to the listed price for suppliers in this Guide. The
buyer (government agency tender) prices listed generally do not require adjustment for ship-
ping charges.
Quality Assurance
We require all suppliers included in the International Drug Price Indicator Guide to complete a
quality assurance questionnaire. The purpose of the mandatory questionnaire is to help ensure
that the prices listed in this Guide are from reputable suppliers with established quality assur-
ance processes in place. The 28 questions address issues including inspection, testing, quality
assurance, licensing, recalls, quality control procedures, standards, and documentation. Al-
though this requirement provides some assurance of quality control processes, it does not
necessarily guarantee the quality of the products listed. Copies of the questionnaire can be
obtained from MSH on request.
The price sources included in the Guide have been screened only through the completeness of
the documents they have provided. This screening in no way constitutes an in-depth review of
product quality. Inclusion in the Guide does not constitute pre-qualification or approval of any
sort by MSH and WHO.
Product Quality
The suppliers and agencies selected for this Guide are not manufacturers, but they offer prod-
ucts that are stated to be in compliance with international quality standards specified by organi-
zations such as the United States Pharmacopeia (USP), the British Pharmacopoeia (BP), and the
European Pharmacopoeia (EP). All suppliers in this guide state that the manufacturing plants
with which they work maintain high quality standards by having in place on-site quality assur-
ance systems in order to ensure that all products are complying with WHO Good Manufactur-
ing Practices (GMP) and with government regulations. Quality certificates in line with the
Information You Should Know E-7

WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International
Commerce should be available from all of these suppliers on request. Suppliers and agencies
listed in the Guide maintain their own independent quality assurance programs. Contact them
directly for these details.
ATC/DDD System1
Drug utilization data have a central role in the quality of care cycle and are essential to the
management of policy related to drug supply, pricing, cost, and use. The anatomical therapeutic
chemical (ATC) and defined daily dose (DDD) methodologies for classification and measure-
ment can be helpful in following and comparing cost trends, but need to be used with caution.
Basing detailed reimbursement, therapeutic group reference pricing, and other specific pricing
decisions on the ATC and DDD assignments is a misuse of the system.
The purpose of the ATC/DDD system is to serve as a tool for drug utilization research in order
to improve drug use practices. One component of this is the presentation and comparison of
drug consumption statistics at international and other levels.
A major aim of the WHO Collaborating Centre for Drug Statistics Methodology and Working
Group is to maintain stable ATC codes and DDDs over time to allow trends in drug consump-
tion to be studied without the complication of frequent changes to the system. There is a strong
reluctance to make changes to classifications or DDDs when such changes are requested for
reasons not directly related to drug consumption studies. For this reason the ATC/DDD system
by itself is not suitable for guiding decisions about reimbursement, pricing, and therapeutic
substitution.
The classification of a substance in the ATC/DDD system is not a recommendation for use, nor
does it imply any judgments about efficacy or relative efficacy of drugs and groups of drugs.
Text in this section is adapted from the WHO Collaborating Centre for Drug Statistics Methodology website (http://
1
www.whocc.no/atcddd/).

List of Price Sources
Three primary types of suppliers and buyers are included in the Guide.
1. Suppliers who maintain a warehouse and supply items directly to customers. All of these suppliers provide a wider range of
products than shown in this Guide. For a complete list of products, contact the vendor directly. The following suppliers are
included in the Guide:
Date of Handling
Supplier Code Price Type Details
List Fee
Prices are effective until publication of revised price list. Transport costs
MEDEOR/ September are charged individually according to expenses. Special packaging in cases
Action Medeor 1% EXW Tönisvorst
EU 2014 costs Euro 26 per case. Minimum handling fee is Euro 50. Only serves non-
profit organizations.
Action Medeor International Healthcare is a not-for profit procurement
agency founded in 2004 and owned by Action Medeor. It supplies the not-
Action Medeor
MEDEOR/ September for-profit market (primarily in Tanzania) and does not supply to individuals
International 0% EXW
TZ 2014 or commercial pharmacies. A 3.5% service charge applies for all non-
Healthare
Tanzanian customers to cover bank charges and currency loss. No
minimum quantities are required.
AMSTEL- January EXW Lelystad, Amstelfarma prices are given as an indication only. There are no minimum
Amstelfarma 0%
FARM 2015 The Netherlands orders required or service charges.
ASRAMES (Association Régionale d'Approvisionnement en Médicaments
August DDP or CIP Essentiels) only serves organizations in the DRC that have been recognized
ASRAMES ASRAMES 0%
2014 Kinshasa by the Ministry of Health as a health institution or as an NGO working in
the health sector.
Durbin supplies pharmaceuticals and medical supplies to doctors,
EXW United pharmacies, hospitals, pharmaceutical wholesalers and traders, military and
Durbin PLC DURBIN 2013-2014 0%
Kingdom government agencies, charities and other relief organisations worldwide.
Minimum order UK £100.

E-9
Date of Handling
Supplier Code Price Type Details
E-10
List Fee
Since 1972, the IDA Foundation has been committed to improving access
to and delivering high-quality essential medicines and medical supplies to
low- and medium-income countries. As an independent and self-supporting
November
IDA Foundation IDA 1.5% FCA Amsterdam foundation, IDA distributes more than 3,000 products to over 100
2014
countries worldwide. Minimum order of Euro 1500. Orders under Euro
5,000 are charged a handling fee of 3%. Orders over Euro 5,000 are
charged a handling fee of 1.5%. Prices are indicative and may change.
January FCA Lelystad,
IMRES IMRES 0% Minimum order quantity is US$1250.
2015 The Netherlands
Medical Export November FCA Gorinchem, Prices are given as an indication only. There are no minimum orders
MEG 0%
Group 2014 The Netherlands required or service charges.
MSD sales prices are valid for all governmental health facilities, approved
Medical Stores NGOs, mission hospitals, charitable hospitals and other health care
International Drug Price Indicator Guide 2014

MSD/
Department, 2014-2015 0% EXW providers in Tanzania, with approval from Ministry of Health & Social
TANZ
Tanzania Welfare. Parastatal companies/organizations will pay 10% on top of these
sales prices.
Mission for Essential MEDS supplies drugs and medical supplies to nonprofit health care
MEDS July 2014 0% FOB Nairobi
Drugs and Supplies providers. Freight charges are added for deliveries outside of Kenya.
2. International development organizations that provide commodities to country programs they and others support. The organi-
zations listed in the Guide are:
International
Date of Handling
Development Code Price Type Details
List Fee
Organization
The Global Drug Facility (GDF) is a mechanism to expand access to, and
availability of, high-quality anti-TB drugs to facilitate global expansion and
maintenance of DOTS, the internationally recommended strategy to
control tuberculosis. Drugs are supplied through free grants, but are also
available for purchase by governments and organizations wishing to take
advantage of the quality, prices, and technical support offered through the
GDF Direct Procurement Service. GDF performs compulsory independent
testing of each batch of drugs it supplies and pre-shipment inspection of
Global TB Drug EXW Supplier each order it delivers to confirm high quality.
GDF 2014 0%
Facility Factory
To facilitate the efficient delivery of products, GDF uses procurement
agents. Prices include the cost of the product as well as quality control
costs and a GDF procurement agent fee. Costs for pre-shipment
inspection, transport (air freight or sea freight) and insurance, are not
included in the listed product prices. GDF sends a team of TB and drug
management experts to the country four months after drugs arrive, to
assess drug usage and provide any needed technical assistance. GDF does
not charge for its technical assistance to countries.
The Supply Chain Management System project delivers essential lifesaving

medicines to HIV/AIDS programs around the world. The project helps
strengthen existing supply chains or establishes new ones to ensure a safe,
EXW (SCMS secure, reliable and sustainable supply chain management system to
regional procure pharmaceuticals and other products for people with HIV/AIDS
Supply Chain
October distribution and related infections. SCMS is funded by the US government as part of the
Management System SCMS 5%
2014 center or directly President's Emergency Plan for AIDS Relief (PEPFAR). The SCMS project
Project
from the can work anywhere in the world, but is initially focused on the 15 PEPFAR
supplier) focus countries. In addition to serving any project or implementing partner
supported by PEPFAR, SCMS can also supply projects supported by

national governments and other donors, subject to individual
arrangements.
E-11
E-12
International
Date of Handling
Development Code Price Type Details
List Fee
Organization
UNFPA conducts annual tenders to purchase goods for their field offices
and on behalf of external clients in more than 168 countries, mainly in the
September developing world. UNFPA serves only governments and nonprofit
UN Population Fund UNFPA 5% FOB
2014 organizations. UNFPA charges a 5% administration fee to non-UNFPA
buyers. There is a minimum order requirement of US$5,000 per item.
Prices are indicative and may change.

3. Buyers (usually public-sector agencies) that procure commodities through international competitive bidding, or tenders. These
are actual prices obtained by the organizations listed and are included for comparison purposes. It is not possible for a reader to
place an order with any of these organizations.
Approx.
Date of Price Value of
Buyer Code Details
List Type Tender
(USD)
The Public Procurement and Asset Disposal Board of
Botswana Public Procurement and January
BOTSWANA N/A N/A Botswana conducts open and closed domestic and
Asset Disposal Board 2014
international tenders on a regular basis.
Costa Rica Social Security conducts an annual, open,
126
Caja Costarricense de Seguro Social CRSS 2014 DDU international tender and negotiates contracts for drugs and
million
medical supplies for its own facilities.
DDP, The Clinton Health Access Initiative contributed price

Clinton Health Access Initiative CHAI 2014 EXW, or N/A information from several partners who are working together
FOB to scale up treatment for diarrhea.
The Democratic Republic of Congo Integrated Health

Democratic Republic of Congo
DRC/IHP May 2014 FCA 3.8 million Project (IHP) conducts an annual, closed, international
Integrated Health Program (IHP)
tender for pharmaceuticals and medical supplies.
República Dominicana Central de The Dominican Republic Essential Medicine Program
Apoyo Logístico Programa de October Central Logistics Support conducts an open, domestic
DOMREPUB N/A 69 million
Medicamentos Esenciales 2014 tender for pharmaceuticals and medical supplies twice a
(PROMESE/CAL) year.
MEMS awards an annual drug and medical supply contract
Mission for Essential Medical Supplies
MEMS July 2014 N/A 0.3 million to a prime vendor, after an open domestic pre-qualification
(MEMS), Tanzania
process and a closed tender process.

E-13
E-14
Approx.
Date of Price Value of
Buyer Code Details
List Type Tender
(USD)
The Namibia Central Medical Stores conducts an open,
August
Namibia Central Medical Stores NAMIBIA DDP 24 million international tender every two years for pharmaceuticals
2014
and medical supplies and once a year for anti-retrovirals.
The OECS/PPS provides its services to member countries of
1 March
Organisation of Eastern Caribbean the Organisation of Eastern Caribbean States only. For these
2014 - 31
States Pharmaceutical Procurement OECS/PPS CIF N/A nine countries, OECS/PPS negotiates contracts and
August
Service (OECS/PPS) purchases through a closed, international tender every 18
2015
months.
The Peru Ministry of Health (MINSA) conducts an annual,
February & 197
Perú Ministerio de Salud PERU DDP domestic, open tender for pharmaceuticals and medical
April 2014 million
supplies.
The System of Central American Integration (SICA)
El Sistema de Integración August

SICA CIF 4.2 million conducts an annual closed, international tender for selected
Centroamericana (SICA) 2014
pharmaceuticals.
The South Africa Department of Health conducts two-year
South Africa Department of Health SAFRICA 2014 DDP N/A domestic, open tenders on a rolling basis for
pharmaceuticals and medical supplies.
The National Health Insurance Fund of Sudan conducts
SUDAN- 16.8
Sudan National Health Insurance Fund June 2014 DDP annual, open, domestic tenders for pharmaceuticals and
NHIF million
medical supplies.
Contact Information
Action Medeor
Deutsches Medikamenten-Hilfswerk
St. Töniser Strasse 21
D-47918 Tönisvorst
GERMANY
Telephone: 49.21.56.97.88.0
Fax: 49.21.56.97.88.88
E-mail: info@medeor.org
URL: http://www.medeor.org
Action Medeor International Healthcare

D-47918 Tönisvorst
GERMANY
and
P.O. Box 72305
Dar es Salaam
TANZANIA
Telephone: 49.21.56.97.88.0
Fax: 49.21.56.97.88.88
E-mail: medeortz@bol.co.tz
Amstelfarma
Nijverheidsweg 37
2102LK Heemstede
THE NETHERLANDS
Telephone: 31-23-5484040
E-mail: sales@amstelfarma.com
URL: http://www.amstelfarma.nl
Contact Information E-15

ASRAMES (Association Régionale D’Approvisionnement en Médicaments
Essentiels)
BP 183
Goma
DRC
Telephone: 243.9.98.08.81.70
E-mail: info@asrames.org
URL: www.asrames.com
Botswana Public Procurement and Asset Disposal Board

Plot 8913 Maakgadigau Way, Gaborone West Industrial
Gaborone
Private Bag 0058
BOTSWANA
Telephone: 267 360 2000

Fax: 267 390 6822
E-mail: sbpac@ppadb.co.bw
URL: http://www.ppadb.co.bw
Caja Costarricense de Seguro Social—CCSS (“Costa Rica Social Security—CRSS”)

Pharmacotherapy Department
Apartado 10105
San José 1000
COSTA RICA
Telephone: 506.222.1878
Fax: 506.257.7004
E-mail: farmaco@ccss.sa.cr
URL: http://www.info.ccss.sa.cr/
Clinton Health Access Initiative

383 Dorchester Avenue, Suite 400
Boston, MA 02127
USA
Telephone: 617.774.0110
E-mail: info@clintonhealthaccess.org
URL: http://www.clintonhealthaccess.org

Democratic Republic of Congo Integrated Health Program (IHP)
MSH
Avenue des Citronnniers numéro 4 (near Cafe Mozart)
Commune de la Gombe
Kinshasa
DEMOCRATIC REPUBLIC OF CONGO
Telephone: 243.99.930.1015
URL: http://www.msh.org/our-work/projects/integrated-health-project
Dominican Republic PROMESE/CAL

Calle “H” No. 15
Zona Industrial de Herrera
Santo Domingo
DOMINICAN REPUBLIC
Telephone: 809.518.1313
E-mail: promesecal@promesecal.gov.do
URL: http://www.promesecal.gov.do/
Durbin PLC
180 Northolt Road
South Harrow
Middlesex
HA2 0LT
UNITED KINGDOM
Telephone: 44.20.8660.2220
Fax: 44.20.8668.0751
E-mail: cataloguesales@durbin.co.uk
URL: http://www.durbin.co.uk
Global TB Drug Facility (GDF)

Stop TB Partnership Secretariat
c/o World Health Organization
20, avenue Appia
1211 Geneva, 27
SWITZERLAND
Telephone: 41.22.791.3647
Fax: 41.22.791.4886
E-mail: gdf@who.int
URL: http://www.globaldrugfacility.org or http://www.stoptb.org/GDF

IDA Foundation
P.O. Box 37098
1030 AB Amsterdam
THE NETHERLANDS
Telephone: 31.20.40.33.051
Fax: 31.20.40.31.854
E-mail: info@idafoundation.org
URL: http://www.idafoundation.org
IMRES
P.O. Box 214
8200 AE Lelystad
THE NETHERLANDS
Telephone: 31.320.296969
Fax: 31.320.296929
E-mail: info@imres.nl
URL: http://www.imres.nl
Medical Export Group, BV

Papland 16
P.O. Box 598
4200 AN Gorinchem
THE NETHERLANDS
Telephone: 31.183.356.100
Fax: 31.183.356.122
E-mail: sales@meg.nl
URL: http://www.meg.nl
Medical Stores Department (MSD)

P.O. Box 9081
Dar es Salaam
TANZANIA
Telephone: 255.22.2860890
Fax: 255.22.2865814
E-mail: info@msd.or.tz
URL: http://www.msd.or.tz

Mission for Essential Medical Supplies (MEMS)
P.O. Box 10810
Arusha
TANZANIA
Telephone: 255.27.250.9366
Fax: 255.27.254.4908
E-mail: info@mems.or.tz
Mission for Essential Drugs and Supplies (MEDS)

MEDS Centre
P.O. Box 78040-00507
Viwandani Nairobi, 00507
KENYA
Telephone: 254.020.3920.404
Fax: 254.020.3920.600
E-mail: customerservice@meds.or.ke
URL: http://www.meds.or.ke
Namibia Central Medical Stores

P.O. Box 5552
Windhoek
NAMIBIA
Phone: 264.61.233151
Fax: 264.61.238746
URL: http://www.cms-namibia.com
Organisation of Eastern Caribbean States Pharmaceutical Procurement Service

OECS
The Morne, P.O. Box 3093
Castries
ST. LUCIA, WEST INDIES
Telephone: 758.452.5895
Fax: 758.453.0227
E-mail: pps@oecs.org
URL: http://www.oecs.org/pps/

Perú Ministerio de Salud (MINSA) (“Peru Ministry of Health”)
Av. Salaverry 801
Jesús Maria
Lima
PERU
Telephone: 51.14.315.6600
E-mail: webmaster@minsa.gob.pe
URL: http://www.minsa.gob.pe/portada/
South Africa Department of Health

Private Bag X828
Pretoria, 0001
SOUTH AFRICA
Telephone: 27.12.312.0000
Fax: 27.12.326.4395
URL: http://www.doh.gov.za
Sudan National Health Insurance Fund

Pharmaceutical Services Department
Baladya Street
P.O. Box: 13267
Khartoum
SUDAN
Telephone: 249 1 837 47618

Fax: 249 1 837 47619
E-mail: info@nhif.gov.sd
URL: http://www.nhif.gov.sd
Supply Chain Management System (SCMS)

1616 Fort Myer Drive
12th Floor
Arlington, VA 22209-3100
USA
Telephone: 1.571.227.8600
Fax: 1.571.227.8601
URL: http://www.pfscm.org

System of Central American Integration (SICA)
Boulevard Orden de Malta No. 470
Urbanización Santa Elena
Antiguo Cuscatlán
Department of La Libertad
EL SALVADOR
Telephone: 503 2248-8800

Fax: 503 2248-8899
E-mail: info.sgsica@sica.int
URL: http://www.sica.int/
United Nations Population Fund (UNFPA)

Midtermolen 3
P.O. Box 2530
Copenhagen
DENMARK
Telephone: 45.3546.7000
Fax: 45.3546.7018
E-mail: accessrh@unfpa.org
URL: http://www.unfpa.org/public/supplies

Format of the Price Lists
The pharmaceutical products are presented in three separate lists, with different formats and
features, but certain elements are common to all.
• List I: Products Sorted Alphabetically
• List II: Products Sorted by Therapeutic Category
• List III: Price Comparison Form
A detailed description of the information included in each list follows.
Format of the Price Lists E-23

List I - Products Sorted Alphabetically
List I is intended for procurement reference and lists drugs in alphabetical order by generic
name to allow a quick search for a particular drug. This list shows the pack size(s) available
from each source and the pack price in U.S. dollars, including the source’s standard service
charges where applicable.
Item Description
The item description includes the generic name, strength, dosage form, and the route of admin-
istration. If the product has two widely used names (for example, vitamin C and ascorbic acid),
one name will appear in brackets. See the List of Synonyms in the Annex.
IC
Products under international narcotics control are identified with (IC) next to the de-
scription.
Nomenclature
International nonproprietary names (INNs) have been used for the list of drugs in this
Guide. If an INN has not been assigned, the most common generic name has been used.
Drug dosage forms listed are generally those included in the World Health
Organization’s 19th Model List of Essential Medicines (revised April 2015), found at
http://www.who.int/medicines.
Route of Administration
Routes of administration are coded as follows:
Item Type Code
Condoms COND
Diagnostic Strips and Tests and Lab Supplies DIAG
Ear Preparations OTIC
Eye Preparations OPHT
Injectable Medicines INJ
Intrauterine Device (IUD) IUD
Intravenous Solutions IV
Medicines for Inhalation INH
Medicines for Nasal and Throat Use N/T
Subcutaneous Medicines S/C
Sublingual Tablets SL
Suppositories/Enemas/Rectal Ointment RECT
Tablets/Capsules/Oral Liquids PO
Topical Medicines (liquids, powders, creams, ointments) TOP
Vaginal Preparations VAG
Not Applicable N/A

Source
The list of price sources can be found on page E-9.
Package
Package sizes are provided by the suppliers and buyers.
Package Price (US$)

Package prices are provided by the suppliers and buyers and have been converted to U.S.
dollars at the exchange rates listed on page E-6 to facilitate comparison. If a supplier charges a
standard handling fee percentage, that percentage has been added to the package price listed.
Unit Price (US$)

The unit price is calculated by dividing the package price by the package size. This format
facilitates the price comparison of different vendor pack sizes. The unit used to compare prices
varies with the type of pharmaceutical preparation as follows:
Pharmaceutical Dosage Form Comparison Unit (Code)
Ampoule or Vial Milliliter (ML)
Cartridge Milliliter (ML)
Condom, Intrauterine Device (IUD), Net, Test Each (EACH)
Ear, Nose, and Throat Preparation Milliliter (ML)
Enema Milliliter (ML)
Gas Cubic Meter (CUBMETER)
Granules Gram (G)
Inhaler Dose (DOSE)
Oral Liquid Milliliter (ML)
Pack Pack (PACK)
Pessary Pessary (PESS)
Suppository Suppository (SUPP)
Syringe Syringe (SYRINGE)
Tablet or Capsule Tablet or Capsule (TAB-CAP)
Topical Liquid Milliliter (ML)
Topical Solid Gram (G)
Treatment Treatment (TREATMEN)
Vaccine Dose (DOSE)
Vial (single strength) Vial (VIAL)
DDD
The DDD is the assumed average maintenance dose per day for a drug used for its main indica-
tion in adults. The defined daily dose is a unit of measurement and does not necessarily reflect
the recommended or prescribed daily dose. Doses for individual patients and patient groups
will often differ from the DDD and will necessarily be based on individual characteristics (e.g.,

age and weight) and pharmacokinetic considerations.
Drug consumption data presented in DDDs give only a rough estimate of consumption and not
an exact picture of actual use. DDDs provide a fixed unit of measurement independent of price
and formulation, enabling the researcher to assess trends in drug consumption and to perform
comparisons between population groups.
The defined daily doses are from the WHO Collaborating Centre for Drug Statistics Methodol-
ogy. They are illustrative defined daily doses, as recommended by the World Health
Organization’s Drug Utilization Research Group (DURG). Not all drugs listed in this price
comparison guide have defined daily doses assigned by this method. A DDD will only be
assigned for drugs that already have an ATC code.
The main use of the DDD is for estimating drug consumption, based on inventory/distribution
data. This estimate can be combined with price information for budgeting purposes.
Note: The defined daily dose should not be used for dosing or therapeutic determinations. Refer to
prescribing information for dosing schedules for specific indications.
WHO EML
The “WHO EML” column indicates whether the product is included on the 2015 WHO Model
List of Essential Medicines. We identify five categories in the International Drug Price Indicator
Guide:
E = On the WHO core list in the same dosage form and strength
C = On the WHO complementary list in the same dosage form and strength
P = On the WHO list, but in a different presentation (different dosage form and/or
strength)
T = Not on the WHO list, but can be an alternative for an item listed as a
therapeutic group example
N = Not on the WHO model list
ATC Code
The ATC code is the anatomical therapeutic chemical classification code assigned by the WHO
Collaborating Centre for Drug Statistics Methodology. The purpose of the ATC/DDD system is
to serve as a tool for drug utilization research in order to improve drug use practices. One
component of this is the presentation and comparison of drug consumption statistics at interna-
tional and other levels.
In the ATC classification system, the drugs are divided into different groups according to the
organ or system on which they act and their chemical, pharmacological, and therapeutic proper-
ties. Drugs are classified in groups at five different levels. The drugs are divided into 14 main
groups (1st level), with one pharmacological/therapeutic subgroup (2nd level). The 3rd and 4th
levels are chemical/pharmacological/therapeutic subgroups, and the 5th level is the chemical
substance.2
2
Adapted from the WHO Collaborating Centre for Drug Statistics Methodology website at http://www.whocc.no/
atcddd/.

Median Price
When using the Guide for comparison with local prices, or for estimating the total value of a
proposed procurement list, an average price can be helpful. There are basically two kinds of
average prices that could be used: the mean price and the median price. The mean price is the
simple average of all prices shown for a drug; the values are added up and divided by the
number of values.
However, there is a problem when one or two prices are much higher or lower than the rest for
a certain drug. These “outliers” skew the mean and make it less representative. For example, in
a series of seven values such as $1, $2, $2, $3, $5, $16, $20, the total of all the values is $49, and
dividing by seven gives a mean value of $7. For comparison or estimation purposes, it is likely
that this average is too high, due to the two prices that are much higher than others in the series.
To avoid this risk, we use the median price.
The median price is a type of average; it is the value that splits a series of values in half when
the series is put in ascending order. This is likely to be a more valuable approach for estimating
actual future prices (or for comparing with local prices) when there is a skewed distribution.
If there is an odd number of values in the series, as in the example above, the median value is
the middle value in the series ($3 in the example). When there is an even number of values in a
series, such as the series $1, $3, $4, $6, $14, $20, the median is calculated by averaging the two
middle values. In this example, the median is the average of $4 and $6, which is $5. Again, this
is likely to be closer to reality for comparison or estimation than the arithmetic mean of $8 ($48
divided by 6).3
High/Low Ratio
The high/low ratio compares the highest unit price with the lowest unit price. For example, a
high/low ratio of 3 means that the highest unit price is three times greater than the lowest unit
price.
3
For further discussion, see Statistics without Tears—A Primer for Non-Mathematicians, by Derek Rowntree (New York: Charles
Scribner’s Sons, 1981), pp. 41–45.

List II - Products Sorted by Therapeutic
Category
For List II, the pharmaceuticals are listed in alphabetical order within each therapeutic class
based on the WHO Essential Medicines List classification system. For products not included on
the latest WHO EML (i.e., those products with an “N” in the “WHO EML” column in this
Guide), we have assigned a therapeutic class based on the WHO EML classification system.
This is done when a non-EML product clearly falls within an EML therapeutic category, as
determined by MSH staff.
This assignment does not reflect a decision by WHO Essential Drugs and Medicines Policy or
MSH staff that the non-EML product is appropriate for inclusion in the WHO Model List of
Essential Medicines. If an unambiguous assignment of an EML therapeutic category was not
possible, we placed the product in the category of “UA – Agents Unclassified in WHO EML.”
Items in a class cannot necessarily directly substitute for each other. All prices on this list are
unit prices. For each item in this list, the following data are shown:
Item Description
IC
scription.
Nomenclature
International nonproprietary names have been used for the list of drugs in this Guide. If
an INN has not been assigned, the most common generic name has been used. Drug
dosage forms listed are generally those included in the World Health Organization’s 19th
Model List of Essential Medicines (revised April 2015), found at http://www.who.int/
medicines.
Route of Administration
Routes of administration are coded as follows:
Item Type Code
Condoms COND
Diagnostic Strips and Tests and Lab Supplies DIAG
Ear Preparations OTIC
Eye Preparations OPHT
Injectable Medicines INJ
Intrauterine Device (IUD) IUD
Intravenous Solutions IV
Medicines for Inhalation INH

Medicines for Nasal and Throat Use N/T
Subcutaneous Medicines S/C
Sublingual Tablets SL
Suppositories/Enemas/Rectal Ointment RECT
Tablets/Capsules/Oral Liquids PO
Topical Medicines (liquids, powders, creams, ointments) TOP
Vaginal Preparations VAG
Not Applicable N/A
WHO EML
Guide:
P = On the WHO list, but in a different presentation (different dosage form and/or
strength)
Number of Suppliers/Buyers
The number of suppliers or buyers offering this product.
Median Price
When using the Guide for comparison with local prices, or for estimating the total value of a
proposed procurement list, an average price can be helpful. There are basically two kinds of
average prices that could be used: the mean price and the median price. The mean price is the
simple average of all prices shown for a drug; the values are added up and divided by the
number of values.
However, there is a problem when one or two prices are much higher or lower than the rest for
a certain drug. These “outliers” skew the mean and make it less representative. For example, in
a series of seven values such as $1, $2, $2, $3, $5, $16, $20, the total of all the values is $49, and
dividing by seven gives a mean value of $7. For comparison or estimation purposes, it is likely
that this average is too high, due to the two prices that are much higher than others in the series.
To avoid this risk, we use the median price.
The median price is a type of average; it is the value that splits a series of values in half when
the series is put in ascending order. This is likely to be a more valuable approach for estimating
actual future prices (or for comparing with local prices) when there is a skewed distribution.
If there is an odd number of values in the series, as in the example above, the median value is
the middle value in the series ($3 in the example). When there is an even number of values in a

series, such as the series $1, $3, $4, $6, $14, $20, the median is calculated by averaging the two
middle values. In this example, the median is the average of $4 and $6, which is $5. Again, this
is likely to be closer to reality for comparison or estimation than the arithmetic mean of $8 ($48
divided by 6).4
Highest Price
The highest price from listed suppliers and buyers.
Lowest Price
The lowest price from listed suppliers and buyers.
High/Low Ratio
The high/low ratio compares the highest unit price with the lowest unit price. For example, a
high/low ratio of 3 means that the highest unit price is three times greater than the lowest unit
price.
DDD
The DDD is the assumed average maintenance dose per day for a drug used for its main indica-
tion in adults. The defined daily dose is a unit of measurement and does not necessarily reflect
the recommended or prescribed daily dose. Doses for individual patients and patient groups
will often differ from the DDD and will necessarily be based on individual characteristics (e.g.,
age and weight) and pharmacokinetic considerations.
Drug consumption data presented in DDDs give only a rough estimate of consumption and not
an exact picture of actual use. DDDs provide a fixed unit of measurement independent of price
and formulation, enabling the researcher to assess trends in drug consumption and to perform
comparisons between population groups.
The defined daily doses are from the WHO Collaborating Centre for Drug Statistics Methodol-
ogy. They are illustrative defined daily doses, as recommended by the World Health
Organization’s Drug Utilization Research Group (DURG). Not all drugs listed in this price
comparison guide have defined daily doses assigned by this method. A DDD will only be
assigned for drugs that already have an ATC code.
The main use of the DDD is for estimating drug consumption, based on inventory/distribution
data. This estimate can be combined with price information for budgeting purposes.
Note: The defined daily dose should not be used for dosing or therapeutic determinations. Refer to
prescribing information for dosing schedules for specific indications.
4
For further discussion, see Statistics without Tears—A Primer for Non-Mathematicians, by Derek Rowntree (New
York: Charles Scribner’s Sons, 1981), pp. 41–45.

List III - Price Comparison Form
The purpose of this list is to help the user compare his or her prices with the prices in the Guide.
Only the median price is displayed here, and a shortened description of the item is used.
Item Description
IC
scription.
Nomenclature
International nonproprietary names have been used as the basis for the list of drugs in
this Guide. If an INN has not been assigned, the most common generic name has been
used. Drug dosage forms listed are generally those included in the World Health
Organization’s 19th Model List of Essential Medicines (revised April 2015), found at
WHO EML
Guide:
P = On the WHO list but in a different presentation (different dosage form and/or
strength)
Pack Size
The blank here is for the user to enter his or her purchase pack size.
Pack Price
This blank is for the user to enter the price for the purchase pack entered in the previous blank.

Unit Price
The user should calculate his or her unit price by dividing the pack price by the pack size. The
comparison units used in the Guide are listed for each item to help ensure that prices are being
compared on an equivalent basis.
Median Int. Supplier/Buyer Unit Price (US$)

The unit price is calculated by dividing the package price by the package size. This format
facilitates the price comparison of different vendor pack sizes. The unit used to compare prices
varies with the type of pharmaceutical preparation as follows:
Pharmaceutical Dosage Form Comparison Unit
Ampoule or Vial Milliliter (ML)
Cartridge Milliliter (ML)
Condom, Intrauterine Device (IUD), Net, Test Each (EACH)
Ear, Nose, and Throat Preparation Milliliter (ML)
Enema Milliliter (ML)
Gas Cubic Meter (CUBMETER)
Granules Gram (G)
Inhaler Dose (DOSE)
Oral Liquid Milliliter (ML)
Pack Pack (PACK)
Pessary Pessary (PESS)
Suppository Suppository (SUPP)
Syringe Syringe (SYRINGE)
Tablet or Capsule Tablet or Capsule (TAB-CAP)
Topical Liquid Milliliter (ML)
Topical Solid Gram (G)
Treatment Treatment (TREATMEN)
Vaccine Dose (DOSE)
Vial (single strength) Vial (VIAL)
The median price is a type of average; it is whatever value splits a series of values in half when
the series is put in ascending order. If there is an odd number of values in the series, the median
value is the middle value in the series. This is likely to be more valuable for estimating actual
future prices (or comparing with local prices), when there is a skewed distribution.
When there is an even number of values in a series, such as the series $1, $3, $4, $6, $14, $20, the
median is calculated by averaging the two middle values. In this example, the median is the
average of $4 and $6, which is $5. Again, this is likely to be closer to reality for comparison or
estimation than the arithmetic mean of $8 ($48 divided by 6).5
5
For further discussion, see Statistics without Tears—A Primer for Non-Mathematicians, by Derek Rowntree (New York: Charles
Scribner’s Sons, 1981), pp. 41–45.

How to Analyze and Compare Your Prices
Comparison of prices that you have paid with international prices is one of the most fundamen-
tal indicators for assessing procurement efficiency. Other key indicators of procurement effi-
ciency are the accuracy of needs estimation, timeliness of deliveries, and quality of products
procured.
With the assistance of this Guide, it is possible for procurement personnel to compare the prices
they pay with international reference prices (refer to the Price Comparison Form, SP-1 and BP-
1). The method below presents one approach to making such comparisons. You may wish to
visit the electronic version of the International Drug Price Indicator Guide in the Electronic
Resource Center at http://erc.msh.org/priceguide. It contains features to help you compare
your prices to those in the Guide and plan a budget or tender.
1. Make a list of products that you routinely procure in large volumes or that represent a high
percentage of the budget.
2. For each product, list the vendor pack size used and the most recent price for this vendor
pack size. Be sure to note whether the price is CIF (cost, insurance, and freight); FOB (free on
board: transportation as far as the port of departure); EXW (ex-works: no transportation
included); or another type of price. Prices may need to be adjusted so that they can be
compared accurately.
3. Choose one of the two price comparison forms included in the Guide, based on the type of
prices you are comparing. The buyer prices include shipping costs, and may be most appro-
priate if they represent a region of the world and tender value similar to yours. The supplier
prices are FOB and EXW and must be adjusted to reflect the usual shipping, handling, and
insurance charges for your situation.
4. On one of the price comparison forms, select the product in this Guide that corresponds
most closely to your product. If the prices you are using locally are CIF prices and you have
selected the buyer comparison form, no adjustment should be needed for either set of prices.
If the prices you are using locally are CIF prices and you have selected the supplier compari-
son form, we suggest that the prices on the supplier list be adjusted upward to reflect the
difference between CIF and EXW/FOB. When prices on this list are FOB or EXW, it is rea-
sonable to add 10% to the list price for freight and insurance, depending on the distance and
the mode of transport. Any standard percentage charged for handling has already been
added to the prices on this list.
When significant fluctuations in exchange rates occur, price adjustments must be made to
reflect these changes.
5. Once the pack prices have been adjusted to reflect freight, insurance, and other additional
costs, divide the pack price by the number of comparison units contained in the vendor pack
(for example, divide the pack price by 1,000 if that pack is a bottle of 1,000 tablets, or by 100
if the pack is a vial of 100 ml). Make sure that the comparison unit used is the same as the
comparison unit on the Guide list. The median international unit price is listed on both price
comparison forms for your convenience.
How to Analyze and Compare Your Prices E-33

Because packaging can add considerably to the cost of a product, caution is needed when
comparing unit prices between different packages. For example, the unit price with strip
packaging is usually much higher than the unit price for tablets packaged in a bottle of
1,000. Prices in the Guide do not cover specialty packaging, except where noted.
An analysis of this type includes many assumptions that affect its outcome. International price
comparisons identify extreme price differences, both high and low. An extremely high ratio
between locally available prices and the prices in this Guide may indicate that a less expensive
source is available. If the locally available prices are much lower than the prices in this Guide, it
might reflect effective procurement, but it could also be the result of a compromise of quality
control, differences in packaging, or other factors that might reduce product quality. These
comparisons are only indicators, and should be viewed as pointers for further investigation.

GUIA INTERNACIONAL DE INDICADORES DE
PRECIOS DE MEDICAMENTOS
Prólogo
La Guía Internacional de Indicadores de Precios de Medicamentos provee exactamente lo que
el nombre implica—una indicación de precios de medicamentos en el mercado internacional.
Management Sciences for Health publica esta Guía desde 1986, y en colaboración con la
Organización Mundial de la Salud (OMS) desde el 2000. La Guía proporciona una gama de
precios ofrecidos por proveedores de medicamentos sin fines de lucro y agencias de adquisición
comerciales, basándose en sus catálogos o listas de precios actuales. También contiene precios
obtenidos de agencias internacionales para el desarrollo y de agencias gubernamentales.
MSH, en colaboración con la OMS, está trabajando con sus asociados para que la información
sobre precios de medicamentos se divulgue más ampliamente con objeto de mejorar la
adquisición de medicamentos de calidad garantizada, al precio más bajo posible. Esto
contribuirá a un acceso equitativo a los servicios y productos de salud, incluyendo los
medicamentos esenciales necesarios para la prevención y el tratamiento de las enfermedades
prevalentes.
Debido a que el costo potencial de ofrecer una gama completa de tratamientos para
enfermedades comunes es alto, los precios y el financiamiento son factores ineludibles en la
determinación del acceso a medicinas esenciales. Pueden obtenerse precios más bajos mediante
compras de volumen, la competencia, negociaciones hábiles y una administración inteligente
de las existencias. La información comparativa de precios es importante para obtener el precio
más bajo. Esta información ayuda a negociar precios, a localizar nuevas fuentes de suministro y
a evaluar la eficiencia de los sistemas de adquisición locales.
La Guía Internacional de Indicadores de Precios de Medicamentos ayuda a los funcionarios
encargados del suministro de medicamentos a determinar el costo probable de los productos
farmacéuticos para sus programas. Se puede usar como una lista de referencia para comparar
los precios actuales con los disponibles en el mercado internacional; también se puede utilizar
para evaluar el posible impacto financiero de los cambios en las listas de medicamentos.
La base de datos sobre precios es mantenida por el Centro de Gestión Farmacéutica de Manage-
ment Sciences for Health, organización sin fines de lucro, como una contribución para poner los
medicamentos esenciales al alcance de todos los ciudadanos del mundo. Se puede copiar la
Guía libremente para fines educacionales en el servicio u otro uso caritativo.
Se puede obtener información adicional sobre los precios internacionales de los medicamentos
en la Web en:
en/index.html), página mantenida por la OMS. Incluye precios de servicios
internacionales para información sobre precios de materiales para comenzar, materias
primas y ciertos medicamentos relacionados con el VIH. Además, presenta información
de precios de medicamentos para enfermedades específicas y servicios informativos
sobre precios individuales por países.
Prólogo S-3
Favor de tomar nota que se puede encontrar una versión electrónica de la Guía Internacional
de Indicadores de Precios de Medicamentos en el Centro de Recursos Electrónicos de MSH en
http://erc.msh.org/priceguide.
Para obtener más información o para hacer comentarios o sugerencias sobre el formato del
contenido de esta publicación, póngase en contacto con nosotros en:
Teléfono: 1.703.524.6575 Avenue Appia 20
Fax: 1.703.524.7898 CH-1211 Geneva 27
Correo electrónico: cpm@msh.org Switzerland
Correo electrónico: forteg@who.int
S-4 Guía Internacional de Indicadores de Precios de Medicamentos 2014

Cómo Usar la Guía
La Guía comienza con una sección titulada “Información Que Usted Debe Saber”, que le
ayudará a entender mejor los datos presentados en ella. A esta le sigue una lista de los
proveedores y compradores mencionados en esta edición y incluye detalles sobre condiciones
de embarque y restricciones. También se dan las direcciones. Después, la Guía pasa a explicar el
formato de los informes sobre comparación de precios, como también los términos usados en
las listas de precios y los códigos y abreviaturas empleados.
En esta Guía se presentan datos sobre precios en tres formatos. Cada formato incluye los precios
del proveedor y del comprador. Los precios del comprador son generalmente los precios de una
agencia gubernamental a través de una licitación competitiva internacional.
• Lista I: Los medicamentos se clasifican en orden alfabético y por nombre genérico. Esta
lista incluye los detalles sobre precios por cada proveedor y comprador. Este formato
sirve para fines de referencia durante el proceso de adquisición, y permite hacer una
búsqueda rápida de cualquier medicamento.
• Lista II: Los medicamentos se clasifican en orden alfabético siguiendo el sistema de
clasificación de la Lista de Medicamentos Esenciales (LME) de la Organización Mundial
de la Salud. Este formato ayuda a crear formularios y permite hacer una comparación
conveniente de los medicamentos dentro de las distintas clases. Los productos en un
mismo grupo no implica que son directamente sustituibles entre ellos.
• Lista III: Los medicamentos se clasifican por orden alfabético, mostrándose solamente el
precio mediano por producto. El formato tiene por objeto facilitar la comparación de los
precios del usuario con los precios de la Guía. Los precios del proveedor y del comprador
están en listas separadas.
Si necesita información sobre cómo usar estos precios para fines comparativos, por favor vea la
sección de esta Guía titulada “Cómo Analizar y Comparar sus Precios.” Además, a modo de
referencia, en los Anexos se incluyen una lista de sinónimos y las categorías terapéuticas de la
OMS.
El propósito de esta Guía es servir únicamente como una referencia para fines comparativos; no
es apropiada para colocar pedidos de productos. Para hacer pedidos, es preciso ponerse en
contacto directamente con el proveedor. No hay garantías implícitas en la lista en cuanto a la
disponibilidad de los precios cotizados, la calidad de los productos o condiciones específicas de
ventas. La lista de proveedores no es una lista completa de todos los proveedores potenciales.
Los precios cotizados por los compradores se muestran para fines comparativos solamente.
Cómo Usar la Guía S-5

Información que Usted Debe Saber
Productos incluidos
La Guía Internacional de Indicadores de Precios de Medicamentos se enfoca principalmente en
medicamentos esenciales, pero incluye también otros productos. Los medicamentos de la lista
de Medicamentos Esenciales de la OMS están siempre incluidos, como también los
medicamentos y productos importantes para el tratamiento y prevención de la tuberculosis,
malaria y VIH/SIDA. Las vacunas, agentes inmunológicos, desinfectantes, líquidos y
electrolitos y pruebas y agentes diagnósticos, son también típicamente cubiertos.
Crecientemente, los medicamentos requeridos para el tratamiento del cáncer y enfermedades
crónicas, y la potencia y dosis de las formulaciones pediátricas, se han incluido en la base de
datos. Nuevos productos son agregados a la Guia cada año, dados los cambios en la
información que nos es reportada.
Conversión de precios
Los precios que figuran en la Guía Internacional de Indicadores de Precios de Medicamentos
están en orden ascendente conforme al precio unitario. Todos los precios obtenidos por las
organizaciones señaladas a continuación han sido convertidos a dólares estadounidenses. Los
tipos de cambio utilizados son los que regían el 1 de julio de 2014 (http://www.oanda.com).
Los demás precios del catálogo ya estaban originalmente en dólares estadounidenses, por lo
que no se convirtieron.
Moneda (Codigo de agencia) Tipo de cambio (a $EE.UU.)
Chelín de Kenia (MEDS) 0.0112
Chelín de Tanzania (MEDEOR/TZ, MEMS) 0.0006
Dólar de Namibia (NAMIBIA) 0.0942
Libra esterlina (DURBIN) 1.7126
Libra sudanesa (SUDANNHIF) 0.1746
Naira nigeriano (CHAI) 0.0061
Nuevo cedi de Ghana (CHAI) 0.3099
Nuevo sol de Perú (PERU) 0.3532
Pesos de la República Dominicana (DOMREP) 0.0228
Rand sudafricano (SAFRICA) 0.0942
Rupia india (CHAI) 0.0166
Las fluctuaciones en los tipos de cambio pueden hacer variar considerablemente los costos.
Siempre deberá usar el tipo de cambio más reciente cuando haga su análisis para calcular los
costos de los medicamentos.

Termos de precios
Los precios de proveedores y los precios de compradores que aparecen en esta Guía están
basados en condiciones de precio diferentes, y por consiguiente no deben compararse en
forma directa. Los Incoterms que siguen a continuación se usan para definir los tipos de
precios:
• CIF (costo, seguro y flete): incluye cargos por concepto de seguro y flete hasta el puerto de
destino (el transporte por agua solamente)
• CIP (transporte y seguro pagados): incluye costo de transporte y seguro al transportista en
el lugar convenido
• DDP (entregado derechos pagados): incluye la entrega, los derechos de introducción y los
costos de desembarque
• DDU (entregado derechos no pagados): incluye la entrega, pero no incluye los derechos de
introducción y los costos de desembarque
• EXW (en fábrica): no incluye costos de carga, seguro o flete
• FCA (franco transportista): el vendedor realiza todas las transacciones y paga el transporte
anticipadamente en el país de exportación
Algunos proveedores y agencias imponen un cargo estándar por manejo, además del costo
EXW o CIF. Los cargos por manejo indicados en las Fuentes de las Listas de Precios ya han sido
añadidos a los precios cotizados en esta Guía.
Cómo calcular los precios

Al calcular y proyectar los costos reales, es importante tener en cuenta factores tales como el
financiamiento, el tiempo de entrega, los tipos de transporte (aire/mar/tierra), y los cargos por
manejo. El análisis de estos factores queda fuera del alcance y la intención de esta Guía. No
obstante, para obtener un estimado, es razonable agregar del 10% por costos de embarque al
precio cotizado por los proveedores en esta Guía. Los precios del compradores (obtenidos en
licitaciones por las agencias de gobiernos) generalmente no requieren hacer ajustes por cargos de
embarque.
Garantía de calidad
Nosotros requerimos que todos los proveedores que figuran en la Guía Internacional de
Indicadores de Precios de Medicamentos llenen un cuestionario sobre garantía de calidad. El
propósito de llenar este cuestionario obligatorio es ayudar a asegurar que los precios cotizados
en esta Guía provengan de proveedores de reputación con procesos de garantía de calidad
debidamente instalados. Las 28 preguntas trata de asuntos como inspección, prueba, garantía
de calidad, concesión de licencias, retirada de productos del mercado, procedimientos de
control de calidad, estándares y documentación. Aunque este requisito brinda cierta garantía
en cuanto a los procesos de control de calidad, no necesariamente garantiza la calidad de los
productos ofrecidos. Se pueden obtener copias del cuestionario solicitándolas de Management
Sciences for Health.
Información Que Usted Debe Saber S-7

Las fuentes de los precios incluidas en la Guía han sido revisadas únicamente desde el punto
de vista de la integridad de los documentos proporcionados. Esta revisión de ningún modo
constituye un estudio a fondo de la calidad de los productos. Su inclusión en la Guía no
constituye una calificación previa o aprobación de ningún tipo por MSH y la OMS.
Calidad de los productos

Los proveedores y agencias seleccionados para esta Guía no son fabricantes, pero sí ofrecen
productos en relación con los cuales han indicado que cumplen con las normas internacionales
de calidad especificadas por organizaciones como la Farmacopea de los Estados Unidos (USP),
la Farmacopea Británica (BP) y la Farmacopea Europea (EP). Todos los proveedores declaran
que las fábricas con quienes se trabjan mantienen normas de alta calidad mediante la
incorporación en el sitio de sistemas de garantía de calidad con objeto de asegurar que todos
los productos cumplan con las Buenas Prácticas de Manufactura (GMP por sus siglas del
inglés) de la OMS y los reglamentos gubernamentales. Los certificados de calidad conforme al
Plan de Certificación de la OMS sobre la Calidad de los Productos Farmacéuticos que se
Mueven en el Comercio Internacional, se deben poder obtener solicitándolos de todos estos
proveedores. Los proveedores y las agencias que figuran en esta Guía mantienen sus propios
programas independientes de garantía de calidad. Comuníquese con ellos directamente para
obtener detalles al respecto.
Sistema ATC/DDD1
Los datos sobre la utilización de medicamentos desempeñan un papel muy importante en la
calidad del ciclo de atención y son esenciales para administrar la política relacionada con el
suministro, fijación de precios, costo y uso de los medicamentos. El sistema de clasificación
anatómica-terapéutica-química (ATC) y la unidad de medida técnica llamada la dosis diaria
definida (DDD) pueden proveer metodologías útiles para el seguimiento y la comparación de
las tendencias en el costo, pero se deben usar con cautela. Basar el reembolso detallado, la
fijación de precios de referencia de grupos terapéuticos y otras decisiones específicas sobre
precios en las clasificaciones asignadas por el sistema ATC/DDD, es una utilización errónea del
mismo.
El sistema ATC/DDD tiene por objeto servir de herramienta para investigar la utilización de
medicamentos a fin de mejorar la calidad del uso de esos medicamentos. Uno de sus
componentes es la presentación y comparación de las estadísticas sobre consumo de
medicamentos al nivel internacional y a otros niveles.
Una de las principales aspiraciones del Collaborating Centre for Drug Statistics Methodology y
Working Group de la OMS es mantener códigos de ATC y DDD estables con el transcurso del
tiempo a fin de poder estudiar las tendencias en el consumo de los medicamentos sin la
complicación de cambios frecuentes al sistema. Existe una renuencia muy grande a hacer
1
El texto de esta sección fue tomado del sitio del Collaborating Centre for Drug Statistics Methodology de la OMS en la Web
en http://www.whocc.no/atcddd/.

cambios a las clasificaciones o dosis diarias definidas cuando esos cambios son solicitados por
razones no relacionadas directamente con estudios del consumo de medicamentos. Por esta
razón, el sistema ATC/DDD por sí solo no es apto para basar decisiones sobre reembolso,
fijación de precios y sustituciones terapéuticas.
La clasificación de una sustancia en el sistema ATC/DDD no representa una recomendación

para su uso, ni tampoco ninguna determinación sobre la eficacia o eficacia relativa de los
medicamentos o grupos de medicamentos.
Información Que Usted Debe Saber S-9

S-10
Fuentes de las Listas de Precios
En la Guía se incluyen tres tipos primarios de proveedores y compradores.
1. Proveedores que mantienen un almacén y suministran productos directamente a los clientes. Todos estos proveedores ofrecen
una mayor variedad de productos que los mostrados en esta Guía. Para ver una lista completa de los productos, comuníquese
con el proveedor directamente. En la Guía se incluyen los proveedores siguientes:
Fecha da Cargo por Tipo de

Proveedor Código Detalles
la lista manejo precio
Los precios son válidos hasta que se publique una nueva lista de precios. Los costos
MEDEOR/ septiembre EXW de trasporte se cargan individualmente de acuerdo con los gastos. Embalaje especial:
Action Medeor 1%
EU 2014 Tönisvorst Euro 26 por caja. Action Medeor cobra una comisión por manejo mínimo de Euro
50. Abastece solamente al mercado sin fines de lucro.
Action Medeor International Healthcare es una agencia de compras sin fines de lucro,
fundada en 2004, que pertenece a Action Medeor. Abastece al mercado sin fines de
Action Medeor
MEDEOR/ septiembre lucro (principalmente Tanzania) y no abastece a individuos o a farmacias comerciales.
International 0% EXW
TZ 2014 Se aplica un 3,5% de recargo por servicios a todos los clientes que no son de
Healthare
Tanzania para cubrir cobros bancarios y pérdidas por cambio de moneda. No se
requieren cantidades mínimas.
EXW
Guía Internacional de Indicadores de Precios de Medicamentos 2014

AMSTEL- Lelystad, Los precios de Amstelfarma solo sirven como una indicación. No existen requisitos
Amstelfarma enero 2015 0%
FARM The mínimos para los pedidos ni cargos por concepto de servicios.
Netherlands
ASRAMES sólo sirve organizaciones en la República Democrática del Congo que han
agosto DDP o CIP
ASRAMES ASRAMES 0% sido reconocidos por el Ministerio de Salud como una institución de salud o como
2014 Kinshasa
una ONG que trabaja en el sector de la salud.
Durbin provee productos farmacéuticos e insumos médicos a médicos, farmacias,
EXW
hospitales, mayoristas y comerciantes farmacéuticos, agencias militares y
Durbin PLC DURBIN 2013-2014 0% United
gubernamentales, organismos caritativos, y otras organizaciones de socorro y
Kingdom
beneficencia a nivel mundial. Se requiere un pedido mínimo de RU £100.
Fecha da Cargo por Tipo de
Proveedor Código Detalles
la lista manejo precio
La Fundación IDA es una organización sin fines de lucro que apoya la atención
médica en los países de ingresos bajos e intermedios, mejorando el acceso y
suministrando medicamentos esenciales e insumos médicos de alta calidad. IDA es
noviembre FCA una fundación independiente y autosuficiente que distribuye más de 3.000 productos
IDA Foundation IDA 1,5%
2014 Amsterdam a más de 100 países alrededor del mundo. A los pedidos inferiores a los 5.000 euros
se les cobra un cargo de manipuleo de 3% y los pedidos de más a los 5.000 euros se
les cobra un cargo de manipuleo de 1,5%. Se requiere un pedido mínimo de 1500
Euros. Los precios son indicativos y pueden cambiar.
FCA
Lelystad,
IMRES IMRES enero 2015 0% La cantidad mínima de un pedido es de US$ 1250.
The
Netherlands
FCA
Medical Export noviembre Gorinchem, Los precios solo sirven como una indicación. No existen requisitos mínimos para los
MEG 0%
Group 2014 The pedidos ni cargos por concepto de servicios.
Netherlands
Los precios de venta de MSD son válidos para todas las instalaciones de salud
Medical Stores gubernamentales, aprobadas ONG, hospitales de misiones, hospitales de beneficencia
MSD/
Department, 2014-2015 0% EXW y otros proveedores de atención de salud en Tanzania, con la aprobación del
TANZ
Tanzania Ministerio de Salud y Bienestar Social. Empresas / organizaciones paraestatales
pagarán el 10% en la parte superior de estos precios de venta.
La Misión de Medicinas esenciales e insumos médicos (MEDS) provee productos
Mission for
farmacéuticos e insumos médicos a los trabajadores de salud asociados con las
Essential Drugs MEDS julio 2014 0% FOB Nairobi
agencias sin fines de lucro. Se añade costos del transporte a las entregas fuera del
and Supplies
Kenia.
Información del Contacto

S-11
2. Organizaciones para el desarrollo internacional que proporcionan productos básicos a los programas de países apoyados por
S-12
ellas y por otras organizaciones. Las organizaciones listadas en la Guía son:
Organización
para el Fecha da Cargo por Tipo de
Código Detalles
desarrollo la lista manejo precio
internacional
Los medicamentos se adquieren como donativos gratuitos, pero también se ofrecen para la
venta a gobiernos y organizaciones que desean valerse de la calidad, los precios y asistencia
técnica/apoyo para la gestión de medicamentos que se ofrece a través del Servicio Directo de
Adquisiciones GDF. El Servicio Mundial de Medicamentos Contra la Tuberculosis (GDF por
sus siglas en Ingles) efectúa pruebas independientes obligatorias de cada lote de medicamentos
que suministra, e inspecciones pre-embarque de cada orden que despacha para asegurar la más
El Servicio
alta calidad. Además del costo de los medicamentos, los costos del control de calidad son
Mundial de
pagados por el cliente (o por el GDF, en el caso de una donación).
Medicamentos
Contra la GDF 2014 0% EXW
El GDF utiliza agentes de compra para asegurar la entrega eficiente de los productos. Un cargo
Tuberculosis por los servicios de compra es agregado al costo de la orden, que incluye el costo de los
(Global TB medicamentos, el de control de calidad y el de transporte. GDF envía al país un equipo de
Drug Facility) expertos en tuberculosis y en gestión de medicamentos 4 meses después del arribo de los
medicamentos, para evaluar su uso y proporcionar la asistencia técnica que fuera requerida.
Esta asistencia técnica del GDF a los países no tiene ningún costo. La GDF es un mecanismo
para ampliar el acceso a, y la disponibilidad de, medicamentos de alta calidad contra la TB para
facilitar la ampliación mundial del tratamiento directamente observado, a corto plazo (DOTS),
la estrategia internacionalmente recomendada para el control de la tuberculosis.

El proyecto “Sistema de Gestión de la Cadena de Suministro” (SCMS por sus siglas en
ingles) distribuye medicamentos esenciales a programas de VIH/SIDA en todo el
EXW
mundo. El proyecto ayuda a fortalecer las cadenas de suministro existentes, o
(Centro
establece nuevas para asegurar que un sistema de gestión del suministro seguro,
regional de
Supply Chain confiable y sustentable, adquiera medicamentos y otros productos para personas con
distribución
Management octubre HIV/SIDA e infecciones relacionadas. SCMS ha sido fundado por el gobierno de los
SCMS 5% de SCMS o
System 2014 Estados Unidos como parte del Plan de Emergencia Presidencial para la Mitigación del
distribución
(proyecto) SIDA (PEPFAR por sus siglas en ingles). SCMS puede trabajar en cualquier lugar del
directa por
mundo, pero inicialmente se ha enfocado en los 15 países de PEPFAR. Además de
el
servir a cualquier proyecto o socio apoyado por PEPFAR, SCMS puede proveer a
proveedor)
proyectos apoyados por gobiernos nacionales y otros donantes, de acuerdo a
arreglos individuales.
Organización
para el Fecha da Cargo por Tipo de
Código Detalles
desarrollo la lista manejo precio
internacional
Fondo de El FNUAP celebra licitaciones anuales para la compra de productos para sus oficinas
Población de las en los países y en nombre de clientes externos en más de 168 países, principalmente
Naciones septiembre los que están en vías de desarrollo. El FNUAP solo abastece a gobiernos y
UNFPA 5% FOB organizaciones sin fines de lucro. El FNUAP cobra una comisión de administración
Unidas (UN 2014
Population del 5% a los compradores que no pertenecen al FNUAP. Hay un requisito mínimo de
Fund) compra de 5.000 dólares EE.UU. por artículo. Los precios son indicativos y pueden
cambiar

S-13
3. Los compradores (generalmente agencias del sector público) que adquieren productos básicos en licitaciones internacionales
S-14
libres. Estos son los precios reales obtenidos por las organizaciones listadas y se incluyen con fines de comparación solamente.
No se pueden colocar pedidos con ninguna de estas organizaciones.
Valor
Fecha Tipo
aprox. de la
Comprador Código de la de Detalles
licitación
lista precio
(USD)
The Public Procurement and Asset Disposal Board of Botswana

Botswana Public Procurement and BOTS- enero
N/D N/D regularmente realiza licitaciones internacionales y nacionales y
Asset Disposal Board WANA 2014
abiertas y cerradas.
La Caja Costarricense de Seguro Social celebra anualmente una

licitación internacional abierta y negocia contratos de
Caja Costarricense de Seguro Social CRSS 2014 DDU 126 millión
abastecimiento de medicamentos e insumos médicos para sus
propias instalaciones.
DDP, La Iniciativa de Acceso a la Salud Clinton contribuyó información

Clinton Health Access Initiative CHAI 2014 EXW, o N/D sobre los precios de varios socios que están trabajando juntos para
FOB ampliar el tratamiento para la diarrea.
La República Democrática del Congo Proyecto Integrado de Salud

Democratic Republic of Congo mayo
DRC/IHP FCA 3,8 millión (DRC/IHP) celebra anualmente una licitación internacional y
Integrated Health Program (IHP) 2014
cerrada.

República Dominicana Central de
La República Dominicana Central de Apoyo Logístico Programa de
Apoyo Logístico Programa de DOM- octubre
N/D 69 millión Medicamentos Esenciales celebra una licitación nacional y abierta
Medicamentos Esenciales REPUB 2014
para medicamentos e insumos médicos dos veces al año.
(PROMESE/CAL)
Después de celebrar un proceso abierto de precalifación seguido
Mission for Essential Medical Supplies julio por una licitación cerrada, MEMS ha concedido a un vendedor
MEMS N/D 0,3 millión
(MEMS), Tanzania 2014 primario un contrato cada año para la provisión de medicinas e
insumos médicos.
Valor
Fecha Tipo
aprox. de la
Comprador Código de la de Detalles
licitación
lista precio
(USD)
El Almacén Médico Central de Namibia celebra una licitación
agosto
Namibia Central Medical Stores NAMIBIA DDP 24 millión internacional y abierta cada dos años para productos farmacéuticos
2014
e insumos médicos y cada año para les antirretrovíricos.
1 marzo El Servicio de Abastecimiento Farmacéutico de la Organización de

Organisation of Eastern Caribbean 2014 - Estados del Caribe Oriental ofrece sus servicios únicamente a países
OECS/
States Pharmaceutical Procurement 31 CIF N/D miembros de la Organización de Estados del Caribe Oriental. Para
PPS
Service (OECS/PPS), St. Lucia agosto estos nueve países, OECS/PPS negocia contratos y compras a través
2015 de una licitación internacional cerrada cada 18 meses.
febrero y
El Ministerio de Salud del Perú celebra anualmente una licitación
Perú Ministerio de Salud PERU abril DDP 197 millión
nacional y abierta para productos farmacéuticos e insumos médicos.
2014
El Sistema de Integración Centroamericana (SICA) celebra
El Sistema de Integración agosto
SICA CIF 4,2 millión anualmente una licitación internacional y cerrada para un grupo de
Centroamericana (SICA) 2014
medicamentos seleccionados.
El Departmento de Salud de Sudáfrica celebra las licitaciónes
South Africa Department of Health SAFRICA 2014 DDP N/D nacionales y abiertos para productos farmacéuticos e insumos
médicos cada dos años.
El Fondo de Seguro Nacional de Salud de Sudán celebra anualmente
Sudan National Health Insurance SUDAN- junio
DDP 16,8 millión las licitaciónes nacionals y abiertas para productos farmacéuticos e
Fund NHIF 2014
insumos médicos.

S-15
Action Medeor
D-47918 Tönisvorst
GERMANY
Teléfono: 49.21.56.97.88.0
Fax: 49.21.56.97.88.88
Correo electrónico: info@medeor.org

D-47918 Tönisvorst
GERMANY
y
P.O. Box 72305
Dar es Salaam
TANZANIA
Teléfono: 49.21.56.97.88.0
Fax: 49.21.56.97.88.88
Correo electrónico: medeortz@bol.co.tz
Amstelfarma
Nijverheidsweg 37
2102LK Heemstede
THE NETHERLANDS
Teléfono: 31-23-5484040
Correo electrónico: sales@amstelfarma.com

ASRAMES (Association Régionale D’Approvisionnement en Médicaments Essentiels)
BP 183
Goma
DRC
Teléfono: 243.9.98.08.81.70
Correo electrónico: info@asrames.org

Gaborone
Private Bag 0058
BOTSWANA
Teléfono: 267 360 2000

Fax: 267 390 6822
Correo electrónico: sbpac@ppadb.co.bw
Caja Costarricense de Seguro Social–CCSS

Departamento de Farmacoterapia
Apartado 10105
San José 1000
COSTA RICA
Teléfono: 506.222.1878
Fax: 506.257.7004
Correo electrónico: farmaco@ccss.sa.cr

Boston, MA 02127
USA
Teléfono: 617.774.0110
Correo electrónico: info@clintonhealthaccess.org
Información del Contacto S-17

MSH
Commune de la Gombe
Kinshasa
Teléfono: 243.99.930.1015

Santo Domingo
DOMINICAN REPUBLIC
Teléfono: 809.518.1313
Correo electrónico: promesecal@promesecal.gov.do
Durbin PLC
180 Northolt Road
South Harrow
Middlesex
HA2 0LT
UNITED KINGDOM
Teléfono: 44.20.8660.2220
Fax: 44.20.8668.0751
Correo electrónico: cataloguesales@durbin.co.uk

20, avenue Appia
1211 Geneva, 27
SWITZERLAND
Teléfono: 41.22.791.3647
Fax: 41.22.791.4886
Correo electrónico: gdf@who.int
URL: http://www.globaldrugfacility.org o http://www.stoptb.org/GDF

IDA Foundation
P.O. Box 37098
1030 AB Amsterdam
THE NETHERLANDS
Teléfono: 31.20.40.33.051
Fax: 31.20.40.31.854
Correo electrónico: info@idafoundation.org
IMRES
P.O. Box 214
8200 AE Lelystad
THE NETHERLANDS
Teléfono: 31.320.296969
Fax: 31.320.296929
Correo electrónico: info@imres.nl

Papland 16
P.O. Box 598
4200 AN Gorinchem
THE NETHERLANDS
Teléfono: 31.183.356.100
Fax: 31.183.356.122
Correo electrónico: info@meg.nl

P.O. Box 9081
Dar es Salaam
TANZANIA
Telephone: 255.22.2860890
Fax: 255.22.2865814
E-mail: info@msd.or.tz

P.O. Box 10810
Arusha
TANZANIA
Teléfono: 255.27.250.9366
Fax: 255.27.254.4908
Correo electrónico: info@mems.or.tz

MEDS Centre
P.O. Box 78040-00507
KENYA
Teléfono: 254.020.3920.404
Fax: 254.020.3920.600
Correo electrónico: customerservice@meds.or.ke

P.O. Box 5552
Windhoek
NAMIBIA
Teléfono: 264.61.233151
Fax: 264.61.238746

OECS
Castries
Teléfono: 758.452.5895
Fax: 758.453.0227
Correo electrónico: pps@oecs.org

Perú Ministerio de Salud (MINSA)
Av. Salaverry 801
Jesús Maria
Lima
PERU
Teléfono: 51.14.315.6600
Correo electrónico: webmaster@minsa.gob.pe

Private Bag X828
Pretoria, 0001
SOUTH AFRICA
Teléfono: 27.12.312.0000
Fax: 27.12.326.4395

Baladya Street
P.O. Box: 13267
Khartoum
SUDAN
Teléfono: 249 1 837 47618

Fax: 249 1 837 47619
Correo electrónico: info@nhif.gov.sd

12th Floor
USA
Teléfono: 1.571.227.8600
Fax: 1.571.227.8601

Antiguo Cuscatlán
EL SALVADOR
Teléfono: 503.2248.8800
Fax: 503.2248.8899
Correo electrónico: info.sgsica@sica.int

Midtermolen 3
P.O. Box 2530
Copenhagen
DENMARK
Teléfono: 45.3546.7000
Fax: 45.3546.7018
Correo electrónico: accessrh@unfpa.org

Formato de las Listas de Precios
Los productos farmacéuticos se presentan en tres listas separadas con formatos y características
diferentes, aunque con ciertos elementos comunes a todas ellas.
• Lista I: Productos Clasificados por Orden Alfabético
• Lista II: Productos Clasificados por Categoría Terapéutica
• Lista III: Formularios para la Comparación de Precios
A continuación se presenta una descripción detallada de la información contenida en cada lista.
Formato de las Listas de Precios S-23

Lista I – Productos Clasificados por Orden
Alfabético
La Lista I tiene por objeto servir de referencia para la adquisición de medicamentos y los
incluye en orden alfabético de sus nombres genéricos para poder localizar rápidamente
cualquier medicamento. Esta lista muestra los tamaños de los paquetes disponibles de cada
fuente y su precio en dólares estadounidenses, incluyendo los cargos regulares por servicio
cuando corresponda.
Descripción del producto

La descripción del producto incluye el nombre genérico, su potencia, la forma de la dosificación
y la vía de administración. Si el producto emplea dos nombres comunes (por ejemplo, vitamina
C y ácido ascórbico), uno de ellos aparecerá entre paréntesis. Véase la Lista de Sinónimos en el
Anexo.
IC
Los productos regulados por el control internacional de narcóticos se identifican con las
siglas (IC) después de la descripción.
Nomenclatura
Se han utilizado la denominación común internacional (INN) como la lista de los
medicamentos incluidos en esta Guía. Si no se asigna un INN, entonces se emplea el
nombre genérico más común. Las formas de dosificación de medicamentos indicadas
suelen ser las que figuran en la 19a Lista Modelo de Medicamentos Esenciales de la
Organización Mundial de la Salud (OMS) (revisada en abril de 2015), y que se puede ver
en http://www.who.int/medicines.
Vía de administración
Las vías de administración se codifican en la forma siguiente:
Tipo de producto Código
Condones COND
Dispositivo intrauterino (DIU) IUD
Medicinas de uso local (líquidos, polvos,
cremas, ungüentos) TOP
Medicinas inyectables INJ
Medicinas para inhalación INH
Medicinas por uso nasal y de la garganta N/T
Medicinas subcutáneas S/C
Preparaciones vaginales VAG
Preparaciones para los ojos OPHT
Preparaciones para los oídos OTIC
Soluciones intravenosas IV
Supositorios/enemas/ungüentos rectales RECT
Tabletas/cápsulas/líquidos de vía oral PO

Tabletas sublinguales SL
Tiras diagnósticas DIAG
No aplicable N/A
Fuente
La lista de fuentes de precios puede verse en la página S-9.
Paquetes
Los proveedores y compradores proporcionan los tamaños de los paquetes.
Precio de los paquetes ($EE.UU.)

Los precios de los paquetes los proporcionan los proveedores y compradores y han sido
convertidos a dólares estadounidenses a los tipos de cambio señalados en la página S-6, con
objeto de facilitar las comparaciones. Si un proveedor cobra un porcentaje como cargo estándar
por manejo, ese porcentaje ha sido añadido al precio de lista del paquete.
Precio unitario ($EE.UU.)

El precio unitario se calcula dividiendo el precio del paquete entre el número de unidades que
contiene. De esta forma se facilita comparar los precios de los paquetes de diferentes
vendedores. La unidad usada para comparar precios varía con el tipo de preparación
farmacéutica, tal como sigue:
Forma de dosificación farmacéutica Unidad de comparación (Código)

Ampolleta o frasco (mililitros) Mililitro (ML)
Cartucho Mililitro (ML)
Condón, DIU (dispositivo intrauterino),
prueba, red Cada (EACH)
Enema Mililitro (ML)
Frasco (potencia única) Frasco (VIAL)
Gas Metro cúbico (CUBMETER)
Granules Gramme (G)
Inhalador Dosis (DOSE)
Jeringa Jeringa (SYRINGE)
Líquido de uso local Mililitro (ML)
Paquete Paquete (PACK)
Pesario Pesario (PESS)
Preparaciones para los oídos, la nariz
y la garganta Mililitro (ML)
Sólido de uso local Gramme (G)
Supositorio Supositorio (SUPP)
2
Suspensión o líquido oral Mililitro (ML)
Tableta/cápsula Tableta/cápsula (TAB-CAP)
Tratamiento Tratamiento (TREATMEN)
Vacuna Dosis (DOSE)

Dosis diaria definida
La dosis diaria definida (DDD) es la dosis de mantenimiento promedio supuesta por día para
un medicamento utilizado para su indicación principal en adultos. Cabe señalar que la dosis
diaria definida es una unidad de medida y no necesariamente refleja la dosis diaria
recomendada o recetada. Las dosis para pacientes individuales y grupos de pacientes con
frecuencia diferirán de la DDD y necesariamente basarse en características individuales (por
ejemplo, edad y peso) y consideraciones farmacocinéticas.
Los datos sobre el consumo de medicamentos presentados en las DDD ofrecen solamente una
estimación aproximada del consumo y no dan una idea exacta del uso real. Las DDD
proporcionan una unidad fija de medida independiente del precio y la formulación, que le
permite al investigador determinar las tendencias en el consumo de medicamentos y hacer
comparaciones entre los distintos grupos de población.
Las dosis diarias definidas fueron tomadas del Collaborating Centre for Drug Statistics Method-
ology de la OMS. Ellas ilustran las DDD recomendadas por el Grupo de Investigación sobre la
Utilización de Medicamentos (DURG) de la Organización Mundial de la Salud. No todos los
medicamentos listados en esta guía de comparación de precios tienen dosis diarias definidas
asignadas por este método. La DDD solo se asigna a los medicamentos que ya tienen un código
de clasificación anatómica-terapéutica-química (ATC).
La DDD se usa principalmente para hacer un cálculo estimado del consumo de los
medicamentos, basado en datos de inventario y distribución. Esta estimación se puede
combinar con la información sobre precios para fines de presupuestación.
Nota: La dosis diaria definida no se debe usar para determinar dosificación o terapias. Véase la
información sobre recetas para los esquemas de dosificación para indicaciones específicas.
WHO LME
La columna “WHO EML” indica si el producto está incluido en la Lista Modelo OMS de
Medicamentos Esenciales de 2015. Identificamos cinco categorías en la Guía Internacional de
Indicadores de Precios de Medicamentos:
E = En la lista básica de la OMS, en la misma forma y potencia de dosificación
C = En la lista complementaria de la OMS, en la misma forma y potencia de
dosificación
P = En la lista de la OMS, pero en una presentación diferente (forma y/o potencia
de dosificación diferente)
T = No está en la lista de la OMS, pero puede ser una alternativa para un producto
listado como un ejemplo de grupo terapéutico
N = No está en la lista modelo de la OMS
Código ATC
El código ATC es el código de clasificación anatómica-terapéutica-química asignado por el
Collaborating Centre for Drug Statistics Methodology de la OMS. El sistema ATC/DDD es una

herramienta usada para investigar la utilización de los medicamentos con objeto de mejorar la
calidad en el uso de los mismos. Un componente de esto es la presentación y comparación de
estadísticas sobre consumo de medicamentos al nivel internacional y a otros niveles.
En el sistema de clasificación ATC, los medicamentos se dividen en grupos diferentes conforme
al órgano o sistema sobre el cual actúan, y a sus propiedades químicas, farmacológicas, y
terapéuticas. Los medicamentos se clasifican en grupos a cinco niveles diferentes. También se
dividen en 14 grupos principales (1r. nivel), con un subgrupo farmacológico/terapéutico (2do.
nivel). Los niveles 3ro. y 4to. son subgrupos químicos/farmacológicos/terapéuticos, y el 5to.
nivel es la sustancia química.2
Precio mediano
Cuando se use la Guía para hacer comparaciones con precios locales, o para calcular el valor
total de una lista de adquisición, un precio promedio puede ser útil. Básicamente hay dos clases
de precios promedio que podrían usarse—el precio medio y el precio mediano. El precio medio
es el promedio simple de todos los precios mostrados para un medicamento; los valores se
suman y luego se dividen entre la cantidad de valores.
Sin embargo, surge un problema cuando uno o dos precios son mucho más altos o más bajos
que los demás en un medicamento determinado. Estos “valores extremos” producen una
desviación en el valor medio y lo hacen menos representativo. Por ejemplo, en una serie de siete
valores, tales como $1, $2, $2, $3, $5, $16 y $20, todos los valores suman $49, y dividiendo este
número entre siete se obtiene un valor medio de $7. Para fines de comparación o de estimados,
es probable que este promedio sea demasiado alto debido a los dos precios mucho más altos
que los demás de la serie. Para evitar este riesgo, usamos el precio mediano.
El precio mediano es un tipo de promedio; es el valor que divida una serie de valores a la mitad
cuando la serie se pone en orden ascendente. Esto probablemente sea un método más útil para
estimar los precios futuros reales (o para hacer comparaciones con precios locales) cuando
exista una distribución sesgada.
Si hay un número impar de valores en la serie, como el ejemplo anterior, el valor mediano es el
valor del medio en la serie ($3 en el ejemplo anterior). Cuando una serie contiene un número
par de valores, como en la serie $1, $3, $4, $6, $14 y $20, el precio mediano se calcula
promediando los dos valores del medio. En este ejemplo, el precio mediano es el promedio de
$4 y $6, o sea, $5. Nuevamente, es probable que esto se aproxime más a la realidad para la
comparación o estimación, que la media aritmética de $8 ($48 dividido entre 6).3
Proporción máxima/mínima
La proporción máxima/mínima (high/low) compara el precio unitario más alto con el precio
unitario más bajo. Por ejemplo, una proporción máxima/mínima de tres significa que el precio
unitario más alto es tres veces mayor que el precio unitario más bajo.
2
Tomado del sitio del Collaborating Centre for Drug Statistics Methodology de la OMS en la Web en http://www.whocc.no/
atcddd/.
3
Para ver más discusiones sobre el tema, ver Statistics without Tears—A Primer for Non-Mathematicians, por Derek
Rowntree (Nueva York: Charles Scribner’s Sons, 1981), pp. 41–45.

Lista II – Productos Clasificados por
Categoría Terapéutica
En Lista II, los medicamentos se muestran en orden alfabético dentro de cada clase terapéutica
partiendo del sistema de clasificación de la Lista de Medicamentos Esenciales de la
Organización Mundial de la Salud. Para los productos no incluidos en la LME más reciente de
la OMS (es decir, los identificados con una “N” en la columna “LME de la OMS” en esta Guía),
hemos asignado una clase terapéutica basada en el sistema de clasificación utilizada por la LME
de la OMS. Esta clase se utiliza cuando, de acuerdo con una determinación hecha por el per-
sonal de MSH, un producto no incluido en la LME corresponde claramente a una categoría
terapéutica de la LME.
Esta asignación no refleja una decisión del Departamento de Medicinas Esenciales y Política
Farmacéutica de la OMS, ni del personal de MSH, de que el producto no incluido en la LME
pueda incluirse en la Lista de Medicinas Esenciales de la OMS. Si no es posible hacer una
asignación inequívoca de una categoría terapéutica de la LME, clasificamos el producto en la
categoría “UA– Agentes No Clasificados en la LME de la OMS”.
Los productos en un mismo grupo no implica que son directamente sustituibles entre ellos.
Todos los precios que figuran en esta lista son unitarios. Por cada producto de la lista se
muestran los datos siguientes:

La descripción del producto incluye el nombre genérico, su potencia, forma de dosificación y la
vía de administración. Si el producto emplea dos nombres comunes (por ejemplo, vitamina C y
ácido ascórbico), uno de ellos aparecerá entre paréntesis. Véase la Lista de Sinónimos en el
Anexo.
IC
Los productos regulados por el control internacional de narcóticos se identifican con las
siglas (IC) después de la descripción.
Nomenclatura
Se han utilizado las denominaciones comunes internacionales (INN) como la lista de los
nombre genérico más común. Las formas de dosificación de los medicamentos indicadas
generalmente son las que figuran en la 19a. Lista Modelo OMS de Medicamentos
Esenciales (revisada en abril de 2015), y que se puede ver en http://www.who.int/
medicines.
Vía de administración
Las vías de administración se codifican en la forma siguiente:
Tipo de producto Código
Condones COND
Dispositivo intrauterino (DIU) IUD

Medicinas de uso local (líquidos, polvos,
cremas, ungüentos) TOP
Medicinas inyectables INJ
Medicinas para inhalación INH
Medicinas por uso nasal y de la garganta N/T
Medicinas subcutáneas S/C
Preparaciones vaginales VAG
Preparaciones para los ojos OPHT
Preparaciones para los oídos OTIC
Soluciones intravenosas IV
Supositorios/enemas/ungüentos rectales RECT
Tabletas/cápsulas/líquidos de vía oral PO
Tabletas sublinguales SL
Tiras y pruebas diagnósticas DIAG
No aplicable N/A
WHO LME
dosificación
Número de proveedores/compradores
El número de proveedores o compradores que ofrecen este producto.
Precio mediano
Cuando se use la Guía para hacer comparaciones con precios locales, o para calcular el valor
total de una lista de adquisición, un precio promedio puede ser útil. Básicamente hay dos clases
de precios promedio que podrían usarse—el precio medio y el precio mediano. El precio medio
es el promedio simple de todos los precios mostrados para un medicamento; los valores se
suman y luego se dividen entre el número de valores.
Sin embargo, surge un problema cuando uno o dos precios son mucho más altos o más bajos
que los demás en un medicamento determinado. Estos “valores extremos” producen una
desviación en el valor medio y lo hacen menos representativo. Por ejemplo, en una serie de
siete valores, tales como $1, $2, $2, $3, $5, $16 y $20, todos los valores suman $49, y dividiendo este

número entre siete se obtiene un valor medio de $7. Para fines de comparación o de estimados,
es probable que este promedio sea demasiado alto debido a los dos precios que son mucho más
altos que los demás en la serie. Para evitar este riesgo, usamos el precio mediano.
El precio mediano es un tipo de promedio; es cualquier valor que divide una serie de valores a
la mitad cuando la serie se pone en orden ascendente. Esto probablemente sea un método más
útil para estimar los precios futuros reales (o para hacer comparaciones con precios locales)
cuando exista una distribución sesgada.
Si hay un número impar de valores en la serie, como el ejemplo anterior, el valor mediano es el
valor del medio en la serie ($3 en el ejemplo anterior). Cuando una serie contiene un número
par de valores, como en la serie $1, $3, $4, $6, $14 y $20, el precio mediano se calcula
Precio más alto

El precio más alto de los proveedores y compradores de la lista.
Precio más bajo

El precio más bajo de los proveedores y compradores de la lista.
Proporción máxima/mínima
La proporción máxima/mínima (high/low) compara el precio unitario más alto con el precio
unitario más bajo. Por ejemplo, una proporción máxima/mínima de tres significa que el precio
unitario más alto es tres veces mayor que el precio unitario más bajo.
Dosis diaria definida (DDD)

La dosis diaria definida es la dosis de mantenimiento promedio supuesta por día para un
medicamento utilizado para su indicación principal en adultos.
Cabe señalar que la dosis diaria definida es una unidad de medida y no necesariamente refleja
la dosis diaria recomendada o recetada. Las dosis para pacientes individuales y grupos de
pacientes con frecuencia diferirán de la DDD y necesariamente basarse en características
individuales (por ejemplo, edad y peso) y consideraciones farmacocinéticas.
Los datos sobre el consumo de medicamentos presentados en las DDD ofrecen solamente una
estimación aproximada del consumo y no dan una idea exacta del uso real. Las DDD
proporcionan una unidad fija de medida independiente del precio y la formulación, que le
permite al investigador determinar las tendencias en el consumo de medicamentos y hacer
4
Para ver más discusiones sobre el tema, ver Statistics without Tears—A Primer for Non-Mathematicians, por Derek Rowntree
(Nueva York: Charles Scribner´s Sons, 1981), pp. 41–45.

comparaciones entre los distintos grupos de población.
Las dosis diarias definidas fueron tomadas del Collaborating Centre for Drug Statistics Meth-
odology de la OMS. Ellas ilustran las DDD recomendadas por el Grupo de Investigación sobre
la Utilización de Medicamentos (DURG) de la Organización Mundial de la Salud. No todos los
medicamentos listados en esta guía de comparación de precios tienen dosis diarias definidas
asignadas por este método. La DDD solo se asignará a los medicamentos que ya tienen un
código de ATC.
El uso principal de la DDD es para hacer un cálculo estimado del consumo de los medicamen-
tos, basado en datos de inventario y distribución. Esta estimación se puede combinar con la
información sobre precios para fines de presupuestación.
Nota: La dosis diaria definida no se debe usar para determinar dosificaciones o terapias. Véase la
información sobre recetas para los esquemas de dosificación para indicaciones específicas.

Lista III – Formulario para la Comparación
de Precios
El propósito de esta lista es ayudar al usuario a comparar sus precios con los de la Guía. En ella
solo se muestra el precio mediano, y se emplea una descripción abreviada del producto.

La descripción del producto incluye el nombre genérico, su potencia, forma de dosificación y la
vía de administración. Si el producto emplea dos nombres comunes (por ejemplo, vitamina C y
ácido ascórbico), uno de ellos aparecerá entre paréntesis. Véase la Lista de Sinónimos en el
Anexo.
IC
Los productos regulados por el Control Internacional de Narcóticos se identifican con
las siglas (IC) después de la descripción.
Nomenclatura
Se han utilizado las denominaciones comunes internacionales (INN) como la lista de los
nombre genérico más común. Las formas de dosificación de medicamentos indicadas
suelen ser las que figuran en la 19a. Lista Modelo de Medicinas Esenciales de la
Organización Mundial de la Salud (revisada en abril de 2015), y que se puede ver en
WHO LME
dosificación

Tamaño del paquete
Este espacio en blanco es para que el usuario apunte el tamaño del paquete que está
comprando.
Precio del paquete

Este espacio en blanco es para que el usuario apunte el precio del paquete comprado que anotó
en el espacio en blanco anterior.
Precio unitario
El usuario debe calcular su precio unitario dividiendo el precio del paquete entre el número de
unidades que contiene el paquete. Se indican las unidades de comparación empleadas en la
Guía para cada producto con objeto de asegurar que los precios se comparen sobre una base
equivalente.
Precio unitario mediano de un proveedor o comprador ($EE.UU.)

El precio unitario se calcula dividiendo el precio del paquete entre el número de unidades que
contiene el paquete. La unidad utilizada para comparar los precios varía según el tipo de
preparación farmacéutica, como sigue:
Forma de dosificación Unidad de comparación
farmacéutica (Código)
Ampolleta o frasco (mililitros) Mililitro (ML)
Cartucho Mililitro (ML)
Condón, DIU (dispositivo intrauterino),
prueba, o red Cada (EACH)
Enema Mililitro (ML)
Frasco (potencia única) Frasco (VIAL)
Gas Metro cúbico (CUBMETER)
Granules Gramme (G)
Inhalador Dosis (DOSE)
Jeringa Jeringa (SYRINGE)
Líquido de uso local Mililitro (ML)
Paquete Paquete (PACK)
Pesario Pesario (PESS)
Preparaciones para los oídos, la nariz
y la garganta Mililitro (ML)
Sólido de uso local Gramme (G)
Supositorio Supositorio (SUPP)
Suspensión o líquido oral Mililitro (ML)
Tableta/cápsula Tableta/cápsula (TAB-CAP)
Tratamiento Tratamiento (TREATMEN)
Vacuna Dosis (DOSE)

El precio mediano es un tipo de promedio; es el valor que divide una serie de valores a la mitad
cuando la serie se pone en orden ascendente. Es probable que esto sea más valioso para
calcular los precios futuros (o comparar con precios locales), cuando existe una distribución
sesgada.
Si hay un número impar de valores en la serie, como $1, $2, $2, $3, $5, $16 y $20, el valor
mediano es el valor del medio en la serie ($3 en el ejemplo). Cuando una serie contiene un
número par de valores, como en la serie $1, $3, $4, $6, $14 y $20, el precio mediano se calcula
5
Para ver más discusiones sobre el tema, ver Statistics without Tears—A Primer for Non-Mathematicians, por Derek Rowntree
(Nueva York: Charles Scribner´s Sons, 1981), pp. 41–45.

Cómo Analizar y Comparar sus Precios
La comparación de los precios que usted ha pagado con los precios internacionales es uno de
los indicadores más fundamentales para evaluar la eficiencia de la adquisición. Otros
indicadores clave de la eficiencia de la adquisición son la precisión del estimado de
necesidades, la puntualidad de las entregas y la calidad de los productos adquiridos.
Con la ayuda de esta Guía, los funcionarios de las oficinas de adquisiciones pueden comparar
los precios que pagan con los precios internacionales de referencia (vea el Formulario de
Comparación de Precios, SP-1 y BP-1). La metodología que se describe a continuación presenta
una manera de hacer esas comparaciones. Usted tal vez desee visitar la versión electrónica de la
Guía Internacional de Indicadores de Precios de Medicamentos en el Centro de Recursos Electrónicos
en http://erc.msh.org/priceguide. Éste contiene sugerencias que le ayudarán a comparar sus
precios con los de la Guía y a planificar un presupuesto o licitación.
1. Haga una lista de los productos que compra rutinariamente en grandes cantidades, o que
representan un gran porcentaje del presupuesto.
2. Por cada producto, anote el tamaño del paquete de venta utilizado y el precio más reciente
de este tamaño de paquete. Asegúrese de ver si el precio es CIF (costo, seguro y flete); FOB
(franco a bordo, transporte hasta el puerto de salida); EXW (franco en almacén, sin
transporte), u otro tipo de precio. Los precios pueden requerir ajustes para que se puedan
comparar con exactitud.
3. Dependiendo del tipo de precios que usted esté comparando, seleccione uno de los dos
formularios de comparación de precios incluidos en la Guía. Los precios de compradores
incluyen costos de transporte y posiblemente sean más apropiados si representan una
región del mundo y valor de licitación similar a la suya. Los precios del proveedor son FOB
y EXW, y se deben ajustar para que reflejen los cargos acostumbrados por embarque,
manejo, y seguro apropiados a su situación.
4. En uno de los formularios para la comparación de precios, seleccione el producto en esta
Guía que corresponda más estrechamente a su producto. Si los precios que está usando
localmente son CIF y ha seleccionado el formulario de comparación de comprador, no será
necesario hacer ajustes en ninguno de los dos grupos de precios.
Si los precios que está usando localmente son CIF y ha seleccionado la lista de comparación
de proveedores, sugerimos ajustar hacia arriba los precios proporcionados en la lista de
proveedores a fin de reflejar la diferencia entre los precios CIF y EXW/FOB. Cuando los
precios de esta lista sean FOB o EXW, es razonable agregar del 10% al precio de lista en
concepto de flete y seguro, dependiendo de la distancia y el modo de transporte. A los
precios de esta lista ya se han agregado los porcentajes usuales cobrados por manejo.
Cuando ocurran fluctuaciones considerables en los tipos cambiarios, se deben ajustar los
precios para que reflejen esos cambios.
5. Una vez que se hayan ajustado los precios de los paquetes para reflejar los costos de flete,
seguro y otros costos adicionales, divida el precio del paquete entre el número de unidades
Cómo Analizar y Comparar sus Precios S-35

de comparación contenidas en el paquete de venta (por ejemplo, divida el precio del
paquete entre 1000 si el paquete es una botella de 1000 tabletas, o entre 100 si es un frasco de
100 ml). Asegúrese que la unidad de comparación utilizada sea la misma que viene en la
lista de la Guía. Para su conveniencia, el precio unitario mediano internacional aparece en
los dos formularios de comparación de precios.
Debido a que el empaque puede aumentar considerablemente los costos de un producto, es
preciso tener cuidado al comparar los precios unitarios entre paquetes diferentes. Por
ejemplo, el precio unitario de empaques en tiras suele ser más alto que el precio unitario de
tabletas empacadas en una botella de 1000. Los precios de la Guía no cubren empaques
especiales, excepto cuando se indique.
Un análisis de este tipo incluye muchas hipótesis que afectan a su resultado. Las comparaciones
de precios internacionales identifican diferencias extremas en los precios, tanto altas como
bajas. Una proporción extremadamente alta entre los precios disponibles localmente y los
mostrados en esta Guía, puede indicar que hay disponible una fuente menos costosa. Si los
precios disponibles localmente son mucho más bajos que los de esta Guía, ello podría reflejar
una adquisición eficaz, pero también pudiera ser el resultado de un comprometimiento entre el
control de calidad, las diferencias en empaques u otros factores que pudieran reducir la calidad
del producto. Estas comparaciones solamente son indicadores y debieran considerarse como
sugerencias para investigar más exhaustivas.

INDICATEUR DE PRIX INTERNATIONAUX
DES MEDICAMENTS
Préface
L’Indicateur de Prix Internationaux des Médicaments est bien ce qu’indique le nom—une
indication des prix des médicaments sur le marché international. Ce Guide est publié par
Management Sciences for Health depuis 1986 et en collaboration avec l’Organisation mondiale
de la Santé depuis 2000. Il fournit une gamme de prix des fournisseurs de médicaments à but
non lucratif et des agences internationales d’approvisionnement, en fonction de leurs listes de
prix ou catalogues actuels. Il comprend également des prix obtenus auprès d’agences de
développement international et d’organismes publics.
MSH, conjointement avec l’OMS, collabore avec d’autres partenaires afin de rendre
l’information existante sur les prix des médicaments plus disponibles et améliorer ainsi l’achat
de médicaments de qualité garantis au prix le plus faible possible. Cela permettra un accès
équitable aux services et produits de santé, dont les médicaments essentiels nécessaires, pour la
prévention et le traitement de maladies courantes.
Comme le coût potentiel d'offrir toute la gamme des traitements pour des maladies courantes
est élevé, les prix et le financement sont des facteurs inévitables pour déterminer les possibilités
d'accéder aux médicaments essentiels. Des prix plus faibles peuvent être obtenus grâce à des
achats en gros, à la concurrence, aux négociations judicieuses et à une bonne gestion de
l’approvisionnement. Une information comparative sur les prix est importante pour obtenir le
meilleur prix. En effet, une telle information aide lors des négociations de prix pour trouver de
nouvelles sources d’approvisionnement et pour évaluer l’efficacité des systèmes locaux
d’approvisionnement.
L’Indicateur de Prix Internationaux des Médicaments aide les responsables de l’approvisionnement
à déterminer le coût probable des produits pharmaceutiques pour leurs programmes. Il peut
être utilisé comme une liste de référence afin de comparer les prix versés et les prix pour des
produits disponibles sur le marché international. Il peut également être utilisé pour évaluer les
effets financiers possibles liés aux changements dans une liste de médicaments.
La base de données sur les prix est maintenue à jour par le Centre pour la Gestion des
Médicaments de Management Sciences for Health, organisation à but non lucratif, dans le but
de rendre les médicaments essentiels disponibles pour ceux qui en ont besoin dans le monde
entier. Le Guide peut être reproduite gratuitement pour des formations en cours d’emploi ou
autre utilisation à but non lucratif.
Des informations supplémentaires sur les prix internationaux des médicaments peuvent être
trouvées sur le web aux adresses suivantes:
en/index.html), page administrée par l’OMS. Elle comprend des prix de services
internationaux d’information sur les prix pour les matières premières, les produits finis
et certains médicaments choisis liés au VIH. En outre, elle notifie les prix pour des
maladies données et de services d’information sur les prix de pays donnés.
Préface F-3
Prière de noter qu’une version électronique de l’Indicateur de Prix Internationaux des
Médicaments est donnée au Centre de Ressources Electroniques de MSH à http://
erc.msh.org/priceguide.
Pour de plus amples informations ou pour faire des commentaires ou suggestions sur la
présentation ou le contenu de la présente publication, prière de nous contacter à l’adresse
suivante:
Téléphone: 1.703.524.6575 Avenue Appia 20
Fax: 1.703.524.7898 CH-1211 Geneva 27
Courrier électronique: cpm@msh.org Switzerland
Courrier électronique: forteg@who.int
F-4 Indicateur de Prix Internationaux des Médicaments 2014

Comment Utiliser le Guide
Le Guide commence par la section « Information que Vous Devriez Connaître » afin de mieux
comprendre les données présentées ici. Une liste de fournisseurs et d’acheteurs compris dans la
présente édition est donnée par la suite et inclut les détails sur les modalités d’expédition et les
restrictions sont indiqués ici. Les adresses sont donnée aussi. Puis, le Guide explique le format
des rapports sur la comparaison des prix, ainsi que les termes utilisés dans les listes de prix
ainsi que les codes et les abréviations.
Les données relatives aux prix sont fournies sous trois formats dans ce Guide. Chaque
présentation comprend des prix des fournisseurs et des prix des acheteurs. Les prix de
l’acheteur sont généralement les prix des appels d’offres internationaux lancés par les
organismes publics.
• Liste I: Les médicaments sont en ordre alphabétique, par nom générique et la liste
comprend les détails sur les prix pour chaque vendeur et acheteur. Ce format facilite les
références pour les achats/approvisionnements et permet une recherche rapide pour un
médicament donné.
• Liste II: Les médicaments sont en ordre alphabétique au sein du système de classification
de l’Organisation mondial de la Santé des Listes de Médicaments essentiels. Ce format
peut aider, par exemple, à mettre au point des formulaires et permet une comparaison
facile des médicaments dans les différentes classes. Les articles d'une classe
thérapeutique ne peuvent pas nécessairement se substituer l'un l'autre directement.
• Liste III: Les médicaments sont en ordre alphabétique avec seulement le prix médian
pour chaque produit présenté. Ce format est destiné à faciliter la comparaison des prix
d’un utilisateur avec les prix du Guide. Les prix des fournisseurs et les prix des acheteurs
figurent sur des listes séparées.
Pour toute information sur la manière d’utiliser ces prix à des fins de comparaison, prière de se
référer à la section intitulée « Comment Analyser et Comparer vos Prix ». Une liste de
synonymes et les catégories de classe thérapeutique de l’OMS sont incluses dans les Annexes
aux fins de référence.
Ce Guide vise uniquement à être un ouvrage de référence comparative. Il ne convient pas à la
commande effective de produits. Pour passer des commandes, le vendeur devra être contacté
directement. Aucune garantie n’est avancée quant à la disponibilité des prix indiqués dans les
listes, sur la qualité des produits ou autres conditions spécifiques se rapportant aux ventes. Les
vendeurs indiqués ne constituent pas une liste exhaustive des éventuels fournisseurs. Les prix
des acheteurs sont donnés aux seules fins de comparaison.
Comment Utiliser le Guide F-5

Information que Vous Devriez Connaître
Produits inclus
L'Indicateur de Prix Internationaux des Médicaments se concentre principalement sur les
médicaments essentiels, mais inclut aussi d'autres produits. Les Médicaments de la Liste
Essentielle de l’Organisation Mondiale de la Santé (OMS) sont toujours inclus, de même que
les médicaments et les produits importants pour le traitement ou la prévention de la
tuberculose, le paludisme et le VIH/SIDA. Vaccins, agents immunologiques, désinfectants,
solutions et électrolytes intraveineux, tests et agents de diagnostic sont également
généralement couverts. De plus en plus, les médicaments nécessaires pour le traitement du
cancer et des maladies chroniques, et les teneurs et les formes posologiques nécessaires pour
les soins pédiatriques sont ajoutés à la base de données. Les nouveaux produits sont ajoutés au
Guide chaque année, en fonction des changements qui nous sont communiqués.
Conversion des prix

Les prix du Guide sont indiqués en ordre croissant en fonction du prix unitaire. Tous les prix
pour les organisations donnés ci-après ont été convertis en dollars américains. Les taux de
change utilisés sont ceux du 1 juillet 2014 (http://www.oanda.com). D’autres prix du cata-
logue ont été donnés au départ en dollars américains et n’ont pas été convertis.
Devise (Code d’agence) Taux de change (en $ américains)
Cedi ghanéen nouvelle (CHAI) 0.3099
Dollar namibien (NAMIBIA) 0.0942
Livre Soudanaise (SUDANNHIF) 0.1746
Livre sterling (DURBIN) 1.7126
Naira nigérian (CHAI) 0.0061
Pesos de la République Dominicaine (DOMREP) 0.0228
Rand sud-africain (SAFRICA) 0.0942
Roupie indienna (CHAI) 0.0166
Shilling kenyan (MEDS) 0.0112
Shilling tanzanien (MEDEOR/TZ, MEMS) 0.0006
Sol Nouveau Péruvien (PERU) 0.3532
Tout changement des taux de change peut influencer nettement le coût. Le taux le plus actuel
au moment de votre analyse devrait toujours être utilisé lorsqu’on calcule les coûts des
médicaments.
Termes des prix

Dans ce Guide, les prix des fournisseurs et les prix des acheteurs sont basés sur des conditions
de prix différentes et ne doit pas être comparé directemente. Les Incotermes suivants sont
utilisés pour définir les types de prix:

• CIF (coût, assurance, fret): inclut l'assurance et les frais de transport (dédouanement à
l’exportation) jusqu'au port de destination (transport maritime seulement)
• CIP (port payé et assuré à): inclut le coût de transport et d’assurance du transporteur au
lieu convenu
• DDP (livraison droits payés) : inclut la livraison, les droits d'importation et les frais de
déchargement
• DDU (livraison droits non-payés) : inclut la livraison, mais pas les droits d'importation et
les frais de déchargement
• EXW (départ usine): n'inclut pas le chargement, l'assurance ou le fret
• FCA (franco transporteur) : le vendeur prend les dispositions nécessaires et paye le trans-
port franco destination dans le pays d’exportation
Certains fournisseurs et agences demandent des frais de manutention standard en plus du

coût départ usine ou du coût CIF. Les frais de manutention indiqués à la Liste des Sources dex
Prix ci-après ont été ajoutés aux prix indiqués dans ce Guide.
Calculer les prix

Lorsqu’on calcule et qu’on projette les coûts en termes réels, il est important de tenir compte
de facteurs tels que le financement, les délais de livraison, les modes de transport (aérien/
maritime/terrestre) et les frais de manutention. Une analyse de ces facteurs n’entre pas dans la
portée du présent Guide. Toutefois, aux fins d’estimation, l’on peut ajouter 10% pour les coûts
de manutention au prix indiqué pour les fournisseurs dans ce Guide. Les prix des acheteurs
(appels d’offres des organismes publics) indiqués généralement n’ont pas besoin d’être ajustés
pour tenir compte des frais d’expédition.
Assurance de la qualité
Nous demandons que tous les fournisseurs compris dans l’Indicateur de Prix Internationaux
des Médicaments remplissent un questionnaire sur l’assurance de la qualité. Ce questionnaire
obligatoire a pour objet d’aider à vérifier que les prix du Guide proviennent de fournisseurs de
bonne réputation qui disposent de méthodes établies d’assurance de la qualité. Les 28 questions
traitent de divers aspects dont l’inspection, les tests, l’assurance de la qualité, les autorisations,
les rappels, les procédures de contrôle de la qualité, les normes et la documentation. Certes,
cette condition confère une certaine assurance des méthodes de contrôle de la qualité, mais elle
ne garantit pas forcément la qualité des produits indiqués dans les listes. Des exemplaires de
questionnaires peuvent être obtenus sur demande auprès de Management Sciences for Health.
Les sources des prix comprises dans le Guide n’ont été examinées qu’en mesure du caractère
complet des documents fournis à cet effet. Un tel dépistage ne constitue nullement une étude
approfondie de la qualité du produit. Le fait qu’elles soient incluses au Guide ne représente pas
une qualification préalable ou une approbation de la part de MSH et de l’OMS.
Information que Vous Devriez Connaître F-7

Qualité des produits
Les fournisseurs et organismes choisis pour ce Guide ne sont pas des fabricants, mais ils offrent
des produits qui sont conformes aux normes de qualité internationales, telles que spécifiées par
des organisations comme la Pharmacopée des Etats-Unis (USP), la Pharmacopée britannique
(BP) et la Pharmacopée européenne (EP). Tous les fournisseurs dans ce guide indiquen que les
usines de fabrication avec lesquels travaillant maintiennent des nomes de haute qualité grâce
aux systèmes d’assurance de la qualité qui sont en place pour vérifier que tous les produits
sont conformes aux bonnes pratiques de fabrication (BPF) de l’OMS et aux réglementations
gouvernementales. Les certificats de qualité, conformes au Schéma de Certification de l’OMS
sur la Qualité des Produits pharmaceutiques circulant dans le Commerce international,
devraient être disponibles sur demande de la part de tous les fournisseurs. Les fournisseurs et
les agences dans ce Guide disposent de leurs propres programmes indépendants d’assurance
de la qualité. Prière de les contacter directement pour de plus amples détails.
Le système ATC/DDD1
Les données sur l’utilisation de médicaments revêtent une importance capitale dans le cycle de
la qualité des soins et sont essentielles pour gérer les politiques relatives à l’approvisionnement,
à la fixation des prix, au coût et à l’utilisation des médicaments. Les méthodologies du système
de classification anatomique-thérapeutique-chimique (ATC) et de dose journalière définie
(defined daily dose - DDD) sont utiles pour suivre et comparer les tendances au niveau des
coûts, mais doivent être utilisées avec circonspection. En effet, on utilise mal le système si l’on
fonde des décisions détaillées de remboursement, de référence de groupe thérapeutique et autres
décisions spécifiques concernant les prix sur les systèmes ATC et DDD.
Le but du système ATC/DDD est de servir d’outil pour la recherche sur l’utilisation des
médicaments aux fins d’améliorer la qualité de l’utilisation des médicaments. Une composante
de ce système concerne la présentation et la comparaison de statistiques sur la consommation
des médicaments, aux niveaux international et autres.
Le Centre collaborateur de l’OMS pour la Méthodologie des Statistiques des Médicaments et le
Groupe de Travail de l’OMS cherchent à maintenir des codes ATC et DDD stables, dans le
temps, afin de pouvoir étudier les tendances au niveau de la consommation des médicaments
sans la complication de changements fréquents portés au système. En effet, on hésite beaucoup
à changer les classifications ou les DDD quand de tels changements sont demandés pour des
raisons qui ne sont pas reliées directement aux études sur la consommation des médicaments.
C’est la raison pour laquelle le système ATC/DDD en lui-même ne convient pas pour éclairer
les décisions sur les remboursements, la fixation de prix et la substitution thérapeutique.
La classification d’une substance dans le système ATC/DDD n’est pas une recommandation
d’utilisation et n’implique aucun jugement sur l’efficacité ou l’efficacité relative des
médicaments et groupes de médicaments.
Le texte dans cette section provient du site web du Centre collaborateur de l’OMS pour la Méthodologie des Statistiques des
1
Médicaments à http://www.whocc.no/atcddd/.

Liste des Sources des Prix
Trois types essentiels de fournisseurs et d’acheteurs sont compris dans le Guide.
1. Les fournisseurs qui maintiennent un dépôt et approvisionnent directement en produits les clients. Tous ces fournisseurs
comptent une gamme plus vaste de produits que celle indiquée dans ce Guide. Pour une liste complète des produits, prière de
contacter directement le vendeur. Les fournisseurs suivants sont compris dans le Guide:
Frais de
Date de la Type de
Fournisseur Code manu- Détails
liste prix
tention
Les prix sont en vigueur jusqu’à la publication de la liste de prix revue. Les frais de
transport sont facturés individuellement selon les dépenses. Pour un emballage
MEDEOR/ septembre Départ usine
Action Medeor 1% spécial (caisses en bois), ils prélèvent 26 euros par caisse. Il y a un droit de
EU 2014 Tönisvorst
manutention minimum de 50 euros. Elle fournit des produits seulemennt au marché
non lucratif.
Action Medeor International Healthcare est une agence d'approvisionnement à but

non lucratif fondée en 2004 et qui appartient à Action Medeor. Elle fournit des
Action Medeor
MEDEOR/ septembre produits au marché non lucratif (principalement en Tanzanie) et n'approvisionne
International 0% Départ usine
TZ 2014 pas les individus ou les pharmacies commerciales. Des frais administratifs de 3.5 %
Healthare
s'appliquent à tous les clients non-Tanzaniens pour couvrir les frais bancaires et les
pertes en devises. Aucune quantité minimale n'est exigée.
Départ usine
AMSTEL- janvier Les prix d'Amstelfarma sont donnés uniquement comme indication. Il n'y a pas de
Amstelfarma 0% Lelystad, The
FARM 2015 quantités de commande minimales ni de frais de service.
Netherlands
ASRAMES fournit ses services uniquement aux aux organisations de la RDC qui
DDP ou CIP
ASRAMES ASRAMES août 2014 0% ont été reconnus par le ministère de la Santé comme une institution de santé ou
Kinshasa
une ONG travaillant dans le secteur de la santé.
Durbin fournit des produits pharmaceutiques et des fournitures médicales aux
Départ usine médecins, pharmacies, hôpitaux, grossistes et détaillants en produits

Durbin PLC DURBIN 2013-2014 0% United pharmaceutiques, organismes militaires et gouvernementaux, oeuvres de charité et
Kingdom autres organisations de secours internationales dans tout le monde. Une commande
minimale de RU £100 est exigée.
F-9
Frais de
Date de la Type de
F-10
Fournisseur Code manu- Détails
liste prix
tention
Organisation à but non lucratif apportant un soutien aux soins de santé dans des
pays à revenus faibles et moyens, la Fondation IDA vise à améliorer l’accès aux
médicaments essentiels et fournitures médicales. IDA est une fondation
novembre Départ usine indépendante distribuant plus de 3000 produits dans 100 pays du monde entier.
IDA Foundation IDA 1,5%
2014 Amsterdam Pour les commandes de moins de 5 000 Euros, des frais de manutention de 3 %
sont demandés. Pour les commandes plus de 5 000 Euros, des frais de manutention
de 1,5 % sont demandés. Une commande minimale de 1500 Euros est exigée. Les
prix sont donnés à titre indicatif et peuvent changer.
FCA Lelystad,
janvier
IMRES IMRES 0% The La quantité minimale pour passer une commande est de 1250$ US.
2015
Netherlands
FCA
Medical Export novembre Gorinchem, Les prix sont donnés uniquement comme indication. Il n'y a pas de quantités de
MEG 0%
Group 2014 The commande minimales ni de frais de service.
Netherlands
Les prix de vente de MSD sont valables pour tous les établissements de santé
Medical Stores gouvernementales, les ONG approuvés, hôpitaux missionnaires, des hôpitaux de
MSD/
Indicateur de Prix Internationaux des Médicaments 2014

Department, 2014-2015 0% Départ usine bienfaisance et d'autres fournisseurs de soins de santé en Tanzanie, avec
TANZ
Tanzania l'approbation du ministère de la Santé et de la protection sociale. Les entreprises /
organisations parapubliques vont payer 10% au-dessus de ces prix de vente.
La Mission de Médicaments essentiels et Fournitures médicales (MEDS) fournit les
Mission for
produits pharmaceutiques et fournitures médicales aux prestataires de soins de
Essential Drugs MEDS juillet 2014 0% FOB Nairobi
santé à but non lucratif. Frais de transport se fait payer pour les livraisons en
and Supplies
dehors du Kenya.
2. Les organismes de développement international qui fournissent des produits aux programmes de divers pays auxquels eux-
mêmes ou d’autres apportent un soutien. Les organismes qui figurent dans ce Guide sont les suivantes:
Organisme de
Frais de
développe- Date de la Type de
Code manu- Détails
ment inter- liste prix
tention
national
Les médicaments sont reçus gratuitement, sous forme de dons, mais ils sont également
disponibles aux fins d’achat par des gouvernements et des organisations qui souhaitent
profiter de la qualité, des prix et d'une assistance technique/soutien à la gestion des
médicaments fournie par l'entremise du Service d'achat direct du GDF. GDF réalise des
tests indépendants obligatoires sur chaque lot de médicaments qu’elle procure ainsi que la
pré-inspection de chaque commande qu’elle délivre pour s’assurer de la haute qualité des
Mécanisme produits. En plus du coût des médicaments, les charges pour le contrôle de qualité sont
global pour les payées par le client (ou bien payées par GDF en cas de don).
médicaments Départ usine,
contre la GDF 2014 0% l'usine de Pour faciliter la livraison efficace des produits, GDF utilise des agents transitaires. Des frais
tuberculose fournisseur supplémentaires pour les services des agents transitaires sont aussi ajoutés au coût de la
commande, qui inclut donc le coût des médicaments, les charges pour le contrôle de la
(Global TB Drug
qualité, et le fret. GDF envoie dans le pays une équipe d’experts en TB et en gestion de
Facility)
médicaments 4 mois après que les médicaments sont délivrés pour évaluer leur utilisation
et fournir l’assistance technique nécessaire. GDF ne charge pas de frais pour l’assistance
technique qu’elle fournit. Le GDF est un mécanisme visant à élargir l’accès aux médicaments
antituberculose de haute qualité, ainsi que la disponibilité de ces médicaments, pour faciliter
l’expansion à échelle mondiale de la stratégie de traitement sous surveillance directe
(DOTS), la stratégie recommandée internationalement pour lutter contre la tuberculose.
Le projet Système de Gestion de la Chaîne d’Approvisionnement (SCMS) délivre des

Départ usine médicaments de première nécessité aux programmes VIH/SIDA dans le monde. Le projet
(des Centres aide à renforcer les chaînes d’approvisionnement existantes ou établit de nouvelles chaînes
de pour assurer un système d’approvisionnement sûr, sans danger, fiable et pérenne pour
l’approvisionnement en médicaments et autres produits pharmaceutiques nécessaires à la
Supply Chain distribution
octobre prise en charge du VIH/SIDA et aux infections associées. SCMS est financé par le
Management SCMS 5% régionaux
2014 gouvernement des Etats-Unis comme une partie du Plan Présidentiel d’Urgence pour la
System (projet) SCMS ou
Lutte contre le SIDA (PEPFAR). Le projet SCMS peut se développer n’importe où dans le
directement

monde, mais a été initialement concentré dans les 15 pays du PEPFAR. En plus d’appuyer
du tout projet ou autre partenaire du PEPFAR, SCMS peut aussi approvisionner les projets
fournisseur) financés par les gouvernements nationaux ou autres bailleurs, sous couvert d’accords
individuels spécifiques.
F-11
F-12
Organisme de
Frais de
développe- Date de la Type de
Code manu- Détails
ment inter- liste prix
tention
national
Le Fonds des Nations Unies pour la Population lance des appels d’offres pour l’achat de
Fonds des produits pour ses bureaux de terrain et pour le compte de clients dans plus de 168 pays,
Nations Unies septembre surtout dans le monde en développement. L'UNFPA ne travaille qu’avec des gouvernements
UNFPA 5% FOB
pour la Popu- 2014 et des organisations à but non lucratif. UNFPA demande des frais administratifs de 5% aux
lation (FNUAP) non-acheteurs de l’UNFPA. Il ya une exigence d'ordre minimum de 5000 $EU par unité. Les
prix sont donnés à titre indicatif et peuvent changer.

3. Les acheteurs (généralement organismes du secteur public) qui obtiennent des produits par l’intermédiaire d’appels d’offres
internationaux. Ce sont des prix effectifs obtenus par les organisations indiquées et qui sont inclus aux fins de comparaison. Le
lecteur ne peut pas passer une commande auprès de l’une de ces organisations.
Valeur
Date de la Type de approx. de
Acheteur Code Détails
liste prix l'appel d'offre
($ américains)
The Public Procurement and Asset Disposal Board of
Botswana Public Procurement and janvier
BOTSWANA P/D P/D Botswana conduit des appels d'offres internationales et
Asset Disposal Board 2014
intérieurs et ouvertes et fermées de façon régulière.
La Sécurité Sociale du Costa Rica lance un appel d'offre
Caja Costarricense de Seguro international, annuel et ouvert, et négocie des contrats pour
CRSS 2014 DDU 126 million
Social des médicaments et des fournitures médicales pour ses
propres établissements.
DDP, La Clinton Health Access Initiative a contribué informations
Clinton Health Access Initiative CHAI 2014 EXW, ou P/D sur les prix de plusieurs partenaires qui travaillent ensemble
FOB pour étendre le traitement de la diarrhée.
La République démocratique du Congo Projet intégré de

Democratic Republic of Congo
DRC/IHP mai 2014 FCA 3,8 million santé (DRC/IHP) lance un appel d'offre international, fermé,
Integrated Health Program (IHP)
et annuel pour des médicaments et fournitures médicales.
Le Centre de soutien logistique pour le Programme de

República Dominicana Central de
médicaments essentiels de la République Dominicaine
Apoyo Logístico Programa de octobre
DOMREPUB P/D 69 million (PROMESE/CAL) lance un appel d'offre intérieur et ouvert
Medicamentos Esenciales 2014
pour des produits pharmaceutiques et fournitures médicales
(PROMESE/CAL)
deux foix par an.
Après un processus ouvert de préqualification et un appel
Mission for Essential Medical d’offres fermé, MEMS a donné un contrat annual pour
MEMS juillet 2014 P/D 0,3 million
Supplies (MEMS), Tanzania l’approvisionnement de médicaments et fournitures
médicales à un vendeur premier.

F-13
F-14
Valeur
Date de la Type de approx. de
Acheteur Code Détails
liste prix l'appel d'offre
($ américains)
Le dépôt central de Namibia lance un appel d'offre
international et ouvert tous les deux ans pour des produits
Namibia Central Medical Stores NAMIBIA août 2014 DDP 24 million
pharmaceutiques et fournitures médicales et chaque année
pour les antirétroviraux.
Le Service d’Approvisionnement pharmaceutique de
l’Organisation des Etats de la Carabe de l’Est (OECS/PPS)
fournit ses services uniquement aux pays membres de
Organisation of Eastern Caribbean 1 mars
l’Organisation des Etats de la Carabe de l’Est. Pour ses neuf
States Pharmaceutical Procurement OECS/PPS 2014 - 31 CIF P/D
pays, le Service d'approvisionnement en produits
Service (OECS/PPS), St. Lucia août 2015
pharmaceutiques de l'Organisation des Pays de la Carabe de
l'Est (OECS) négocie et achète par le moyen d'un appel
d'offre international et fermé chaque 18 mois.
Le Ministère de la Santé de Pérou lance un appel d'offre
fevrier et
Perú Ministerio de Salud PERU DDP 197 million intérieur, annuel et ouvert pour des produits
abril 2014
pharmaceutiques et fournitures médicales.

Le Système d'intégration d'Amérique centrale (SICA) lance
El Sistema de Integración
SICA août 2014 CIF 4,2 million un appel d'offre annuel, international et fermé pour certains
Centroamericana (SICA)
produits pharmaceutiques.
Le Département de la Santé d'Afrique du Sud lance les
South Africa Department of Health SAFRICA 2014 DDP P/D appels d'offre intérieurs et ouverts pour des produits
pharmaceutiques et fournitures médicales tous les deux ans.
Le Caisse nationale d'assurance-maladie du Soudan lance les

Sudan National Health Insurance SUDAN-
juin 2014 DDP 16,8 million appels d'offre intérieurs, annuels et ouverts pour des
Fund NHIF
produits pharmaceutiques et fournitures médicales.
Information de Contact
Action Medeor
D-47918 Tönisvorst
GERMANY
Téléphone: 49.21.56.97.88.0
Fax: 49.21.56.97.88.88
Courrier électronique: info@medeor.org

D-47918 Tönisvorst
GERMANY
and
P.O. Box 72305
Dar es Salaam
TANZANIA
Téléphone: 49.21.56.97.88.0
Fax: 49.21.56.97.88.88
Courrier électronique: medeortz@bol.co.tz
Amstelfarma
Nijverheidsweg 37
2102LK Heemstede
THE NETHERLANDS
Téléphone: 31-23-5484040
Courrier électronique: sales@amstelfarma.com
ASRAMES (Association Régionale D’Approvisionnement en Médicaments Essentiels)

BP 183
Goma
DRC
Téléphone: 243.9.98.08.81.70
Courrier électronique: info@asrames.org
Information de Contact F-15

Gaborone
Private Bag 0058
BOTSWANA
Téléphone: 267 360 2000

Fax: 267 390 6822
Courrier électronique: sbpac@ppadb.co.bw
Caja Costarricense de Seguro Social–CCSS (“La Sécurité Sociale du Costa Rica”)

Pharmacotherapy Department
Apartado 10105
San José 1000
COSTA RICA
Téléphone: 506.222.1878
Fax: 506.257.7004
Courrier électronique: farmaco@ccss.sa.cr

Boston, MA 02127
USA
Téléphone: 617.774.0110
Courrier électronique: info@clintonhealthaccess.org

MSH
Commune de la Gombe
Kinshasa
Téléphone: 243.99.930.1015

Santo Domingo
DOMINICAN REPUBLIC
Téléphone: 809.518.1313
Courrier électronique: promesecal@promesecal.gov.do
Durbin PLC
180 Northolt Road
South Harrow
Middlesex
HA2 0LT
UNITED KINGDOM
Téléphone: 44.20.8660.2220
Fax: 44.20.8668.0751
Courrier électronique: cataloguesales@durbin.co.uk

Papland 16
P.O. Box 598
4200 AN Gorinchem
THE NETHERLANDS
Téléphone: 31.183.356.100
Fax: 31.183.356.122
Courrier électronique: info@meg.nl

P.O. Box 10810
Arusha
TANZANIA
Téléphone: 255.27.250.9366
Fax: 255.27.254.4908
Courrier électronique: info@mems.or.tz

20, avenue Appia
1211 Geneva, 27
SWITZERLAND
Téléphone: 41.22.791.3647
Fax: 41.22.791.4886
Courrier électronique: gdf@who.int
URL: http://www.globaldrugfacility.org ou http://www.stoptb.org/GDF
IDA Foundation
P.O. Box 37098
1030 AB Amsterdam
THE NETHERLANDS
Téléphone: 31.20.40.33.051
Fax: 31.20.40.31.854
Courrier électronique: info@idafoundation.org
IMRES
P.O. Box 214
8200 AE Lelystad
THE NETHERLANDS
Téléphone: 31.320.296969
Fax: 31.320.296929
Courrier électronique: info@imres.nl

P.O. Box 9081
Dar es Salaam
TANZANIA
Téléphone: 255.22.2860890
Fax: 255.22.2865814
Courrier électronique: info@msd.or.tz

MEDS Centre
P.O. Box 78040-00507
KENYA
Téléphone: 254.020.3920.404
Fax: 254.020.3920.600
Courrier électronique: customerservice@meds.or.ke

P.O. Box 5552
Windhoek
NAMIBIA
Téléphone: 264.61.233151
Fax: 264.61.238746

(OECS/PPS)
OECS
Castries
Téléphone: 758.452.5895
Fax: 758.453.0227
Courrier électronique: pps@oecs.org
Perú Ministerio de Salud (MINSA) (“Le Ministère de la Santé de Pérou”)

Av. Salaverry 801
Jesús Maria
Lima
PERU
Téléphone: 51.14.315.6600
Courrier électronique: webmaster@minsa.gob.pe

Private Bag X828
Pretoria, 0001
SOUTH AFRICA
Téléphone: 27.12.312.0000
Fax: 27.12.326.4395

Baladya Street
P.O. Box: 13267
Khartoum
SUDAN
Téléphone: 249 1 837 47618

Fax: 249 1 837 47619
Courrier électronique: info@nhif.gov.sd

12th Floor
USA
Téléphone: 1.571.227.8600
Fax: 1.571.227.8601

Antiguo Cuscatlán
EL SALVADOR
Téléphone: 503 2248-8800

Fax: 503 2248-8899
Courrier électronique: info.sgsica@sica.int

Midtermolen 3
P.O. Box 2530
Copenhagen
DENMARK
Téléphone: 45.3546.7000
Fax: 45.3546.7018
Courrier électronique: accessrh@unfpa.org

Format des Listes de Prix
Les produits pharmaceutiques sont présentés dans trois listes séparées, avec des
caractéristiques et des formats différents, mais certains éléments sont les mêmes pour tout.
• Liste I : Produits pharmaceutiques classés par ordre alphabétique
• Liste II : Produits pharmaceutiques classés par classe thérapeutique
• Liste III : Formulaire pour la comparaison des prix
Une description détaillée de l’information incluse dans chaque liste suivit ci-après.

Liste I - Produits pharmaceutiques classés par
ordre alphabétique
La Liste I est une référence pour les achats et elle présente les médicaments en ordre
alphabétique par nom générique pour permettre une recherche rapide concernant un
médicament particulier. La liste indique la taille du conditionnement disponible de chaque
organisation et le prix de chaque conditionnement en dollars américains, y compris les frais
standard de service, le cas échéant.
Description du produit
La description du produit comprend le nom générique, l’efficacité, la présentation et la voie
d’administration. Si le produit a deux noms très utilisés (par exemple, vitamine C et acide
ascorbique), un nom apparaîtra entre crochets. Voir la Liste des Synonymes dans l’Annexe.
IC
Les produits sous contrôle international (narcotiques) sont identifiés avec (IC) à côté de
la description.
Nomenclature
La dénomination internationale est utilisée comme la liste des médicaments dans ce
Guide. Si elle n’a pas été donnée, c’est le nom générique le plus courant qui est utilisé.
Les présentations des médicaments indiqués sont généralement celles incluses dans la
19e liste modèle OMS des médicaments essentiels (revue en avril 2015), indiquée à
Voie d’administration
Les voies d’administration sont codées de la manière suivante:
Type Code
Bandes de diagnostic DIAG
Comprimés/dragées/liquides oraux PO
Comprimés sublinguaux SL
Dispositif intra-utérin (Stérilet) IUD
Inhalation INH
Médicaments injectables INJ
Médicaments sous-cutanés S/C
Préparations auriculaires OTIC
Préparations nasales et pour la gorge N/T
Préparations ophtalmiques OPHT
Préparations vaginales VAG
Préservatifs (Condoms) COND
Produits dermatologiques (liquides, poudres,
crèmes et pommades) TOP
Solutés intraveineux IV
Suppositoires/lavement/pommade rectale RECT
Pas applicable N/A
Format des Listes de Prix F-23

Source
La liste des sources des prix se trouve à la page F-9.
Conditionnement
Les tailles du conditionnement sont données par les fournisseurs et les acheteurs.
Prix du conditionnement ($ américains)

Les prix du conditionnement sont donnés par les fournisseurs et les acheteurs et ont été
convertis en dollars américains aux taux de change indiqués à la page F-6 pour faciliter la
comparaison. Si un fournisseur demande un pourcentage donné de frais de manutention, le
pourcentage a été ajouté au prix du conditionnement.
Prix unitaire ($ américains)

Le prix unitaire est calculé en divisant le prix du conditionnement par la taille du
conditionnement. Cette présentation facilite la comparaison de prix entre les différentes tailles
de produits des vendeurs. L’unité utilisée pour comparer les prix varie en fonction de la forme
pharmaceutique, telle qu’indiquée ci-après:
Forme pharmaceutique Unité de comparaison (Code)
Ampoule ou flacon Millilitre (ML)
Cartouche Millilitre (ML)
Comprimé/dragée Comprimé ou dragée (TAB-CAP)
Condom, DIU, Mosquitaire, Test Chacun (EACH)
Dermatologique solide Gramme (G)
Dermatologique liquide Millilitre (ML)
Flacon (dosage unique) Vial (VIAL)
Gaz Mètre cube (CUBMETER)
Granules Gramme (G)
Inhalateur Dose (DOSE)
Lavement Millilitre (ML)
Paquet Paquet (PACK)
Pessaire Pessaire (PESS)
Préparation ORL Millilitre (ML)
Seringue Seringue (SYRINGE)
Suspension ou forme orale liquide Millilitre (ML)
Suppositoire Suppositoire (SUPP)
Traitement Traitement (TREATMEN)
Vaccin Dose (DOSE)
Dose journalière définie (DDD)

La DDD est la dose de maintien moyenne assumée par jour pour un médicament utilisé pour sa
principale indication chez les adultes. Il faut souligner que la dose journalière définie est une

unité de mesure et ne reflète pas forcément la dose journalière recommandée ou prescrite. Les
doses pour les patients pris individuellement et les groupes de patients sont souvent
différentes de la DDD et devront forcément être définies en fonction des caractéristiques
individuelles (par exemple, âge et poids) et des considérations pharmacocinétiques.
Les données sur la consommation de médicaments présentées dans les DDD n’indiquent
qu’une estimation approximative de la consommation et ne sont pas une indication exacte de
l’utilisation effective. Les DDD fournissent une unité fixe de mesure indépendante du prix et de
la formulation, permettant ainsi aux chercheurs d’évaluer les tendances au niveau de la
consommation de médicaments et de faire des comparaisons entre les groupes de population.
Les doses journalières définies sont tirées du Centre collaborateur de l'OMS pour la
Méthodologie des Statistiques des Médicaments. Il s'agit de doses journalières définies, telles
que recommandées par le Groupe de Recherche de l'Utilisation des Médicaments (DURG) de
l'OMS. Les médicaments indiqués dans ce Guide de comparaison des prix n’ont pas tous des
doses journalières définies assignées par cette méthode. Une DDD ne sera assignée qu’aux
médicaments qui ont déjà un code de classification anatomique-thérapeutique-chimique.
La DDD sert essentiellement à estimer la consommation de médicaments en fonction des
données sur l’inventaire/distribution. Cette estimation peut être combiné à l’information sur
les prix aux fins de budgétisation.
Note: La dose journalière définie ne devrait pas être utilisée pour le dosage ou les indications thérapeutiques.
Prière de consulter la posologie conseillée pour chaque indication.
LME de l’OMS
La colonne intitulée « WHO EML » indique si le produit fait partie de la Liste Modèle OMS de
Médicaments essentiels de 2015. Nous avons identifié cinq catégories dans l’Indicateur de Prix
Internationaux des Médicaments.
E = Appartient à la liste principale de l’OMS avec la même présentation et la même
efficacité/teneur
C = Appartient à la liste complémentaire de l’OMS avec la même présentation et la
même efficacité/teneur
P = Appartient à la liste de l’OMS, mais sous une présentation différente (forme et/
ou teneur différente)
T = Ne figure pas sur la liste de l’OMS, mais est un produit de remplacement pour
produit indiqué comme exemple d’un groupe thérapeutique
N = N’appartient pas à la liste modèle de l’OMS
Code ATC
Le code ATC est le code de classification anatomique-thérapeutique-chimique assigné par le
Centre collaborateur de l’OMS pour la Méthodologie des Statistiques des Médicaments. Le
système ATC/DDD sert d’outil pour la recherche en matière d’utilisation de médicaments afin
d’améliorer la qualité de l’utilisation des médicaments. Une des composantes de ce système
concerne la présentation et la comparaison de statistiques sur la consommation de
médicaments aux niveaux international et autres.

Dans le système de classification ATC, les médicaments sont divisés en différents groupes selon
l’organe ou le système sur lequel ils agissent et en fonction de leurs propriétés chimiques,
pharmacologiques et thérapeutiques. Les médicaments sont classés en groupes à cinq niveaux
différents. Les médicaments sont divisés en 14 groupes essentiels (1er niveau) avec un sous-
groupe pharmacologique/thérapeutique (2e niveau). Les 3e et 4e niveaux sont les sous-groupes
chimiques/pharmacologiques/thérapeutiques et le 5e niveau est la substance chimique.2
Prix médian
Un prix moyen peut être utile lorsqu’on utilise le Guide pour comparer avec des prix locaux
ou pour estimer la valeur totale d’une liste d’achat proposée. En fait, il existe deux types de
prix moyens qui peuvent être utilisés—le prix moyen et le prix médian. Le prix moyen est la
simple moyenne de tous les prix indiqués pour un médicament; les valeurs sont ajoutées et
divisées par le nombre de valeurs.
Toutefois, les choses sont plus difficiles lorsqu’un ou deux prix sont plus élevés ou plus faibles
que le reste pour un médicament donné. Ce prix moyen sera « faussé », ce qui le rend moins
représentatif. Par exemple, dans une série de sept valeurs, telle que $1, $2, $2, $3, $5, $16, $20, le
total de toutes les valeurs est de $49 et, quand on divise cette valeur par sept, on obtient un prix
moyen égal à $7. Aux fins de comparaison ou d’estimation, il est probable que cette moyenne
est trop élevée à cause des deux prix qui sont bien plus élevés que les autres dans la série. Pour
éviter ce risque, nous utilisons le prix médian.
Le prix médian est un type de prix moyen. C’est la valeur qui sépare au milieu une série de
valeurs quand la série est mise en ordre croissant. Ceci serait probablement une approche plus
valable pour estimer les prix futurs réels (ou pour comparer avec les prix locaux) lorsque la
distribution n'est pas directe.
S’il existe un nombre impair de valeurs dans cette série, comme dans l’exemple ci-dessus, la
valeur médiane est la valeur du milieu de la série ($3 dans notre exemple). Dans le cas d’un
nombre pair de valeurs dans une série, tel que $1, $3, $4, $6, $14, $20, la valeur médiane est
calculée en faisant la moyenne de la somme des deux valeurs du milieu de la série. Dans cet
exemple, la médiane est la moyenne de $4 et de $6, à savoir $5. Là aussi, c’est probablement
plus proche de la réalité aux fins de comparaison ou d’estimation que la moyenne arithmétique
de $8 ($48 divisé par 6).3
Ratio elevé/faible
Le ratio elevé/faible (« high/low ») compare le prix unitaire le plus élevé avec le prix unitaire
le plus faible. Par exemple, un ratio elevé/faible de 3 signifie que le prix unitaire le plus élevé
est trois fois supérieur au prix unitaire le plus faible.
2
Pris du site web du Centre collaborateur de l’OMS pour la Méthodologie des Statistiques des Médicaments à http://
www.whocc.no/atcddd/.
3
Pour de plus amples détails, voir Statistics Without Tears—A Primer for Non-Mathematicians, par Derek Rowntree (New York:
Charles Scribner’s Sons, 1981), pp. 41–45.

Liste II - Produits pharmaceutiques classés par
classe thérapeutique
Pour Liste II, les produits pharmaceutiques sont classés par ordre alphabétique au sein de
chaque classe thérapeutique, en fonction du système de classification de la Liste des
Médicaments essentiels de l’OMS. Pour les produits qui ne figurent pas sur la liste des
médicaments essentiels de l’OMS (c’est-à-dire les produits désignés par la lettre N dans la
colonne « WHO EML » de ce guide), nous avons attribué une classe thérapeutique basée sur le
système de classification des médicaments de l’OMS. Cette classe est utilisée lorsqu’un produit
non LME appartient clairement à une catégorie thérapeutique LME, tel que déterminé par le
personnel de MSH.
Cette attribution ne reflète pas une décision prise par le Département l’OMS de médicaments
essentiels et politiques pharmaceutiques, ou par les membres de MSH selon laquelle le produit
non LME convient pour être inscrit sur la liste modèle des médicaments essentiels de l’OMS. Si
l’attribution d’une catégorie thérapeutique LME ne peut se faire sans ambiguïté, nous plaçons
le produit dans la catégorie « UA - agents non classés sur la liste LME de l’OMS ».
Les articles d'une classe thérapeutique ne peuvent pas nécessairement se substituer l'un l'autre
directement. Tous les prix de cette liste sont des prix unitaires. Pour chaque produit de cette
liste, les données suivantes sont indiquées:
La description du produit comprend le nom générique, l’efficacité, le dosage et la voie
d’administration. Si le produit a deux noms très utilisés (par exemple, vitamine C et
acide ascorbique), un nom apparaîtra entre crochets. Voir la Liste des Synonymes dans
l’Annexe.
IC
la description.
Nomenclature
19e Liste modèle OMS des médicaments essentiels (revue en avril 2015), indiquée à
Voie d’administration
Les voies d’administration sont codées de la manière suivante:
Type Code
Bandes et tests de diagnostic DIAG
Comprimés/dragées/liquides oraux PO
Comprimés sublinguaux SL

Dispositif intra-utérin (Stérilet) IUD
Inhalation INH
Médicaments injectables INJ
Médicaments sous-cutanés S/C
Préparations auriculaires OTIC
Préparations nasales et pour la gorge N/T
Préparations ophtalmiques OPHT
Préparations vaginales VAG
Préservatifs (Condoms) COND
Produits dermatologiques (liquides, poudres,
crèmes et pommades) TOP
Solutés intraveineux IV
Suppositoires/lavement/pommade rectale RECT
Pas applicable N/A
LME de l’OMS
Internationaux des Médicaments.
efficacité/teneur
T = Ne figure pas sur la liste de l’OMS, mais est un produit de remplacement pour
Nombre de fournisseurs/acheteurs
Le nombre de fournisseurs ou d’acheteurs offrant ce produit.
Prix médian
Un prix moyen peut être utile lorsqu’on utilise le Guide pour comparer avec des prix locaux ou
pour estimer la valeur totale d’une liste d’achat proposée. En fait, il existe deux types de prix
moyens qui peuvent être utilisés—le prix moyen et le prix médian. Le prix moyen est la simple
moyenne de tous les prix indiqués pour un médicament; les valeurs sont ajoutées et divisées
par le nombre de valeurs.
Toutefois, les choses sont plus difficiles lorsqu’un ou deux prix sont plus élevés ou plus faibles
que le reste pour un médicament donné. Ce prix moyen sera « faussé », ce qui le rend moins
représentatif. Par exemple, dans une série de sept valeurs, telle que $1, $2, $2, $3, $5, $16, $20, le

total de toutes les valeurs est de $49 et, quand on divise cette valeur par sept, on obtient un
prix moyen égal à $7. Aux fins de comparaison ou d’estimation, il est probable que cette
moyenne est trop élevée à cause des deux prix qui sont bien plus élevés que les autres dans la
série. Pour éviter ce risque, nous utilisons le prix médian.
valeurs quand la série est mise en ordre croissant. Ceci serait probablement une approche plus
valable pour estimer les prix futurs réels (ou pour comparer avec les prix locaux) lorsque la
distribution n'est pas directe.
S’il existe un nombre impair de valeurs dans cette série, comme dans l’exemple ci-dessus, la
valeur médiane est la valeur du milieu de la série ($3 dans notre exemple). Dans le cas d’un
nombre pair de valeurs dans une série, tel que $1, $3, $4, $6, $14, $20, la valeur médiane est
calculée en faisant la moyenne de la somme des deux valeurs du milieu de la série. Dans cet
exemple, la médiane est la moyenne de $4 et de $6, à savoir $5. Là aussi, c’est probablement
plus proche de la réalité aux fins de comparaison ou d’estimation que la moyenne arithmétique
de $8 ($48 divisé par 6).4
Prix le plus élevé

Le prix le plus élevé parmi les fournisseurs et les acheteurs de ce produit.
Prix le plus faible

Le prix le plus faible parmi les fournisseurs et les acheteurs de ce produit.
Ratio elevé/faible
Le ratio elevé/faible (« high/low ») compare le prix unitaire le plus élevé avec le prix unitaire le
plus faible. Par exemple, un ratio elevé/faible de 3 signifie que le prix unitaire le plus élevé est
trois fois supérieur au prix unitaire le plus faible.
Dose journalière définie (DDD)

La DDD est la dose de maintien moyenne assumée par jour pour un médicament utilisé pour
sa principale indication chez les adultes.
Il faut souligner que la dose journalière définie est une unité de mesure et ne reflète pas
forcément la dose journalière recommandée ou prescrite. Les doses pour les patients pris
individuellement et les groupes de patients sont souvent différentes de la DDD et devront
forcément être définies en fonction des caractéristiques individuelles (par example, âge et
poids) et des conditions pharmacocinétiques.
Les données sur la consommation de médicaments présentées dans les DDD n’indiquent
qu’une estimation approximative de la consommation et ne sont pas une indication exacte de
4
Charles Scribner’s Sons, 1981), pp. 41–45.

l’utilisation effective. Les DDD fournissent une unité fixe de mesure indépendante du prix et
de la formulation, permettant ainsi aux chercheurs d’évaluer les tendances au niveau de la
consommation de médicaments et de faire des comparaisons entre les groupes de population.
Les doses journalières définies sont tirées du Centre collaborateur de l'OMS pour la
Méthodologie des Statistiques des Médicaments. Il s'agit de doses journalières définies, telles
que recommandées par le Groupe de Recherche de l'Utilisation des Médicaments (DURG) de
l'OMS. Les médicaments indiqués dans ce guide de comparaison des prix n’ont pas tous des
doses journalières définies, assignées par cette méthode. Une DDD ne sera assignée qu’aux
médicaments qui ont déjà un code ATC.
La DDD sert essentiellement à estimer la consommation de médicaments en fonction des
données sur l’inventaire/distribution. Cette estimation peut être combiné à l’information sur
les prix aux fins de budgétisation.
Note: La dose journalière définie ne devrait pas être utilisée pour le dosage ou les indications thérapeutiques.
Prière de consulter la posologie conseillée pour chaque indication.

Liste III - Formulaire pour la Comparaison des
Prix
Le but de cette liste est d’aider l’utilisateur à comparer ses prix aux prix du Guide. Seul le prix
médian est affiché ici et une brève description du produit est utilisée.
La description du produit comprend le nom générique, l’efficacité, le dosage et la voie
d’administration. Si le produit a deux noms très utilisés (par exemple, vitamine C et acide
ascorbique), un nom apparaîtra entre crochets. Voir la Liste des Synonymes dans l’Annexe.
IC
la description.
Nomenclature
19e liste modèle OMS des médicaments essentiels (revue en avril 2015), indiquée à
LME de l’OMS
Internationaux des Médicaments:
efficacité/teneur
T = Ne figure sur la liste de l’OMS, mais est un produit de remplacement pour

Taille du conditionnement
L’espace en blanc ici permet à l’utilisateur d’indiquer la taille du conditionnement pour son
achat.
Prix du conditionnement
L’espace en blanc ici permet à l’utilisateur d’indiquer le prix pour le conditionnement de
l’achat indiqué dans l’espace précédent.
Prix unitaire
L’utilisateur devrait calculer son prix unitaire en divisant le prix du conditionnement par la
taille du conditionnement. L’unité de comparaison utilisée dans ce Guide est indiquée pour
chaque produit pour vérifier que les prix sont comparés sur une base équivalente.
Prix unitaire médian du fournisseur/acheteur

($ américains)
Le prix unitaire est calculé en divisant le prix du conditionnement par la taille du
conditionnement. Cette présentation facilite la comparaison de prix entre les différentes tailles
de produits des vendeurs. L’unité utilisée pour comparer les prix varie en fonction de la forme
pharmaceutique, telle qu’indiquée ci-après:
Forme pharmaceutique Unité de comparaison (Code)

Ampoule ou flacon Millilitre (ML)
Cartouche Millilitre (ML)
Comprimé/dragée Comprimé ou dragée (TAB-CAP)
Condom, DIU, Mosquitaire, Test Chacun (EACH)
Dermatologique solide Gramme (G)
Dermatologique liquide Millilitre (ML)
Flacon (dosage unique) Vial (VIAL)
Gaz Mètre cube (CUBMETER)
Granules Gramme (G)
Inhalateur Dose (DOSE)
Lavement Millilitre (ML)
Paquet Paquet (PACK)
Pessaire Pessaire (PESS)
Préparation ORL Millilitre (ML)
Seringue Seringue (SYRINGE)
Suspension ou forme orale liquide Millilitre (ML)
Traitement Traitement (TREATMEN)
Suppositoire Suppositoire (SUPP)
Vaccin Dose (DOSE)

valeurs quand la série est mise en ordre croissant. S’il existe un nombre impair de valeurs dans
série, comme dans une série de sept valeurs $1, $2, $2, $3, $5, $16, $20, la valeur médiane est la
valeur du milieu de la série. Ceci serait probablement une approche plus valable pour estimer
les prix futurs réels (ou pour comparer avec les prix locaux) lorsque la distribution n'est pas
directe.
Dans le cas d’un nombre pair de valeurs dans une série, tel que $1, $3, $4, $6, $14, $20, la valeur
médiane est calculée en faisant la moyenne de la somme des deux valeurs du milieu de la série.
Dans cet exemple, la médiane est la moyenne de $4 et de $6, à savoir $5. Là aussi, c’est
probablement plus proche de la réalité aux fins de comparaison ou d’estimation que la
moyenne arithmétique de $8 ($48 divisé par 6).5
5
Charles Scribner’s Sons, 1981), pp. 41–45
Comment Analyser et Comparer vos Prix F-33

Comment Analyser et Comparer vos Prix
La comparaison des prix que vous avez payés avec les prix sur le marché international est un
critère essentiel pour évaluer l’efficacité de votre système d’approvisionnement. L’exactitude
de l’estimation des besoins, le caractère ponctuel des livraisons et la qualité des produits
achetés sont d’autres indicateurs clés de l’efficacité de l’approvisionnement.
Avec l’aide de ce Guide, le personnel chargé des achats peut comparer les prix qu’il paye avec
les prix de référence internationaux (se rapporter au Formulaire pour la Comparaison des Prix,
SP-1 et BP-1). La méthode ci-après présente une approche pour faire de telles comparaisons.
Vous pouvez consulter la version électronique de l’Indicateur de Prix Internationaux des
Médicaments au Centre de Ressources électroniques à http://erc.msh.org/priceguide. Cette
version vous aide à comparer vos prix avec ceux du Guide à planifier un budget ou un appel
d’offres.
1. Faire une liste des produits que vous achetez régulièrement en volumes importants ou qui
représentent un pourcentage élevé du budget.
2. Pour chaque produit, indiquer la taille du conditionnement du vendeur qui est utilisé et le
prix le plus récent pour cette taille du produit. Ne pas oublier de noter si le prix est CIF
(coût, assurance et fret); FOB (franco à bord—transport au port de départ); départ usine
(pas de transport) ou autre type de prix. Les prix devront peut-être être ajustés pour être
comparés avec exactitude.
3. Choisir un des deux formulaires de comparaison des prix compris dans le Guide, en
fonction du type de prix que vous comparez. Les prix d'acheteurs incluent le transport et
conviendront mieux s'ils représentent une région du monde (et valeur d’appel d’offre)
semblable à la vôtre. Les prix des fournisseurs sont des prix FOB et départ usine et doivent
être ajustés pour refléter les frais habituels d’expédition, de manutention et d’assurance
dans votre situation.
4. Sur les formulaires de comparaison des prix, choisissez dans ce Guide, le produit qui se
rapproche le plus de votre produit. Si les prix que vous utilisez localement sont des prix
CIF et si vous avez choisi le formulaire de comparaison de l’acheteur, aucun ajustement
n’est nécessaire pour l’un ou l’autre de cet ensemble de prix.
Si les prix que vous utilisez localement sont des prix CIF et si vous avez choisi la liste de
comparaison du fournisseur, nous recommandons que les prix indiqués sur la liste du
fournisseur soient ajustés à la hausse pour refléter les différences entre CIF et départ
usine/FOB. Quand les prix sur cette liste sont FOB ou départ usine, il est raisonnable
d’ajouter 10% au prix de la liste pour le fret et l’assurance en fonction de la distance et du
mode de transport. Tout pourcentage standard demandé pour la manutention a été ajouté
aux prix de cette liste.
En cas de fluctuations importantes des taux de change, des ajustements de prix doivent
être faits pour refléter ces changements.
5. Une fois les prix du conditionnement soient ajustés pour refléter le fret, l’assurance et
autres coûts supplémentaires, diviser le prix du conditionnement par le nombre d’unité de
comparaison contenues dans le conditionnement du vendeur (par exemple, diviser le prix

du conditionnement par 1000 si c’est un flacon de 1000 comprimés, ou par 100 si c’est un
flacon de 100 ml). Vérifier que l’unité de comparaison utilisée est la même que l’unité de
comparaison dans la liste du Guide. Le prix médian international d’une unité est indiqué
sur les deux formulaires de comparaison des prix.
Vu que la nature du conditionnement peut augmenter nettement le coût d’un produit, il
faut faire attention lorsqu’on compare les prix unitaires entre les différents
conditionnements. Par exemple, le prix unitaire de médicaments emballés individuellement
sous film d’aluminium est généralement bien plus élevé que le prix unitaire de comprimés
en vrac dans un flacon de 1000. Les prix du Guide ne couvrent pas un conditionnement
spécial, sauf s’il est indiqué.
Une analyse de ce type repose sur de nombreuses hypothèses qui influencent son résultat. Les
comparaisons de prix internationaux identifient des différences extrêmes de prix, tant élevées
que faibles. Un ratio extrêmement élevé entre des prix locaux et des prix du Guide pourrait
indiquer qu’il existe une source moins chère. Si les prix disponibles localement sont nettement
plus faibles que les prix dans ce Guide, cela pourrait témoigner d’un approvisionnement mené
efficacement, mais pourrait également être le résultat d’un compromis entre le contrôle de
qualité, les différences de conditionnement ou autres facteurs susceptibles de réduire la qualité
du produit. Ces comparaisons ne sont que des indicateurs et devraient être vues comme des
points de départ pour un examen plus approfondi.
Comment Analyser et Comparer vos Prix F-35

List I: Products Sorted Alphabetically
Lista I: Productos Clasificados por

Orden Alfabético
Liste I : Produits Pharmaceutiques Classés

par Ordre Alphabétique
ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC

SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE
ABACAVIR (ABC) 20 mg/ml solution (PO) Price/ml 0.6 g E J05AF06

Supplier SCMS 1 BOTT (240 ml) 7.80 0.0325
Supplier IDA 1 BOTT (240 ml) 11.67 0.0486
Supplier Median Price/ml=0.0406 High/Low Ratio=1.50
Buyer SAFRICA 1 BOTT (240 ml) 4.73 0.0197
ABACAVIR (ABC) 300 mg tab-cap (PO) Price/tab-cap 0.6 g E J05AF06

Supplier SCMS 60 TAB-CAP 11.74 0.1957 AS SULFATE, TABLETS
Supplier IDA 60 TAB-CAP 13.20 0.2199 TABLETS
Supplier MEG 60 TAB-CAP 25.00 0.4167 TABLETS
Supplier Median Price/tab-cap=0.2199 High/Low Ratio=2.13
Buyer SAFRICA 60 TAB-CAP 10.90 0.1816 TABLETS
Buyer PERU 100 TAB-CAP 23.42 0.2342 TABLETS, ILLUSTRATIVE PACK SIZE
Buyer NAMIBIA 60 TAB-CAP 14.67 0.2446 TABLETS
Buyer Median Price/tab-cap=0.2342 High/Low Ratio=1.35
ABACAVIR SULFATE 60 mg tab-cap (PO) Price/tab-cap 0.6 g P J05AF06

ABACAVIR+LAMIVUDINE 60mg+30mg tab-cap (PO) Price/tab-cap P J05AR

Supplier SCMS 60 TAB-CAP 4.20 0.0700 TABLETS
ABACAVIR+LAMIVUDINE (ABC/3TC) 600 mg+300mg tab-cap (PO) Price/tab-cap 1 tab P J05AR02

ABACAVIR+LAMIVUDINE (DISPERSIBLE) 60mg+30mg tab-cap (PO) Price/tab-cap E J05AR02

Buyer NAMIBIA 60 TAB-CAP 5.50 0.0917 SCORED TABLETS
ACETAZOLAMIDE 250 mg tab-cap (PO) Price/tab-cap 0.75 g E S01EC01

Supplier ASRAMES 1000 TAB-CAP 15.59 0.0156 TABLETS
Supplier DURBIN 1000 TAB-CAP 28.69 0.0287 TABLETS
Supplier MEDEOR/TZ 100 TAB-CAP 4.76 0.0476 TABLETS
Buyer OECS/PPS 100 TAB-CAP 2.88 0.0288 TABLETS
Buyer MEMS 100 TAB-CAP 6.87 0.0687 TABLETS
Buyer DOMREPUB 100 TAB-CAP 18.81 0.1881 TABLETS, ILLUSTRATIVE PACK SIZE
ACETYLSALICYLIC ACID 100 mg tab-cap (PO) Price/tab-cap 3 g E B01AC06

Supplier IMRES 1000 TAB-CAP 1.95 0.0019 TABLETS
Supplier MEDEOR/EU 3500 TAB-CAP 17.69 0.0051 TABLETS
Buyer SUDANNHIF 100 TAB-CAP 0.98 0.0098 TABLETS, ILLUSTRATIVE PACK SIZE
ACETYLSALICYLIC ACID 300 mg tab-cap (PO) Price/tab-cap 3 g E N02BA01

Supplier MSD/TANZ 1000 TAB-CAP 2.82 0.0028 TABLETS
Supplier MEDS 1000 TAB-CAP 3.36 0.0034 TABLETS
Supplier AMSTELFAR 1000 TAB-CAP 4.95 0.0050 TABLETS
Buyer BOTSWANA 1000 TAB-CAP 4.99 0.0050 TABLETS
Buyer OECS/PPS 100 TAB-CAP 1.75 0.0175 325 MG, E.C. TABLETS
WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list
*The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use.
A-1 International Drug Price Indicator Guide, 2014



Buyer DRC/IHP 1000 TAB-CAP 3.33 0.0033 TABLETS
ACETYLSALICYLIC ACID 75 mg tab-cap (PO) Price/tab-cap 3 g P B01AC06

Supplier DURBIN 1000 TAB-CAP 3.60 0.0036 DISPERSIBLE TABLETS
Supplier MEDS 28 TAB-CAP 0.39 0.0140 ENTERIC-COATED TABLETS
Buyer DOMREPUB 100 TAB-CAP 0.30 0.0030 81 MG TABLET, ILLUSTRATIVE PACK SIZE
Buyer OECS/PPS 120 TAB-CAP 1.40 0.0117 81 MG, E.C. TABLETS
ACICLOVIR 200 mg tab-cap (PO) Price/tab-cap 4 g E J05AB01

Supplier IMRES 100 TAB-CAP 4.00 0.0400 BLISTER-PACK TABLETS
ACICLOVIR 200 mg/5 ml suspen (PO) Price/ml 4 g P J05AB01

Buyer DOMREPUB 1 BOTT (60 ml) 1.92 0.0320
Buyer OECS/PPS 1 BOTT (125 ml) 20.80 0.1664
Buyer Median Price/ml=0.1664 High/Low Ratio=9.37
ACICLOVIR 3% opht oint (OPHT) Price/g N S01AD03

Supplier MEDS 1 TUBE (4.50 g) 9.02 2.0036
Supplier DURBIN 1 TUBE (4.50 g) 20.47 4.5479
Supplier Median Price/g=3.2758 High/Low Ratio=2.27
Buyer PERU 1 TUBE (5 g) 2.37 0.4733
Buyer SAFRICA 1 TUBE (4.50 g) 22.43 4.9851
Buyer Median Price/g=2.7292 High/Low Ratio=10.53
ACICLOVIR 400 mg tab-cap (PO) Price/tab-cap 4 g P J05AB01

Buyer DOMREPUB 1 TAB-CAP 0.03 0.0300 BLISTER PACK TABLETS
Buyer CRSS 100 TAB-CAP 3.85 0.0385
ACICLOVIR 5% cream (TOP) Price/g N D06BB03

Supplier MEDEOR/TZ 1 TUBE (5 g) 0.64 0.1284
Supplier IDA 1 TUBE (2 g) 1.32 0.6599
Buyer DOMREPUB 1 TUBE (5 g) 0.18 0.0360
ACICLOVIR (DISPERSIBLE) 200 MG tab-cap (PO) Price/tab-cap 4 G EP J05AB01

ACICLOVIR (POWDER) 250 mg vial (INJ) Price/vial 4 g E J05AB01

Buyer PERU 1 VIAL 3.17 3.1717
Buyer SAFRICA 1 VIAL 5.53 5.5343

ACICLOVIR (POWDER) 250 mg vial (INJ) Price/vial 4 g E J05AB01

Buyer CRSS 1 VIAL 5.74 5.7400
Buyer DOMREPUB 1 VIAL 9.26 9.2600
Buyer Median Price/vial=5.6372 High/Low Ratio=2.92
ADENOSINE 3 mg/ml ampoule (INJ) Price/ml 15 mg N C01EB10

Buyer OECS/PPS 6 AMP (2 ml) 17.94 1.4950
Buyer SAFRICA 1 AMP (2 ml) 7.34 3.6681
ALBENDAZOLE 100 mg/5 ml suspen (PO) Price/ml 0.4 g P P02CA03

Supplier MEDS 1 BOTT (20 ml) 0.21 0.0106
Buyer PERU 1 BOTT (20 ml) 0.27 0.0136

Buyer MEMS 1 BOTT (10 ml) 0.41 0.0414
ALBENDAZOLE 200 mg tab-cap (PO) Price/tab-cap 0.4 g P P02CA03

ALBENDAZOLE 200 mg/5 ml suspen (PO) Price/ml 0.4 g P P02CA03

Supplier IMRES 1 BOTT (10 ml) 0.32 0.0320
Supplier MEDEOR/TZ 1 BOTT (10 ml) 0.34 0.0336
ALBENDAZOLE 400 mg tab-cap (PO) Price/tab-cap 0.4 g P P02CA03

ALBENDAZOLE (CHEWABLE) 200 mg tab-cap (PO) Price/tab-cap 0.4 g P P02CA03

Supplier IMRES 1000 TAB-CAP 11.00 0.0110 FLAVORED
ALBENDAZOLE (CHEWABLE) 400 mg tab-cap (PO) Price/tab-cap 0.4 g E P02CA03

ALBUMIN, HUMAN NORMAL 20-25% vial (INJ) Price/ml N B05AA01

Buyer DOMREPUB 1 AMP (50 ml) 28.16 0.5632
ALCOHOL (ETHANOL) 95-96% liquid (TOP) Price/ml N V07AV

Supplier MSD/TANZ 1 BOTT (1000 ml) 2.94 0.0029 96%
Supplier ASRAMES 1 BOTT (1000 ml) 43.35 0.0433
Buyer SAFRICA 20 BOTT (1000 ml) 44.83 0.0022 96.1%
Buyer DOMREPUB 1 BOTT (3785.41 ml 15.12 0.0040
Buyer MEMS 1 BOTT (2500 ml) 23.52 0.0094 ETHANOL, 96%
ALCOHOL, DENATURED 70% liquid (TOP) Price/ml N V07AV


ALCOHOL, DENATURED 70% liquid (TOP) Price/ml N V07AV

ALCOHOL, DENATURED 95-96% liquid (TOP) Price/ml N V07AV

ALCOHOL, ISOPROPYL 70% liquid (TOP) Price/ml N V07AV

ALENDRONATE 10 mg tab-cap (PO) Price/tab-cap N M05BA04

ALLOPURINOL 100 mg tab-cap (PO) Price/tab-cap 0.4 g E M04AA01

Supplier IMRES 100 TAB-CAP 1.75 0.0175 BLISTER PACK TABLETS
Supplier IDA 28 TAB-CAP 0.83 0.0298 7 X 4 BLISTER PACK TABLETS
ALLOPURINOL 300 mg tab-cap (PO) Price/tab-cap 0.4 g C M04AA01

ALPRAZOLAM 0.25 mg tab-cap (PO) Price/tab-cap 1 mg N N05BA12

ALPRAZOLAM 0.5 mg tab-cap (PO) Price/tab-cap 1 mg T N05BA12

ALUMINIUM HYDR.+ MAGNESIUM HYDR. 250+120 mg tab-cap (PO) Price/tab-cap P A02AB10

ALUMINIUM HYDROXIDE 500 mg tab-cap (PO) Price/tab-cap 3 g N A02AB01

Supplier IMRES 1000 TAB-CAP 5.50 0.0055 MINT-FLAVORED TABLETS
Supplier IDA 1000 TAB-CAP 6.67 0.0067 BLISTER PACK TABLETS
ALUMINIUM HYDROXIDE (CHEWABLE) 500 mg tab-cap (PO) Price/tab-cap 3 g N A02AB01

AMIDOTRIZOATE 76% ampoule (INJ) Price/ml P V08AA01

Supplier IDA 1 AMP (20 ml) 5.49 0.2744
AMIKACIN SULFATE 250 mg/ml vial (INJ) Price/ml 1 g P J01GB06

Supplier GDF 10 AMP (2 ml) 8.56 0.4280
Supplier AMSTELFAR 10 AMP (2 ml) 21.75 1.0875

AMIKACIN SULFATE 250 mg/ml vial (INJ) Price/ml 1 g P J01GB06

Buyer DOMREPUB 1 VIAL (2 ml) 0.23 0.1150
Buyer PERU 1 AMP (2 ml) 0.36 0.1819
Buyer SAFRICA 1 VIAL (2 ml) 0.40 0.1997
Buyer PERU 1 VIAL (4 ml) 1.04 0.2605
AMIKACIN SULFATE 50 mg/ml ampoule (INJ) Price/ml 1 g P J01GB06

Buyer CRSS 1 AMP (2 ml) 1.39 0.6950
AMINOPHYLLINE 100 mg tab-cap (PO) Price/tab-cap 0.6 g N R03DA05

AMINOPHYLLINE 25 mg/ml ampoule (INJ) Price/ml 0.6 g N R03DA05

Supplier MEDS 1 AMP (10 ml) 0.16 0.0157
Supplier ASRAMES 100 AMP (10 ml) 19.57 0.0196
Supplier MSD/TANZ 10 AMP (10 ml) 2.64 0.0264
Supplier DURBIN 100 AMP (10 ml) 26.55 0.0265
Supplier MEG 100 AMP (10 ml) 26.79 0.0268
Supplier IMRES 50 AMP (10 ml) 21.00 0.0420
Supplier MEDEOR/TZ 50 AMP (10 ml) 31.00 0.0620
Buyer CRSS 1 AMP (10 ml) 0.48 0.0480
Buyer PERU 1 AMP (10 ml) 0.49 0.0491
Buyer MEMS 10 AMP (10 ml) 5.87 0.0586
AMIODARONE 200 mg tab-cap (PO) Price/tab-cap 0.2 g C C01BD01

AMIODARONE 50 mg/ml vial (INJ) Price/ml 0.2 g C C01BD01

AMITRIPTYLINE 10 mg tab-cap (PO) Price/tab-cap 75 mg P N06AA09

AMITRIPTYLINE 25 mg tab-cap (PO) Price/tab-cap 75 mg E N06AA09

Supplier IMRES 1000 TAB-CAP 6.50 0.0065 HCL, COATED TABLETS
Supplier IDA 1000 TAB-CAP 7.15 0.0072 COATED TABLETS

AMITRIPTYLINE 25 mg tab-cap (PO) Price/tab-cap 75 mg E N06AA09

Buyer MEMS 1000 TAB-CAP 19.51 0.0195 TABLET
AMITRIPTYLINE 50 mg tab-cap (PO) Price/tab-cap 75 mg P N06AA09

AMLODIPINE 10 mg tab-cap (PO) Price/tab-cap 5 mg N C08CA01

Buyer DOMREPUB 100 TAB-CAP 0.43 0.0043 BLISTER PACK TABLETS, ILLUSTRATIVE PACK SIZE
Buyer OECS/PPS 500 TAB-CAP 5.80 0.0116 CAPSULES
AMLODIPINE 5 mg tab-cap (PO) Price/tab-cap 5 mg T C08CA01

Supplier IMRES 1000 TAB-CAP 7.00 0.0070 BESYLATE, BASE TABLETS
Buyer CRSS 100 TAB-CAP 0.32 0.0032 TABLETS
AMODIAQUINE 150-200 mg tab-cap (PO) Price/tab-cap 0.5 g E P01BA06

Supplier MEDEOR/TZ 1000 TAB-CAP 11.00 0.0110 200 MG TABLETS
Supplier DURBIN 1000 TAB-CAP 16.87 0.0169 200 MG TABLETS
Buyer MEMS 100 TAB-CAP 1.21 0.0121 200 MG TABLETS
AMODIAQUINE 50 mg/5 ml suspen (PO) Price/ml 0.5 g P P01BA06

AMOXICILLIN 125 mg/5 ml suspen (PO) Price/ml 1 g E J01CA04

Supplier MEDS 1 BOTT (100 ml) 0.39 0.0039 POWDER FOR SYRUP
Supplier MEDS 1 BOTT (60 ml) 0.26 0.0043 POWDER
Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.50 0.0050 POWDER
Supplier MEG 10 BOTT (100 ml) 5.07 0.0051 POWDER
Supplier IMRES 10 BOTT (100 ml) 5.40 0.0054 POWDER
Supplier MSD/TANZ 24 BOTT (100 ml) 13.20 0.0055
Supplier DURBIN 1 BOTT (100 ml) 0.69 0.0069 POWDER FOR SYRUP
Supplier AMSTELFAR 25 BOTT (100 ml) 18.80 0.0075 POWDER
Supplier MEDEOR/EU 25 BOTT (100 ml) 20.18 0.0081
Buyer SAFRICA 1 BOTT (100 ml) 0.48 0.0048 GRANULES
AMOXICILLIN 250 mg tab-cap (PO) Price/tab-cap 1 g E J01CA04

Supplier IDA 1000 TAB-CAP 17.57 0.0176 CAPSULES
Supplier MEDS 1000 TAB-CAP 17.58 0.0176 CAPSULES
Supplier UNFPA 1000 TAB-CAP 18.38 0.0184 CAPSULES
Supplier MEDEOR/TZ 1000 TAB-CAP 18.72 0.0187 CAPSULES


Supplier DURBIN 1000 TAB-CAP 19.69 0.0197 CAPSULES, ANHYDROUS
Supplier MSD/TANZ 1000 TAB-CAP 19.80 0.0198 CAPSULES
Supplier AMSTELFAR 1000 TAB-CAP 23.20 0.0232 CAPSULES
Buyer MEMS 1000 TAB-CAP 19.20 0.0192 CAPSULE
Buyer SAFRICA 100 TAB-CAP 2.07 0.0207 CAPSULES
Buyer SUDANNHIF 100 TAB-CAP 3.56 0.0356 CAPSULES, ILLUSTRATIVE PACK SIZE
AMOXICILLIN 250 mg/5 ml suspen (PO) Price/ml 1 g P J01CA04

Supplier UNFPA 10 BOTT (100 ml) 6.83 0.0068 POWDER
Supplier IDA 40 BOTT (100 ml) 27.85 0.0070 POWDER
Supplier AMSTELFAR 25 BOTT (100 ml) 24.10 0.0096 POWDER
Supplier MEDS 1 BOTT (100 ml) 1.77 0.0177 POWDER
Buyer DRC/IHP 40 BOTT (100 ml) 20.22 0.0051 POWDER
Buyer PERU 1 BOTT (60 ml) 0.47 0.0078 POWDER
Buyer OECS/PPS 1 BOTT (100 ml) 1.27 0.0127 POWDER

Supplier ASRAMES 1000 TAB-CAP 27.26 0.0273 CAPSULES
Supplier IMRES 1000 TAB-CAP 27.50 0.0275 CAPSULES
Supplier MEG 1000 TAB-CAP 31.07 0.0311 CAPSULES
Supplier DURBIN 1000 TAB-CAP 32.97 0.0330 CAPSULES, ANHYDROUS
Buyer DOMREPUB 1 TAB-CAP 0.02 0.0200 BLISTER PACK CAPSULES
Buyer DRC/IHP 1000 TAB-CAP 24.78 0.0248 CAPSULES
AMOXICILLIN (DISPERSIBLE) 125 MG tab-cap (PO) Price/tab-cap 1 G EP J01CA04

Supplier IDA 100 TAB-CAP 1.67 0.0167
AMOXICILLIN (DISPERSIBLE) 250 mg tab-cap (PO) Price/tab-cap 1 g EP J01CA04

AMOXICILLIN+CLAVULANIC ACID 1000+200 mg vial (INJ) Price/vial 1 g P J01CR02

Supplier IDA 10 VIAL 9.03 0.9030
Supplier IMRES 10 VIAL 57.50 5.7500
Supplier Median Price/vial=3.3265 High/Low Ratio=6.37
Buyer DRC/IHP 10 VIAL 6.95 0.6950
Buyer SAFRICA 1 VIAL 1.12 1.1200 POWDER
Buyer OECS/PPS 10 VIAL 16.20 1.6200
Buyer SUDANNHIF 1 VIAL 6.02 6.0185
AMOXICILLIN+CLAVULANIC ACID 250mg+125mg tab-cap (PO) Price/tab-cap 1 g P J01CR02

Supplier GDF 20 TAB-CAP 2.70 0.1350 FILM-COATED, BLISTER PACK TABLETS


AMOXICILLIN+CLAVULANIC ACID 500mg+100mg vial (INJ) Price/vial 1 g P J01CR02

AMOXICILLIN+CLAVULANIC ACID 500mg+125mg tab-cap (PO) Price/tab-cap 1 g E J01CR02

Supplier GDF 15 TAB-CAP 2.21 0.1473 FILM-COATED TABLETS
Supplier GDF 20 TAB-CAP 3.00 0.1500 BLISTER PACK, FILM-COATED TABLETS
Supplier IMRES 50 TAB-CAP 8.25 0.1650 BLISTER PACK, TABLETS
Supplier MEDEOR/EU 60 TAB-CAP 11.20 0.1866 BLISTER PACK TABLETS
Supplier MEG 50 TAB-CAP 10.77 0.2154 10 X 5 TABLETS, BLISTER PACK
Buyer DOMREPUB 1 TAB-CAP 0.09 0.0900 BLISTER PACK

AMOXICILLIN+CLAVULANIC ACID (125+31.25 MG/5ML) suspen (PO) Price/ml 1 g P J01CR02

Supplier AMSTELFAR 1 BOTT (100 ml) 3.95 0.0395
AMOXICILLIN+CLAVULANIC ACID (250+62.5 MG/5ML) suspen (PO) Price/ml 1 g P J01CR02

AMPHOTERICIN B 50 mg vial (INJ) Price/vial 35 mg E J02AA01

Supplier MEDS 1 VIAL 5.33 5.3312 IV USE ONLY
Buyer DOMREPUB 1 AMP (1 VIAL) 15.96 15.9600
AMPICILLIN 1 g vial (INJ) Price/vial 2 g E J01CA01

Supplier ASRAMES 50 VIAL 6.93 0.1386
Supplier MEG 50 VIAL 7.86 0.1572 POWDER
Supplier UNFPA 50 VIAL 8.40 0.1680 POWDER
Supplier DURBIN 50 VIAL 11.90 0.2381 POWDER, SODIUM SALT
Supplier AMSTELFAR 100 VIAL 60.90 0.6090

AMPICILLIN 1 g vial (INJ) Price/vial 2 g E J01CA01

Buyer DRC/IHP 50 VIAL 7.52 0.1504 POWDER
Buyer PERU 1 VIAL 0.29 0.2896 WITH DILUENT
Buyer MEMS 1 VIAL 1.18 1.1760
AMPICILLIN 250 mg vial (INJ) Price/vial 2 g P J01CA01

Supplier MEDS 1 VIAL 0.12 0.1232
AMPICILLIN 500 mg tab-cap (PO) Price/tab-cap 2 g P J01CA01

Supplier IMRES 100 TAB-CAP 3.50 0.0350 BLISTER PACK CAPSULES
Supplier MEDEOR/EU 1000 TAB-CAP 46.45 0.0464 TABLETS/CAPSULES
AMPICILLIN 500 mg vial (INJ) Price/vial 2 g E J01CA01

Supplier UNFPA 50 VIAL 5.20 0.1040 POWDER
Supplier MEDEOR/EU 50 VIAL 9.61 0.1922 SODIUM
Supplier MSD/TANZ 50 VIAL 14.16 0.2832 POWDER
Supplier MEDEOR/TZ 1 VIAL 0.38 0.3780 POWDER
Buyer OECS/PPS 50 AMP (1 VIAL) 8.58 0.1716
Buyer MEMS 1 VIAL 0.34 0.3450 POWDER
AMPICILLIN+SULBACTAM 1000mg+500mg vial (INJ) Price/vial 2 g N J01CR01

ANASTROZOLE 1 mg tab-cap (PO) Price/tab-cap 1 mg C L02BG03

Buyer CRSS 100 TAB-CAP 93.80 0.9380 COATED TABLETS
Buyer DOMREPUB 1 TAB-CAP 1.02 1.0200 BLISTER PACK TABLET
ANTIHAEMORRHOIDAL ointment (RECT) Price/g E C05A

Supplier IMRES 1 TUBE (30 g) 0.85 0.0283
Supplier ASRAMES 10 TUBE (30 g) 17.88 0.0596
Supplier MEDS 1 TUBE (15 g) 1.22 0.0814 CREAM/OINTMENT
ANTIHAEMORRHOIDAL suppos (RECT) Price/supp E C05A

Supplier AMSTELFAR 100 SUPP 12.95 0.1295
Supplier IMRES 100 SUPP 14.00 0.1400
Supplier ASRAMES 100 SUPP 14.06 0.1406
Supplier DURBIN 100 SUPP 14.56 0.1456 BISMUTH SUBGALL. 100 MG+ZINC OXIDE 100 MG+LIDOCAINE 60 MG
Supplier MEG 100 SUPP 14.82 0.1482
Supplier MEDS 6 SUPP 0.97 0.1624
Supplier IDA 100 SUPP 17.78 0.1778
Supplier MSD/TANZ 12 SUPP 11.52 0.9600
Supplier Median Price/supp=0.1469 High/Low Ratio=7.41
Buyer OECS/PPS 12 SUPP 4.82 0.4017 HYDROCORTISONE
Buyer MEMS 10 SUPP 5.38 0.5382
Buyer Median Price/supp=0.4700 High/Low Ratio=1.34
ANTIVENOM SERUM vial (INJ) Price/vial E J06AA03

Supplier ASRAMES 1 AMP (1 VIAL) 26.16 26.1600 10 ML
Supplier MEDS 1 VIAL 51.63 51.6320 BITIS SP, DENDROASPIS SP, NAJA SP, ECHIS CARINATUS
Supplier MSD/TANZ 1 VIAL 118.80 118.8000 CENTRAL AFRICAN SNAKE

ANTIVENOM SERUM vial (INJ) Price/vial E J06AA03

Buyer SUDANNHIF 1 VIAL 9.00 8.9954 ANTI-SCORPION VENOM
Buyer CRSS 1 VIAL 19.40 19.4000 10 ML, POLYVALENT
Buyer CRSS 1 VIAL 21.34 21.3400 10 ML, CORAL SNAKES
Buyer SUDANNHIF 1 VIAL 46.67 46.6706 ANTI-SNAKE VENOM
ARTEMETHER 20 mg/ml ampoule (INJ) Price/ml 120 mg P P01BE02

ARTEMETHER 80 mg/ml ampoule (INJ) Price/ml 120 mg C P01BE02

Supplier MEDEOR/TZ 6 AMP (0.50 ml) 5.58 1.8600
ARTEMETHER+LUMEFANTRINE 15+90mg/5ml suspen (PO) Price/ml P P01BE52

ARTEMETHER+LUMEFANTRINE 20 mg+120 mg tab-cap (PO) Price/tab-cap E P01BE52

Supplier AMSTELFAR 360 TAB-CAP 58.40 0.1622 30X12 BLISTER PACK
Supplier AMSTELFAR 240 TAB-CAP 42.80 0.1783 10X24 BLISTER PACK
ARTEMETHER+LUMEFANTRINE (6 + 1 TABLETS CO-PACK) 20 mg+120 Price/pack E P01BE52

mg tab-cap (PO)
Supplier MEDEOR/EU 30 PACK 18.45 0.6152 BLISTER PACK DISPERSIBLE TABLETS

mg tab-cap (PO)
Supplier MEDEOR/EU 30 PACK 36.56 1.2188 BLISTER PACK DISPERSIBLE TABLETS

mg tab-cap (PO)
Supplier IDA 30 PACK 49.04 1.6347 TABLETS
Supplier MEDEOR/EU 30 PACK 51.77 1.7257 BLISTER PACK TABLETS
Supplier Median Price/pack=1.6802 High/Low Ratio=1.06

mg tab-cap (PO)
Supplier MEDEOR/TZ 1 PACK 0.36 0.3600 TABLETS
Supplier IDA 30 PACK 63.49 2.1163 TABLETS
Supplier MEDEOR/EU 30 PACK 66.98 2.2326 BLISTER PACK TABLETS
ARTEMETHER+LUMEFANTRINE (DISPERSIBLE) 20 mg+120 mg tab-cap Price/tab-cap E P01BE52

(PO)
Supplier MEDEOR/TZ 180 TAB-CAP 4.84 0.0269 30 X 6 TABLETS
ARTESUNATE 60 mg vial (INJ) Price/vial E P01BE03

Supplier IMRES 1 VIAL 2.40 2.4000 WITH SODIUM CHLORIDE 5 ML & SODIUM BICARB 5% 1 ML
Supplier IDA 1 VIAL 2.57 2.5701 +SOLVENTS

ARTESUNATE+AMODIAQUINE (12 + 12 TABLETS CO-PACK) 50 mg+153 Price/pack E P01B

mg tab-cap (PO)
Supplier ASRAMES 1 PACK 0.88 0.8800 BLISTER PACK TABLETS
Supplier MEG 10 PACK 10.38 1.0380 BLISTER
Supplier IMRES 1 PACK 1.45 1.4500 TABLETS

mg tab-cap (PO)
Supplier MEG 10 PACK 2.86 0.2860 BLISTER PACK TABLETS
ARTESUNATE+AMODIAQUINE (3 FIXED DOSE COMBO TABS) Price/treatmen P P01B

100mg+270mg tab-cap (PO)
Supplier IMRES 1 TREATMENT 0.85 0.8500 BLISTER PACK TABLETS
Supplier IDA 25 TREATMENT 23.20 0.9280 TABLETS
Supplier ASRAMES 1 TREATMENT 1.52 1.5200 BLISTER PACK TABLETS
Supplier Median Price/treatmen=0.9280 High/Low Ratio=1.79
ARTESUNATE+AMODIAQUINE (3 FIXED DOSE COMBO TABS) Price/treatmen P P01B

25mg+67.5mg tab-cap (PO)
Supplier ASRAMES 1 TREATMENT 0.52 0.5200 BILSTER PACK TABLETS
ARTESUNATE+AMODIAQUINE (3 FIXED DOSE COMBO TABS) 50 mg+135 Price/treatmen P P01B

mg tab-cap (PO)

mg tab-cap (PO)
ARTESUNATE+AMODIAQUINE (6 FIXED-DOSE COMBO TABS) Price/treatmen P P01B

100mg+270mg tab-cap (PO)
Supplier ASRAMES 1 TREATMENT 1.14 1.1400 BLISTER PACK TABLETS
Supplier IMRES 1 TREATMENT 1.50 1.5000 BLISTER PACK TABLETS
ARTESUNATE+AMODIAQUINE (FDC) 50 mg+153 mg tab-cap (PO) Price/tab-cap P P01B

Supplier ASRAMES 3 TAB-CAP 0.86 0.2867 BLISTER PACK TABLETS
ARTESUNATE+SULFADOXINE/PYRIMETHAMINE (6 TAB ARTES.+3 TAB Price/pack E P01BD51

SP CO-PACK) 100+500/25mg tab-cap (PO)
ASPARAGINASE 1,000 IU/ml ampoule (INJ) Price/ml P L01XX02

Buyer CRSS 1 AMP (10 ml) 42.00 4.2000
ASPARAGINASE 10,000 IU/ml vial (INJ) Price/ml C L01XX02

Buyer DOMREPUB 1 AMP (4 ml) 58.83 14.7075 POWDER
ATAZANAVIR 150 mg tab-cap (PO) Price/tab-cap 0.3 g E J05AE08

ATAZANAVIR+RITONAVIR 300+100 mg tab-cap (PO) Price/tab-cap N J05AR

ATENOLOL 100 mg tab-cap (PO) Price/tab-cap 75 mg E C07AB03



Buyer SUDANNHIF 100 TAB-CAP 3.33 0.0333 TABLET, ILLUSTRATIVE PACK SIZE

ATORVASTATIN 10 mg tab-cap (PO) Price/tab-cap 20 mg N C10AA05

ATORVASTATIN 20 mg tab-cap (PO) Price/tab-cap 20 mg T C10AA05

ATORVASTATIN 40 mg tab-cap (PO) Price/tab-cap 20 mg N C10AA05

Buyer PERU 1 TAB-CAP 3.25 3.2494 TABLET
ATOVAQUONE+PROGUANIL 250mg+100mg tab-cap (PO) Price/tab-cap 4 tab N P01BB51

ATRACURIUM 10 mg/ml ampoule (INJ) Price/ml N M03AC04

Buyer BOTSWANA 1 AMP (2.50 ml) 1.69 0.6760
Buyer DOMREPUB 1 AMP (2.50 ml) 1.87 0.7480
ATROPINE SULFATE 0.25 mg/ml ampoule (INJ) Price/ml 1.5 mg P A03BA01

ATROPINE SULFATE 0.5 mg/ml ampoule (INJ) Price/ml 1.5 mg P A03BA01

Buyer OECS/PPS 100 AMP (1 ml) 36.40 0.3640 IM/IV/SC
ATROPINE SULFATE 1 mg/ml ampoule (INJ) Price/ml 1.5 mg E A03BA01

Supplier UNFPA 100 AMP (1 ml) 10.50 0.1050

ATROPINE SULFATE 1 mg/ml ampoule (INJ) Price/ml 1.5 mg E A03BA01

Supplier MEDEOR/EU 50 AMP (1 ml) 22.12 0.4424
Buyer DRC/IHP 100 AMP (1 ml) 10.34 0.1034
ATROPINE SULFATE 1% opht drop (OPHT) Price/ml E S01FA01

Supplier DURBIN 1 BOTT (10 ml) 17.90 1.7897
Buyer SAFRICA 1 BOTT (5 ml) 2.13 0.4267 DROPPER
AZATHIOPRINE 50 mg tab-cap (PO) Price/tab-cap 0.15 g C L04AX01

AZITHROMYCIN 200 mg/5 ml suspen (PO) Price/ml 0.3 g E J01FA10

Supplier UNFPA 1 BOTT (15 ml) 0.84 0.0560
AZITHROMYCIN 250 mg tab-cap (PO) Price/tab-cap 0.3 g E J01FA10

Supplier IDA 6 TAB-CAP 0.90 0.1505 BLISTER PACK CAPSULES
Supplier IMRES 4 TAB-CAP 0.75 0.1875 FILM-COATED TABLETS, BLISTER PACK
Supplier UNFPA 4 TAB-CAP 0.79 0.1969 FILM-COATED, BLISTER-PACK TABLETS
AZITHROMYCIN 500 mg tab-cap (PO) Price/tab-cap 0.3 g E J01FA10

Supplier IMRES 3 TAB-CAP 0.70 0.2333 BLISTER PACK, FILM-COATED TABLETS
Supplier UNFPA 500 TAB-CAP 279.96 0.5599 TABLETS
Buyer DOMREPUB 1 TAB-CAP 0.10 0.1000 CAPSULES
BALANCED SALT SOLUTION solution (OPHT) Price/ml N S01XA


BALANCED SALT SOLUTION solution (TOP) Price/ml N B05CB10

Buyer CRSS 1 BAG (500 ml) 8.78 0.0176
BALANCED SALT SOLUTION solution (OPHT) Price/ml N S01XA

BARIUM SULFATE powder (PO) Price/kg P V08BA02

Supplier MEDEOR/TZ 1 BAG (3.50 kg) 132.30 37.8000
Buyer OECS/PPS 24 BAG (0.39 kg) 742.50 79.3269 397 GM
BECLOMETASONE 100 mcg/dose inhaler (INH) Price/dose 0.8 mg P R03BA01

Supplier MEDS 1 INHALER (200 DOSE) 2.25 0.0113
Supplier DURBIN 1 INHALER (200 DOSE) 15.84 0.0792
Supplier Median Price/dose=0.0453 High/Low Ratio=7.01
Buyer SAFRICA 200 DOSE 3.20 0.0160
BECLOMETASONE 250 mcg/dose inhaler (INH) Price/dose 0.8 mg E R03BA01

Buyer PERU 1 INHALER (200 DOSE) 2.82 0.0141
Buyer OECS/PPS 1 INHALER (200 DOSE) 3.97 0.0198
Buyer Median Price/dose=0.0170 High/Low Ratio=1.40
BECLOMETASONE 50 mcg nasal (N/T) Price/dose 0.4 mg E R01AD01

Buyer OECS/PPS 1 BOTT (200 DOSE) 2.54 0.0127
BECLOMETASONE 50 mcg/dose inhaler (INH) Price/dose 0.8 mg E R03BA01

Supplier MEG 1 INHALER (200 DOSE) 2.05 0.0102
Supplier IMRES 1 INHALER (200 DOSE) 2.80 0.0140
Supplier AMSTELFAR 1 INHALER (200 DOSE) 3.00 0.0150
Supplier IDA 1 INHALER (200 DOSE) 3.06 0.0153
Supplier MEDEOR/EU 1 INHALER (200 DOSE) 3.53 0.0176
Buyer SAFRICA 1 INHALER (200 DOSE) 2.36 0.0118
Buyer OECS/PPS 1 INHALER (200 DOSE) 2.86 0.0143 CFC-FREE
Buyer DOMREPUB 1 INHALER (200 DOSE) 2.90 0.0145
BENDROFLUMETHIAZIDE 2.5 mg tab-cap (PO) Price/tab-cap 2.5 mg T C03AA01

BENDROFLUMETHIAZIDE 5 mg tab-cap (PO) Price/tab-cap 2.5 mg T C03AA01

BENZATROPINE MESILATE 1 mg/ml ampoule (INJ) Price/ml 2 mg N N04AC01

BENZATROPINE MESILATE 2 mg tab-cap (PO) Price/tab-cap 2 mg N N04AC01

BENZOIC & SALICYLIC ACID (WHITFIELD'S) 6% + 3% ointment Price/g N D01AE20

(TOP)
Supplier MEDS 1 JAR (400 g) 1.84 0.0046
Supplier ASRAMES 1 JAR (800 g) 4.04 0.0050
Supplier IDA 1 JAR (800 g) 6.95 0.0087
Supplier AMSTELFAR 1 JAR (500 g) 5.70 0.0114
Supplier DURBIN 1 JAR (500 g) 6.42 0.0128
Supplier MSD/TANZ 1 TUBE (40 g) 0.54 0.0135
Supplier MEG 1 JAR (500 g) 7.50 0.0150
Buyer MEMS 1 TUBE (40 g) 0.38 0.0095

BENZYL BENZOATE 25% lotion (TOP) Price/ml E P03AX01

Supplier MEDS 1 BOTT (5000 ml) 10.64 0.0021 EMULSION
Supplier MEG 1 BOTT (1000 ml) 4.00 0.0040
Supplier MSD/TANZ 12 BOTT (100 ml) 5.46 0.0046 EMULSION
Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.50 0.0050 EMULSION
Buyer DRC/IHP 1 BOTT (1000 ml) 3.09 0.0031
BENZYL BENZOATE (CONCENTRATED) 90% solution (TOP) Price/ml P P03AX01

BETAMETHASONE 4 mg/ml ampoule (INJ) Price/ml 1.5 mg N H02AB01

BETAMETHASONE (OPHT/OTIC) 0.1% opht drop (OPHT) Price/ml P S03BA03

BETAMETHASONE VALERATE 0.1% cream (TOP) Price/g E D07AC01

Supplier MEDS 1 TUBE (15 g) 0.24 0.0157
Supplier AMSTELFAR 50 TUBE (15 g) 30.20 0.0403
Supplier MEG 50 TUBE (15 g) 37.14 0.0495
Supplier MEDEOR/EU 50 TUBE (15 g) 38.36 0.0511
Supplier DURBIN 10 TUBE (15 g) 8.13 0.0542
Buyer SAFRICA 1 TUBE (50 g) 0.68 0.0137
Buyer CRSS 1 TUBE (15 g) 0.54 0.0360
Buyer MEMS 1 TUBE (15 g) 0.77 0.0516
Buyer OECS/PPS 1 TUBE (15 g) 1.18 0.0787
BETAMETHASONE VALERATE 0.1% ointment (TOP) Price/g E D07AC01

Buyer CRSS 1 TUBE (15 g) 1.03 0.0687
BEVACIZUMAB 25 mg/ml vial (INJ) Price/ml C L01XC07

BICALUTAMIDE 50 mg tab-cap (PO) Price/tab-cap 50 mg C L02BB03

BIPERIDEN 2 mg tab-cap (PO) Price/tab-cap 10 mg E N04AA02

BISACODYL 10 mg suppos (RECT) Price/supp 10 mg N A06AB02


BISACODYL 10 mg suppos (RECT) Price/supp 10 mg N A06AB02

Buyer OECS/PPS 50 SUPP 5.11 0.1022
BISACODYL 5 mg tab-cap (PO) Price/tab-cap 10 mg N A06AB02

Supplier IDA 1000 TAB-CAP 7.02 0.0070 ENTERIC COATED TABLETS
Supplier IMRES 100 TAB-CAP 1.10 0.0110 ENTERIC-COATED TABLETS
Supplier MEDEOR/EU 1000 TAB-CAP 11.40 0.0114 DRAGEES
BISOPROLOL 5 mg tab-cap (PO) Price/tab-cap 10 mg E C07AB07

BLEOMYCIN 15 IU vial (INJ) Price/vial C L01DC01

Supplier IDA 1 VIAL 38.76 38.7595 POWDER
Buyer DOMREPUB 1 VIAL 18.24 18.2400 POWDER
Buyer SAFRICA 1 AMP (1 VIAL) 20.73 20.7334
BROMOCRIPTINE MESILATE 2.5 mg tab-cap (PO) Price/tab-cap 40 mg N G02CB01

BUDESONIDE 100 mcg/dose inhaler (PO) Price/dose 0.8 mg E R03BA02

BUDESONIDE 200 mcg/dose inhaler (PO) Price/dose 0.8 mg E R03BA02

BUPIVACAINE HCL 0.25% ampoule (INJ) Price/ml E N01BB01

BUPIVACAINE HCL 0.5% ampoule (INJ) Price/ml E N01BB01

Supplier SCMS 5 VIAL (20 ml) 3.21 0.0321
Supplier IMRES 5 VIAL (20 ml) 6.00 0.0600
Supplier MEG 10 VIAL (20 ml) 15.18 0.0759
Supplier AMSTELFAR 10 VIAL (20 ml) 16.40 0.0820
Supplier IDA 10 VIAL (20 ml) 16.60 0.0830
Supplier MEDS 1 AMP (4 ml) 0.62 0.1540 HEAVY, SPINAL
Supplier MEDEOR/TZ 1 VIAL (20 ml) 4.64 0.2322
Buyer PERU 1 AMP (20 ml) 0.61 0.0304
Buyer OECS/PPS 1 VIAL (20 ml) 2.10 0.1050
Buyer DRC/IHP 20 AMP (4 ml) 15.28 0.1910 SPINAL HEAVY
BUPIVACAINE HCL + DEXTROSE 0.5% + 8% ampoule (INJ) Price/ml E N01BB51


BUPIVACAINE HCL + DEXTROSE 0.5% + 8% ampoule (INJ) Price/ml E N01BB51

BUPIVACAINE HCL + EPINEPHRINE (0.5% + 1:200,000) vial Price/ml N N01BB51

(INJ)
CALAMINE lotion (TOP) Price/ml E D02AB

Supplier MEDS 1 BOTT (1000 ml) 2.89 0.0029 15%
Supplier IMRES 1 BOTT (100 ml) 0.75 0.0075 15%
CALCIUM FOLINATE 15 mg tab-cap (PO) Price/tab-cap 60 mg C V03AF03

CALCIUM FOLINATE 50 mg vial (INJ) Price/vial 60 mg P V03AF03

CALCIUM GLUCONATE 100 mg/ml ampoule (INJ) Price/ml 3 g E A12AA03

Supplier MEDS 1 AMP (10 ml) 0.54 0.0538 10%
Buyer PERU 1 AMP (10 ml) 0.23 0.0226
Buyer CRSS 1 AMP (10 ml) 0.92 0.0920
Buyer MEMS 1 AMP (10 ml) 1.34 0.1344
CALCIUM LACTATE 250-300 mg tab-cap (PO) Price/tab-cap 2 g P A12AA05

Supplier MEDEOR/EU 1000 TAB-CAP 4.63 0.0046 300 MG TABLETS
Supplier IMRES 1000 TAB-CAP 15.00 0.0150 300 MG TABLETS
Supplier IDA 1000 TAB-CAP 23.76 0.0238 300 MG TABLET
Buyer MEMS 1000 TAB-CAP 16.80 0.0168 300 MG TABLET
CAMPHOR 10% ointment (TOP) Price/g N M02AB

CAPECITABINE 150 mg tab-cap (PO) Price/tab-cap C L01BC06

CAPECITABINE 500 mg tab-cap (PO) Price/tab-cap C L01BC06

CAPREOMYCIN 0.5 g vial (INJ) Price/vial 1 g CP J04AB30

Supplier GDF 1 VIAL 2.99 2.9900 POWDER


CAPREOMYCIN 1 g vial (INJ) Price/vial 1 g C J04AB30

Supplier GDF 1 VIAL 6.25 6.2500 POWDER FOR INJECTION
Buyer BOTSWANA 1 VIAL 7.79 7.7900 POWDER

Buyer SAFRICA 1 VIAL 8.98 8.9839 10 ML
CAPTOPRIL 12.5 mg tab-cap (PO) Price/tab-cap 50 mg T C09AA01

CAPTOPRIL 25 mg tab-cap (PO) Price/tab-cap 50 mg T C09AA01

Supplier MEDEOR/EU 1000 TAB-CAP 9.12 0.0091 SCORED TABLETS
CAPTOPRIL 50 mg tab-cap (PO) Price/tab-cap 50 mg T C09AA01

CARBAMAZEPINE 100 mg/5 ml suspen (PO) Price/ml 1 g E N03AF01

CARBAMAZEPINE 200 mg tab-cap (PO) Price/tab-cap 1 g E N03AF01

Buyer PERU 100 TAB-CAP 1.77 0.0177 TABLET, ILLUSTRATIVE PACK SIZE
CARBAMAZEPINE (SUSTAINED-RELEASE) 200 mg tab-cap (PO) Price/tab-cap 1 g E N03AF01

CARBIMAZOLE 5 mg tab-cap (PO) Price/tab-cap 15 mg N H03BB01

Supplier MEDS 100 TAB-CAP 2.46 0.0246 BLISTER PACK TABLETS

CARBIMAZOLE 5 mg tab-cap (PO) Price/tab-cap 15 mg N H03BB01

CARBOPLATIN 150 mg vial (INJ) Price/vial C L01XA02

CARBOPLATIN 450 mg vial (INJ) Price/vial C L01XA02

CARVEDILOL 12.5 mg tab-cap (PO) Price/tab-cap 37.5 mg T C07AG02

Buyer SAFRICA 30 TAB-CAP 1.00 0.0334 TABLETS, SCORED IN QUARTERS
CARVEDILOL 25 mg tab-cap (PO) Price/tab-cap 37.5 mg T C07AG02

CARVEDILOL 6.25 mg tab-cap (PO) Price/tab-cap 37.5 mg N C07AG02


CEFADROXIL 250 mg/5 ml suspen (PO) Price/ml 2 g N J01DA09

Buyer DOMREPUB 1 BOTT (120 ml) 1.09 0.0091 POWDER
CEFADROXIL MONOHYDRATE 500 mg tab-cap (PO) Price/tab-cap 2 g N J01DA09

CEFALEXIN 125 mg/5 ml suspen (PO) Price/ml 2 g E J01DA01

Supplier DURBIN 1 BOTT (100 ml) 1.80 0.0180 SYRUP

CEFALEXIN 125 mg/ml suspen (PO) Price/ml 2 g P J01DA01

CEFALEXIN 250 mg tab-cap (PO) Price/tab-cap 2 g E J01DA01

Supplier MEDEOR/EU 1000 TAB-CAP 44.93 0.0449 CAPSULES
Supplier DURBIN 100 TAB-CAP 6.17 0.0617 CAPSULES

CEFALEXIN 250 mg/5 ml suspen (PO) Price/ml 2 g E J01DA01

CEFALEXIN 500 mg tab-cap (PO) Price/tab-cap 2 g P J01DA01

CEFAZOLIN 1 g vial (INJ) Price/vial 3 g E J01DA04

CEFAZOLIN 500 mg ampoule (INJ) Price/vial 3 g P J01DA04

CEFEPIME 1 g vial (INJ) Price/vial 2 g T J01DA24

CEFIXIME 100 mg/5 ml suspen (PO) Price/ml 0.4 g P J01DA23

CEFIXIME 200 mg tab-cap (PO) Price/tab-cap 0.4 g P J01DA23

Supplier MEG 100 TAB-CAP 19.07 0.1907 25 X 4 BLISTER PACK TABLETS
Supplier ASRAMES 100 TAB-CAP 19.62 0.1962 BILSTER PACK TABLETS
Buyer DRC/IHP 100 TAB-CAP 12.73 0.1273 BLISTER PACK TABLETS
CEFIXIME 400 mg tab-cap (PO) Price/tab-cap 0.4 g E J01DA23

Supplier UNFPA 10 TAB-CAP 4.20 0.4200 FILM-COATED, BLISTER-PACK TABLETS
Buyer SAFRICA 1 TAB-CAP 2.09 2.0865 TABLET
CEFOTAXIME 1 g vial (INJ) Price/vial 4 g CP J01DA10

CEFOTAXIME 500 mg vial (INJ) Price/vial 4 g CP J01DA10

CEFTAZIDIME 1 g vial (INJ) Price/vial 4 g P J01DA11


CEFTAZIDIME 1 g vial (INJ) Price/vial 4 g P J01DA11

CEFTAZIDIME 250 mg vial (INJ) Price/vial 4 g C J01DD02

CEFTRIAXONE 1 g vial (INJ) Price/vial 2 g E J01DA13

Supplier MEDS 1 VIAL 0.54 0.5376 IV/IM
Supplier MEDEOR/EU 10 VIAL 16.59 1.6589 POWDER
Buyer DRC/IHP 10 VIAL 2.47 0.2470 POWDER
CEFTRIAXONE 250 mg vial (INJ) Price/vial 2 g E J01DA13

Supplier MEDS 1 VIAL 0.52 0.5152 IV/IM
Supplier MEDEOR/TZ 1 VIAL 0.68 0.6810
CEFTRIAXONE 500 mg vial (INJ) Price/vial 2 g P J01DA13

Supplier MEDS 1 VIAL 1.23 1.2320 IM
Supplier MEDS 1 VIAL 1.34 1.3440 IV
CEFUROXIME 1.5 g vial (INJ) Price/vial 3 g N J01DA06

CEFUROXIME 125 mg/5 ml suspen (PO) Price/ml 0.5 g N J01DA06

Buyer BOTSWANA 1 BOTT (100 ml) 4.32 0.0432

CEFUROXIME 250 mg tab-cap (PO) Price/tab-cap 0.5 g N J01DA06


CEFUROXIME 250 mg tab-cap (PO) Price/tab-cap 0.5 g N J01DA06

CEFUROXIME 500 mg tab-cap (PO) Price/tab-cap 0.5 g N J01DC02

CEFUROXIME 750 mg vial (INJ) Price/vial 3 g N J01DA06

Supplier DURBIN 10 VIAL 16.70 1.6698 POWDER
CETIRIZINE 10 mg tab-cap (PO) Price/tab-cap 10 mg N R06AE07

Buyer DOMREPUB 1 TAB-CAP 0.01 0.0100 TABLET
CETIRIZINE 5 mg/5 ml syrup (PO) Price/ml 10 mg N R06AE07

CETRIMIDE+CHLORHEXIDINE GLUCONATE 15%+1.5% solution (TOP) Price/ml P D08AC52

Supplier MEDEOR/TZ 1 BOTT (5000 ml) 18.00 0.0036 1 JERRYCAN
Supplier MEG 1 BOTT (1000 ml) 4.71 0.0047 DI-GLUCONATE
Supplier DURBIN 1 BOTT (1000 ml) 5.39 0.0054 CONCENTRATE
CHARCOAL, ACTIVATED 125 mg tab-cap (PO) Price/tab-cap 5 g P A07BA01

CHLORAMBUCIL 2 mg tab-cap (PO) Price/tab-cap C L01AA02

CHLORAMINE 500 mg tab-cap (TOP) Price/tab-cap N

Supplier IMRES 1000 TAB-CAP 15.50 0.0155 TOSYLCHLORAMIDE
CHLORAMPHENICOL 0.5% opht drop (OPHT) Price/ml P S01AA01


CHLORAMPHENICOL 0.5% opht drop (OPHT) Price/ml P S01AA01

CHLORAMPHENICOL 1% opht oint (OPHT) Price/g P S01AA01

Supplier MSD/TANZ 100 TUBE (3.50 g) 12.72 0.0363
Supplier MEDEOR/TZ 1 TUBE (3.50 g) 0.18 0.0514
Buyer MEMS 1 TUBE (3.50 g) 0.21 0.0591
Buyer SAFRICA 1 TUBE (3.50 g) 0.50 0.1437
Buyer DOMREPUB 1 TUBE (3.50 g) 2.74 0.7829
CHLORAMPHENICOL 10 mcg disc (DIAG) Price/each N V07AR

Supplier MSD/TANZ 50 DISC (1 EACH) 4.44 0.0888
CHLORAMPHENICOL 125 mg/5 ml suspen (PO) Price/ml 3 g P J01BA01

Supplier ASRAMES 10 BOTT (100 ml) 3.14 0.0031 PALMITATE
Supplier MSD/TANZ 24 BOTT (100 ml) 13.86 0.0058 SYRUP
Supplier DURBIN 1 BOTT (100 ml) 0.94 0.0094 PALMITATE
Supplier MEDEOR/EU 10 BOTT (60 ml) 12.93 0.0215 PALMITATE
CHLORAMPHENICOL 250 mg tab-cap (PO) Price/tab-cap 3 g E J01BA01

Buyer MEMS 1000 TAB-CAP 30.36 0.0304 CAPSULES
CHLORAMPHENICOL 5% otic drop (OTIC) Price/ml P S02AA01


CHLORAMPHENICOL 500 mg tab-cap (PO) Price/tab-cap 3 g P J01BA01

Buyer PERU 100 TAB-CAP 5.09 0.0509 CAPSULES, ILLUSTRATIVE PACK SIZE
CHLORAMPHENICOL (BASE) 1 g vial (INJ) Price/vial 3 g E J01BA01

Supplier ASRAMES 50 VIAL 24.51 0.4902 SODIUM SUCCINATE
Supplier MEDEOR/EU 50 VIAL 24.81 0.4963
Supplier DURBIN 50 VIAL 25.26 0.5052 POWDER, SODIUM SUCCINATE
Supplier MEG 50 VIAL 25.38 0.5076 SODIUM SUCCINATE, POWDER

CHLORAMPHENICOL (BASE) 1 g vial (INJ) Price/vial 3 g E J01BA01

Supplier IMRES 50 VIAL 26.00 0.5200 SODIUM SUCCINATE
Buyer DRC/IHP 50 VIAL 20.22 0.4044 SODIUM SUCCINATE
CHLORAMPHENICOL IN OIL 250 mg/ml ampoule (INJ) Price/ml 3 g E J01BA01

CHLORAMPHENICOL+DEXAMETHASONE 0.5%+0.1% opht drop (OPHT) Price/ml N S01AA20

CHLORHEXIDINE 1% cream (TOP) Price/g P D08AC02

CHLORHEXIDINE GLUCONATE 20% solution (TOP) Price/ml P D08AC02

Supplier IMRES 1 BOTT (5000 ml) 47.50 0.0095 DI-GLUCONATE
CHLORHEXIDINE GLUCONATE 5% solution (TOP) Price/ml E D08AC02

Supplier UNFPA 1 BOTT (1000 ml) 3.10 0.0031 DI-GLUCONATE
Supplier IMRES 1 BOTT (1000 ml) 4.25 0.0043 DI-GLUCONATE
Supplier DURBIN 1 BOTT (1000 ml) 5.39 0.0054 DIGLUCONATE
CHLORHEXIDINE SURGICAL SCRUB 4% liquid (TOP) Price/ml P D08AC02

Buyer SAFRICA 5 LITER (1000 ml) 14.49 0.0029 DRUM
CHLOROQUINE (BASE) 100 mg tab-cap (PO) Price/tab-cap 0.5 g E P01BA01

CHLOROQUINE (BASE) 150 mg tab-cap (PO) Price/tab-cap 0.5 g E P01BA01

Supplier DURBIN 1000 TAB-CAP 14.56 0.0146 TABLETS, PHOSPHATE
Supplier IMRES 100 TAB-CAP 2.10 0.0210 242 MG BLISTER PACK TABLETS, PHOSPHATE
Buyer OECS/PPS 1000 TAB-CAP 29.70 0.0297 SULFATE TABLETS
CHLOROQUINE (BASE) 50 mg/5 ml syrup (PO) Price/ml 0.5 g E P01BA01

CHLOROXYLENOL 4.8% solution (N/A) Price/ml E D08AE05

Supplier MEDEOR/TZ 1 BOTT (5000 ml) 10.08 0.0020 1 JERRYCAN

CHLOROXYLENOL 4.8% solution (N/A) Price/ml E D08AE05

Supplier MEDS 1 BOTT (5000 ml) 24.47 0.0049 5%
Buyer MEMS 1 BOTT (5000 ml) 30.91 0.0062 5%
CHLORPHENAMINE MALEATE 10 mg/ml ampoule (INJ) Price/ml 12 mg E R06AB04

Buyer OECS/PPS 100 AMP (2 ml) 43.55 0.2177 IV/IM/SC
CHLORPHENAMINE MALEATE 2 mg/5 ml elixir (PO) Price/ml 6 mg P R06AB02

Supplier MEDS 1 BOTT (5000 ml) 2.54 0.0005 SYRUP
Buyer PERU 1 BOTT (120 ml) 0.30 0.0025 SYRUP

CHLORPHENAMINE MALEATE 4 mg tab-cap (PO) Price/tab-cap 12 mg E R06AB04

Supplier DURBIN 1000 TAB-CAP 3.94 0.0039 HYDROGEN, TABLETS
CHLORPROMAZINE HCL 100 mg tab-cap (PO) Price/tab-cap 0.3 g C N05AA01

Supplier IMRES 1000 TAB-CAP 17.00 0.0170 COATED TABLETS



CHLORPROMAZINE HCL 25 mg/ml ampoule (INJ) Price/ml 0.1 g C N05AA01

Buyer MEMS 1 AMP (2 ml) 0.28 0.1380

CHLORPROPAMIDE 250 mg tab-cap (PO) Price/tab-cap 0.375 g T A01BB02

CHLORTHALIDONE 50 mg tab-cap (PO) Price/tab-cap 25 mg N C03BA04

Buyer OECS/PPS 100 TAB-CAP 3.75 0.0375 SCORED TABLETS
CICLOSPORIN 100 mg tab-cap (PO) Price/tab-cap 0.25 g P S01XA18

CICLOSPORIN 100 mg/ml solution (PO) Price/ml 0.25 g CP S01XA18

CICLOSPORIN 25 mg tab-cap (PO) Price/tab-cap 0.25 g C S01XA18

CIMETIDINE 100 mg/ml vial (INJ) Price/ml 0.8 g T A02BA01

CIMETIDINE 200 mg tab-cap (PO) Price/tab-cap 0.8 g T A02BA01

CIMETIDINE 400 mg tab-cap (PO) Price/tab-cap 0.8 g T A02BA01

CIPROFLOXACIN 2 mg/ml vial (INJ) Price/ml 0.5 g P J01MA02

Supplier MEDEOR/TZ 1 VIAL (100 ml) 0.48 0.0048 INFUSION

CIPROFLOXACIN 2 mg/ml vial (INJ) Price/ml 0.5 g P J01MA02

Supplier IMRES 1 BOTT (100 ml) 1.00 0.0100 FOR INFUSION, NIPPLEHEAD
Buyer MEMS 1 VIAL (100 ml) 0.76 0.0076
Buyer SAFRICA 1 BOTT (200 ml) 4.21 0.0210 LACTATE, INFUSION
CIPROFLOXACIN 250 mg tab-cap (PO) Price/tab-cap 1 g E J01MA02

Supplier IMRES 100 TAB-CAP 2.00 0.0200 FILM-COATED TABLETS
Supplier DURBIN 100 TAB-CAP 3.43 0.0343 TABLETS, HYDROCHLORIDE
CIPROFLOXACIN 250 mg/5 ml suspen (PO) Price/ml 1 g E J01MA02

CIPROFLOXACIN 3 mg/ml opht drop (OPHT) Price/ml P S01AX13

CIPROFLOXACIN 500 mg tab-cap (PO) Price/tab-cap 1 g P J01MA02

Supplier IDA 100 TAB-CAP 4.51 0.0451 TABLETS, BLISTER PACK
Supplier UNFPA 100 TAB-CAP 4.99 0.0499 FILM-COATED TABLETS
CISATRACURIUM 2 mg/ml ampoule (INJ) Price/ml N M03AC11

Buyer SAFRICA 1 AMPOULE (5 ml) 5.63 1.1268
CISPLATIN 1 mg/ml vial (INJ) Price/ml C L01XA01

Buyer BOTSWANA 1 VIAL (50 ml) 8.47 0.1694


CISPLATIN 10 mg vial (INJ) Price/ml C L01XA01

CISPLATIN 50 mg vial (INJ) Price/vial C L01XA01

CITALOPRAM 20 mg tab-cap (PO) Price/tab-cap 20 mg N N06AB04

CLARITHROMYCIN 125 mg/5 ml suspen (PO) Price/ml 0.5 g N J01FA09

CLARITHROMYCIN 250 mg tab-cap (PO) Price/tab-cap 0.5 g N J01FA09

Supplier GDF 14 TAB-CAP 4.01 0.2864 BILSTER PACK, FILM-COATED TABLETS
CLARITHROMYCIN 250 mg/5 ml suspen (PO) Price/ml 0.5 g N J01FA09

CLARITHROMYCIN 500 mg tab-cap (PO) Price/tab-cap 0.5 g N J01FA09

Supplier IMRES 14 TAB-CAP 5.50 0.3929 FILM-COATED, BLISTER PACK TABLETS
Supplier GDF 14 TAB-CAP 6.22 0.4443 BLISTER PACK FILM-COATED TABLETS
CLINDAMYCIN 300 mg tab-cap (PO) Price/tab-cap 1.2 g P J01FF01

CLINDAMYCIN (BASE) 150 mg tab-cap (PO) Price/tab-cap 0.1 g C J01FF01


CLINDAMYCIN (BASE) 150 mg/ml vial (INJ) Price/ml 1.8 g C J01FF01

CLOBETASOL PROPRIONATE 0.05% cream (TOP) Price/g N D07AD01

Buyer PERU 1 TUBE (25 g) 0.37 0.0148
CLOFAZIMINE (LAMPRENE) 100 mg tab-cap (PO) Price/tab-cap 0.1 g E J04BA01

Supplier GDF 100 TAB-CAP 126.72 1.2672 CAPSULES

Supplier GDF 100 TAB-CAP 66.70 0.6670 CAPSULES

CLOMIFENE 50 mg tab-cap (PO) Price/tab-cap 9 mg C G03GB02


CLOMIPRAMINE 25 mg tab-cap (PO) Price/tab-cap 0.1 g E N06AA04

CLONAZEPAM 0.5 mg tab-cap (PO) Price/tab-cap 8 mg N N03AE01

CLONAZEPAM 2 mg tab-cap (PO) Price/tab-cap 8 mg N N03AE01

CLONAZEPAM 2.5 mg/ml drops (PO) Price/ml 8 mg N N03AE01

Buyer CRSS 1 BOTT (10 ml) 1.66 0.1660
CLOPIDOGREL BISULFATE 75 mg tab-cap (PO) Price/tab-cap 75 mg E B01AC04

Buyer SICA 14 TAB-CAP 0.36 0.0257 COATED, BLISTER PACK TABLETS
CLOTRIMAZOLE 1% cream (TOP) Price/g E D01AC01

Buyer PERU 1 TUBE (20 g) 0.25 0.0125
Buyer PERU 1 TUBE (30 g) 0.39 0.0128
CLOTRIMAZOLE 1% cream (VAG) Price/g 0.1 g E G01AF02

CLOTRIMAZOLE 1% cream (TOP) Price/g E D01AC01

Buyer MEMS 1 TUBE (15 g) 0.48 0.0322
CLOTRIMAZOLE 1% cream (VAG) Price/g 0.1 g E G01AF02

CLOTRIMAZOLE 100 mg pessary (VAG) Price/pessary 0.1 g E G01AF02

Supplier MSD/TANZ 6 PESS 0.36 0.0600 WITH APPLICATOR
Supplier IMRES 6 PESS 0.45 0.0750
Supplier MEDEOR/TZ 6 PESS 0.50 0.0840 WITH APPLICATOR


Supplier AMSTELFAR 6 PESS 1.25 0.2083 WITH APPLICATOR
Supplier IDA 6 PESS 1.53 0.2547
Supplier UNFPA 6 PESS 16.20 2.7003
Supplier Median Price/pessary=0.1462 High/Low Ratio=45.01
Buyer DOMREPUB 1 PESS 0.03 0.0300
Buyer MEMS 6 PESS 0.59 0.0977
Buyer OECS/PPS 6 PESS 3.36 0.5600
Buyer Median Price/pessary=0.0977 High/Low Ratio=18.67

Supplier IMRES 100 PESS 7.50 0.0750 10 X 10 BLISTER PACK, 10 APPLICATORS
Supplier UNFPA 100 PESS 16.20 0.1620 BLISTER PACK 10 X 10, WITH APPLICATOR
Supplier AMSTELFAR 100 PESS 17.95 0.1795 10 X 10
Supplier ASRAMES 1 PESS 0.22 0.2200 BLISTER PACK
Buyer PERU 100 PESS 8.84 0.0884 ILLUSTRATIVE PACK SIZE
Buyer DRC/IHP 1 PESS 0.19 0.1900
Buyer SAFRICA 1 PESS 0.80 0.8035 WITH APPLICATOR
Buyer Median Price/pessary=0.1900 High/Low Ratio=9.09
CLOXACILLIN SODIUM 125 mg/5 ml suspen (PO) Price/ml 2 g T J01CF02

Supplier DURBIN 1 BOTT (100 ml) 1.37 0.0137 POWDER FOR SYRUP, SODIUM SALT
CLOXACILLIN SODIUM 250 mg tab-cap (PO) Price/tab-cap 2 g T J01CF02

Supplier MEDEOR/TZ 1000 TAB-CAP 18.00 0.0180
CLOXACILLIN SODIUM 250 mg vial (INJ) Price/vial 2 g T J01CF02

CLOXACILLIN SODIUM 500 mg tab-cap (PO) Price/tab-cap 2 g T J01CF02




CLOZAPINE 100 mg tab-cap (PO) Price/tab-cap 0.3 g C N05AH02

CLOZAPINE 25 mg tab-cap (PO) Price/tab-cap 0.3 g C N05AH02

CODEINE (IC) 30 mg tab-cap (PO) Price/tab-cap 0.1 g E R05DA04

Supplier DURBIN 1000 TAB-CAP 35.88 0.0359 TABLETS, PHOSPHATE
Supplier MEDS 100 TAB-CAP 7.95 0.0795 TABLETS, PHOSPHATE
COLCHICINE 0.5-0.6 mg tab-cap (PO) Price/tab-cap 1 mg N M04AC01

Buyer PERU 100 TAB-CAP 2.05 0.0205 0.5 MG TABLET, ILLUSTRATIVE PACK SIZE
Buyer OECS/PPS 100 TAB-CAP 5.14 0.0514 0.5 MG TABLETS
Buyer SAFRICA 50 TAB-CAP 3.95 0.0790 0.5 MG TABLETS
CONDOM, FEMALE condom (N/A) Price/condom P V07AY

Supplier UNFPA 1 CONDOM 0.49 0.4935 CUPID
Supplier UNFPA 1 CONDOM 0.63 0.6300 FC2
Supplier IDA 1000 CONDOM 854.24 0.8542
Supplier ASRAMES 100 CONDOM 94.87 0.9487
Supplier Median Price/condom=0.7421 High/Low Ratio=1.92
CONDOMS (LUBRICATED) condom (N/A) Price/condom E V07AY

Supplier UNFPA 144 CONDOM 4.17 0.0289 53 MM
Supplier UNFPA 144 CONDOM 4.56 0.0316 THICK CONDOMS, 0.1 MM
Supplier IDA 144 CONDOM 6.25 0.0434
Supplier MEG 144 CONDOM 6.53 0.0453
Supplier ASRAMES 144 CONDOM 11.38 0.0790
Supplier Median Price/condom=0.0341 High/Low Ratio=2.73
COUGH PREPARATION syrup (PO) Price/ml N R05D

Supplier MEDS 1 BOTT (5000 ml) 6.68 0.0013 EXPECTORANT
Supplier MEDS 1 BOTT (100 ml) 0.38 0.0038 SUPPRESSANT
Supplier MSD/TANZ 24 BOTT (100 ml) 14.04 0.0058 ADULT, EXPECTORANT
Supplier MSD/TANZ 24 BOTT (100 ml) 16.20 0.0067 CHILD, EXPECTORANT
Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.72 0.0072 ANTI-TUSSIVE
Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.72 0.0072 EXPECTORANT
Buyer DOMREPUB 1 BOTT (120 ml) 0.34 0.0028 SUPPRESSANT
Buyer OECS/PPS 1 BOTT (2000 ml) 11.77 0.0059 EXPECTORANT
Buyer MEMS 1 BOTT (100 ml) 0.80 0.0080 EXPECTORANT, ADULT
CROMOGLICIC ACID (SODIUM CROMOGLICATE) 2% opht drop (OPHT) Price/ml N S01GX01

CYCLOPENTOLATE 1% opht drop (OPHT) Price/ml N S01FA04


CYCLOPHOSPHAMIDE 1 g vial (INJ) Price/vial P L01AA01


CYCLOPHOSPHAMIDE 200 mg vial (INJ) Price/vial P L01AA01

CYCLOPHOSPHAMIDE 50 mg tab-cap (PO) Price/tab-cap P L01AA01

CYCLOPHOSPHAMIDE 500 mg vial (INJ) Price/vial C L01AA01

Buyer SICA 1 VIAL 3.98 3.9800

Buyer CRSS 1 VIAL 8.68 8.6800 20 ML
CYCLOSERINE 250 mg tab-cap (PO) Price/tab-cap 0.75 g C J04AB01

Supplier GDF 100 TAB-CAP 33.00 0.3300 HARD CAPSULES
Supplier GDF 100 TAB-CAP 43.00 0.4300 BLISTER PACK HARD CAPSULES
CYPROTERONE ACETATE 50 mg tab-cap (PO) Price/tab-cap 0.1 g N G03HA01

CYTARABINE 100 mg vial (INJ) Price/vial C L01BC01

Buyer SAFRICA 1 VIAL 2.24 2.2391 WITH DILUENT
Buyer PERU 1 VIAL 4.34 4.3408 NO PRESERVATIVES
CYTARABINE 500 mg vial (INJ) Price/vial C L01BC01

DACARBAZINE 200 mg vial (INJ) Price/vial P L01AX04

DACTINOMYCIN 500 mcg vial (INJ) Price/vial C L01DA01

DANAZOL 200 mg tab-cap (PO) Price/tab-cap 0.6 g N G03XA01

DAPSONE 100 mg tab-cap (PO) Price/tab-cap 50 mg E J04BA02


DAPSONE 100 mg tab-cap (PO) Price/tab-cap 50 mg E J04BA02

DARUNAVIR 300 mg tab-cap (PO) Price/tab-cap 1.2 g EP J05AE10

DAUNORUBICIN 20 mg vial (INJ) Price/vial CP L01DB02

Buyer PERU 1 VIAL 37.18 37.1849 CHLORHYDRATE
DEFEROXAMINE MESILATE 500 mg ampoule (INJ) Price/ampoule E V03AC01

Buyer SAFRICA 1 VIAL (1 AMPOULE) 6.76 6.7579 POWDER
DETERMINE CHASE BUFFER vial (N/A) Price/ml N V07AZ

Supplier IMRES 1 BOTT (2.50 ml) 10.00 4.0000 FOR 100 DETERMINE TESTS (HEP.B, HIV 1&2, SYPHILIS)
Supplier IDA 1 BOTT (2.50 ml) 10.42 4.1677
Buyer DRC/IHP 100 VIAL (2.50 ml) 8.21 0.0328
DEXAMETHASONE 0.1% opht drop (OPHT) Price/ml P S01BA01

Buyer SAFRICA 1 BOTT (5 ml) 1.10 0.2206 PHOSPHATE SOLUTION, DROPPER
DEXAMETHASONE 0.5 mg tab-cap (PO) Price/tab-cap 1.5 mg E H02AB02

DEXAMETHASONE 4 mg/ml ampoule (INJ) Price/ml 1.5 mg E H02AB02

Supplier IMRES 100 AMP (1 ml) 8.75 0.0875 SODIUM PHOSPHATE
Supplier MEG 100 AMP (1 ml) 22.94 0.2294 SODIUM PHOSPHATE
Supplier UNFPA 100 AMP (1 ml) 24.15 0.2415 SODIUM PHOSPHATE
Buyer OECS/PPS 100 VIAL (1 ml) 32.25 0.3225 SODIUM PHOSPHATE
DEXAMETHASONE 5 mg/ml ampoule (INJ) Price/ml 1.5 mg P H02AB02

Buyer DRC/IHP 100 AMP (1 ml) 8.25 0.0825 SODIUM PHOSPHATE
DEXTRAN 70 6% IN SOD. CHLORIDE 0.9% solution (IV) Price/ml E B05AA05

DEXTROSE 10% IN WATER solution (IV) Price/ml E B05BA03

Supplier ASRAMES 1 BAG (500 ml) 0.58 0.0012


Buyer SAFRICA 1 BAG (1000 ml) 1.25 0.0013
Buyer OECS/PPS 24 BAG (500 ml) 21.81 0.0018
DEXTROSE 2.5% IN SOD. CHLORIDE 0.45% solution (IV) Price/ml P B05BB02

Supplier IDA 12 BAG (1000 ml) 16.95 0.0014
DEXTROSE 4.3-5% IN WATER solution (IV) Price/ml E B05BA03

Supplier MSD/TANZ 24 BAG (500 ml) 10.56 0.0009 5%
DEXTROSE 5% IN SODIUM CHLORIDE 0.45% solution (IV) Price/ml P B05BB02

DEXTROSE 5% IN SODIUM CHLORIDE 0.9% solution (IV) Price/ml P B05BB02

Supplier MEDS 1 BAG (1000 ml) 0.87 0.0009
Buyer PERU 1 BAG (1000 ml) 2.28 0.0023

Buyer DRC/IHP 20 BOTT (500 ml) 6.36 0.0006 WITH NIPPLE
DEXTROSE 50% IN WATER (HYPERTONIC) solution (IV) Price/ml E B05BA03

Supplier MEDS 1 VIAL (50 ml) 0.66 0.0132

DEXTROSE 50% IN WATER (HYPERTONIC) solution (IV) Price/ml E B05BA03

Supplier MSD/TANZ 1 BAG (100 ml) 3.96 0.0396
Supplier DURBIN 25 VIAL (50 ml) 66.36 0.0531
Supplier MEDEOR/EU 25 VIAL (50 ml) 73.27 0.0586
Buyer PERU 1 BAG (1000 ml) 1.89 0.0019
Buyer DRC/IHP 20 VIAL (50 ml) 9.89 0.0099
DIALYSIS SOL. PERITONEAL W/ DEXTROSE 1.5% solution (IV) Price/ml C V07A

Buyer DOMREPUB 1 BAG (2000 ml) 6.77 0.0034
DIAZEPAM (IC) 10 mg tab-cap (PO) Price/tab-cap 10 mg E N05BA01

DIAZEPAM (IC) 5 mg tab-cap (PO) Price/tab-cap 10 mg E N05BA01

DIAZEPAM (IC) 5 mg/ml ampoule (INJ) Price/ml 10 mg E N05BA01

Supplier MEDS 1 AMP (2 ml) 0.13 0.0672 IM/IV
Buyer OECS/PPS 100 AMP (2 ml) 39.00 0.1950 IM/IV
DICLOFENAC 1% ointment (TOP) Price/g N D11AX18

DICLOFENAC 1.8 mg/ml suspen (PO) Price/ml N S01BC03

DICLOFENAC 100 mg suppos (RECT) Price/supp 0.1 g N M01AB05


DICLOFENAC 100 mg suppos (RECT) Price/supp 0.1 g N M01AB05

DICLOFENAC 12.5 mg suppos (RECT) Price/supp N S01BC03

Buyer DOMREPUB 1 SUPP 0.23 0.2300
DICLOFENAC SODIUM 0.1% opht drop (OPHT) Price/ml N S01BC03

DICLOFENAC SODIUM 25 mg tab-cap (PO) Price/tab-cap 0.1 g N M01AB05

Supplier MEG 100 TAB-CAP 0.79 0.0079 10 X 10 BLISTER PACK ENTERIC-COATED TABLETS
DICLOFENAC SODIUM 25 mg/ml ampoule (INJ) Price/ml 0.1 g N M01AB05

Supplier MEDS 1 AMP (3 ml) 0.06 0.0187 IM
DICLOFENAC SODIUM 50 mg tab-cap (PO) Price/tab-cap 0.1 g N M01AB05

Supplier MEG 1000 TAB-CAP 6.25 0.0063 ENTERIC-COATED TABLETS
Supplier AMSTELFAR 1000 TAB-CAP 22.20 0.0222 ENTERIC COATED TABLET
Buyer DRC/IHP 1000 TAB-CAP 5.46 0.0055 ENTERIC-COATED TABLETS
DICLOFENAC SODIUM (SUSTAINED-RELEASE) 75 mg tab-cap (PO) Price/tab-cap 0.1 g N M01AB05

DICLOXACILLIN 250 mg tab-cap (PO) Price/tab-cap 2 g E J01CF01

DICLOXACILLIN 500 mg tab-cap (PO) Price/tab-cap 2 g N J01CF01

DICLOXACILLIN 500 mg vial (INJ) Price/vial 2 g P J01CF01

DIDANOSINE (CHEWABLE, DISPERSIBLE) 200 mg tab-cap (PO) Price/tab-cap 0.4 g N J05AF02


DIDANOSINE (CHEWABLE, DISPERSIBLE) 200 mg tab-cap (PO) Price/tab-cap 0.4 g N J05AF02
DIDANOSINE (DDI) 10 mg/ml powder (PO) Price/g 0.4 g N J05AF02

Supplier SCMS 1 PACKET (2 g) 13.22 6.6098 RECONSTITUTE TO 200 ML
DIDANOSINE (DDI) 200 mg tab-cap (PO) Price/tab-cap 0.4 g N J05AF02



Supplier IDA 30 TAB-CAP 24.36 0.8120 ENTERIC-COATED TABLETS
Buyer SAFRICA 30 TAB-CAP 11.15 0.3717 ENTERIC-COATED TABLETS
DIDANOSINE (DDI, CHEWABLE) 100 mg tab-cap (PO) Price/tab-cap 0.4 g N J05AF02


Buyer SAFRICA 60 TAB-CAP 4.25 0.0709 DISPERSIBLE TABLETS

DIDANOSINE (DDI, DELAYED-RELEASE) 125 mg tab-cap (PO) Price/tab-cap 0.4 g N J05AF02

Supplier SCMS 30 TAB-CAP 8.93 0.2975 CAPSULES



DIDANOSINE (DISPERSIBLE) 400 mg tab-cap (PO) Price/tab-cap 0.4 g N J05AF02

DIETHYLCARBAMAZINE CITRATE 50 mg tab-cap (PO) Price/tab-cap 0.4 g C P02CB02

DIGOXIN 0.05 mg/ml solution (PO) Price/ml 0.25 mg E C01AA05

Buyer OECS/PPS 1 BOTT (60 ml) 6.76 0.1127 PEDIATRIC ELIXIR
DIGOXIN 0.125 mg tab-cap (PO) Price/tab-cap 0.25 mg P C01AA05

DIGOXIN 0.25 mg tab-cap (PO) Price/tab-cap 0.25 mg E C01AA05


DIGOXIN 0.25 mg tab-cap (PO) Price/tab-cap 0.25 mg E C01AA05

Buyer CRSS 100 TAB-CAP 22.00 0.2200 SCORED TABLETS
DIGOXIN 0.25 mg/ml ampoule (INJ) Price/ml 0.25 mg E C01AA05

DIHYDROARTEMISININ + PIPERAQUINE 40 + 320 mg tab-cap (PO) Price/tab-cap N P01B

DIHYDROCODEINE (IC) 30 mg tab-cap (PO) Price/tab-cap 0.15 g N N02AA08

DILTIAZEM HCL 60 mg tab-cap (PO) Price/tab-cap 0.24 g N C08DB01

Buyer DOMREPUB 1 TAB-CAP 0.08 0.0800 BLISTER PACK SCORED TABLET
DIMENHYDRINATE 50 mg tab-cap (PO) Price/tab-cap N R06AA02

DIMENHYDRINATE 50 mg/ml vial (INJ) Price/ml N R06AA02

DIPHENHYDRAMINE 25 mg tab-cap (PO) Price/tab-cap 0.3 g T R06AA02

DOBUTAMINE 12.5 mg/ml vial (INJ) Price/ml 0.5 g N C01CA07

Buyer SICA 1 VIAL (20 ml) 1.30 0.0650


DOCETAXEL 20 mg vial (INJ) Price/vial C L01CD02

Buyer PERU 1 VIAL 7.84 7.8410 0.5 ML
Buyer DOMREPUB 1 AMP (1 VIAL) 10.83 10.8300 1.5 ML
DOCETAXEL 40 mg vial (INJ) Price/vial C L01CD02

Buyer OECS/PPS 1 VIAL 108.00 108.0000 2 ML
DOCETAXEL 80 mg vial (INJ) Price/vial CP L01CD02

Buyer DOMREPUB 1 VIAL 27.89 27.8900 6 ML
DOPAMINE HCL 40 mg/ml ampoule (INJ) Price/ml 0.5 g C C01CA04

DORZOLAMIDE CHLORHYDRATE 2% opht drop (OPHT) Price/ml 0.3 ML N S01EC03

DOXAZOSIN 4 mg tab-cap (PO) Price/tab-cap 4 mg N C02CA04

DOXORUBICIN HCL 10 mg vial (INJ) Price/vial C L01DB01

Buyer SAFRICA 1 VIAL 2.14 2.1383 FREEZE-DRIED POWDER

DOXORUBICIN HCL 50 mg vial (INJ) Price/vial C L01DB01


DOXYCYCLINE 100 mg tab-cap (PO) Price/tab-cap 0.1 g C J01AA02

Supplier IMRES 1000 TAB-CAP 13.00 0.0130 FILM-COATED TABLETS, HYCLATE
Supplier DURBIN 1000 TAB-CAP 16.18 0.0162 TABLETS, HYCLATE
Supplier AMSTELFAR 1000 TAB-CAP 18.15 0.0181 FILM-COATED TABLETS
Buyer DRC/IHP 1000 TAB-CAP 10.63 0.0106 HYCLATE, TABLETS
DROPERIDOL 2.5 mg/ml ampoule (INJ) Price/ml N N01AX01


DROPERIDOL 2.5 mg/ml ampoule (INJ) Price/ml N N01AX01
EFAVIRENZ (EFV) 100 mg tab-cap (PO) Price/tab-cap 0.6 g E J05AG03


EFAVIRENZ (EFV) 30 mg/ml syrup (PO) Price/ml 0.6 g P J05AG03

Supplier SCMS 1 BOTT (180 ml) 17.81 0.0989 SOLUTION


EFAVIRENZ+EMTRICITABINE+TENOFOVIR DF (600+200+300 MG) tab- Price/tab-cap E J05AR06

cap (PO)
Buyer SAFRICA 28 TAB-CAP 10.00 0.3572

EFAVIRENZ+LAMIVUDINE+TENOFOVIR DISOP. (600+300+300 MG) Price/tab-cap P J05AR

tab-cap (PO)
ENALAPRIL 10 mg tab-cap (PO) Price/tab-cap 10 mg P C09AA02



ENOXAPARIN 100 mg syringe (INJ) Price/syringe 2 TU E B01AB05

Buyer SAFRICA 1 SYRINGE 4.03 4.0318

Buyer DOMREPUB 1 SYRINGE 2.03 2.0300


Buyer OECS/PPS 2 SYRINGE 8.78 4.3900
Buyer Median Price/syringe=3.2100 High/Low Ratio=2.16

Buyer SAFRICA 1 SYRINGE 1.90 1.9038 0.4 ML
Buyer DOMREPUB 1 SYRINGE 2.65 2.6500
Buyer CRSS 1 SYRINGE 3.34 3.3400
Buyer PERU 1 SYRINGE 3.39 3.3943

Buyer SAFRICA 1 SYRINGE 2.90 2.9004 0.6 ML
Buyer PERU 1 SYRINGE 3.41 3.4119

EPHEDRINE 0.5% nasal (NASA) Price/ml P R01AA03

EPHEDRINE 30 mg/ml vial (INJ) Price/ml 50 mg P R03CA02

Supplier MSD/TANZ 10 VIAL (1 ml) 13.50 1.3500
EPHEDRINE HCL 30 mg tab-cap (PO) Price/tab-cap 50 mg C R03CA02

EPHEDRINE SULFATE 50 mg/ml ampoule (INJ) Price/ml 50 mg P R03CA02

Supplier ASRAMES 100 AMP (1 ml) 19.18 0.1918 HCL
EPINEPHRINE (ADRENALINE) 1 mg/ml ampoule (INJ) Price/ml 0.5 mg E C01CA24

EPIRUBICIN 10 mg vial (INJ) Price/vial N L01DB03




EPOETIN ALPHA 2000 IU vial (INJ) Price/vial N B03XA02

Buyer OECS/PPS 6 SYRINGE (1 VIAL) 6.40 1.0667
EPOETIN ALPHA 4000 IU vial (INJ) Price/vial N B03XA02

Buyer OECS/PPS 6 SYRINGE (1 VIAL) 7.95 1.3250
Buyer DOMREPUB 1 SYRINGE (1 VIAL) 2.96 2.9600
EPOETIN BETA 50,000 IU vial (INJ) Price/vial N B03XA

Buyer CRSS 1 VIAL 149.60 149.6000
ERGOMETRINE MALEATE 0.2 mg tab-cap (PO) Price/tab-cap 0.2 mg N G02AB03

ERGOMETRINE MALEATE 0.2 mg/ml ampoule (INJ) Price/ml 0.2 mg E G02AB03


ERGOMETRINE MALEATE 0.5 mg tab-cap (PO) Price/tab-cap 0.2 mg N G02AB03

ERGOMETRINE MALEATE 0.5 mg/ml ampoule (INJ) Price/ml 0.2 mg P G02AB03

ERGOTAMINE+CAFFEINE 1+100 mg tab-cap (PO) Price/tab-cap N N02CA52

ERYTHROMYCIN 15 mcg disc (DIAG) Price/each N V07AR

ERYTHROMYCIN (BASE) 125 mg/5 ml suspen (PO) Price/ml 1 g E J01FA01

Supplier MEDS 1 BOTT (100 ml) 0.63 0.0063 STEARATE SYRUP
Supplier MEG 1 BOTT (100 ml) 1.02 0.0102 POWDER, AS STEARATE
Supplier IMRES 10 BOTT (100 ml) 12.00 0.0120 ESTOLATE
Supplier DURBIN 1 BOTT (100 ml) 1.28 0.0128 POWDER FOR SYRUP, AS ETHYL SUCCINATE OR ETHYL STEARATE

ERYTHROMYCIN (BASE) 125 mg/5 ml suspen (PO) Price/ml 1 g E J01FA01

Supplier MEDEOR/EU 12 BOTT (100 ml) 20.87 0.0174 ETHYLSUCCINATE
Buyer SAFRICA 1 BOTT (100 ml) 0.93 0.0093 ESTOLATE
ERYTHROMYCIN (BASE) 250 mg tab-cap (PO) Price/tab-cap 1 g E J01FA01

Supplier MEDS 1000 TAB-CAP 29.06 0.0291 STEARATE TABLETS
Supplier MEG 1000 TAB-CAP 35.83 0.0358 STEARATE, FILM-COATED TABLETS
Supplier IDA 1000 TAB-CAP 39.32 0.0393 TABLETS, AS STEARATE
Supplier DURBIN 1000 TAB-CAP 41.53 0.0415 TABLETS, AS ETHYL SUCCINATE OR ETHYL STEARATE
Supplier AMSTELFAR 1000 TAB-CAP 47.30 0.0473 STEARATE TABLETS
Supplier MEDEOR/EU 1000 TAB-CAP 51.49 0.0515 STEARATE, TABLETS
ERYTHROMYCIN (BASE) 250 mg/5 ml suspen (PO) Price/ml 1 g P J01FA01

Supplier IMRES 10 BOTT (100 ml) 20.00 0.0200 ESTOLATE BASE
Supplier IDA 1 BOTT (100 ml) 7.85 0.0785 POWDER
Buyer SAFRICA 1 BOTT (100 ml) 1.41 0.0141 ESTOLATE
Buyer PERU 1 BOTT (60 ml) 0.88 0.0147 POWDER
ERYTHROMYCIN (BASE) 500 mg tab-cap (PO) Price/tab-cap 1 g P J01FA01

Supplier MEG 500 TAB-CAP 37.14 0.0743 STEARATE, TABLETS
Supplier IMRES 500 TAB-CAP 41.00 0.0820 BLISTER PACK FILM-COATED TABLETS
Supplier AMSTELFAR 1000 TAB-CAP 89.90 0.0899 STEARATE TABLETS
ERYTHROMYCIN LACTOBIONATE 500 mg vial (INJ) Price/vial 1 g E J01FA01

ESTROGENS, CONJUGATED 0.625 mg tab-cap (PO) Price/tab-cap 0.625 mg N G03CA57

ETHAMBUTOL 100 mg tab-cap (PO) Price/tab-cap 1.2 g E J04AK02

Supplier GDF 100 TAB-CAP 3.60 0.0360 10 FILM-COATED TABLETS PER BLISTER PACK SHEET
ETHAMBUTOL 400 mg tab-cap (PO) Price/tab-cap 1.2 g E J04AK02

Buyer OECS/PPS 100 TAB-CAP 2.87 0.0287 10 X 10 BLISTER PACK TABLETS
Buyer SAFRICA 100 TAB-CAP 5.25 0.0525 BLISTER PACK 10 X 10 TABLETS
ETHAMBUTOL+ISONIAZID 400mg+150 mg tab-cap (PO) Price/tab-cap E J04AM03


ETHAMBUTOL+ISONIAZID 400mg+150 mg tab-cap (PO) Price/tab-cap E J04AM03

Supplier GDF 672 TAB-CAP 22.27 0.0331 28 FILM-COATED TABLETS PER BLISTER SHEET
ETHER, ANAESTHETIC solution (INH) Price/ml E N01AA01

ETHINYLESTRADIOL+DESOGESTREL 0.03+0.15mg tab-cap (PO) Price/cycle N G03FB10

Supplier UNFPA 1 CYCLE 0.72 0.7245 28 TABLETS
ETHINYLESTRADIOL+LEVONORGESTREL 0.03+0.15 mg tab-cap (PO) Price/cycle E G03FA11

Supplier UNFPA 1 CYCLE 0.25 0.2520 WITH FERROUS FUMARATE 75 MG
Supplier IMRES 3 CYCLE 1.50 0.5000
Supplier DURBIN 3 CYCLE 1.54 0.5138 28 TABLETS/CYCLE, IRON
Supplier AMSTELFAR 3 CYCLE 1.55 0.5167
Supplier IDA 200 CYCLE 183.10 0.9155 TABLETS
Supplier Median Price/cycle=0.5138 High/Low Ratio=3.63
Buyer PERU 1 CYCLE 0.17 0.1731 28 TABLETS
Buyer SAFRICA 1 CYCLE 0.22 0.2167 28 TABLETS
Buyer OECS/PPS 1 CYCLE 1.76 1.7600 21-DAY
Buyer Median Price/cycle=0.2167 High/Low Ratio=10.17
ETHINYLESTRADIOL+NORGESTREL 0.05+0.5 mg tab-cap (PO) Price/cycle N G03FA10

Buyer SAFRICA 1 CYCLE 0.27 0.2741 28 BLISTER-PACK TABLETS
ETHIONAMIDE 125 mg tab-cap (PO) Price/tab-cap 0.75 g C J04AD03

Supplier GDF 90 TAB-CAP 10.06 0.1118 FILM-COATED TABLETS IN BLISTER PACK
ETHIONAMIDE 250 mg tab-cap (PO) Price/tab-cap 0.75 g C J04AD03

ETHOSUXIMIDE 250 mg tab-cap (PO) Price/tab-cap 1.25 g C N03AD01

ETOMIDATE 2 mg/ml ampoule (INJ) Price/ml N N01AX07

ETONOGESTREL 68 mg/rod rod (SC) Price/rod 68 mcg N G03AC08

Supplier UNFPA 1 ROD 8.93 8.9250 SET
Supplier ASRAMES 1 ROD 13.29 13.2900
Supplier Median Price/rod=11.1075 High/Low Ratio=1.49
Buyer SAFRICA 1 ROD 10.02 10.0172 WITH APPLICATOR
ETOPOSIDE 20 mg/ml vial (INJ) Price/ml C L01CB01

Buyer CRSS 1 VIAL (5 ml) 3.24 0.6480
Buyer BOTSWANA 1 VIAL (5 ml) 4.15 0.8300
ETRAVIRINE 100 mg tab-cap (PO) Price/tab-cap 0.4 g N J05AG04

FACTOR VIIA 100,000 U vial (INJ) Price/vial 6 TU N B02BD05

FACTOR VIII 1000 IU vial (INJ) Price/vial 500 U C B02BD02




Buyer SAFRICA 1 VIAL 119.61 119.6142 HEAT TREATED
Buyer CRSS 1 VIAL 497.50 497.5000
FAMOTIDINE 20 mg tab-cap (PO) Price/tab-cap 40 mg T A02BA03

Buyer DOMREPUB 100 TAB-CAP 0.62 0.0062 BLISTER PACK TABLET, ILLUSTRATIVE PACK SIZE
FAMOTIDINE 40 mg tab-cap (PO) Price/tab-cap 40 mg T A02BA03

FENTANYL CITRATE (IC) 50 mcg/ml vial (INJ) Price/ml N N01AH01


FERROUS SALT 20 mg/ml suspen (PO) Price/ml 0.2 g P B03AA

Buyer PERU 1 BOTT (30 ml) 2.83 0.0944 25 MG/ML, SOLUTION
FERROUS SALT 40 mg/ml solution (PO) Price/ml 0.2 g P B03AA

Supplier DURBIN 1 BOTT (200 ml) 9.42 0.0471 45 MG/5 ML SYRUP, FUMARATE
FERROUS SALT (IRON=60-65 MG) 200 mg tab-cap (PO) Price/tab-cap 0.2 g E B03AA
Supplier UNFPA 1000 TAB-CAP 1.58 0.0016 SUGAR-COATED TABLETS, 60-65 MG FE
Supplier MEG 1000 TAB-CAP 2.13 0.0021 SULFATE, TABLETS
Supplier ASRAMES 1000 TAB-CAP 2.28 0.0023 TABLETS, SULFATE
Supplier IMRES 1000 TAB-CAP 2.50 0.0025 SUGAR-COATED TABLETS, SULFATE
Supplier MEDS 1000 TAB-CAP 2.96 0.0030 TABLETS, SULFATE
Supplier AMSTELFAR 5000 TAB-CAP 14.85 0.0030 65 MG IRON, COATED TABLET
Supplier MEDEOR/EU 5000 TAB-CAP 24.12 0.0048 SULFATE TABLETS
Buyer OECS/PPS 1000 TAB-CAP 21.00 0.0210 60 MG IRON SULFATE TABLETS
FERROUS SALT+FOLIC ACID (IRON=60 MG) 200 mg+0.4mg tab-cap Price/tab-cap 0.2 g E B03AD
(PO)
Supplier UNFPA 1000 TAB-CAP 2.21 0.0022 COATED TABLETS
Supplier MEG 1000 TAB-CAP 2.50 0.0025 SUGAR-COATED TABLETS
Supplier IMRES 1000 TAB-CAP 2.95 0.0030 COATED TABLETS, SULFATE
Supplier MEDEOR/EU 5000 TAB-CAP 30.34 0.0061 COATED TABLETS
FERROUS SALT+FOLIC ACID (IRON=60 MG) 200+0.25 mg tab-cap Price/tab-cap 0.2 g P B03AD
(PO)
Supplier ASRAMES 1000 TAB-CAP 2.10 0.0021 TABLETS, FERROUS SULFATE
Supplier IMRES 1000 TAB-CAP 2.75 0.0027 COATED TABLETS, SULFATE
Supplier MEG 1000 TAB-CAP 2.75 0.0027 SULFATE, TABLETS

FERROUS SULFATE 125 mg/ml drops (PO) Price/ml 0.2 g EP B03AA07

FILGRASTIM 300 mcg/ml vial (INJ) Price/ml 0.35 mg C L03AA02

FILGRASTIM 480mcg/0.8ml syringe (INJ) Price/syringe 0.35 mg C L03AA02

FILGRASTIM 480mcg/1.6ml vial (INJ) Price/vial 0.35 mg C L03AA02

FLUCLOXACILLIN 250 mg tab-cap (PO) Price/tab-cap 2 g N J01CF05

FLUCONAZOLE 100 mg tab-cap (PO) Price/tab-cap 0.2 g P J02AC01


Buyer OECS/PPS 1 TAB-CAP 0.41 0.4100 TABLET
FLUCONAZOLE 2 mg/ml vial (INJ) Price/ml 0.2 g E J02AC01


Buyer CRSS 100 TAB-CAP 5.94 0.0594 CAPSULES
FLUCONAZOLE 50 mg tab-cap (PO) Price/tab-cap 0.2 g E J02AC01

FLUCONAZOLE 50 mg/5 ml suspen (PO) Price/ml 0.2 g E J02AC01

FLUDARABINE PHOSPHATE 50 mg vial (INJ) Price/vial C L01BB05

FLUMAZENIL 0.1 mg/ml vial (INJ) Price/ml N V03AB25


FLUMAZENIL 0.1 mg/ml vial (INJ) Price/ml N V03AB25

FLUOCINOLONE 0.025% cream (TOP) Price/g N D07AC04

Buyer SAFRICA 1 TUBE (15 g) 1.22 0.0813 OINTMENT
FLUORESCEIN 100 mg/ml ampoule (INJ) Price/ml EP S01JA01

FLUORESCEIN SODIUM opht strp (OPHT) Price/each P S01JA01

Supplier MEDS 100 EACH 4.85 0.0485
Supplier IMRES 100 STRIPS (1 EACH) 7.25 0.0725
Supplier MEDEOR/TZ 100 STRIPS (1 EACH) 9.83 0.0983
Supplier DURBIN 100 STRIPS (1 EACH) 12.67 0.1267
Supplier Median Price/each=0.0854 High/Low Ratio=2.61
Buyer OECS/PPS 100 STRIPS (1 EACH) 15.22 0.1522
FLUOROURACIL 25 mg/ml vial (INJ) Price/ml P L01BC02

FLUOROURACIL 50 mg/ml ampoule (INJ) Price/ml C L01BC02

Buyer PERU 1 AMP (10 ml) 1.19 0.1187
FLUOXETINE 20 mg tab-cap (PO) Price/tab-cap 20 mg E N06AB03

FLUPHENAZINE DECANOATE 25 mg/ml ampoule (INJ) Price/ml 1 mg E N05AB02

Supplier DURBIN 10 AMP (1 ml) 8.48 0.8477 OILY, LONG-ACTING INJECTION
FLUTAMIDE 250 mg tab-cap (PO) Price/tab-cap 0.75 g N L02BB01

FOLIC ACID 1 mg tab-cap (PO) Price/tab-cap 0.4 mg E B03BB01





FORMALDEHYDE 40% liquid (N/A) Price/ml N V04C

Buyer MEMS 1 BOTT (5000 ml) 34.78 0.0070 37%, TECHNICAL GRADE
FUROSEMIDE 10 mg/ml ampoule (INJ) Price/ml 40 mg E C03CA01

FUROSEMIDE 10 mg/ml solution (PO) Price/ml 40 mg P C03CA01

Buyer SAFRICA 1 BOTT (100 ml) 20.09 0.2009 CALIBRATED DROPPER
FUROSEMIDE 40 mg tab-cap (PO) Price/tab-cap 40 mg E C03CA01

FUSIDIC ACID 2% cream (TOP) Price/g N D06AX01

Buyer PERU 1 TUBE (15 g) 1.95 0.1302
GABAPENTIN 100 mg tab-cap (PO) Price/tab-cap 1.8 g N N03AX12





GANCICLOVIR 500 mg vial (INJ) Price/vial 0.5 g N J05AB06

GEMCITABINE 1 g vial (INJ) Price/vial C L01BC05

GEMCITABINE 200 mg vial (INJ) Price/vial C L01BC05

GEMFIBROZIL 600 mg tab-cap (PO) Price/tab-cap 1.2 g N C10AB04

Buyer CRSS 100 TAB-CAP 6.82 0.0682 SCORED, COATED TABLETS
GENTAMICIN 10 mcg disc (DIAG) Price/each N V07AR

GENTAMICIN (BASE) 0.3% opht drop (OPHT) Price/ml E S01AA11

GENTAMICIN SULFATE 10 mg/ml ampoule (INJ) Price/ml 0.24 g E J01GB03




GENTIAN VIOLET (METHYLROSANILINIUM CHLORIDE) powder (TOP) Price/g N D01AE02

Supplier ASRAMES 1 PACKET (25 g) 1.20 0.0480
Supplier IMRES 1 JAR (25 g) 3.15 0.1260
Supplier MEDEOR/EU 10 JAR (25 g) 36.84 0.1474
Buyer MEMS 1 JAR (500 g) 10.39 0.0208
GLIBENCLAMIDE 5 mg tab-cap (PO) Price/tab-cap 10 mg N A10BB01

Supplier MEDEOR/EU 1000 TAB-CAP 8.29 0.0083 SCORED TABLETS
GLICLAZIDE 80 mg tab-cap (PO) Price/tab-cap 0.16 g E A10BB09

GLICLAZIDE (SLOW-RELEASE) 30 mg tab-cap (PO) Price/tab-cap 60 mg E A10BB09

GLIMEPIRIDE 2 mg tab-cap (PO) Price/tab-cap 2 mg N A10BB12

GLIMEPIRIDE 4 mg tab-cap (PO) Price/tab-cap 2 mg N A01BB12

GLUCAGON 1 mg vial (INJ) Price/vial 1 mg N H04AA01

Buyer SAFRICA 1 VIAL 25.75 25.7458 WITH SOLVENT IN 1 ML SYRINGE
GLUTARALDEHYDE 2% solution (TOP) Price/ml E V07AV

Supplier IMRES 1 BOTT (5000 ml) 13.50 0.0027 WITH ACTIVATOR
GLYCERIN 1 g suppos (RECT) Price/supp N A06AX01



Buyer SAFRICA 12 SUPP 4.08 0.3401


GLYCERYL TRINITRATE 0.4 mg/dose nasal spr (N/T) Price/dose EP L01DA02

Buyer OECS/PPS 1 BOTT (200 DOSE) 5.95 0.0298
GLYCERYL TRINITRATE (NITROGLYCERIN) 0.5 mg tab-cap (SL) Price/tab-cap 5 mg E C01DA02

GLYCERYL TRINITRATE (NITROGLYCERIN) 5 mg/ml ampoule (INJ) Price/ml P C01DA

GRANISETRON 1 mg tab-cap (PO) Price/tab-cap 2 mg N A04AA02

GRANISETRON 1 mg/ml ampoule (INJ) Price/ml 3 mg N A04AA02

GRISEOFULVIN 125 mg tab-cap (PO) Price/tab-cap 0.5 g E D01BA01

GRISEOFULVIN 250 mg tab-cap (PO) Price/tab-cap 0.5 g E D01BA01

Supplier MEDS 100 TAB-CAP 3.58 0.0358 SCORED TABLETS
GRISEOFULVIN 500 mg tab-cap (PO) Price/tab-cap 0.5 g P D01BA01

HALOPERIDOL 0.5 mg tab-cap (PO) Price/tab-cap 8 mg E N05AD01


HALOPERIDOL 1.5-2 mg tab-cap (PO) Price/tab-cap 8 mg E N05AD01

Supplier MSD/TANZ 250 TAB-CAP 2.64 0.0106 1.5 MG TABLETS
Supplier MEDEOR/TZ 100 TAB-CAP 3.72 0.0372 1.5 MG TABLETS
Buyer SAFRICA 100 TAB-CAP 1.34 0.0134 1.5 MG TABLETS
Buyer MEMS 100 TAB-CAP 3.86 0.0386 1.5 MG TABLETS
HALOPERIDOL 10 mg tab-cap (PO) Price/tab-cap 8 mg P N05AD01

HALOPERIDOL 2 mg/ml syrup (PO) Price/ml 8 mg E N05AD01

Buyer DOMREPUB 1 BOTT (15 ml) 0.39 0.0260 DROPS

Buyer PERU 1 BOTT (20 ml) 0.72 0.0362 SOLUTION
HALOPERIDOL 5 mg tab-cap (PO) Price/tab-cap 8 mg E N05AD01

HALOPERIDOL 5 mg/ml ampoule (INJ) Price/ml 3.3 mg E N05AD01

Buyer OECS/PPS 100 AMP (1 ml) 39.00 0.3900 LACTATE
HALOTHANE liquid (INH) Price/ml E N01AB01

Buyer MEMS 1 BOTT (250 ml) 46.37 0.1855 CAN; SPRAY FOR INHALATION
HEPARIN 1000 IU/ml ampoule (INJ) Price/ml 10 TU C B01AB01




HUMAN CHORIONIC GONADOTROPHIN 5000 IU ampoule (INJ) Price/ampoule 250 U N G03GA01

Buyer SUDANNHIF 1 AMP 11.83 11.8309
HUMAN MENOPAUSAL GONADOTROPHIN 75 IU vial (INJ) Price/vial 30 U N G03GA02

HYDRALAZINE 20 mg ampoule (INJ) Price/ampoule 0.1 g N C02DB02

Supplier UNFPA 5 AMP 3.29 0.6573 HYDROCHLORIDE
Supplier ASRAMES 5 AMP 7.15 1.4300
Supplier MEG 5 AMP 21.41 4.2820 2 ML
Supplier IMRES 5 AMP 22.50 4.5000 POWDER
Supplier MSD/TANZ 5 VIAL (1 AMPOULE) 23.10 4.6200 POWDER
Supplier IDA 5 AMP 23.62 4.7234 POWDER
Supplier DURBIN 5 AMP 23.72 4.7439
Supplier MEDS 1 AMP 5.07 5.0736
Supplier MEDEOR/TZ 5 AMP 26.20 5.2392
Supplier MEDEOR/EU 5 AMP 31.24 6.2484 POWDER
Supplier Median Price/ampoule=4.6717 High/Low Ratio=9.51
Buyer CRSS 1 AMP 0.94 0.9400 1 ML
Buyer DOMREPUB 1 AMP 1.69 1.6900
Buyer OECS/PPS 5 AMP 33.15 6.6300
Buyer MEMS 1 AMP 7.73 7.7280
Buyer Median Price/ampoule=4.1600 High/Low Ratio=8.22
HYDRALAZINE 25 mg tab-cap (PO) Price/tab-cap 0.1 g N C02DB01

HYDRALAZINE 50 mg tab-cap (PO) Price/tab-cap 0.1 g N C02DB01

Supplier UNFPA 500 TAB-CAP 73.50 0.1470 TABLETS, HYDROCHLORIDE
Buyer BOTSWANA 100 TAB-CAP 4.52 0.0452 FILM-COATED TABLETS
HYDROCHLOROTHIAZIDE 12.5 mg tab-cap (PO) Price/tab-cap 25 mg E C03AA03

HYDROCHLOROTHIAZIDE 25 mg tab-cap (PO) Price/tab-cap 25 mg E C03AA03




HYDROCHLOROTHIAZIDE+TRIAMTERENE 25 mg+50 mg tab-cap (PO) Price/tab-cap N C03EA01

HYDROCORTISONE 1% cream (TOP) Price/g E D07AA02

Buyer MEMS 1 TUBE (15 g) 0.79 0.0529
Buyer PERU 1 TUBE (20 g) 1.11 0.0555
HYDROCORTISONE 1% ointment (TOP) Price/g E D07AA02

Supplier IMRES 1 TUBE (15 g) 0.57 0.0380 ACETATE
Supplier MEG 50 TUBE (15 g) 55.80 0.0744 ACETATE
Supplier MEDEOR/EU 50 TUBE (15 g) 63.11 0.0841 ACETATE
HYDROCORTISONE 1% opht drop (OPHT) Price/ml P S01BA02

HYDROCORTISONE 10 mg tab-cap (PO) Price/tab-cap 30 mg E H02AB09

HYDROCORTISONE (SODIUM SUCCINATE) 100 mg vial (INJ) Price/vial 30 mg E H02AB09

Supplier ASRAMES 100 AMP (1 VIAL) 52.63 0.5263
Supplier MEG 50 VIAL 27.18 0.5436

HYDROCORTISONE (SODIUM SUCCINATE) 100 mg vial (INJ) Price/vial 30 mg E H02AB09

HYDROGEN PEROXIDE 3% solution (TOP) Price/ml N D08AX01

Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.23 0.0023 MOUTHWASH
HYDROGEN PEROXIDE 6% solution (TOP) Price/ml N D08AX01

Supplier MEDS 1 BOTT (5000 ml) 2.41 0.0005 STABILIZED
Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.23 0.0023 WOUNDWASH
HYDROXYCARBAMIDE (HYDROXYUREA) 500 mg tab-cap (PO) Price/tab-cap C L01XX05

HYDROXYCHLOROQUINE 300 mg tab-cap (PO) Price/tab-cap 0.516 g N P01BA02

Buyer PERU 100 TAB-CAP 35.32 0.3532 310 MG TABLET, ILLUSTRATIVE PACK SIZE
HYDROXYCHLOROQUINE SULFATE 200 mg tab-cap (PO) Price/tab-cap 0.516 g N P01BA02

HYDROXYZINE 10 mg/5 ml syrup (PO) Price/ml 75 mg N N05BB01

HYDROXYZINE 25 mg tab-cap (PO) Price/tab-cap 75 mg N N05BB01

HYOSCINE BUTYLBROMIDE 10 mg tab-cap (PO) Price/tab-cap 60 mg N A03BB01

HYOSCINE BUTYLBROMIDE 10 mg/ml ampoule (INJ) Price/ml 60 mg N A03BB01

HYOSCINE BUTYLBROMIDE 20 mg tab-cap (PO) Price/tab-cap 60 mg N A03BB01

HYOSCINE BUTYLBROMIDE 20 mg/ml ampoule (INJ) Price/ml 60 mg E A03BB01


HYOSCINE BUTYLBROMIDE 20 mg/ml ampoule (INJ) Price/ml 60 mg E A03BB01

HYPROMELLOSE 0.3% opht drop (OPHT) Price/ml N S01KA02

IBUPROFEN 100 mg/5 ml suspen (PO) Price/ml 1.2 g P M01AE01

Buyer BOTSWANA 1 BOTT (100 ml) 3.67 0.0367
IBUPROFEN 200 mg tab-cap (PO) Price/tab-cap 1.2 g E C01EB16

Supplier IDA 1000 TAB-CAP 7.29 0.0073 FILM COATED TABLETS
IBUPROFEN 400 mg tab-cap (PO) Price/tab-cap 1.2 g E C01EB16

Supplier IDA 500 TAB-CAP 6.67 0.0133 FILM COATED TABLETS
IBUPROFEN 600 mg tab-cap (PO) Price/tab-cap 1.2 g E M01AE01

ICHTHAMMOL 20% ointment (TOP) Price/g N D10AX

IDARUBICIN 10 mg vial (INJ) Price/vial N L01DB06

IDARUBICIN 5 mg vial (INJ) Price/vial N L01DB06

Buyer CRSS 1 VIAL 140.00 140.0000 POWDER
IFOSFAMIDE 1 g vial (INJ) Price/vial C L01AA06




IFOSFAMIDE 500 mg vial (INJ) Price/vial C L01AA06

IMATINIB 100 mg tab-cap (PO) Price/tab-cap C L01XE01

Buyer DOMREPUB 1 TAB-CAP 86.66 86.6600
IMATINIB 400 mg tab-cap (PO) Price/tab-cap C L01XE01

IMIPENEM+CILASTATIN 500mg+500mg vial (INJ) Price/vial 2 g C J01DH51


IMIPRAMINE HCL 10 mg tab-cap (PO) Price/tab-cap 0.1 g T N06AA02

IMIPRAMINE HCL 25 mg tab-cap (PO) Price/tab-cap 0.1 g T N06AA02

IMMUNOGLOBULIN, ANTI-HEPATITIS B 200 U ampoule (INJ) Price/ampoule N J06BB04

Buyer CRSS 1 AMP 32.72 32.7200
IMMUNOGLOBULIN, ANTI-TETANUS (HUMAN) 250 IU vial (INJ) Price/ml P J06BB02

Buyer DOMREPUB 1 SYRINGE (1 ml) 11.70 11.7000
IMMUNOGLOBULIN, VARICELLA ZOSTER (HUMAN) 125 IU/ml vial Price/vial N J06BB03

(INJ)
Buyer CRSS 1 VIAL 125.65 125.6500
INDINAVIR (IDV) 400 mg tab-cap (PO) Price/tab-cap 2.4 g N J05AE02

INDOMETACIN 100 mg suppos (RECT) Price/supp 0.1 g N M01AB01

Buyer CRSS 100 SUPP 9.95 0.0995
INDOMETACIN 25 mg tab-cap (PO) Price/tab-cap 0.1 g N M01AB01


INDOMETACIN 25 mg tab-cap (PO) Price/tab-cap 0.1 g N M01AB01

INSULIN, ISOPHANE (NPH) 100 IU/ml vial (SC) Price/ml 40 IU E A10AC

Buyer SAFRICA 1 VIAL (10 ml) 2.40 0.2405 HUMAN, BIOSYNTHETIC, YEAST-DERIVATIVE
Buyer OECS/PPS 1 VIAL (10 ml) 4.80 0.4800 HUMAN
Buyer MEMS 1 VIAL (10 ml) 10.35 1.0350 HUMAN
INSULIN, ISOPHANE (NPH) 40 IU/ml vial (SC) Price/ml 40 IU E A10AC

INSULIN, NEUT. SOL/ISOPHANE 30/70 (HUMAN, MIXTARD) 100 Price/ml 40 U P A10AD01

IU/ml vial (SC)
Buyer SAFRICA 1 VIAL (10 ml) 2.40 0.2405 HUMAN, BIOSYNTHETIC, YEAST-DERIVATIVE
INSULIN, NEUTRAL SOLUBLE (REGULAR) 100 IU/ml vial (SC) Price/ml 40 IU E A10AB
Supplier MEDS 1 VIAL (10 ml) 4.37 0.4368 ACTRAPID
Buyer MEMS 1 VIAL (10 ml) 5.04 0.5037 HUMAN
Buyer SAFRICA 1 CRTDGS (3 ml) 2.65 0.8839
INSULIN, NEUTRAL SOLUBLE (REGULAR) 40 IU/ml vial (SC) Price/ml 40 IU E A10AB

INSULIN, ZINC SUSP (LENTE) 100 IU/ml vial (SC) Price/ml 40 IU E A10AE
IOHEXOL 350 mg/ml vial (INJ) Price/ml E V08AB02

IPRATROPIUM BROMIDE 20 mcg/dose inhaler (INH) Price/dose 0.12 mg E R03BB01

IPRATROPIUM BROMIDE 250 mcg/ml respsol (INH) Price/ml 0.12 mg P R03BB01

IRBESARTAN 150 mg tab-cap (PO) Price/tab-cap 0.15 g N C09CA04

IRON DEXTRAN 50 mg/ml ampoule (INJ) Price/ml 0.1 g N B03AC01


ISOFLURANE liquid (INH) Price/ml E N01AB06

ISONIAZID (INH) 100 mg tab-cap (PO) Price/tab-cap 0.3 g E J04AC01

ISONIAZID (INH) 300 mg tab-cap (PO) Price/tab-cap 0.3 g E J04AC01

Supplier GDF 672 TAB-CAP 13.52 0.0201 28 TABLETS PER BLISTER PACK SHEET
ISONIAZID (INH) 50 mg/5 ml elixir (PO) Price/ml 0.3 g E J04AC01

ISONIAZID (INH, DISPERSIBLE) 100 mg tab-cap (PO) Price/tab-cap 0.3 g E J04AC01

Supplier GDF 100 TAB-CAP 0.93 0.0093 10 X 10 BLISTER PACK TABLETS
ISOSORBIDE DINITRATE 10 mg tab-cap (PO) Price/tab-cap 60 mg P C01DA08

Supplier MEDS 100 TAB-CAP 12.26 0.1226 SUB-LINGUAL TABLETS
ISOSORBIDE DINITRATE 20 mg tab-cap (PO) Price/tab-cap 60 mg P C01DA08

ISOSORBIDE DINITRATE 5 mg tab-cap (SL) Price/tab-cap 20 mg E C01DA08

ISOSORBIDE DINITRATE 5 mg tab-cap (PO) Price/tab-cap 60 mg E C01DA08

ISOSORBIDE DINITRATE 5 mg tab-cap (SL) Price/tab-cap 20 mg E C01DA08

ISOSORBIDE MONONITRATE 20 mg tab-cap (PO) Price/tab-cap 40 mg N C01DA14

ITRACONAZOLE 100 mg tab-cap (PO) Price/tab-cap 0.2 g N J02AC02


IUD (COPPER) iud (VAG) Price/iud E G02BA02

Supplier UNFPA 1 IUD 0.37 0.3675 COPPER T 380
Supplier IMRES 1 IUD 0.75 0.7500 COPPER SURFACE 380 SQ.MM

IUD (COPPER) iud (VAG) Price/iud E G02BA02

Supplier IDA 50 IUD 71.41 1.4281
Supplier ASRAMES 50 IUD 111.90 2.2380 DOP
Supplier Median Price/iud=1.0891 High/Low Ratio=6.09
Buyer OECS/PPS 1 IUD 3.00 3.0000 COPPER-T 380-A
IUD (LEVONORGESTREL) 52 mg iud (VAG) Price/each EP G02BA03

Buyer SAFRICA 1 EACH 122.46 122.4600
KANAMYCIN SULFATE 1 g vial (INJ) Price/vial 1 g C J01GB04

KETAMINE 10 mg/ml vial (INJ) Price/ml P N01AX03

Buyer CRSS 1 AMP (20 ml) 6.37 0.3185
KETAMINE 50 mg/ml vial (INJ) Price/ml E N01AX03

Supplier UNFPA 25 VIAL (10 ml) 21.00 0.0840 HCL
Supplier MEG 25 VIAL (10 ml) 29.27 0.1171 HCL
Supplier MEDEOR/EU 25 VIAL (10 ml) 31.31 0.1252 HCL
KETOCONAZOLE 2% cream (TOP) Price/g N D01AC08

KETOCONAZOLE 200 mg tab-cap (PO) Price/tab-cap 0.2 g T J02AB02

LABETALOL 5 mg/ml ampoule (INJ) Price/ml 0.6 g N C07AG01

LACTULOSE 3.35 g/5 ml solution (PO) Price/ml 6.7 g E A06AD11

Buyer PERU 1 BOTT (240 ml) 2.53 0.0106 3.33 G/5 ML, SUSPENSION
Buyer DOMREPUB 1 BOTT (240 ml) 2.85 0.0119 SYRUP

LACTULOSE 3.35 g/5 ml solution (PO) Price/ml 6.7 g E A06AD11

Buyer SAFRICA 1 BOTT (500 ml) 6.42 0.0128 3.3 G/5 ML, SYRUP
LAMIVUDINE (3TC) 10 mg/ml solution (PO) Price/ml 0.3 g E J05AF05

Buyer NAMIBIA 1 BOTT (240 ml) 7.83 0.0326
LAMIVUDINE (3TC) 150 mg tab-cap (PO) Price/tab-cap 0.3 g E J05AF05

LAMIVUDINE (3TC) 300 mg tab-cap (PO) Price/tab-cap 0.3 g P J05AF05

LAMIVUDINE+STAVUDINE (3TC+D4T) 150 mg+30 mg tab-cap (PO) Price/tab-cap P J05AF30

LAMIVUDINE+STAVUDINE (3TC+D4T) 150 mg+40 mg tab-cap (PO) Price/tab-cap P J05AF30

LAMIVUDINE+STAVUDINE (DISPERSIBLE, 3TC+D4T) 30 mg+6 mg Price/tab-cap EP J05A

tab-cap (PO)
Supplier SCMS 60 TAB-CAP 2.00 0.0332
LAMIVUDINE+STAVUDINE (TABLET FOR ORAL SUSPENSION) 60+12 mg Price/tab-cap N J05AR

tab-cap (PO)
Supplier SCMS 60 TAB-CAP 3.46 0.0577
LAMIVUDINE+STAVUDINE+NEVIRAPINE (3TC+D4T+NVP) 150+30+200mg Price/tab-cap E J05AF30

tab-cap (PO)
LAMIVUDINE+STAVUDINE+NEVIRAPINE (3TC+D4T+NVP) 150+40+200mg Price/tab-cap P J05AF30

tab-cap (PO)
LAMIVUDINE+STAVUDINE+NEVIRAPINE (3TC+D4T+NVP) 30+6+50 mg Price/tab-cap P J05A

tab-cap (PO)
LAMIVUDINE+STAVUDINE+NEVIRAPINE (3TC+D4T+NVP) 60+12+100 mg Price/tab-cap P J05A

tab-cap (PO)

LAMIVUDINE+TENOFOVIR DF (3TC+TDF) 300+300 mg tab-cap (PO) Price/tab-cap P J05AF

LAMIVUDINE+ZIDOVUDINE (3TC+AZT) 150mg+300mg tab-cap (PO) Price/tab-cap 2 TAB E J05AF30

LAMIVUDINE+ZIDOVUDINE (3TC+AZT) 30+60 mg tab-cap (PO) Price/tab-cap E J05AR01

LAMIVUDINE+ZIDOVUDINE (DISPERSIBLE) 30 mg+60 mg tab-cap Price/tab-cap E J05AR01

(PO)
LAMIVUDINE+ZIDOVUDINE+ABACAVIR (150+300+300 MG) tab-cap Price/tab-cap P J05AR04

(PO)
LAMIVUDINE+ZIDOVUDINE+NEVIRAPINE (150+300+200 MG) Price/tab-cap E J05A

3TC+AZT+NVP tab-cap (PO)
LAMIVUDINE+ZIDOVUDINE+NEVIRAPINE (3TC/AZT/NVP) 30+60+50 mg Price/tab-cap E J05AR05

tab-cap (PO)
LAMIVUDINE+ZIDOVUDINE+NEVIRAPINE (3TC/AZT/NVP, Price/tab-cap E J05AR05

DISPERSIBLE) 30+60+50 mg tab-cap (PO)
Supplier SCMS 60 TAB-CAP 3.92 0.0653 DISPERSIBLE TABLETS
LAMIVUDINE/ZIDOVUDINE + EFAVIRENZ (2 TAB L/Z.+ 1 TAB EF. Price/tab-cap P J05A

CO-PACK) 150/300+600m tab-cap (PO)
Supplier IDA 90 TAB-CAP 13.70 0.1522 60+30 TABLETS
Supplier SCMS 90 TAB-CAP 18.90 0.2100 60 + 30 BLISTER PACK TABLETS
LAMIVUDINE/ZIDOVUDINE + NEVIRAPINE (1 TAB L/Z. + 1 TAB N. Price/tab-cap E J05AR05

CO-PACK) 150/300+200m tab-cap (PO)
Supplier SCMS 120 TAB-CAP 17.85 0.1488 60 + 60 BLISTER PACK TABLETS
LAMIVUDINE/ZIDOVUDINE+ABACAVIR (150/300+300 MG CO-PACK) Price/tab-cap P J05AR04

tab-cap (PO)
Supplier SCMS 120 TAB-CAP 46.73 0.3894 60 + 60 TABLETS; BLISTER
LAMOTRIGINE 100 mg tab-cap (PO) Price/tab-cap 0.3 g N N03AX09




LANCET, BLOOD (STERILE, DISPOSIBLE) each (DIAG) Price/each N V04C

Supplier DURBIN 200 EACH 3.43 0.0171
LATANOPROST 0.005% opht drop (OPHT) Price/ml 0.1 ml E S01EX03

Buyer PERU 1 BOTT (2.50 ml) 0.69 0.2769
Buyer OECS/PPS 1 BOTT (2.50 ml) 3.79 1.5160
LETROZOLE 2.5 mg tab-cap (PO) Price/tab-cap 2.5 mg N L02BG04

LEVAMISOLE 40 mg tab-cap (PO) Price/tab-cap 0.15 g P P02CE01

LEVAMISOLE 50 mg tab-cap (PO) Price/tab-cap 0.15 g E P02CE01

LEVODOPA+CARBIDOPA 100+25 mg tab-cap (PO) Price/tab-cap 0.6 g P N04BA02

LEVODOPA+CARBIDOPA 250+25 mg tab-cap (PO) Price/tab-cap 0.6 g E N04BA02

LEVOFLOXACIN 250 mg tab-cap (PO) Price/tab-cap 0.5 g T J01MA12

LEVOFLOXACIN 5 mg/ml vial (INJ) Price/ml 0.5 g T J01MA12

Supplier MEDS 1 BOTT (100 ml) 1.67 0.0167 INFUSION
LEVOFLOXACIN 500 mg tab-cap (PO) Price/tab-cap 0.5 g C J01MA12

LEVONORGESTREL 0.03 mg tab-cap (PO) Price/cycle E G03AC03

Supplier IMRES 3 CYCLE 1.70 0.5667 35 TABLETS/CYCLE
Supplier Median Price/cycle=0.4409 High/Low Ratio=1.80
Buyer SAFRICA 1 CYCLE 0.22 0.2223 28-TABLET BLISTER PACK
Buyer OECS/PPS 1 CYCLE 1.39 1.3900 28-TABLET
Buyer Median Price/cycle=0.8062 High/Low Ratio=6.25
LEVONORGESTREL 0.75 mg tab-cap (PO) Price/tab-cap E G03AC03


LEVONORGESTREL 0.75 mg tab-cap (PO) Price/tab-cap E G03AC03

Supplier ASRAMES 2 TAB-CAP 1.41 0.7050 PACK OF TABLETS
LEVONORGESTREL 1.5 mg tab-cap (PO) Price/tab-cap 1.5 mg E G03AD01

Supplier UNFPA 1 TAB-CAP 0.23 0.2310 TABLET
Supplier ASRAMES 1 TAB-CAP 1.41 1.4100 PACK OF TABLET
LEVONORGESTREL 75 mg/rod rod (SC) Price/set E G03AC03

Supplier UNFPA 2 ROD (1 SET) 8.93 4.4625 SET
Supplier ASRAMES 2 ROD (1 SET) 13.29 6.6450
Supplier Median Price/set=5.5538 High/Low Ratio=1.49
Buyer SAFRICA 2 ROD (1 SET) 9.58 4.7920
LEVOTHYROXINE 100 mcg tab-cap (PO) Price/tab-cap 0.15 mg E H03AA01

Supplier DURBIN 1000 TAB-CAP 83.66 0.0837 TABLETS, THYROXINE SODIUM
Buyer DOMREPUB 1 TAB-CAP 0.02 0.0200 BLISTER PACK SCORED TABLETS
LEVOTHYROXINE 200 mcg tab-cap (PO) Price/tab-cap 0.15 mg P H03AA01

Buyer DOMREPUB 1 TAB-CAP 0.02 0.0200 BLISTER PACK SCORED TABLETS
LEVOTHYROXINE 50 mcg tab-cap (PO) Price/tab-cap 0.15 mg E H03AA01

LIDOCAINE HCL 1% vial (INJ) Price/ml E C01BB01

Supplier ASRAMES 25 VIAL (50 ml) 15.44 0.0124
Supplier UNFPA 10 VIAL (50 ml) 6.30 0.0126
Buyer SAFRICA 1 VIAL (20 ml) 0.58 0.0288 NOT FOR IV USE
LIDOCAINE HCL 2% gel (TOP) Price/g E D04AB01

Buyer SAFRICA 1 TUBE (20 g) 2.27 0.1135 WITH URETHRAL NOZZLE
Buyer PERU 1 TUBE (10 g) 1.64 0.1639 GEL
Buyer OECS/PPS 1 TUBE (30 g) 5.48 0.1827 JELLY
LIDOCAINE HCL 2% vial (INJ) Price/ml 3 g E C01BB01

Supplier ASRAMES 25 VIAL (50 ml) 23.44 0.0188

LIDOCAINE HCL 2% vial (INJ) Price/ml 3 g E C01BB01

Buyer PERU 1 VIAL (20 ml) 0.43 0.0214 NO PRESERVATIVES
Buyer PERU 1 VIAL (20 ml) 0.64 0.0318 WITH PRESERVATIVES
LIDOCAINE HCL + EPINEPHRINE DENTAL 2%+1:80000 crtdgs (INJ) Price/ml E N01BB52

Supplier AMSTELFAR 100 CRTDGS (1.80 ml) 36.25 0.2014
Supplier IMRES 100 CRTDGS (1.80 ml) 42.50 0.2361
Supplier IDA 100 CRTDGS (1.80 ml) 52.51 0.2917
Supplier DURBIN 50 CRTDGS (1.80 ml) 47.10 0.5233
Buyer OECS/PPS 50 VIAL (1.80 ml) 18.50 0.2056
Buyer SAFRICA 1 CRTDGS (1.80 ml) 0.47 0.2611
LIDOCAINE HCL 5% (IN DEXTROSE 7.5%) vial (INJ) Price/ml E N01BB02

Supplier MEG 100 AMP (2 ml) 47.86 0.2393 SPINAL HEAVY
Supplier MSD/TANZ 10 AMP (2 ml) 8.28 0.4140 SPINAL
LIDOCAINE+EPINEPHRINE 1%+1:100000 vial (INJ) Price/ml P N01BB52

LIDOCAINE+EPINEPHRINE 2%+1:100000 vial (INJ) Price/ml P N01BB52

Buyer OECS/PPS 1 VIAL (30 ml) 1.46 0.0487 FLIP TOP VIAL
LINEZOLID 2 mg/ml vial (INJ) Price/ml 1.2 g C J01XX08

LINEZOLID 600 mg tab-cap (PO) Price/tab-cap 1.2 g C J01XX08

Supplier GDF 20 TAB-CAP 138.00 6.9000 FILM-COATED TABLETS IN 10 X 2 BLISTERS
LISINOPRIL 10 mg tab-cap (PO) Price/tab-cap 10 mg T C09AA03


LISINOPRIL 20 mg tab-cap (PO) Price/tab-cap 10 mg T C09AA03

LISINOPRIL 5 mg tab-cap (PO) Price/tab-cap 10 mg N C09AA03

LITHIUM CARBONATE 300 mg tab-cap (PO) Price/tab-cap 24 MMO E N05AN01


LOPERAMIDE HCL 2 mg tab-cap (PO) Price/tab-cap 10 mg E A07DA03

Supplier MEDEOR/EU 1000 TAB-CAP 6.57 0.0066 HCL, TABLETS
LOPINAVIR+RITONAVIR (LPV/R) 100 mg+25 mg tab-cap (PO) Price/tab-cap P J05AE

Buyer SAFRICA 60 TAB-CAP 4.97 0.0828 FILM-COATED TABLETS
LOPINAVIR+RITONAVIR (LPV/R) 133.3+33.3mg tab-cap (PO) Price/tab-cap E J05AE30

Supplier SCMS 180 TAB-CAP 43.16 0.2398 2 X 90 CAPSULES
LOPINAVIR+RITONAVIR (LPV/R) 200 mg+50 mg tab-cap (PO) Price/tab-cap P J05AE

Buyer SAFRICA 120 TAB-CAP 18.96 0.1580 FILM-COATED TABLETS
LOPINAVIR+RITONAVIR (LPV/R) 80+20 mg/ml solution (PO) Price/ml E J05AE30


Buyer NAMIBIA 1 BOTT (300 ml) 26.90 0.0897
LORATADINE 10 mg tab-cap (PO) Price/tab-cap 10 mg N R06AX13

LORATADINE 5 mg/5 ml syrup (PO) Price/ml 10 mg N R06AX13

LORAZEPAM 1 mg tab-cap (PO) Price/tab-cap 2.5 mg P N05BA06

LORAZEPAM 2 mg tab-cap (PO) Price/tab-cap 2.5 mg P N05BA06


LOSARTAN 50 mg tab-cap (PO) Price/tab-cap 50 mg N C09CA01

LOVASTATIN 20 mg tab-cap (PO) Price/tab-cap 45 mg T C10AA02

LUBRICATING JELLY ointment (TOP) Price/g N D02AC

Supplier MEDS 1 TUBE (50 g) 1.52 0.0305 STERILE
Buyer MEMS 1 TUBE (42 g) 2.58 0.0614 JELLY
LYNESTRENOL 0.5 mg tab-cap (PO) Price/cycle N G03AC02

MAGNESIUM SULFATE powder (PO) Price/g N A06AD04

Buyer SAFRICA 1 JAR (500 g) 0.73 0.0015
MAGNESIUM SULFATE 20% vial (INJ) Price/ml 1 g EP A12CC02

MAGNESIUM SULFATE 50% vial (INJ) Price/ml 3 g E A12CC02

Buyer SUDANNHIF 1 AMP (1 ml) 0.87 0.8730
MAGNESIUM TRISILICATE COMPOUND (CHEWABLE) tab-cap (PO) Price/tab-cap T A02AA10

MANNITOL 20% solution (IV) Price/ml C B05BC01

Buyer SAFRICA 1 BOTT (500 ml) 2.85 0.0057 20%

MANNITOL 20% solution (IV) Price/ml C B05BC01

MEBENDAZOLE 100 mg tab-cap (PO) Price/tab-cap 0.2 g E P02CA01

MEBENDAZOLE 100 mg/5 ml suspen (PO) Price/ml 0.2 g P P02CA01

MEBENDAZOLE 500 mg tab-cap (PO) Price/tab-cap 0.2 g E P02CA01

MEBENDAZOLE (CHEWABLE) 100 mg tab-cap (PO) Price/tab-cap 0.2 g E P02CA01

Supplier AMSTELFAR 1000 TAB-CAP 7.70 0.0077
MEBENDAZOLE (CHEWABLE) 500 mg tab-cap (PO) Price/tab-cap 0.2 g E P02CA01

Supplier IMRES 1000 TAB-CAP 30.00 0.0300 FLAVORED
Supplier AMSTELFAR 500 TAB-CAP 16.70 0.0334
MEDROXYPROGESTERONE 10 mg tab-cap (PO) Price/tab-cap 5 mg EP G03DA02

MEDROXYPROGESTERONE 5 mg tab-cap (PO) Price/tab-cap 5 mg C G03DA02

MEDROXYPROGESTERONE ACETATE 150 mg/ml vial (INJ) Price/ml 1.67 mg E G03AC06

Buyer SICA 1 AMP (1 ml) 1.57 1.5700
MEFENAMIC ACID 250 mg tab-cap (PO) Price/tab-cap 1 g N M01AG01




MEFLOQUINE 250 mg tab-cap (PO) Price/tab-cap 1 g E P01BC02

Supplier AMSTELFAR 100 TAB-CAP 94.25 0.9425 TABLETS, 5 YEAR SHELF LIFE
MEGLUMINE ANTIMONATE 30-45% ampoule (INJ) Price/ml 0.85 g E P01CB01

Buyer CRSS 1 AMP (5 ml) 4.32 0.8640 30%
MELOXICAM 7.5 mg tab-cap (PO) Price/tab-cap 15 mg N M01AC06

MELPHALAN 2 mg tab-cap (PO) Price/tab-cap N L01AA03

MELPHALAN 50 mg vial (INJ) Price/vial N L01AA03

MERCAPTOPURINE 50 mg tab-cap (PO) Price/tab-cap C L01BB02

MEROPENEM 1 g vial (INJ) Price/vial 2 g N J01DH02

Supplier MSD/TANZ 10 AMP (1 VIAL) 73.44 7.3440

Buyer BOTSWANA 1 VIAL 14.26 14.2600
MEROPENEM 500 mg vial (INJ) Price/vial 2 g N J01DH02

MESNA 100 mg/ml ampoule (INJ) Price/ml C V03AF01

Buyer SICA 1 AMP (4 ml) 1.36 0.3400
MESNA 400 mg ampoule (INJ) Price/ampoule CP V03AF01

Buyer SAFRICA 1 AMP 3.50 3.4976
METFORMIN HCL 500 mg tab-cap (PO) Price/tab-cap 2 g C A10BA02


METFORMIN HCL 500 mg tab-cap (PO) Price/tab-cap 2 g C A10BA02

METFORMIN HCL 850 mg tab-cap (PO) Price/tab-cap 2 g CP A10BA02

METHADONE (IC) 5 mg tab-cap (PO) Price/tab-cap 25 mg CP N07BC02

METHOTREXATE SODIUM 2.5 mg tab-cap (PO) Price/tab-cap 2.5 mg C L01BA01

METHOTREXATE SODIUM 25 mg/ml vial (INJ) Price/ml P L01BA01


Buyer PERU 1 VIAL (2 ml) 8.38 4.1907 NO PRESERVATIVES
METHYLDOPA 250 mg tab-cap (PO) Price/tab-cap 1 g E C02AB01

Supplier IDA 1000 TAB-CAP 30.56 0.0306 FILM-COATED TABLETS
Buyer DRC/IHP 1000 TAB-CAP 25.86 0.0259 FILM-COATED TABLETS
METHYLDOPA 500 mg tab-cap (PO) Price/tab-cap 1 g P C02AB01

METHYLERGOMETRINE MALEATE 0.2 mg/ml ampoule (INJ) Price/ml 0.2 mg T G02AB01


METHYLPHENIDATE HYDROCHLORIDE (IC) 10 mg tab-cap (PO) Price/tab-cap 30 mg N N06BA04

METHYLPREDNISOLONE (SODIUM SUCCINATE) 1 g vial (INJ) Price/vial 20 mg CP H02AB04

Buyer SAFRICA 1 VIAL 14.82 14.8186 WITH 16 ML DILUENT
METHYLPREDNISOLONE (SODIUM SUCCINATE) 500 mg vial (INJ) Price/vial 20 mg CP H02AB04

Buyer SAFRICA 1 VIAL 3.81 3.8104 WITH 8 ML DILUENT
METHYLPREDNISOLONE ACETATE 40 mg vial (INJ) Price/vial 20 mg N H02AB04

METOCLOPRAMIDE HCL 10 mg tab-cap (PO) Price/tab-cap 30 mg E A03FA01

METOCLOPRAMIDE HCL 4 mg/ml drops (PO) Price/ml 30 mg P A03FA01

METOCLOPRAMIDE HCL 5 mg/5 ml syrup (PO) Price/ml 30 mg E A03FA01

METOCLOPRAMIDE HCL 5 mg/ml ampoule (INJ) Price/ml 30 mg E A03FA01


METOPROLOL 100 mg tab-cap (PO) Price/tab-cap 0.15 g E C07AB02

METRONIDAZOLE 1 g suppos (RECT) Price/supp 2 g E P01AB01


METRONIDAZOLE 125 mg/5 ml syrup (PO) Price/ml 1.5 g P P01AB01

Supplier MEG 1 BOTT (100 ml) 0.60 0.0060 POWDER FOR SUSPENSION
Supplier IMRES 10 BOTT (100 ml) 6.00 0.0060 SUSPENSION
Supplier DURBIN 1 BOTT (100 ml) 0.77 0.0077 POWDER
METRONIDAZOLE 200 mg/5 ml syrup (PO) Price/ml 1.5 g E P01AB01

Supplier MSD/TANZ 24 BOTT (100 ml) 10.56 0.0044 SUSPENSION
Supplier MEDS 1 BOTT (100 ml) 0.53 0.0053 SUSPENSION
Supplier IMRES 10 BOTT (100 ml) 8.00 0.0080 BENZOATE, SUSPENSION
Buyer DOMREPUB 1 BOTT (120 ml) 0.38 0.0032 250 MG/5 ML
Buyer MEMS 1 BOTT (100 ml) 0.69 0.0069 SUSPENSION
Buyer SAFRICA 1 BOTT (100 ml) 1.09 0.0109 SUSPENSION
METRONIDAZOLE 200-250 mg tab-cap (PO) Price/tab-cap 1.5 g E P01AB01

Supplier MEDS 1000 TAB-CAP 3.98 0.0040 200 MG TABLETS
Supplier MSD/TANZ 1000 TAB-CAP 4.50 0.0045 200 MG TABLETS
Supplier ASRAMES 1000 TAB-CAP 5.52 0.0055 250 MG TABLETS
Supplier IDA 1000 TAB-CAP 6.32 0.0063 200 MG TABLETS
Supplier UNFPA 1000 TAB-CAP 6.91 0.0069 250 MG TABLETS
Supplier MEG 1000 TAB-CAP 6.96 0.0070 250 MG TABLETS
Supplier AMSTELFAR 1000 TAB-CAP 8.70 0.0087 250 MG TABLETS
Buyer MEMS 1000 TAB-CAP 4.55 0.0046 200 MG TABLETS
Buyer SAFRICA 250 TAB-CAP 1.32 0.0053 200 MG TABLETS
Buyer DRC/IHP 1000 TAB-CAP 5.29 0.0053 250 MG TABLETS
Buyer SUDANNHIF 100 TAB-CAP 1.05 0.0105 250 MG TABLETS, ILLUSTRATIVE PACK SIZE
Buyer OECS/PPS 500 TAB-CAP 6.00 0.0120 250 MG TABLETS
METRONIDAZOLE 400-500 mg tab-cap (PO) Price/tab-cap 1.5 g E P01AB01

Supplier MEDS 1000 TAB-CAP 7.60 0.0076 400 MG TABLETS
Buyer DOMREPUB 1 TAB-CAP 0.01 0.0100 500 MG, BLISTER PACK TABLETS
Buyer SAFRICA 100 TAB-CAP 1.21 0.0121 400 MG TABLETS
Buyer PERU 100 TAB-CAP 1.70 0.0170 500 MG TABLETS, ILLUSTRATIVE PACK SIZE
Buyer SUDANNHIF 100 TAB-CAP 2.15 0.0215 500 MG TABLETS, ILLUSTRATIVE PACK SIZE
METRONIDAZOLE 5 mg/ml vial (INJ) Price/ml 1.5 g E J01XD01

Supplier UNFPA 1 BOTT (100 ml) 0.38 0.0038 FOR INFUSION
Supplier IMRES 1 BOTT (100 ml) 0.50 0.0050 FOR INFUSION

METRONIDAZOLE 5 mg/ml vial (INJ) Price/ml 1.5 g E J01XD01

METRONIDAZOLE 500 mg pessary (VAG) Price/pessary 0.5 g P G01AF01

Supplier AMSTELFAR 1000 PESS 33.35 0.0334
Supplier DURBIN 1000 PESS 33.82 0.0338
Supplier MEDEOR/EU 1000 PESS 41.20 0.0412
METRONIDAZOLE 500 mg suppos (RECT) Price/supp 2 g E P01AB01

MICONAZOLE 25 mg/ml oral gel (PO) Price/g 0.2 g P A01AB09

Buyer SAFRICA 1 TUBE (30 g) 2.97 0.0991 2%
MICONAZOLE NITRATE 2% cream (TOP) Price/g E D01AC02

Buyer DRC/IHP 10 TUBE (30 g) 2.30 0.0077
MICONAZOLE NITRATE (BUCCAL MUCO-ADHESIVE) 10 mg tab-cap Price/tab-cap 0.2 g N A01AB09

(PO)
Supplier MEG 70 TAB-CAP 17.86 0.2551 BLISTER PACK TABLETS
MIDAZOLAM 15 mg tab-cap (PO) Price/tab-cap 15 mg E N05CD08

MIDAZOLAM (IC) 1 mg/ml ampoule (INJ) Price/ml 15 mg E N05CD08

MIDAZOLAM (IC) 5 mg/ml ampoule (INJ) Price/ml 15 mg E N05CD08

Buyer PERU 1 AMP (10 ml) 2.45 0.2451
MINOXIDIL 10 mg tab-cap (PO) Price/tab-cap 20 mg N C02DC01

MISOPROSTOL 100 mcg tab-cap (PO) Price/tab-cap 0.8 mg P G02AD06

MISOPROSTOL 200 mcg tab-cap (PO) Price/tab-cap 0.8 mg E A02BB01

Supplier MEDS 30 TAB-CAP 5.15 0.1717
Supplier UNFPA 60 TAB-CAP 30.45 0.5075 BILSTER-PACK TABLETS, 6 X 10

MISOPROSTOL 200 mcg tab-cap (PO) Price/tab-cap 0.8 mg E A02BB01

MITOMYCIN 5 mg vial (INJ) Price/vial N L01DC03

Buyer CRSS 1 VIAL 21.50 21.5000 5 ML
MORPHINE (IC, SUSTAINED-RELEASE) 10 mg tab-cap (PO) Price/tab-cap 0.1 g E N02AA01

MORPHINE SULFATE (IC) 10 mg tab-cap (PO) Price/tab-cap 0.1 g E N02AA01

MORPHINE SULFATE (IC) 10 mg/ml ampoule (INJ) Price/ml 0.1 g E N02AA01

MORPHINE SULFATE (IC) 15 mg/ml ampoule (INJ) Price/ml 0.1 g P N02AA01

MORPHINE SULFATE (IC, SUSTAINED-RELEASE) 30 mg tab-cap Price/tab-cap 0.1 g P N02AA01

(PO)
Buyer SAFRICA 60 TAB-CAP 14.42 0.2404 FILM-COATED TABLET

MORPHINE SULFATE (SLOW RELEASE) 100 mg tab-cap (PO) Price/tab-cap 0.1 g E N02AA01
MORPHINE SULFATE (SLOW RELEASE) 60 mg tab-cap (PO) Price/tab-cap 0.1 g E N02AA01

MOSQUITO NET, 1-PERSON, LLIN (70 X 180 X 150 CM) net (N/A) Price/each N V07A
Supplier DURBIN 25 EACH 154.13 6.1654 PERMANET
MOSQUITO NET, 2-PERSON, IMPREGNATED (130 X 180 X 150 CM) Price/each N V07A
net (N/A)
Supplier MEDEOR/TZ 1 EACH 5.39 5.3940
MOSQUITO NET, 2-PERSON, LLIN (130 X 180 X 150 CM) net Price/each N V04C
(N/A)
Supplier IDA 1 EACH 3.40 3.4036
MOSQUITO NET, FAMILY, IMPREGNATED (190 X 180 X 150 CM) net Price/each N V07A
(N/A)
MOSQUITO NET, FAMILY, LLIN (190 X 180 X 150 CM) net (N/A) Price/each N V04C
Supplier ASRAMES 1 EACH 6.80 6.8000
Supplier IMRES 1 EACH 7.00 7.0000
Supplier DURBIN 25 EACH 203.80 8.1520 PERMANET
MOSQUITO NET, FAMILY, NON-IMPREG. (190 X 180 X 150 CM) net Price/each N V07A
(N/A)

Supplier MSD/TANZ 1 EACH 1.14 1.1400
MOSQUITO NET, IMPREGNATED (100 X 180 X 150 CM) net (N/A) Price/each N V04C
MOSQUITO NET, IMPREGNATED (160 X 180 X 150 CM) net (N/A) Price/each N V04C
MOSQUITO NET, LLIN (160 X 180 X 150 CM) net (N/A) Price/each N
Supplier ASRAMES 1 EACH 4.48 4.4800
Supplier IDA 1 EACH 5.70 5.6958 75 DENIER
MOXIFLOXACIN 400 mg tab-cap (PO) Price/tab-cap 0.4 g N J01MA14


MUPIROCIN 2% cream (TOP) Price/g E D06AX09

Buyer PERU 1 TUBE (15 g) 2.17 0.1448
MUPIROCIN 2% ointment (TOP) Price/g E D06AX09

MYCOPHENOLATE MOFETIL 250 mg tab-cap (PO) Price/tab-cap 2 g N L04AA06

Buyer BOTSWANA 100 TAB-CAP 46.25 0.4625 CAPSULES
NALBUFINE CHLORHYDRATE 10 mg/ml vial (INJ) Price/ml 80 mg N N02AF02

NALIDIXIC ACID 500 mg tab-cap (PO) Price/tab-cap 4 g N J01MB02

NALOXONE HCL 0.02 mg/ml vial (INJ) Price/ml P V03AB15

NALOXONE HCL 0.4 mg/ml ampoule (INJ) Price/ml E V03AB15


NAPROXEN 250 mg tab-cap (PO) Price/tab-cap 0.5 g E M01AE02

NAPROXEN 500 mg tab-cap (PO) Price/tab-cap 0.5 g N M01AE02

NATAMYCIN 50 mg/ml opht drop (OPHT) Price/ml N S01AA10

NELFINAVIR (NFV) 250 mg tab-cap (PO) Price/tab-cap 2.25 g E J05AE04

Supplier SCMS 270 TAB-CAP 140.30 0.5196 AS MESILATE, TABLETS
NELFINAVIR (NFV) 50 mg/g powder (PO) Price/g 2.25 g E J05AE04

Supplier SCMS 1 BOTT (144 g) 42.57 0.2956
NEOMYCIN+BACITRACIN 5mg+500IU/g ointment (TOP) Price/g N D06AX04

NEOSTIGMINE METHYLSULFATE 0.5 mg/ml ampoule (INJ) Price/ml 60 mg E N07AA01

NEOSTIGMINE METHYLSULFATE 2.5 mg/ml ampoule (INJ) Price/ml E N07AA01

NEVIRAPINE (NVP) 200 mg tab-cap (PO) Price/tab-cap 0.4 g E J05AG01

NEVIRAPINE (NVP) 50 mg/5 ml suspen (PO) Price/ml 0.4 g E J05AG01

Supplier SCMS 1 BOTT (240 ml) 1.59 0.0066 WITH SYRINGE
NICLOSAMIDE 500 mg tab-cap (PO) Price/tab-cap 2 g E P02DA01


NICLOSAMIDE 500 mg tab-cap (PO) Price/tab-cap 2 g E P02DA01
NICLOSAMIDE (CHEWABLE) 500 mg tab-cap (PO) Price/tab-cap 2 g E P02DA01

NIFEDIPINE 10 mg tab-cap (PO) Price/tab-cap 30 mg E C08CA05

NIFEDIPINE 20 mg tab-cap (PO) Price/tab-cap 30 mg EP C08CA05

NIFEDIPINE (SUSTAINED-RELEASE) 10 mg tab-cap (PO) Price/tab-cap 30 mg T C08CA05


Buyer DOMREPUB 100 TAB-CAP 5.82 0.0582 CAPSULES, ILLUSTRATIVE PACK SIZE

NIMODIPINE 30 mg tab-cap (PO) Price/tab-cap 0.3 g T C08CA06

NITROFURANTOIN 100 mg tab-cap (PO) Price/tab-cap 0.2 g E J01XE01

NITROFURANTOIN 25 mg/5 ml suspen (PO) Price/ml 0.2 g P J01XE01

NITROFURANTOIN 50 mg tab-cap (PO) Price/tab-cap 0.2 g P J01XE01


NITROFURAZONE 0.2% ointment (TOP) Price/g N D08AF

Buyer BOTSWANA 1 JAR (500 g) 33.57 0.0671
NOREPINEPHRINE 1 mg/ml vial (INJ) Price/ml 6 mg N C01CA03

NORETHISTERONE 200 mg/ml ampoule (INJ) Price/ml E G03AC01

Supplier UNFPA 1 AMP (1 ml) 1.37 1.3650 ENANTHATE
NORETHISTERONE 5 mg tab-cap (PO) Price/tab-cap 5 mg E G03DC02

NORETHISTERONE+ESTRADIOL CYPIONATE (IN OIL) 50mg+5mg/ml Price/ml N G03AA05

vial (INJ)
Supplier UNFPA 1 AMP (1 ml) 1.97 1.9740 WITH SOLOSHOT SYRINGE
NORFLOXACIN 400 mg tab-cap (PO) Price/tab-cap 0.8 g T J01MA06

NOSCAPINE 15 mg tab-cap (PO) Price/tab-cap 0.125 g N R05DA07

NYSTATIN 100,000 IU pessary (VAG) Price/pessary 0.1 MU E G01AA01

Supplier MEG 100 PESS 2.60 0.0260
Supplier DURBIN 100 PESS 3.00 0.0300
Supplier MEDEOR/EU 1000 PESS 37.53 0.0375
Supplier MEDEOR/TZ 15 PESS 0.57 0.0380
Supplier ASRAMES 100 PESS 4.05 0.0405
Supplier MEDS 14 PESS 0.85 0.0608
Supplier MSD/TANZ 15 PESS 1.98 0.1320 WITH APPLICATOR
Buyer DOMREPUB 1 PESS 0.10 0.1000
NYSTATIN 100,000 IU tab-cap (PO) Price/tab-cap 1.5 MU E A07AA02

NYSTATIN 100,000 IU/g cream (TOP) Price/g P D01AA01

NYSTATIN 100,000 IU/g ointment (TOP) Price/g P D01AA01


NYSTATIN 100000 IU/ml suspen (PO) Price/ml 1.5 MU P A07AA02

Supplier AMSTELFAR 50 BOTT (30 ml) 62.00 0.0413 + PIPETTE
Buyer OECS/PPS 1 BOTT (48 ml) 3.28 0.0683 WITH DROPPER
NYSTATIN 500,000 IU tab-cap (PO) Price/tab-cap 1.5 MU E A07AA02

Supplier DURBIN 100 TAB-CAP 7.71 0.0771 COATED TABLETS
Supplier MEG 100 TAB-CAP 8.82 0.0882 TABLETS, 10X10 BLISTER PACK
Buyer DRC/IHP 100 TAB-CAP 5.89 0.0589 COATED TABLETS
OCTREOTIDE 0.1 mg/ml ampoule (INJ) Price/ml 0.7 mg N H01CB02

OFLOXACIN 0.3% opht drop (OPHT) Price/ml E S01AX11

OFLOXACIN 200 mg tab-cap (PO) Price/tab-cap 0.4 g C J01MA01

OFLOXACIN 400 mg tab-cap (PO) Price/tab-cap 0.4 g C J01MA01

OLANZAPINE 10 mg tab-cap (PO) Price/tab-cap 10 mg N N05AH03

OLANZAPINE 5 mg tab-cap (PO) Price/tab-cap 10 mg N N05AH03

OMEPRAZOLE 10 mg tab-cap (PO) Price/tab-cap 20 mg E A02BC01


Supplier MEDS 30 TAB-CAP 0.49 0.0164 TABLETS WITH ENTERIC COATED GRANULES


Buyer OECS/PPS 500 TAB-CAP 7.65 0.0153 TABLET
OMEPRAZOLE 40 mg vial (INJ) Price/vial 20 mg E A02BC01

ONDANSETRON 2 mg/ml ampoule (INJ) Price/ml 16 mg E A04AA01

ONDANSETRON 4 mg tab-cap (PO) Price/tab-cap 16 mg E A04AA01

Supplier IMRES 10 TAB-CAP 4.00 0.4000 BLISTER PACK COATED TABLETS
ONDANSETRON 8 mg tab-cap (PO) Price/tab-cap 16 mg E A04AA01

Buyer OECS/PPS 10 TAB-CAP 3.35 0.3350 2 X 5 TABLETS
Buyer PERU 1 TAB-CAP 2.74 2.7373 TABLETS
ORAL REHYDRATION SALTS (ORS) 1 PKT/1 l powder (PO) Price/packet E A07CA

Supplier IDA 100 PACKET 7.15 0.0715
Supplier ASRAMES 50 PACKET 3.98 0.0796 20.5 G/LITER
Supplier IMRES 50 PACKET 4.25 0.0850 20.5 G, 2004 WHO FORMULA
Supplier MEG 100 PACKET 8.84 0.0884 20.5G:NACL 2.6G,KCL 1.5G,TRISOD.CIT.DIH 2.9G,GLU ANH 13.5G
Supplier AMSTELFAR 100 PACKET 9.80 0.0980
Supplier DURBIN 100 PACKET 11.56 0.1156 20.5 G; NEW 2003 WHO FORMULA
Supplier MEDEOR/TZ 100 PACKET 12.96 0.1296
Supplier MSD/TANZ 100 PACKET 13.26 0.1326
Supplier MEDEOR/EU 100 PACKET 13.62 0.1362 20.5 G
Supplier ASRAMES 50 PACKET 7.20 0.1440 27.9 G/LITER
Supplier Median Price/packet=0.1068 High/Low Ratio=2.01
Buyer CHAI 1 PACKET 0.03 0.0300 INDIA (CHAI-MP)
Buyer CHAI 1 PACKET 0.03 0.0300 INDIA (CHAI), FLAVORED
Buyer CHAI 1 PACKET 0.04 0.0400 INDIA (JAMSON), FLAVORED
Buyer CHAI 1 PACKET 0.04 0.0400 INDIA (PAMPER), FLAVORED
Buyer CHAI 1 PACKET 0.05 0.0500 INDIA (ECON), FLAVORED
Buyer CHAI 1 PACKET 0.05 0.0500 INDIA (TENGEE), FLAVORED
Buyer CHAI 1 PACKET 0.05 0.0500 INDIA (AAROGYAM), FLAVORED
Buyer CHAI 1 PACKET 0.05 0.0500 INDIA (SALVO), FLAVORED
Buyer CHAI 1 PACKET 0.05 0.0500 INDIA (PAMPER), FLAVORED
Buyer CHAI 1 PACKET 0.05 0.0500 INDIA (UTOPIA), FLAVORED
Buyer CHAI 1 PACKET 0.05 0.0500 INDIA (BIOAX), FLAVORED
Buyer CHAI 1 PACKET 0.05 0.0500 INDIA (SAI), FLAVORED
Buyer DOMREPUB 1 PACKET 0.07 0.0700 27.9 G/L
Buyer CHAI 1 PACKET 0.08 0.0800 INDIA (SSS), FLAVORED
Buyer CHAI 1 PACKET 0.08 0.0800 INDIA (PAHEL), FLAVORED
Buyer MEMS 1 PACKET 0.11 0.1104
Buyer CHAI 60 PACKET 7.74 0.1290 NIGERIA (EMZOR), FLAVORED, EXW
Buyer PERU 1 PACKET 0.14 0.1448 20.5 G
Buyer CHAI 5 PACKET 0.73 0.1460 NIGERIA (OLPHARM), FLAVORED, EXW
Buyer CHAI 3 PACKET 0.45 0.1500 NIGERIA (CHI), FLAVORED, EXW
Buyer OECS/PPS 100 PACKET 20.00 0.2000
Buyer Median Price/packet=0.0500 High/Low Ratio=6.67
ORAL REHYDRATION SALTS (ORS) 1 pkt/500 ml powder (PO) Price/packet E A07CA

Supplier MEDS 20 PACKET 1.06 0.0532 FLAVORED

ORAL REHYDRATION SALTS (ORS) 1 pkt/500 ml powder (PO) Price/packet E A07CA
ORS+ZINC CO-PACK (1-LT PACKET ORS+1 TAB ZINC) 1 ORS+20 mg Price/each EP A07CA
each (PO)
Buyer CHAI 1 EACH 0.48 0.4800 NIGERIA (FIDSON), SCORED, DISPERSIBLE, FLAVORED TAB,EXW
Buyer CHAI 1 EACH 0.58 0.5800 NIGERIA (OLPHARM), SCORED DISPERSIBLE TAB, FLAVORED,EXW
Buyer CHAI 1 EACH 0.91 0.9100 NIGERIA (CHI), SCORED DISPERSIBLE TAB, FLAVORED, EXW
Buyer Median Price/each=0.5800 High/Low Ratio=1.90
ORS+ZINC CO-PACK (2 1-LT ORS PACKETS+1 TAB ZINC) 2 ORS+20 Price/each EP A07CA
mg each (PO)
Buyer CHAI 15 EACH 5.75 0.3833 NIGERIA (EMZOR), SCORED DISPERSIBLE TAB, FLAVORED, EXW
Buyer CHAI 1 EACH 0.80 0.8000 UGANDA (ASTRA PHARMA), SCORED DISPERSIBLE TAB, DDP
Buyer CHAI 1 EACH 0.80 0.8000 UGANDA (GITTOES), SCORED DISPERSIBLE TABLET, DDP
Buyer Median Price/each=0.8000 High/Low Ratio=2.09
ORS+ZINC CO-PACK (2 1-LT ORS+10 TABS ZINC) 2 ORS+20 mg Price/each EP A07CA

each (PO)
Buyer DRC/IHP 1 EACH 0.45 0.4500
ORS+ZINC CO-PACK (4 500ML PACKETS+10 TABS ZINC) 4 ORS+20 Price/each EP A07CA

mg each (PO)
Supplier MEDS 1 EACH 0.50 0.5040
OSELTAMIVIR 75 mg tab-cap (PO) Price/tab-cap 0.15 g E J05AH02

OXACILLIN 1 g vial (INJ) Price/vial 2 g T J01CF04

OXACILLIN 1 mcg disc (N/A) Price/each N V07AR

OXACILLIN 500 mg ampoule (INJ) Price/vial 2 g N J01CF04

OXALIPLATIN 100 mg vial (INJ) Price/vial C L01XA03

OXALIPLATIN 50 mg vial (INJ) Price/vial C L01XA03

OXYBUPROCAINE 0.4% opht drop (OPHT) Price/ml N S01HA02

OXYBUTYNIN 5 mg tab-cap (PO) Price/tab-cap 15 mg N G04BD04

OXYTOCIN 10 IU ampoule (INJ) Price/ml 15 U E H01BB02


OXYTOCIN 10 IU ampoule (INJ) Price/ml 15 U E H01BB02

Buyer SAFRICA 1 AMP (1 ml) 0.45 0.4456 SYNTHETIC
OXYTOCIN 5 IU ampoule (INJ) Price/ml 15 U P H01BB02

Buyer SAFRICA 1 AMP (1 ml) 0.50 0.4993 SYNTHETIC
P-AMINOSALICYLIC ACID (PAS) 4 g powder (PO) Price/packet 12 g C J04AA01

Supplier GDF 30 PACKET 40.00 1.3333 ENTERIC-COATED, DELAYED-RELEASE GRANULES
Buyer SAFRICA 30 PACKET 82.55 2.7516
P-AMINOSALICYLIC ACID (PAS) 60% w/w granules (PO) Price/g P J04AA

Supplier GDF 1 JAR (100 g) 12.49 0.1249
P-AMINOSALICYLIC ACID (PAS) (60% W/W) 9.2 g granules (PO) Price/packet P J04AA
Supplier GDF 30 PACKET 34.50 1.1500
P-AMINOSALICYLIC ACID (PAS) (FOR ORAL SOLUTION) 5.52 g Price/packet P J04AA

powder (PO)
Supplier GDF 25 PACKET 34.25 1.3700
PACLITAXEL 100 mg vial (INJ) Price/vial CP L01CD01

PACLITAXEL 6 mg/ml vial (INJ) Price/ml C L01CD01

Supplier IDA 1 VIAL (1 ml) 164.14 164.1376 POWDER

Buyer DOMREPUB 1 VIAL (16.70 ml) 15.85 0.9491
Buyer CRSS 1 AMP (50 ml) 48.48 0.9696
PANCURONIUM BROMIDE 2 mg/ml ampoule (INJ) Price/ml N M03AC01

PARACETAMOL 100 mg suppos (RECT) Price/supp 3 g E N02BE01

PARACETAMOL 100 mg tab-cap (PO) Price/tab-cap 3 g E N02BE01



PARACETAMOL 100 mg/ml suspen (PO) Price/ml 3 g P N02BE01

Buyer PERU 1 BOTT (10 ml) 0.27 0.0268 SOLUTION
PARACETAMOL 120 mg/5 ml suspen (PO) Price/ml 3 g P N02BE01

Supplier MSD/TANZ 24 BOTT (100 ml) 12.12 0.0050 SYRUP
Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.54 0.0054 SYRUP
Supplier MEG 1 BOTT (60 ml) 0.54 0.0090 SYRUP
Buyer SAFRICA 1 BOTT (500 ml) 1.18 0.0024 SYRUP
Buyer OECS/PPS 1 BOTT (125 ml) 1.39 0.0111 125 MG/5 ML
PARACETAMOL 125 mg suppos (RECT) Price/supp 3 g P N02BE01

Supplier MEDEOR/EU 250 SUPP 18.59 0.0744
Supplier DURBIN 100 SUPP 8.56 0.0856
Supplier IDA 100 SUPP 10.56 0.1056 120 MG
Supplier MEDEOR/TZ 10 SUPP 2.74 0.2736
Buyer SUDANNHIF 100 SUPP 20.84 0.2084 ILLUSTRATIVE PACK SIZE
Buyer MEMS 10 SUPP 3.35 0.3347

Supplier MEDEOR/EU 250 SUPP 19.98 0.0799
Supplier MEDEOR/TZ 10 SUPP 2.73 0.2730
Buyer SUDANNHIF 100 SUPP 22.44 0.2244 ILLUSTRATIVE PACK SIZE




PARAFFIN, LIQUID (MINERAL OIL) liquid (TOP) Price/ml N V03A


PARAFFIN, WHITE SOFT ointment (TOP) Price/g N D02AC

PENICILLAMINE 250 mg tab-cap (PO) Price/tab-cap 0.5 g C M01CC01

PENICILLIN, BENZATHINE BENZYL (1.44 G OF PEN. G) 2.4M IU Price/vial 3.6 g E J01CE08

powder (INJ)
Supplier UNFPA 50 VIAL 9.77 0.1953
Supplier DURBIN 50 VIAL 18.84 0.3768
Buyer SUDANNHIF 10 VIAL 2.24 0.2244 ILLUSTRATIVE NUMBER OF VIALS
PENICILLIN, BENZATHINE BENZYL (720 MG OF PEN. G) 1.2M IU Price/vial 3.6 g P J01CE08

powder (INJ)
Supplier UNFPA 50 VIAL 5.55 0.1111
Buyer SUDANNHIF 10 VIAL 1.16 0.1158 ILLUSTRATIVE NUMBER OF VIALS
PENICILLIN, BENZYL (3 G, PEN. G) 5M IU powder (INJ) Price/vial 3.6 g E J01CE01

Supplier MEDEOR/EU 50 VIAL 10.64 0.2129 10 ML

PENICILLIN, BENZYL (3 G, PEN. G) 5M IU powder (INJ) Price/vial 3.6 g E J01CE01

PENICILLIN, BENZYL (600 MG, PEN. G) 1M IU powder (INJ) Price/vial 3.6 g E J01CE01
Supplier DURBIN 50 VIAL 5.14 0.1028
PENICILLIN, PHENOXYMETHYL (PEN. V) 125 mg/5 ml suspen (PO) Price/ml 2 g P J01CE02

Supplier MSD/TANZ 24 BOTT (100 ml) 11.76 0.0049 GRANULES
Supplier DURBIN 1 BOTT (100 ml) 1.20 0.0120 POWDER FOR SYRUP
Supplier AMSTELFAR 1 BOTT (100 ml) 1.35 0.0135 DRY
PENICILLIN, PHENOXYMETHYL (PEN. V) 250 mg tab-cap (PO) Price/tab-cap 2 g E J01CE02

Supplier IMRES 1000 TAB-CAP 17.85 0.0179 TABLETS, POTASSIUM
Supplier MEDEOR/EU 1000 TAB-CAP 19.84 0.0198 TABLETS, 400,000 IU
PENICILLIN, PHENOXYMETHYL (PEN. V) 250 mg/5 ml syrup (PO) Price/ml 2 g E J01CE02

Buyer SAFRICA 1 BOTT (100 ml) 0.71 0.0071 SUSPENSION
PENICILLIN, PROCAINE BENZYL (1.8 G OF PEN. G) 3M IU powder Price/vial 0.6 g E J01CE09

(INJ)
PENICILLIN, PROCAINE BENZYL (2.4 G OF PEN. G) 4M IU powder Price/vial 0.6 g P J01CE09

(INJ)
Supplier MSD/TANZ 50 VIAL 12.54 0.2508 FORTIFIED

PENICILLIN, PROCAINE BENZYL (2.4 G OF PEN. G) 4M IU powder Price/vial 0.6 g P J01CE09

(INJ)
PENICILLIN, PROCAINE BENZYL (600 MG OF PEN. G) 1M IU Price/vial 0.6 g E J01CE09

powder (INJ)
PENICILLIN, PROCAINE+BENZYL 3M IU+1M IU vial (INJ) Price/vial 0.6 g P J01CE30

PENTAZOCINE (IC) 30 mg/ml ampoule (INJ) Price/ml 0.2 g N N02AD01

PERMETHRIN 1% lotion (TOP) Price/ml E P03AC04

PERMETHRIN 2.5% ointment (TOP) Price/g P P03AC04

PERMETHRIN 5% cream (TOP) Price/g E P03AC04

Buyer PERU 1 TUBE (60 g) 3.30 0.0550
PERMETHRIN (FOR MOSQUITO NET TREATMENT) 10% solution (N/A) Price/ml N P03AC04
Supplier DURBIN 1 BOTT (105 ml) 17.13 0.1631 WITH PLASTIC SHEET, PLASTIC BAG, PVC GLOVES
PETHIDINE (IC) 50 mg tab-cap (PO) Price/tab-cap 0.4 g E N02AB02

PETHIDINE HCL (IC) 50 mg/ml ampoule (INJ) Price/ml 0.4 g E N02AB02

PHENOBARBITAL (IC) 100 mg tab-cap (PO) Price/tab-cap 0.1 g E N03AA02

PHENOBARBITAL (IC) 100 mg/ml ampoule (INJ) Price/ml 0.1 g P N03AA02


PHENOBARBITAL (IC) 100 mg/ml ampoule (INJ) Price/ml 0.1 g P N03AA02

PHENOBARBITAL (IC) 15 mg/5 ml elixir (PO) Price/ml 0.1 g E N03AA02

PHENOBARBITAL (IC) 20 mg/5 ml elixir (PO) Price/ml 0.1 g P N03AA02

Buyer DOMREPUB 1 BOTT (120 ml) 0.51 0.0043 SYRUP
PHENOBARBITAL (IC) 200 mg/ml vial (INJ) Price/ml 0.1 g E N03AA02

PHENOBARBITAL (IC) 30 mg tab-cap (PO) Price/tab-cap 0.1 g E N03AA02

PHENOBARBITAL (IC) 50-60 mg tab-cap (PO) Price/tab-cap 0.1 g E N03AA02

PHENYTOIN 100 mg tab-cap (PO) Price/tab-cap 0.3 g E N03AB02

Supplier IMRES 1000 TAB-CAP 8.50 0.0085 SODIUM, COATED TABLETS
Supplier MEDEOR/EU 1000 TAB-CAP 8.57 0.0086 TABLETS, SODIUM
Supplier MEDS 84 TAB-CAP 7.84 0.0933 SODIUM, CAPSULES
PHENYTOIN 125 mg/5 ml suspen (PO) Price/ml 0.3 g P N03AB02

PHENYTOIN 50 mg/ml ampoule (INJ) Price/ml 0.3 g E N03AB02

PILOCARPINE 1% opht drop (OPHT) Price/ml 0.4 ML P S01EB01

PILOCARPINE 2% opht drop (OPHT) Price/ml 0.4 ML E S01EB01



Supplier DURBIN 1 BOTT (10 ml) 4.88 0.4881 NITRATE OR HYDROCHLORIDE

Buyer OECS/PPS 1 BOTT (10 ml) 5.73 0.5730 NITRATE
PIPERACILLIN+TAZOBACTAM 4 g+500 mg vial (INJ) Price/vial 14 g N J01CR05

PIROXICAM 20 mg tab-cap (PO) Price/tab-cap 20 mg N M01AC01

Buyer MEMS 100 TAB-CAP 1.62 0.0162
POLYGELINE 3.5% solution (INJ) Price/ml N B05AA

Supplier ASRAMES 1 BAG (500 ml) 4.47 0.0089 3.5-4%, WITH KIT
Buyer OECS/PPS 1 BOTT (500 ml) 11.95 0.0239 35 GMS
POTASSIUM CHLORIDE 15% vial (INJ) Price/ml 3 g P B05XA01

Supplier MEDS 1 AMP (10 ml) 1.05 0.1053 SLOW IV INFUSION

Buyer OECS/PPS 20 AMP (10 ml) 5.40 0.0270 2 MEQ/ML
POTASSIUM CHLORIDE 600 mg tab-cap (PO) Price/tab-cap 3 g P A12BA01

POTASSIUM CHLORIDE (KCL, 20 MEQ/15 ML) 10% vial (INJ) Price/ml 3 g P B05XA01
Supplier IMRES 50 AMP (10 ml) 20.00 0.0400 100 MG/ML
POTASSIUM CHLORIDE (SUSTAINED-RELEASE) 600 mg tab-cap (PO) Price/tab-cap 3 g P A12BA01

POTASSIUM PERMANGANATE powder (TOP) Price/g E D08AX06

Buyer MEMS 1 JAR (200 g) 2.46 0.0123
POVIDONE IODINE 10% ointment (TOP) Price/g T D08AG02

POVIDONE IODINE 10% solution (TOP) Price/ml E D08AG02

Supplier MEDS 1 BOTT (5000 ml) 16.74 0.0033 AQUEOUS, STABILIZED
Supplier DURBIN 1 BOTT (500 ml) 5.14 0.0103 AVAILABLE IODINE 1%

POVIDONE IODINE 10% solution (TOP) Price/ml E D08AG02

POVIDONE IODINE (SCRUB) 7.5% liquid (TOP) Price/ml P D08AG02

PRAZIQUANTEL 600 mg tab-cap (PO) Price/tab-cap 3 g E P02BA01

PREDNISOLONE 1 mg tab-cap (PO) Price/tab-cap P H02AB06

PREDNISOLONE 1% opht drop (OPHT) Price/ml P S01BA04

PREDNISOLONE 25 mg tab-cap (PO) Price/tab-cap 10 mg E H02AB06

PREDNISOLONE 5 mg tab-cap (PO) Price/tab-cap 10 mg E H02AB06

PREDNISOLONE (BASE) 15 mg/5 ml syrup (PO) Price/ml 10 mg P H02AB06

PREDNISONE 20 mg tab-cap (PO) Price/tab-cap 10 mg N H02AB07

PREDNISONE 5 mg tab-cap (PO) Price/tab-cap 10 mg T H02AB07


PREDNISONE 50 mg tab-cap (PO) Price/tab-cap 10 mg N H02AB07

PRIMAQUINE (BASE) 15 mg tab-cap (PO) Price/tab-cap 15 mg E P01BA03

Supplier MEG 1000 TAB-CAP 21.67 0.0217 PHOSPHATE, TABLETS
PROCHLORPERAZINE 5 mg tab-cap (PO) Price/tab-cap 0.1 g T N05AB04

PROGUANIL 100 mg tab-cap (PO) Price/tab-cap 0.2 g E P01BB01

PROMETHAZINE HCL 25 mg tab-cap (PO) Price/tab-cap 25 mg T R06AD02

Supplier AMSTELFAR 1000 TAB-CAP 10.15 0.0102 COATED TABLETS
Buyer DRC/IHP 1000 TAB-CAP 4.29 0.0043 COATED TABLETS
PROMETHAZINE HCL 25 mg/ml ampoule (INJ) Price/ml 25 mg T R06AD02

Supplier MEDS 1 AMP (2 ml) 0.10 0.0504 IM
PROMETHAZINE HCL 5 mg/5 ml suspen (PO) Price/ml 25 mg T R06AD02

Supplier MEDEOR/TZ 1 BOTT (60 ml) 0.35 0.0059 SYRUP
Supplier DURBIN 1 BOTT (100 ml) 4.02 0.0402 SYRUP
Buyer MEMS 1 BOTT (100 ml) 0.45 0.0045 SYRUP
Buyer SAFRICA 1 BOTT (100 ml) 0.65 0.0065 ELIXIR
PROPARACAINE 0.5% opht drop (OPHT) Price/ml T S01HA04

PROPOFOL 10 mg/ml vial (INJ) Price/ml E N01AX10


PROPOFOL 10 mg/ml vial (INJ) Price/ml E N01AX10

PROPRANOLOL 1 mg/ml ampoule (INJ) Price/ml 0.16 g P C07AA05

PROPRANOLOL HCL 10 mg tab-cap (PO) Price/tab-cap 0.16 g P C07AA05

PROPRANOLOL HCL 40 mg tab-cap (PO) Price/tab-cap 0.16 g E C07AA05

PROPRANOLOL HCL 80 mg tab-cap (PO) Price/tab-cap 0.16 g P C07AA05

PROPYLTHIOURACIL 50 mg tab-cap (PO) Price/tab-cap 0.1 g C H03BA02

PROTAMINE SULFATE 10 mg/ml ampoule (INJ) Price/ml C V03AB14


PROTIONAMIDE 250 mg tab-cap (PO) Price/tab-cap 0.75 mg C J04AD01

Supplier GDF 140 TAB-CAP 18.10 0.1293 FILM-COATED, BLISTER PACK TABLETS
PYRAZINAMIDE 400 mg tab-cap (PO) Price/tab-cap 1.5 g E J04AK01

PYRAZINAMIDE 500 mg tab-cap (PO) Price/tab-cap 1.5 g P J04AK01

Supplier GDF 672 TAB-CAP 21.00 0.0312 28 TABLETS PER BLISTER SHEET
PYRAZINAMIDE 750 mg tab-cap (PO) Price/tab-cap 1.5 g EP J04AK01

PYRIDOSTIGMINE BROMIDE 60 mg tab-cap (PO) Price/tab-cap 0.18 g C N07AA02


PYRIDOSTIGMINE BROMIDE 60 mg tab-cap (PO) Price/tab-cap 0.18 g C N07AA02

QUINIDINE SULFATE 200 mg tab-cap (PO) Price/tab-cap 1.2 g N C01BA01

QUININE DIHYDROCHLORIDE 100 mg/5 ml syrup (PO) Price/ml 1.5 g P P01BC01

Supplier MEDS 1 BOTT (15 ml) 1.16 0.0777 DROPS
QUININE DIHYDROCHLORIDE 125-150mg/ml ampoule (INJ) Price/ml 0.3 g P P01BC01

Supplier AMSTELFAR 100 AMP (2 ml) 48.60 0.2430 150 MG/ML
QUININE DIHYDROCHLORIDE 250-300mg/ml ampoule (INJ) Price/ml 0.3 g E P01BC01

Supplier ASRAMES 100 AMP (2 ml) 15.18 0.0759 300 MG/ML
Supplier MEDS 1 AMP (2 ml) 0.25 0.1232 300 MG/ML, IM/IV
Supplier MEDEOR/TZ 100 AMP (2 ml) 25.92 0.1296 300 MG/ML
Supplier IMRES 100 AMP (2 ml) 27.50 0.1375 300 MG/ML
Supplier IDA 100 AMP (2 ml) 29.24 0.1462 300 MG/ML
Supplier MEDEOR/EU 100 AMP (2 ml) 35.46 0.1773 300 MG/ML
Supplier DURBIN 100 AMP (2 ml) 39.39 0.1969 300 MG/ML
Supplier MEG 100 AMP (2 ml) 43.63 0.2182 300 MG/ML
Buyer MEMS 1 AMP (2 ml) 0.41 0.2070 300 MG/ML
Buyer SAFRICA 1 AMP (1 ml) 0.79 0.7903 300 MG/ML
QUININE HYDROCHLORIDE 300 mg/ml ampoule (INJ) Price/ml 1.5 g P P01BC01

QUININE SULFATE 100 mg/5 ml syrup (PO) Price/ml 1.5 g P P01B

QUININE SULFATE 200-250 mg tab-cap (PO) Price/tab-cap 0.3 g P P01BC01

QUININE SULFATE 300 mg tab-cap (PO) Price/tab-cap 0.3 g E P01BC01

Supplier IDA 1000 TAB-CAP 64.18 0.0642 FILM-COATED TABLETS
QUININE SULFATE 50 mg/5 ml syrup (PO) Price/ml 1.5 g EP P01BC01

QUININE SULFATE 500 mg tab-cap (PO) Price/tab-cap 0.3 g P P01BC01


RALTEGRAVIR 400 mg tab-cap (PO) Price/tab-cap 0.8 g N J05AX08

RANITIDINE 150 mg tab-cap (PO) Price/tab-cap 0.3 g E A02BA02

RANITIDINE 25 mg/ml ampoule (INJ) Price/ml 0.3 g E A02BA02

Supplier MEDS 1 AMP (2 ml) 0.10 0.0504 IM/IV
RANITIDINE 300 mg tab-cap (PO) Price/tab-cap 0.3 mg P A02BA02

RIFABUTIN 150 mg tab-cap (PO) Price/tab-cap 0.15 g E J04AB04

Supplier GDF 30 TAB-CAP 30.00 1.0000 HARD CAPSULES
RIFAMP.+ISONIAZID+PYRAZIN.+ETHAMBUT. (150+75+400+275 MG) Price/tab-cap E J04AM02

tab-cap (PO)
Buyer SAFRICA 112 TAB-CAP 8.47 0.0756 TABLETS, PATIENT-READY PACK
RIFAMPICIN 100 mg/5 ml syrup (PO) Price/ml 0.6 g P J04AB02

Buyer PERU 1 BOTT (60 ml) 1.88 0.0313 SUSPENSION
Buyer CRSS 1 BOTT (60 ml) 14.75 0.2458 SUSPENSION
RIFAMPICIN 150 mg tab-cap (PO) Price/tab-cap 0.6 g E J04AB02

Buyer SAFRICA 100 TAB-CAP 8.41 0.0841 CAPSULE
RIFAMPICIN 300 mg tab-cap (PO) Price/tab-cap 0.6 g E J04AB02

RIFAMPICIN 600 mg tab-cap (PO) Price/tab-cap 0.6 g EP J04AB02

Buyer SAFRICA 100 TAB-CAP 12.65 0.1265
RIFAMPICIN+ISONIAZID 150+75 mg tab-cap (PO) Price/tab-cap E J04AM02


RIFAMPICIN+ISONIAZID 150mg+150mg tab-cap (PO) Price/tab-cap E J04AM02

RIFAMPICIN+ISONIAZID 300+150 mg tab-cap (PO) Price/tab-cap 2 TAB E J04AM02

RIFAMPICIN+ISONIAZID (DISPERSIBLE) 60 mg+30 mg tab-cap Price/tab-cap E J04AM02

(PO)
RIFAMPICIN+ISONIAZID (DISPERSIBLE) 60 mg+60 mg tab-cap Price/tab-cap E J04AM02

(PO)
Buyer SAFRICA 56 TAB-CAP 2.49 0.0445 BLISTER PACK TABLETS, PATIENT-READY
RIFAMPICIN+ISONIAZID+ETHAMBUTOL 150+75+275mg tab-cap (PO) Price/tab-cap P J04AM

RIFAMPICIN+ISONIAZID+PYRAZINAMIDE (DISPERSIBLE) 60+30+150 Price/tab-cap E J04AM05

mg tab-cap (PO)
RISPERIDONE 0.5 mg tab-cap (PO) Price/tab-cap 5 mg E N05AX08

RISPERIDONE 1 mg tab-cap (PO) Price/tab-cap 5 mg E N05AX08

RISPERIDONE 1 mg/ml solution (PO) Price/ml 5 mg EP N05AX08



RITONAVIR (RTV) 100 mg tab-cap (PO) Price/tab-cap 1.2 g E J05AE03

Supplier IDA 60 TAB-CAP 6.95 0.1159 HEAT STABLE TABLETS
Supplier SCMS 336 TAB-CAP 40.28 0.1199 4 X 84 CAPSULES
Supplier DURBIN 60 TAB-CAP 42.64 0.7107 SOFTGEL CAPSULES
Buyer NAMIBIA 84 TAB-CAP 15.01 0.1787 CAPSULES
RITONAVIR (RTV) 80 mg/ml solution (PO) Price/ml 1.2 g E J05AE03


RITONAVIR (RTV) 80 mg/ml solution (PO) Price/ml 1.2 g E J05AE03

RITUXIMAB 10 mg/ml ampoule (INJ) Price/ml C L01XC02

Buyer PERU 1 AMP (10 ml) 159.29 15.9293
ROCURONIUM BROMIDE 50 mg/5 ml vial (INJ) Price/ml N M03AC09

SALBUTAMOL 0.2% respsol (INH) Price/ml 10 mg P R03AC02

Supplier DURBIN 20 BOTT (2.50 ml) 7.28 0.1456
SALBUTAMOL 0.5 mg/ml ampoule (INJ) Price/ml 12 mg E R03CC02

SALBUTAMOL 0.5% respsol (INH) Price/ml 10 mg E R03AC02

SALBUTAMOL 100 mcg/dose inhaler (INH) Price/dose 0.8 mg E R03AC02

Supplier IMRES 1 INHALER (200 DOSE) 1.80 0.0090 CFC-FREE
Supplier IDA 1 INHALER (200 DOSE) 2.01 0.0101
Supplier MEG 1 INHALER (200 DOSE) 2.14 0.0107
Supplier AMSTELFAR 1 INHALER (200 DOSE) 2.15 0.0107
Supplier MEDEOR/TZ 1 INHALER (200 DOSE) 2.27 0.0114
Supplier MEDEOR/EU 1 INHALER (200 DOSE) 2.42 0.0121
Buyer DRC/IHP 1 INHALER (200 DOSE) 1.57 0.0078
Buyer MEMS 1 INHALER (200 DOSE) 2.64 0.0132
SALBUTAMOL 2 mg tab-cap (PO) Price/tab-cap 12 mg E R03CC02

SALBUTAMOL 2 mg/5 ml syrup (PO) Price/ml 12 mg E R03CC02


SALBUTAMOL 4 mg tab-cap (PO) Price/tab-cap 12 mg E R03CC02

Buyer OECS/PPS 100 TAB-CAP 3.00 0.0300 TABLETS, SULFATE
SALMETEROL+FLUTICASONE (25+250 MCG/DOSE) inhaler (INH) Price/dose N R03AK06

SAQUINAVIR (SQV) 200 mg tab-cap (PO) Price/tab-cap 1.8 g E J05AE01

Buyer BOTSWANA 270 TAB-CAP 65.89 0.2440 CAPSULES
SAQUINAVIR (SQV) 500 mg tab-cap (PO) Price/tab-cap 1.8 g P J05AE01

SENNA (SENNOSIDES) 7.5 mg tab-cap (PO) Price/tab-cap 15 mg E A06AB06

SERTRALINE 50 mg tab-cap (PO) Price/tab-cap 50 mg N N06AB06

SEVOFLURANE solution (INH) Price/ml N N01AB08

SILVER SULFADIAZINE 1% cream (TOP) Price/g E D06BA01

Buyer PERU 1 JAR (400 g) 6.01 0.0150
Buyer OECS/PPS 1 JAR (450 g) 18.80 0.0418
Buyer MEMS 1 TUBE (10 g) 0.72 0.0724
SIMVASTATIN 10 mg tab-cap (PO) Price/tab-cap 30 mg E C10AA01


SIMVASTATIN 10 mg tab-cap (PO) Price/tab-cap 30 mg E C10AA01

SIMVASTATIN 20 mg tab-cap (PO) Price/tab-cap 30 mg T C10AA01

SODIUM AMIDOTRIZOATE (MEGLUMINE DIATRIZOATE) 76% vial Price/ml E V08AA01

(INJ)
SODIUM BICARBONATE 8.4% solution (INJ) Price/ml T B05XA02

Supplier DURBIN 50 AMP (20 ml) 43.67 0.0437 EQUIV TO NA+ 1MOL/L, HCO3- 1MOL/L
Buyer OECS/PPS 1 VIAL (50 ml) 1.60 0.0320 FLIP-TOP VIAL
SODIUM CHLORIDE IN WATER 0.45% solution (IV) Price/ml P B05XA03

SODIUM CHLORIDE IN WATER (NORMAL SALINE) 0.9% solution Price/ml E B05XA03

(IV)
Supplier IMRES 1 BOTT (1000 ml) 0.95 0.0009 NIPPLEHEAD
Supplier IMRES 1 BOTT (500 ml) 0.55 0.0011 NIPPLEHEAD
Supplier DURBIN 10 BOTT (1000 ml) 12.84 0.0013 + SET
Buyer CRSS 1 BAG (500 ml) 2.10 0.0042
SODIUM DICHLOROISOCYANURATE (NADCC) 1.67 g tab-cap (N/A) Price/tab-cap N V07A

Supplier MEDEOR/EU 200 TAB-CAP 6.57 0.0328 TABLETS, 1 TAB FOR 200 LITERS

SODIUM DICHLOROISOCYANURATE (NADCC) 1.67 g tab-cap (N/A) Price/tab-cap N V07A

SODIUM DICHLOROISOCYANURATE (NADCC) 8.5 mg tab-cap (N/A) Price/tab-cap N V07A

Supplier MEDEOR/EU 5000 TAB-CAP 32.28 0.0065 TABLETS, 1 TAB FOR 1 LITER
SODIUM LACTATE COMPOUND (RINGER'S/HARTMANN'S SOL.) Price/ml E B05BB02

solution (IV)
Supplier MSD/TANZ 12 BAG (1000 ml) 10.44 0.0009
SODIUM STIBOGLUCONATE (10% SB) 33% vial (INJ) Price/ml 0.85 g E P01CB02
SODIUM VALPROATE 200 mg tab-cap (PO) Price/tab-cap 1.5 g E N03AG01

Supplier DURBIN 100 TAB-CAP 6.85 0.0685 ENTERIC COATED TABLETS
SODIUM VALPROATE 250 mg/5 ml suspen (PO) Price/ml 1.5 g N N03AG

SODIUM VALPROATE 500 mg tab-cap (PO) Price/tab-cap 1.5 g E N03AG01

SPECTINOMYCIN 2 g vial (INJ) Price/vial 3 g E J01XX04

Supplier IMRES 1 VIAL 4.50 4.5000 WITH SOLVENT
Supplier AMSTELFAR 1 VIAL 5.10 5.1000 + SOLVENT
SPIRONOLACTONE 100 mg tab-cap (PO) Price/tab-cap 75 mg CP C03DA01


SPIRONOLACTONE 100 mg tab-cap (PO) Price/tab-cap 75 mg CP C03DA01

Buyer DOMREPUB 1 TAB-CAP 0.07 0.0700 TABLETS
SPIRONOLACTONE 25 mg tab-cap (PO) Price/tab-cap 75 mg C C03DA01

STAVUDINE (D4T) 1 mg/ml solution (PO) Price/ml 80 mg E J05AF04

Supplier SCMS 1 BOTT (200 ml) 1.31 0.0066 POWDER
STAVUDINE (D4T) 15 mg tab-cap (PO) Price/tab-cap 80 mg E J05AF04




STREPTOKINASE (POWDER) 1,500,000 IU vial (INJ) Price/vial 1.5 MU C B01AD01

STREPTOMYCIN SULFATE 1 g vial (INJ) Price/vial 1 g E J01GA01

SULFACETAMIDE SODIUM 10% opht drop (OPHT) Price/ml N S01AB04

SULFADIAZINE 500 mg tab-cap (PO) Price/tab-cap 0.6 g E J01EC02

SULFADOXINE+PYRIMETHAMINE 500 mg+25 mg tab-cap (PO) Price/tab-cap C P01BD51


SULFADOXINE+PYRIMETHAMINE 500 mg+25 mg tab-cap (PO) Price/tab-cap C P01BD51

Supplier MEDEOR/TZ 90 TAB-CAP 7.56 0.0840 30 X 3 TABLETS
SULFADOXINE+PYRIMETHAMINE (250 MG+12.5 MG/5 ML) Price/ml 75 mg CP P01BD51

250+12mg/5ml suspen (PO)
SULFAMETHOXAZOLE+TRIMETHOPRIM (CO-TRIMOXAZOLE) 100 mg+20 Price/tab-cap E J01EE01

mg tab-cap (PO)
SULFAMETHOXAZOLE+TRIMETHOPRIM (CO-TRIMOXAZOLE) 200 mg+40 Price/tab-cap P J01EE01

mg tab-cap (PO)
Supplier MEDS 100 TAB-CAP 1.33 0.0133 DISPERSIBLE, FLAVORED TABLETS; BLISTER PACK
SULFAMETHOXAZOLE+TRIMETHOPRIM (CO-TRIMOXAZOLE) Price/ml E J01EE01

200+40mg/5ml suspen (PO)
Supplier DURBIN 1 BOTT (100 ml) 0.69 0.0069 POWDER
Supplier MEDEOR/EU 12 BOTT (100 ml) 14.17 0.0118 POWDER
SULFAMETHOXAZOLE+TRIMETHOPRIM (CO-TRIMOXAZOLE) 400 mg+80 Price/tab-cap E J01EE01

mg tab-cap (PO)
SULFAMETHOXAZOLE+TRIMETHOPRIM (CO-TRIMOXAZOLE) 80+16 mg/ml Price/ml E J01EE01

ampoule (INJ)

SULFAMETHOXAZOLE+TRIMETHOPRIM (CO-TRIMOXAZOLE) 80+16 mg/ml Price/ml E J01EE01

ampoule (INJ)
SULFAMETHOXAZOLE+TRIMETHOPRIM (CO-TRIMOXAZOLE) 800 Price/tab-cap P J01EE01

mg+160mg tab-cap (PO)
SULFAMETHOXAZOLE+TRIMETHOPRIM (DISPERSIBLE) 100 mg+20 mg Price/tab-cap E J01EE01

tab-cap (PO)
SULFASALAZINE 500 mg tab-cap (PO) Price/tab-cap 2 g C A07EC01

SULPHAMETOPYRAZINE-PYRIMETHAMINE 500+25 mg tab-cap (PO) Price/tab-cap 75 mg N P01BD51

SUXAMETHONIUM CL (SUCCINYLCHOLINE) 20 mg/ml vial (INJ) Price/ml P M03AB01

SUXAMETHONIUM CL (SUCCINYLCHOLINE) 50 mg/ml ampoule (INJ) Price/ml E M03AB01

TACROLIMUS 1 mg tab-cap (PO) Price/tab-cap 5 mg N L04AD02

TAMOXIFEN CITRATE 10 mg tab-cap (PO) Price/tab-cap 20 mg C L02BA01

Supplier AMSTELFAR 30 TAB-CAP 5.35 0.1783 3 X 10 TABLETS
TAMOXIFEN CITRATE 20 mg tab-cap (PO) Price/tab-cap 20 mg C L02BA01

TAMSULOSIN 0.4 mg tab-cap (PO) Price/tab-cap 0.4 mg N G04CA02

TEMOZOLOMIDE 100 mg tab-cap (PO) Price/tab-cap N L01AX03


TENOFOVIR DF+EMTRICITABINE (TDF+FTC) 300 mg+200mg tab-cap Price/tab-cap 1 tab E J05AR03

(PO)
TENOFOVIR DF+LAMIVUDINE 300mg+300mg tab-cap (PO) Price/tab-cap P J05AR


TENOFOVIR DISOPROXIL FUMERATE (TDF) (EQUIV.245MG TENOFOVIR Price/tab-cap 0.245 g E J05AF07

DISOPRO) 300 mg tab-cap (PO)
TENOXICAM 20 mg tab-cap (PO) Price/tab-cap 20 mg N M01AC02

TERBINAFINE 1% cream (TOP) Price/g E D01AE15

TERIZIDONE 250 mg tab-cap (PO) Price/tab-cap N J04AK03

Supplier GDF 50 TAB-CAP 83.30 1.6660 BLISTER PACK CAPSULES
TEST, BLOODGROUP ANTI-A, MONOCLONAL test (DIAG) Price/ml N V04

Supplier ASRAMES 1 BOTT (10 ml) 3.49 0.3490 200 TESTS
TEST, BLOODGROUP ANTI-A/B, MONOCLONAL test (DIAG) Price/ml N V04

TEST, BLOODGROUP, ANTI-B, MONOCLONAL test (DIAG) Price/ml N V04

TEST, BLOODGROUP, ANTI-D, MONOCLONAL test (DIAG) Price/ml N V04

TEST, BRUCELLA MELITENSIS ANTIGEN (RAPID) test (DIAG) Price/test N V04

Buyer MEMS 100 TEST 18.98 0.1897 B. ABORTUS AND B. MELLITENSIS KIT
TEST, GLUCOSE IN URINE test (DIAG) Price/strip N V04B

Supplier ASRAMES 100 TEST (1 STRIP) 4.35 0.0435
Supplier MSD/TANZ 50 STRIPS 4.08 0.0816
Supplier Median Price/strip=0.0626 High/Low Ratio=1.88
Buyer MEMS 100 STRIPS 7.02 0.0702

TEST, GLUCOSE METER (ON CALL PLUS) each (DIAG) Price/each N V04C
TEST, GLUCOSE METER (SD CHECK GOLD) each (DIAG) Price/each N

TEST, GLUCOSE METER STRIPS (FOR ON CALL PLUS) test (DIAG) Price/strip N V04C
Supplier MEDEOR/TZ 50 STRIPS 14.40 0.2880
Supplier MEDS 50 STRIPS 16.02 0.3203
TEST, GLUCOSE METER STRIPS (FOR SD CHECK GOLD) each (DIAG) Price/each N
Supplier IDA 50 STRIPS (1 EACH) 18.96 0.3793
TEST, HEPATITIS B HBSAG ELISA (VERSION 3) test (DIAG) Price/test N V04

Supplier IDA 96 TEST 191.71 1.9970
TEST, HEPATITIS B, HBSAG, DETERMINE test (DIAG) Price/test N V04CX

Supplier ASRAMES 100 TEST 167.30 1.6730 KIT
Buyer DRC/IHP 100 TEST 128.54 1.2854
TEST, HEPATITIS BSAG test (DIAG) Price/test N V04CX

Supplier MEDS 50 TEST 13.55 0.2710 SINGLE, SEALED DIPSTICKS
Supplier IMRES 50 TEST 30.00 0.6000 TESTSTRIP
Supplier MEDEOR/TZ 50 TEST 37.20 0.7440 RAPID TEST, KIT
Supplier Median Price/test=0.6720 High/Low Ratio=5.99
Buyer MEMS 50 TEST 26.57 0.5313 KIT
TEST, HEPATITIS C ELISA test (DIAG) Price/test N V04

TEST, HEPATITIS C, HCVSCAN (TM) (RAPID TEST) test (DIAG) Price/test N V04CX
Supplier MEDEOR/TZ 50 TEST 52.08 1.0416
TEST, HIV 1+2 INSTANTCHEK (TM) test (DIAG) Price/test N V04CX

TEST, HIV 1+2 SD BIOLINE 3.0 (TM) test (DIAG) Price/test N V04CX
Supplier MEDEOR/TZ 25 TEST 42.00 1.6800 KIT
TEST, HIV 1+2 STAT PAK (TM) test (DIAG) Price/test N V04CX
TEST, HIV 1+2+O AG/AB MUREX (TM) test (DIAG) Price/test N V04CX
TEST, HIV 1+2, INTEC test (DIAG) Price/test N V04CX

Supplier ASRAMES 25 TEST 14.79 0.5916 KIT WITH CASSETTES, BUFFER, LANCETS
TEST, HIV, CAPILLUS HIV-1/2 (TM) test (DIAG) Price/test N V04CX


TEST, HIV, CAPILLUS HIV-1/2 (TM) test (DIAG) Price/test N V04CX

Buyer MEMS 100 TEST 98.28 0.9828
TEST, HIV, DETERMINE HIV-1/2 (TM) test (DIAG) Price/test N V04CX

Supplier MEDEOR/TZ 100 TEST 81.84 0.8184 INCLUDING CHASE BUFFER & TUBES
Supplier MEG 100 TEST 112.50 1.1250 KIT
Supplier IMRES 100 TEST 120.00 1.2000
Buyer Median Price/test=1.0699 High/Low Ratio=1.18
TEST, HIV, UNIGOLD I/II (TM) test (DIAG) Price/test N V04CX

Supplier DURBIN 20 TEST 51.81 2.5903
TEST, MALARIA P. FALCIPARUM (PARACHECK) test (DIAG) Price/test N V07A

Supplier ASRAMES 25 TEST 19.15 0.7660
Supplier MEDS 25 TEST 25.42 1.0170 KIT
TEST, MALARIA, P. FALCIPARUM (FIRST RESPONSE AG RAPID Price/test N V04CX

TEST) test (DIAG)
Buyer SAFRICA 25 TEST 15.51 0.6203
TEST, MALARIA, P. FALCIPARUM (VISITECT) test (DIAG) Price/test N V04CX

Supplier DURBIN 25 TEST 42.81 1.7126
TEST, MALARIA, P. FALCIPARUM+P. PAN (FIRST RESPONSE AG Price/test N V04CX

RAPID TEST) test (DIAG)
TEST, MALARIA, P. FALCIPARUM/P. OVALE test (DIAG) Price/test N V04CX

Supplier MEDS 25 TEST 15.40 0.6160 KIT
TEST, MALARIA, P.FALCIPARUM, P.VIVAX test (DIAG) Price/test N V04CX

TEST, MALARIA, SD-BIOLINE test (DIAG) Price/test N V07AR

TEST, PREGNANCY (URINE) test (DIAG) Price/test N V04CX

Supplier MEDS 50 TEST 4.10 0.0820 RAPID TEST STRIP
Supplier MEDEOR/TZ 1 TEST 0.08 0.0840
Supplier IMRES 1 TEST 0.09 0.0900 DIP STRIP
Supplier MEG 50 TEST 5.47 0.1094 URINE STRIPS, 2.5 MM
Supplier MSD/TANZ 25 TEST 3.96 0.1584
Buyer DRC/IHP 100 TEST 5.40 0.0540 HCG TEST STRIPS
Buyer MEMS 50 TEST 3.45 0.0690 STRIP

TEST, PREGNANCY (URINE) test (DIAG) Price/test N V04CX

Buyer DOMREPUB 50 TEST 5.12 0.1024
Buyer Median Price/test=0.0690 High/Low Ratio=1.90
TEST, SYPHILIS (RPR FORTRESS) test (DIAG) Price/test N V04CX

TEST, SYPHILIS (VDRL CARBON ANTIGEN FORTRESS) bott (DIAG) Price/ml N V04CX
TEST, SYPHILIS DETERMINE (TM) test (DIAG) Price/test N V04CX

Supplier IMRES 100 TEST 175.00 1.7500 10 X 10
TEST, SYPHILIS RPR (TM) test (DIAG) Price/test N V04CX

TEST, SYPHILIS SD BIOLINE 3.0 (TM) (RAPID TEST) test Price/test N V04CX
(DIAG)
Supplier IMRES 30 TEST 23.50 0.7833 KIT
Supplier MSD/TANZ 1 KIT (30 TEST) 36.42 1.2140
TEST, URINE GLUCOSE/PROTEIN STRIP test (DIAG) Price/strip N V04C

Supplier IDA 100 STRIPS 4.10 0.0410
Supplier IMRES 100 STRIPS 4.50 0.0450
TETANUS ANTITOXIN 1500 IU ampoule (INJ) Price/ampoule N J06AA02

Supplier IMRES 50 AMP 62.50 1.2500 1 ML
Supplier MSD/TANZ 1 AMP 3.60 3.6000
TETRACAINE 0.5% opht drop (OPHT) Price/ml E S01HA03

TETRACYCLINE 3% ointment (TOP) Price/g P D06AA04

TETRACYCLINE 500 mg tab-cap (PO) Price/tab-cap 1 g T J01AA07

TETRACYCLINE HCL 1% ointment (TOP) Price/g P D06AA04

TETRACYCLINE HCL 1% opht oint (OPHT) Price/g E S01AA09

Supplier MEDEOR/TZ 1 TUBE (3.50 g) 0.18 0.0514
Supplier MEDS 1 TUBE (3.50 g) 0.20 0.0576
Supplier UNFPA 50 TUBE (5 g) 23.36 0.0935
Buyer DRC/IHP 50 TUBE (5 g) 8.62 0.0345

TETRACYCLINE HCL 1% opht oint (OPHT) Price/g E S01AA09

Buyer MEMS 1 TUBE (3.50 g) 0.24 0.0690
Buyer PERU 1 TUBE (6 g) 1.55 0.2590
TETRACYCLINE HCL 250 mg tab-cap (PO) Price/tab-cap 1 g P J01AA07

THALIDOMIDE 100 mg tab-cap (PO) Price/tab-cap 0.1 g N L04AX02

THEOPHYLLINE (SUSTAINED-RELEASE) 200 mg tab-cap (PO) Price/tab-cap 0.4 g N R03DA04

THIOPENTAL SODIUM 1 g vial (INJ) Price/vial E N01AF03

Supplier DURBIN 50 AMP (1 VIAL) 123.74 2.4747 POWDER
Buyer OECS/PPS 1 VIAL 1.98 1.9800 POWDER
THIOPENTAL SODIUM 500 mg vial (INJ) Price/vial E N01AF03

Supplier DURBIN 50 AMP (1 VIAL) 112.95 2.2589 POWDER
Buyer SAFRICA 1 VIAL 1.93 1.9311 20 ML VIAL
TIABENDAZOLE 500 mg tab-cap (PO) Price/tab-cap 3 g N P02CA02

TIABENDAZOLE (CHEWABLE) 500 mg tab-cap (PO) Price/tab-cap 3 g N P02CA02

TIMOLOL MALEATE 0.25% opht drop (OPHT) Price/ml 0.2 ML E S01ED01




TINIDAZOLE 500 mg tab-cap (PO) Price/tab-cap 1.5 g T P01AB02

Supplier MEDEOR/TZ 80 TAB-CAP 3.41 0.0427 TABLETS, STRIP PACK 20 X 4 TABS
TIOGUANINE 40 mg tab-cap (PO) Price/tab-cap C L01BB03

TOPIRAMATE 100 mg tab-cap (PO) Price/tab-cap 0.3 g N N03AX11

TOPIRAMATE 25 mg tab-cap (PO) Price/tab-cap 0.3 g N N03AX11

TRAMADOL HYDROCHLORIDE 100 mg/ml ampoule (INJ) Price/ml 0.3 g E N02AX02

TRAMADOL HYDROCHLORIDE 100 mg/ml solution (PO) Price/ml 0.3 g N N02AX02

TRAMADOL HYDROCHLORIDE 50 mg tab-cap (PO) Price/tab-cap 0.3 g E N02AX02

TRAMADOL HYDROCHLORIDE 50 mg/ml ampoule (INJ) Price/ml 0.3 g E N02AX02

Buyer MEMS 10 AMP (2 ml) 4.14 0.2070
Buyer BOTSWANA 1 AMP (2 ml) 1.13 0.5650

TRANEXAMIC ACID 100 mg/ml ampoule (INJ) Price/ml 2 g E B02AA02

Buyer BOTSWANA 1 AMP (5 ml) 5.48 1.0960
TRASTUZUMAB 440 mg vial (INJ) Price/vial N L01XC03

Buyer CRSS 1 VIAL 1800.00 1800.0000
TRIAMCINOLONE ACETONIDE 10 mg/ml ampoule (INJ) Price/ml 7.5 mg N H02AB08

TRIFLUOPERAZINE 5 mg tab-cap (PO) Price/tab-cap 20 mg T N05AB06


TRIHEXYPHENIDYL (BENZHEXOL) 2 mg tab-cap (PO) Price/tab-cap 10 mg T N04AA01

TRIHEXYPHENIDYL (BENZHEXOL) 5 mg tab-cap (PO) Price/tab-cap 10 mg T N04AA01

TROPICAMIDE 0.5% opht drop (OPHT) Price/ml E S01FA06

TROPICAMIDE 1% opht drop (OPHT) Price/ml P S01FA06


TUBERCULIN (PPD) 5 IU vial (INJ) Price/dose E V04CF01

Buyer CRSS 1 VIAL (10 DOSE) 2.18 0.2180
UROGRAPHIN 76% solution (INJ) Price/ml N V09X

VACCINE, BCG (DRIED) powder (INJ) Price/dose E L03AX03

Buyer SAFRICA 1 VIAL (20 DOSE) 3.13 0.1564
VACCINE, DIPHTHERIA-TETANUS vial (INJ) Price/dose E J07AM51

Buyer CRSS 1 AMP (10 DOSE) 1.27 0.1270
Buyer SAFRICA 1 VIAL (10 DOSE) 9.92 0.9916 ADULT; IN SYRINGE
VACCINE, HEPATITIS B vial (INJ) Price/vial E J07BC01

Supplier MEDS 1 VIAL 2.00 2.0048 20 MCG/ML, 1 ML, ADULT
Supplier MSD/TANZ 1 AMP (1 VIAL) 13.20 13.2000 SINGLE DOSE
Buyer CRSS 1 VIAL 0.58 0.5800 20 MCG/ML, 1 ML, ADULT
Buyer SAFRICA 1 VIAL 1.66 1.6617 20 MCG, 1 ML
VACCINE, HPV vial (INJ) Price/ml N J07BM

Buyer DOMREPUB 1 VIAL (0.50 ml) 47.25 94.5000
VACCINE, INFLUENZA 0.5 ml ampoule (INJ) Price/vial E J07BB01

Buyer SAFRICA 1 SYRINGE (1 VIAL) 5.26 5.2592 0.5 ML DOSE, SYRINGE
VACCINE, MEASLES vial (INJ) Price/dose E J07BJ01

Buyer SAFRICA 1 VIAL (10 DOSE) 7.02 0.7016 LIVE, ATTENUATED

VACCINE, MEASLES vial (INJ) Price/dose E J07BJ01
VACCINE, MEASLES-MUMPS-RUBELLA vial (INJ) Price/dose E J07BD52

Buyer CRSS 1 VIAL (10 DOSE) 2.37 0.2370
VACCINE, MENINGOCOCCAL vial (INJ) Price/dose E J07AH

Supplier MSD/TANZ 1 AMP (10 DOSE) 32.34 3.2340
Buyer SAFRICA 1 VIAL (1 DOSE) 10.77 10.7708 GROUP A & C, PLUS DILUENT
VACCINE, PENTAVALENT (TETANUS,DIP,PERTUS,POLIO,HIB) vial Price/dose EP J07A

(INJ)
VACCINE, PNEUMOCOCCAL vial (INJ) Price/dose E J07AL

Buyer CRSS 1 VIAL (1 DOSE) 16.55 16.5500 HEPTA-VALENT
Buyer SAFRICA 1 vial (1 DOSE) 17.42 17.4176 POLYVALENT, 0.5 ML DOSE
VACCINE, POLIO (ORAL) vial (PO) Price/dose E J07BF01

Buyer SAFRICA 1 VIAL (20 DOSE) 4.93 0.2465 TRIVALENT
VACCINE, RABIES vial (INJ) Price/vial E J07BD01

Supplier MEDS 1 VIAL 8.74 8.7360 0.5 ML, 5 DOSES REQ. FOR FULL TX, W/ SYRINGE DILUENT
Supplier MSD/TANZ 1 AMP (1 VIAL) 12.54 12.5400 POTENCY OF ANTIGEN < 2.5 IU/DOSE
Buyer SAFRICA 1 VIAL 15.63 15.6334 1 DOSE VIAL PLUS SOLVENT
VACCINE, ROTAVIRUS vial (PO) Price/dose E J07BH

Supplier MEDS 1 VIAL (1 DOSE) 20.66 20.6640 1 ML
VACCINE, TETANUS TOXOID vial (INJ) Price/dose E J07AM01

Supplier IDA 25 VIAL (20 DOSE) 88.22 0.1764
VACCINE, TYPHOID vial (INJ) Price/dose E J07AP

Supplier MEDS 1 VIAL (20 DOSE) 88.70 4.4352 10 ML
VACCINE, YELLOW FEVER vial (INJ) Price/dose E J07BL01

Supplier MSD/TANZ 1 VIAL (10 DOSE) 42.90 4.2900
Buyer SAFRICA 1 VIAL (1 DOSE) 21.28 21.2817 1 DOSE AMP PLUS DILUENT
VALACICLOVIR 500 mg tab-cap (PO) Price/tab-cap 3 g T J05AB11

VALGANCICLOVIR 450 mg tab-cap (PO) Price/tab-cap 0.9 g E J05AB14

VALPROIC ACID 150 mg tab-cap (PO) Price/tab-cap 1.5 g P N03AG01

VALPROIC ACID 500 mg tab-cap (PO) Price/tab-cap 1.5 g E N03AG01

VALPROIC ACID (SLOW RELEASE) 200 mg tab-cap (PO) Price/tab-cap 1.5 g P N03AG01
Buyer OECS/PPS 100 TAB-CAP 17.55 0.1755 E.C. TABLETS
VALPROIC ACID (SODIUM VALPROATE) 200 mg/5 ml syrup (PO) Price/ml 1.5 g E N03AG01
VANCOMYCIN 500 mg vial (INJ) Price/vial 2 g N J01XA01


VANCOMYCIN 500 mg vial (INJ) Price/vial 2 g N J01XA01

Buyer OECS/PPS 1 VIAL 3.00 3.0000 POWDER
VDRL CARBON ANTIGEN (VD24) solution (N/A) Price/ml N V07AZ

Supplier IMRES 1 BOTT (5 ml) 5.25 1.0500 VD24, 250 TESTS
VECURONIUM 4 mg vial (INJ) Price/vial P M03AC03

Supplier ASRAMES 10 AMP (1 VIAL) 20.06 2.0060
Buyer SAFRICA 1 AMP (1 VIAL) 1.13 1.1266 POWDER, 2 ML
VENLAFAXINE 75 mg tab-cap (PO) Price/tab-cap 0.1 g N N06AX16

VERAPAMIL HCL 2.5 mg/ml vial (INJ) Price/ml 0.24 g E C08DA01

VERAPAMIL HCL 40 mg tab-cap (PO) Price/tab-cap 0.24 g E C08DA01

VERAPAMIL HCL 80 mg tab-cap (PO) Price/tab-cap 0.24 g E C08DA01

VERAPAMIL HCL (SLOW-RELEASE) 240 mg tab-cap (PO) Price/tab-cap 0.24 g P C08DA01

VINBLASTINE 10 mg vial (INJ) Price/vial C L01CA01

VINCRISTINE 1 mg vial (INJ) Price/vial C L01CA02

Supplier MEDS 1 VIAL 5.00 4.9952 10 ML
VINORELBINE 10 mg/1 ml vial (INJ) Price/vial C L01CA04

VINORELBINE 50 mg/5 ml vial (INJ) Price/vial C L01CA04


VITAMIN A (RETINOL (10,000 IU)) 3 mg tab-cap (PO) Price/tab-cap 50 TU E A11CA01


Buyer SAFRICA 50 TAB-CAP 3.02 0.0605 SOFT GEL CAPSULE

Buyer SAFRICA 50 TAB-CAP 4.48 0.0895 SOFT GEL CAPSULES
VITAMIN A (RETINOL (25,000 IU)) 7.5 mg tab-cap (PO) Price/tab-cap 50 TU P A11CA01


Supplier IMRES 1000 TAB-CAP 17.50 0.0175 CAPSULES, PALMITATE
Buyer DOMREPUB 1 TAB-CAP 0.02 0.0200 BLISTER PACK PEARLS
Buyer SAFRICA 50 TAB-CAP 2.26 0.0451 SOFT GEL CAPSULE
VITAMIN B COMPLEX ampoule (INJ) Price/ml N A11EA

Supplier DURBIN 100 AMP (2 ml) 27.14 0.1357 TABLETS, NIC. 40 MG, PAN. 6 MG, B6 4 MG, B2 4 MG, B1 10 MG
Buyer DOMREPUB 1 VIAL (10 ml) 0.27 0.0270 100MG B1, 10MG B2, 10MG B6, 100MG NICOTINAMIDE
Buyer BOTSWANA 1 AMP (10 ml) 0.95 0.0950 CONCENTRATED INFUSION MIXTURE
VITAMIN B COMPLEX syrup (PO) Price/ml N A11EA

Buyer DOMREPUB 1 BOTT (120 ml) 0.25 0.0021 50 MG B1, 50 MG B6, 200 MCG B12/15 ML
Buyer OECS/PPS 1 BOTT (250 ml) 2.82 0.0113 2.5MG B1, 3MG B2, 6.25MG B6, 37.5MG NIC, 25MG VIT.C/5ML
VITAMIN B COMPLEX tab-cap (PO) Price/tab-cap N A11EA

Supplier MEDS 1000 TAB-CAP 1.39 0.0014 THIAMINE HCL, RIBOFLAVIN, NICOTINAMIDE TABLETS
Supplier DURBIN 1000 TAB-CAP 6.85 0.0069 TABLETS, NICOTINAMIDE 15MG, RIBOFLAVIN 1MG, THIAMINE 1MG

VITAMIN B COMPLEX tab-cap (PO) Price/tab-cap N A11EA

Buyer DOMREPUB 100 TAB-CAP 0.55 0.0055 15MG B1,1MG B2,2.6MG B6,2MCG B12,10MG NICOT. BLIST.TAB
VITAMIN B1 (THIAMINE HCL) 100 mg tab-cap (PO) Price/tab-cap 50 mg P A11DA01

VITAMIN B1 (THIAMINE HCL) 100 mg/ml ampoule (INJ) Price/ml 50 mg P A11DA01

VITAMIN B1 (THIAMINE HCL) 50 mg tab-cap (PO) Price/tab-cap 50 mg E A11DA01

VITAMIN B12 (CYANOCOBALAMIN) 1 mg/ml ampoule (INJ) Price/ml 0.02 mg N B03BA01

Buyer OECS/PPS 100 AMP (1 ml) 69.15 0.6915 HYDROXOCOBALAMIN
VITAMIN B6 (PYRIDOXINE) 25 mg tab-cap (PO) Price/tab-cap 0.16 g E A11HA02

VITAMIN B6 (PYRIDOXINE) 50 mg tab-cap (PO) Price/tab-cap 0.16 g P A11HA02

VITAMIN B6 (PYRIDOXINE) 50 mg/ml ampoule (INJ) Price/ml 0.16 g P A11HA02


VITAMIN C (ASCORBIC ACID) 100 mg tab-cap (PO) Price/tab-cap 0.2 g P A11GA01





VITAMIN D (ALFACALCIDOL) 0.25 mcg tab-cap (PO) Price/tab-cap 1 mcg T A11CC03

VITAMIN D3 (CHLOECALCIFEROL) 10,000 IU/ml drops (PO) Price/ml N A11CC

VITAMIN K1 (PHYTOMENADIONE) 1 mg/ml ampoule (INJ) Price/ml 20 mg P B02BA01

VITAMIN K1 (PHYTOMENADIONE) 10 mg tab-cap (PO) Price/tab-cap 20 mg E B02BA01

VITAMIN K1 (PHYTOMENADIONE) 10 mg/ml ampoule (INJ) Price/ml 20 mg E B02BA01

Buyer SAFRICA 1 AMP (1 ml) 1.27 1.2708 FOR IV USE
VITAMIN, MULTI syrup (PO) Price/ml N A11BA

Supplier MEDS 1 BOTT (5000 ml) 5.31 0.0011 VITS A,B1,B2,B6,B12,D3,NIACINAMIDE,D-PANTHENOL
Supplier DURBIN 1 BOTT (100 ml) 1.46 0.0146 50 MG/5 ML
Buyer OECS/PPS 1 BOTT (250 ml) 3.14 0.0126 WITH IRON
VITAMIN, MULTI tab-cap (PO) Price/tab-cap N A11BA

Supplier MEDS 1000 TAB-CAP 3.89 0.0039 VITS A, B1, B2, D3, C, NICOTINAMIDE, TABLETS
Supplier DURBIN 1000 TAB-CAP 4.80 0.0048 TABLETS; D3 300IU,NIC. 7.5MG, A 2500IU, B2 0.5MG, B1 1MG
Supplier UNFPA 5000 TAB-CAP 36.75 0.0073 COATED TABLETS
Supplier MEG 1000 TAB-CAP 7.50 0.0075 FC TABS:C 15MG,D3 300IU,B3 7.5MG,A 2500IU,B2 0.5MG,B1 1MG
Supplier MEDEOR/EU 10000 TAB-CAP 76.24 0.0076 DRGES,C15MG,D3 300IU,A 2500IU,B2 0.5MG,B1 1MG,NICOT 7.5MG
Buyer DOMREPUB 100 TAB-CAP 1.66 0.0166 VIT. A, B, C, D, BLISTER PACK TABLETS, ILLUST. PACK SZ

VITAMIN, MULTI tab-cap (PO) Price/tab-cap N A11BA

Buyer OECS/PPS 130 TAB-CAP 9.16 0.0705 TABLETS, 100% RDA C,D,E,B1,B2,B3,B6,FOLIC,B12,PANT;5% CAL.
VITAMIN, MULTI (PEDIATRIC) drops (PO) Price/ml N A11BA

VITAMIN, MULTI + IRON tab-cap (PO) Price/tab-cap N A11AA01

VITAMIN, MULTI + MINERALS tab-cap (PO) Price/tab-cap N A11AA04

WARFARIN SODIUM 1 mg tab-cap (PO) Price/tab-cap 7.5 mg C B01AA03

Buyer OECS/PPS 100 TAB-CAP 4.00 0.0400 TABLETS, CRYSTALLINE

Buyer OECS/PPS 100 TAB-CAP 4.00 0.0400 TABLET, CRYSTALLINE
WARFARIN SODIUM 3 mg tab-cap (PO) Price/tab-cap 7.5 mg P B01AA03


Buyer OECS/PPS 100 TAB-CAP 4.00 0.0400 SCORED TABLETS, CRYSTALLINE
WATER FOR INJECTION 10 ml ampoule (INJ) Price/ampoule E V07AB

Supplier MEDEOR/TZ 100 VIAL (1 AMPOULE) 4.46 0.0446
Supplier MEDS 1 VIAL (1 AMPOULE) 0.04 0.0448 WITHOUT PRESERVATIVE
Supplier IMRES 50 AMP 2.25 0.0450
Supplier MSD/TANZ 100 VIAL (1 AMPOULE) 4.68 0.0468
Supplier IDA 50 AMP 2.64 0.0528
Supplier MEG 100 AMP 5.36 0.0536 PLASTIC
Supplier UNFPA 100 AMP 5.51 0.0551 PLASTIC AMPOULES
Supplier AMSTELFAR 100 AMP 9.10 0.0910
Supplier MEDEOR/EU 100 AMP 12.99 0.1299
Buyer DRC/IHP 50 AMP 1.84 0.0368
Buyer MEMS 1 AMP 0.07 0.0690
Buyer OECS/PPS 20 AMP 2.99 0.1495
WATER FOR INJECTION 100 ml vial (INJ) Price/vial P V07AB

Supplier MEDS 1 VIAL 0.37 0.3696 WITH PRESERVATIVE

Supplier IMRES 50 AMP 1.95 0.0390
Supplier MEG 100 AMP 4.71 0.0471 PLASTIC
Supplier IDA 50 AMP 2.43 0.0486
Supplier AMSTELFAR 100 AMP 7.15 0.0715


Supplier GDF 100 AMP 10.40 0.1040
Buyer PERU 100 AMP 3.99 0.0399 ILLUSTRATIVE NUMBER OF AMPS
XYLOMETAZOLINE 0.05% nasal (N/T) Price/ml 0.8 mg E R01AA07

ZIDOVUDINE (AZT) 100 mg tab-cap (PO) Price/tab-cap 0.6 g E J05AF01

ZIDOVUDINE (AZT) 300 mg tab-cap (PO) Price/tab-cap 0.6 g E J05AF01

ZIDOVUDINE (AZT) 50 mg/5 ml solution (PO) Price/ml 0.6 g E J05AF01

Supplier SCMS 1 BOTT (240 ml) 2.09 0.0087 WITH SYRINGE
Buyer SAFRICA 1 BOTT (200 ml) 1.57 0.0079 10 ML DOSAGE SYRINGE
ZINC OXIDE 10% ointment (TOP) Price/g N D02AB

Supplier MEG 1 JAR (500 g) 6.61 0.0132
ZINC SULFATE 10 mg/5 ml syrup (PO) Price/ml 0.6 g E A12CB01

ZINC SULFATE 20 mg tab-cap (PO) Price/tab-cap E A12CB01

ZINC SULFATE 20 mg/5 ml syrup (PO) Price/ml 0.6 g EP A12CB01

Buyer CHAI 1 BOTT (60 ml) 0.12 0.0020 INDIA (UTOPIA), FLAVORED
Buyer CHAI 1 BOTT (100 ml) 0.21 0.0021 INDIA (ECON), FLAVORED, GLUCONATE
Buyer CHAI 1 BOTT (60 ml) 0.15 0.0025 INDIA (JAMSON), FLAVORED, ACETATE
Buyer CHAI 1 BOTT (60 ml) 0.15 0.0025 INDIA (AAROGYAM), FLAVORED
Buyer CHAI 1 BOTT (60 ml) 0.15 0.0025 INDIA (SALVO), FLAVORED
Buyer CHAI 1 BOTT (60 ml) 0.15 0.0025 INDIA (PAMPER), FLAVORED
Buyer CHAI 1 BOTT (60 ml) 0.16 0.0027 INDIA (TENGEE), FLAVORED
Buyer CHAI 1 BOTT (60 ml) 0.17 0.0028 INDIA (BIOAX), FLAVORED, GLUCONATE
Buyer CHAI 1 BOTT (60 ml) 0.19 0.0032 INDIA (SSS), FLAVORED

ZINC SULFATE 20 mg/5 ml syrup (PO) Price/ml 0.6 g EP A12CB01

Buyer CHAI 1 BOTT (60 ml) 0.19 0.0032 INDIA (PAHEL), FLAVORED
ZINC SULFATE (DISPERSIBLE) 10 mg tab-cap (PO) Price/tab-cap 0.6 g EP A12CB01

Buyer CHAI 500 TAB-CAP 3.34 0.0067 GHANA (GIHOC), SCORED TAB, FLAVORED, FOB
Buyer CHAI 1000 TAB-CAP 7.70 0.0077 GHANA (M&G PHARM), SCORED TAB, FLAVORED, FOB
ZINC SULFATE (DISPERSIBLE) 20 mg tab-cap (PO) Price/tab-cap 0.6 g P A12CB01

Supplier MEG 100 TAB-CAP 2.15 0.0215 10X10 BLISTER PACK TABLETS
Supplier IMRES 100 TAB-CAP 3.00 0.0300 BLISTER PACK TABLETS, 10 X 10
Buyer CHAI 10 TAB-CAP 0.02 0.0020 INDIA (CHAI), FLAVORED
Buyer CHAI 14 TAB-CAP 0.05 0.0036 INDIA (BIOAX), FLAVORED TABLETS
Buyer CHAI 14 TAB-CAP 0.06 0.0043 INDIA (JAMSON), FLAVORED BLISTER PACK TABLETS
Buyer CHAI 10 TAB-CAP 0.05 0.0050 INDIA (ECON), SCORED TABS, FLAVORED
Buyer CHAI 10 TAB-CAP 0.05 0.0050 INDIA (TENGEE), SCORED TABS, FLAVORED
Buyer CHAI 10 TAB-CAP 0.06 0.0060 INDIA (AAROGYAM), SCORED TAB, FLAVORED
Buyer CHAI 10 TAB-CAP 0.06 0.0060 INDIA (SALVO), SCORED TABS, FLAVORED
Buyer CHAI 10 TAB-CAP 0.06 0.0060 INDIA (UTOPIA), FLAVORED TABLETS
Buyer CHAI 100 TAB-CAP 0.66 0.0066 MALAWI (MOH), TABLETS, FOB
Buyer SAFRICA 100 TAB-CAP 0.91 0.0091 SCORED TABLETS
Buyer CHAI 500 TAB-CAP 4.68 0.0094 GHANA (GIHOC), SCORED TAB, FLAVORED, FOB
Buyer CHAI 10 TAB-CAP 0.11 0.0110 INDIA (PAMPER), SCORED TABS, FLAVORED
Buyer CHAI 10 TAB-CAP 0.11 0.0110 INDIA (SSS), FLAVORED TABLETS
Buyer CHAI 10 TAB-CAP 0.11 0.0110 INDIA (PAHEL), FLAVORED TABLETS
Buyer CHAI 1000 TAB-CAP 11.89 0.0119 NIGERIA (OLPHARM), SCORED TAB, FLAVORED, EXW
Buyer CHAI 1000 TAB-CAP 12.46 0.0125 GHANA (M&G PHARM), SCORED TAB, FLAVORED, FOB
Buyer CHAI 100 TAB-CAP 1.36 0.0136 NIGERIA (EMZOR), SCORED TAB, FLAVORED, EXW
Buyer CHAI 10 TAB-CAP 0.16 0.0160 UGANDA (GITTOES), SCORED TAB, DDP
Buyer CHAI 100 TAB-CAP 1.60 0.0160 MALAWI (INTERMED), SCORED TAB, FOB
Buyer CHAI 10 TAB-CAP 0.24 0.0240 INDIA (CHAI-MP), TABLETS, FLAVORED
Buyer CHAI 100 TAB-CAP 4.00 0.0400 UGANDA (ABACUS), SCORED TAB, DDP
Buyer CHAI 10 TAB-CAP 0.61 0.0610 NIGERIA (CHI), SCORED TAB, FLAVORED, EXW
ZOLEDRONIC ACID 4 mg/5 ml vial (INJ) Price/vial N M05BA08

List II: Products Sorted by
Therapeutic Category
Lista II: Productos Clasificados por

Categoría Terapéutica
Liste II : Produits Pharmaceutiques Classés

par Classe Thérapeutique
List II: Products Sorted by Therapeutic Category
WHO DEFINED
ITEM DESCRIPTION EML DAILY DOSE*
WHO ESSENTIAL MEDICINES LIST CATEGORIES
1.1. GENERAL ANAESTHETICS AND OXYGEN
DROPERIDOL 2.5 mg/ml ampoule (INJ) N

Buyer Number of Prices=1 Price=0.5350/ml
ETHER, ANAESTHETIC solution (INH) E
ETOMIDATE 2 mg/ml ampoule (INJ) N
FENTANYL CITRATE (IC) 50 mcg/ml vial (INJ) N
Supplier Number of Prices=1 Price=0.4828/ml
Buyer Number of Prices=5 High/Low Ratio=11.65 Median Price=0.3675/ml
SEVOFLURANE solution (INH) N
THIOPENTAL SODIUM 1 g vial (INJ) E
Supplier Number of Prices=6 High/Low Ratio=1.83 Median Price=2.3797/vial
Buyer Number of Prices=3 High/Low Ratio=5.47 Median Price=2.0300/vial
THIOPENTAL SODIUM 500 mg vial (INJ) E
1.1.1. INHALATIONAL MEDICINES
HALOTHANE liquid (INH) E

Supplier Number of Prices=8 High/Low Ratio=2.02 Median Price=0.1250/ml
ISOFLURANE liquid (INH) E
1.1.2. INJECTABLE MEDICINES
KETAMINE 10 mg/ml vial (INJ) P

KETAMINE 50 mg/ml vial (INJ) E
PROPOFOL 10 mg/ml vial (INJ) E
1.2. LOCAL ANAESTHETICS
BUPIVACAINE HCL 0.25% ampoule (INJ) E

BUPIVACAINE HCL 0.5% ampoule (INJ) E
BUPIVACAINE HCL + DEXTROSE 0.5% + 8% ampoule (INJ) E
BUPIVACAINE HCL + EPINEPHRINE (0.5% + 1:200,000) vial (INJ) N
EPHEDRINE 30 mg/ml vial (INJ) P 50 mg
LIDOCAINE HCL 1% vial (INJ) E
LIDOCAINE HCL 2% gel (TOP) E
Buyer Number of Prices=3 High/Low Ratio=1.61 Median Price=0.1639/g
WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on List
T-1 International Drug Price Indicator Guide, 2014

WHO DEFINED
LIDOCAINE HCL 2% vial (INJ) E 3 g

LIDOCAINE HCL + EPINEPHRINE DENTAL 2%+1:80000 crtdgs (INJ) E
LIDOCAINE HCL 5% (IN DEXTROSE 7.5%) vial (INJ) E
LIDOCAINE+EPINEPHRINE 1%+1:100000 vial (INJ) P
LIDOCAINE+EPINEPHRINE 2%+1:100000 vial (INJ) P
1.3. PREOPERATIVE MEDICATION AND SEDATION FOR SHORT-TERM PROCEDURES
ATROPINE SULFATE 0.25 mg/ml ampoule (INJ) P 1.5 mg

ATROPINE SULFATE 0.5 mg/ml ampoule (INJ) P 1.5 mg
ATROPINE SULFATE 1 mg/ml ampoule (INJ) E 1.5 mg
CISATRACURIUM 2 mg/ml ampoule (INJ) N
DIAZEPAM (IC) 5 mg/ml ampoule (INJ) E 10 mg
MIDAZOLAM 15 mg tab-cap (PO) E 15 mg
Buyer Number of Prices=1 Price=0.2922/tab-cap
MIDAZOLAM (IC) 5 mg/ml ampoule (INJ) E 15 mg
MORPHINE SULFATE (IC) 10 mg/ml ampoule (INJ) E 0.1 g
MORPHINE SULFATE (IC) 15 mg/ml ampoule (INJ) P 0.1 g
PROMETHAZINE HCL 25 mg/ml ampoule (INJ) T 25 mg
PROMETHAZINE HCL 5 mg/5 ml suspen (PO) T 25 mg
2.1. 2.1-OPIOID ANALGESICS & NSAIMS
ACETYLSALICYLIC ACID 100 mg tab-cap (PO) E 3 g

Supplier Number of Prices=5 High/Low Ratio=2.68 Median Price=0.0020/tab-cap
Buyer Number of Prices=2 High/Low Ratio=1.96 Median Price=0.0074/tab-cap
ACETYLSALICYLIC ACID 75 mg tab-cap (PO) P 3 g
DICLOFENAC 1.8 mg/ml suspen (PO) N
DICLOFENAC 100 mg suppos (RECT) N 0.1 g

WHO DEFINED
Supplier Number of Prices=2 High/Low Ratio=1.99 Median Price=0.1152/supp

DICLOFENAC 12.5 mg suppos (RECT) N
Buyer Number of Prices=1 Price=0.2300/supp
DICLOFENAC SODIUM 25 mg tab-cap (PO) N 0.1 g
DICLOFENAC SODIUM 25 mg/ml ampoule (INJ) N 0.1 g
DICLOFENAC SODIUM 50 mg tab-cap (PO) N 0.1 g
DICLOFENAC SODIUM (sustained-release) 75 mg tab-cap (PO) N 0.1 g
IBUPROFEN 100 mg/5 ml suspen (PO) P 1.2 g
IBUPROFEN 200 mg tab-cap (PO) E 1.2 g
INDOMETACIN 100 mg suppos (RECT) N 0.1 g
INDOMETACIN 25 mg tab-cap (PO) N 0.1 g
MEFENAMIC ACID 250 mg tab-cap (PO) N 1 g
Supplier Number of Prices=1 Price=0.0074/tab-cap
MEFENAMIC ACID 500 mg tab-cap (PO) N 1 g
MELOXICAM 7.5 mg tab-cap (PO) N 15 mg
NAPROXEN 250 mg tab-cap (PO) E 0.5 g
NAPROXEN 500 mg tab-cap (PO) N 0.5 g
PARACETAMOL 100 mg suppos (RECT) E 3 g
Supplier Number of Prices=1 Price=0.0700/supp
PARACETAMOL 100 mg tab-cap (PO) E 3 g
PARACETAMOL 100 mg/ml suspen (PO) P 3 g
PARACETAMOL 120 mg/5 ml suspen (PO) P 3 g
PARACETAMOL 125 mg suppos (RECT) P 3 g
Buyer Number of Prices=4 High/Low Ratio=2.23 Median Price=0.2103/supp
PIROXICAM 20 mg tab-cap (PO) N 20 mg

WHO DEFINED

TENOXICAM 20 mg tab-cap (PO) N 20 mg
TRAMADOL HYDROCHLORIDE 100 mg/ml solution (PO) N 0.3 g
2.2. OPIOID ANALGESICS
CODEINE (IC) 30 mg tab-cap (PO) E 0.1 g

DIHYDROCODEINE (IC) 30 mg tab-cap (PO) N 0.15 g
MORPHINE (IC, sustained-release) 10 mg tab-cap (PO) E 0.1 g
MORPHINE SULFATE (IC) 10 mg tab-cap (PO) E 0.1 g
MORPHINE SULFATE (IC) 10 mg/ml ampoule (INJ) E 0.1 g
MORPHINE SULFATE (IC) 15 mg/ml ampoule (INJ) P 0.1 g
MORPHINE SULFATE (IC, sustained-release) 30 mg tab-cap (PO) P 0.1 g
MORPHINE SULFATE (slow release) 100 mg tab-cap (PO) E 0.1 g
MORPHINE SULFATE (slow release) 60 mg tab-cap (PO) E 0.1 g
NALBUFINE CHLORHYDRATE 10 mg/ml vial (INJ) N 80 mg
PENTAZOCINE (IC) 30 mg/ml ampoule (INJ) N 0.2 g
PETHIDINE (IC) 50 mg tab-cap (PO) E 0.4 g
PETHIDINE HCL (IC) 50 mg/ml ampoule (INJ) E 0.4 g
TRAMADOL HYDROCHLORIDE 100 mg/ml ampoule (INJ) E 0.3 g
TRAMADOL HYDROCHLORIDE 50 mg tab-cap (PO) E 0.3 g
TRAMADOL HYDROCHLORIDE 50 mg/ml ampoule (INJ) E 0.3 g
2.3. MEDICINES FOR OTHER COMMON SYMPTOMS IN PALLIATIVE CARE
AMITRIPTYLINE 10 mg tab-cap (PO) P 75 mg

AMITRIPTYLINE 25 mg tab-cap (PO) E 75 mg
DEXAMETHASONE 4 mg/ml ampoule (INJ) E 1.5 mg
DIAZEPAM (IC) 10 mg tab-cap (PO) E 10 mg

WHO DEFINED

FLUOXETINE 20 mg tab-cap (PO) E 20 mg
GRANISETRON 1 mg tab-cap (PO) N 2 mg
HALOPERIDOL 0.5 mg tab-cap (PO) E 8 mg
HALOPERIDOL 1.5-2 mg tab-cap (PO) E 8 mg
HALOPERIDOL 2 mg/ml syrup (PO) E 8 mg
HALOPERIDOL 5 mg tab-cap (PO) E 8 mg
HALOPERIDOL 5 mg/ml ampoule (INJ) E 3.3 mg
HYOSCINE BUTYLBROMIDE 20 mg/ml ampoule (INJ) E 60 mg
LACTULOSE 3.35 g/5 ml solution (PO) E 6.7 g
LOPERAMIDE HCL 2 mg tab-cap (PO) E 10 mg
METOCLOPRAMIDE HCL 10 mg tab-cap (PO) E 30 mg
METOCLOPRAMIDE HCL 5 mg/5 ml syrup (PO) E 30 mg
METOCLOPRAMIDE HCL 5 mg/ml ampoule (INJ) E 30 mg
MIDAZOLAM 15 mg tab-cap (PO) E 15 mg
ONDANSETRON 2 mg/ml ampoule (INJ) E 16 mg
ONDANSETRON 4 mg tab-cap (PO) E 16 mg
SENNA (sennosides) 7.5 mg tab-cap (PO) E 15 mg
3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
CHLORPHENAMINE MALEATE 10 mg/ml ampoule (INJ) E 12 mg


WHO DEFINED

CHLORPHENAMINE MALEATE 2 mg/5 ml elixir (PO) P 6 mg
CHLORPHENAMINE MALEATE 4 mg tab-cap (PO) E 12 mg
DEXAMETHASONE 0.5 mg tab-cap (PO) E 1.5 mg
DEXAMETHASONE 5 mg/ml ampoule (INJ) P 1.5 mg
DIPHENHYDRAMINE 25 mg tab-cap (PO) T 0.3 g
EPINEPHRINE (adrenaline) 1 mg/ml ampoule (INJ) E 0.5 mg
HYDROCORTISONE (sodium succinate) 100 mg vial (INJ) E 30 mg
HYDROXYZINE 10 mg/5 ml syrup (PO) N 75 mg
HYDROXYZINE 25 mg tab-cap (PO) N 75 mg
LORATADINE 10 mg tab-cap (PO) N 10 mg
LORATADINE 5 mg/5 ml syrup (PO) N 10 mg
METHYLPREDNISOLONE (sodium succinate) 1 g vial (INJ) CP 20 mg
METHYLPREDNISOLONE (sodium succinate) 500 mg vial (INJ) CP 20 mg
METHYLPREDNISOLONE ACETATE 40 mg vial (INJ) N 20 mg
Supplier Number of Prices=1 Price=3.8640/vial
Buyer Number of Prices=1 Price=1.5590/vial
PREDNISOLONE 1 mg tab-cap (PO) P
PREDNISOLONE 25 mg tab-cap (PO) E 10 mg
PREDNISOLONE (BASE) 15 mg/5 ml syrup (PO) P 10 mg
PREDNISONE 5 mg tab-cap (PO) T 10 mg
PREDNISONE 50 mg tab-cap (PO) N 10 mg
PROMETHAZINE HCL 25 mg tab-cap (PO) T 25 mg
PROMETHAZINE HCL 25 mg/ml ampoule (INJ) T 25 mg
PROMETHAZINE HCL 5 mg/5 ml suspen (PO) T 25 mg

WHO DEFINED

TRIAMCINOLONE ACETONIDE 10 mg/ml ampoule (INJ) N 7.5 mg
4.1. GENERAL ANTIDOTES
CHARCOAL, ACTIVATED 125 mg tab-cap (PO) P 5 g

4.2. SPECIFIC ANTIDOTES
ATROPINE SULFATE 1 mg/ml ampoule (INJ) E 1.5 mg

DEFEROXAMINE MESILATE 500 mg ampoule (INJ) E
Buyer Number of Prices=1 Price=6.7579/ampoule
FLUMAZENIL 0.1 mg/ml vial (INJ) N
GLUCAGON 1 mg vial (INJ) N 1 mg
NALOXONE HCL 0.02 mg/ml vial (INJ) P
NALOXONE HCL 0.4 mg/ml ampoule (INJ) E
PENICILLAMINE 250 mg tab-cap (PO) C 0.5 g
5. ANTICONVULSANTS/ANTIEPILEPTICS
CARBAMAZEPINE 100 mg/5 ml suspen (PO) E 1 g

CARBAMAZEPINE 200 mg tab-cap (PO) E 1 g
CARBAMAZEPINE (sustained-release) 200 mg tab-cap (PO) E 1 g
CLONAZEPAM 0.5 mg tab-cap (PO) N 8 mg
CLONAZEPAM 2 mg tab-cap (PO) N 8 mg
CLONAZEPAM 2.5 mg/ml drops (PO) N 8 mg
DROPERIDOL 2.5 mg/ml ampoule (INJ) N
ETHOSUXIMIDE 250 mg tab-cap (PO) C 1.25 g
GABAPENTIN 100 mg tab-cap (PO) N 1.8 g

WHO DEFINED

LAMOTRIGINE 100 mg tab-cap (PO) N 0.3 g
LORAZEPAM 1 mg tab-cap (PO) P 2.5 mg
MAGNESIUM SULFATE 20% vial (INJ) EP 1 g
MAGNESIUM SULFATE 50% vial (INJ) E 3 g
PHENOBARBITAL (IC) 100 mg tab-cap (PO) E 0.1 g
PHENOBARBITAL (IC) 100 mg/ml ampoule (INJ) P 0.1 g
PHENOBARBITAL (IC) 15 mg/5 ml elixir (PO) E 0.1 g
PHENOBARBITAL (IC) 20 mg/5 ml elixir (PO) P 0.1 g
PHENOBARBITAL (IC) 200 mg/ml vial (INJ) E 0.1 g
PHENOBARBITAL (IC) 30 mg tab-cap (PO) E 0.1 g
PHENOBARBITAL (IC) 50-60 mg tab-cap (PO) E 0.1 g
PHENYTOIN 100 mg tab-cap (PO) E 0.3 g
PHENYTOIN 125 mg/5 ml suspen (PO) P 0.3 g
PHENYTOIN 50 mg/ml ampoule (INJ) E 0.3 g
SODIUM VALPROATE 200 mg tab-cap (PO) E 1.5 g
SODIUM VALPROATE 250 mg/5 ml suspen (PO) N 1.5 g
TOPIRAMATE 100 mg tab-cap (PO) N 0.3 g
TOPIRAMATE 25 mg tab-cap (PO) N 0.3 g
VALPROIC ACID 150 mg tab-cap (PO) P 1.5 g
VALPROIC ACID 500 mg tab-cap (PO) E 1.5 g
VALPROIC ACID (slow release) 200 mg tab-cap (PO) P 1.5 g
VALPROIC ACID (sodium valproate) 200 mg/5 ml syrup (PO) E 1.5 g

WHO DEFINED
6.1.1. INTESTINAL ANTHELMINTHICS
ALBENDAZOLE 100 mg/5 ml suspen (PO) P 0.4 g

ALBENDAZOLE 200 mg tab-cap (PO) P 0.4 g
ALBENDAZOLE 200 mg/5 ml suspen (PO) P 0.4 g
ALBENDAZOLE 400 mg tab-cap (PO) P 0.4 g
ALBENDAZOLE (chewable) 200 mg tab-cap (PO) P 0.4 g
ALBENDAZOLE (chewable) 400 mg tab-cap (PO) E 0.4 g
LEVAMISOLE 40 mg tab-cap (PO) P 0.15 g
LEVAMISOLE 50 mg tab-cap (PO) E 0.15 g
MEBENDAZOLE 100 mg tab-cap (PO) E 0.2 g
MEBENDAZOLE 100 mg/5 ml suspen (PO) P 0.2 g
MEBENDAZOLE 500 mg tab-cap (PO) E 0.2 g
MEBENDAZOLE (chewable) 100 mg tab-cap (PO) E 0.2 g
MEBENDAZOLE (chewable) 500 mg tab-cap (PO) E 0.2 g
NICLOSAMIDE 500 mg tab-cap (PO) E 2 g
NICLOSAMIDE (chewable) 500 mg tab-cap (PO) E 2 g
PRAZIQUANTEL 600 mg tab-cap (PO) E 3 g
TIABENDAZOLE 500 mg tab-cap (PO) N 3 g
TIABENDAZOLE (chewable) 500 mg tab-cap (PO) N 3 g
6.1.2. ANTIFILARIALS
DIETHYLCARBAMAZINE CITRATE 50 mg tab-cap (PO) C 0.4 g

6.1.3. ANTISCHISTOSOMALS AND ANTITREMATODE MEDICINES
PRAZIQUANTEL 600 mg tab-cap (PO) E 3 g


WHO DEFINED
6.2.1. BETA LACTAM MEDICINES
AMOXICILLIN 125 mg/5 ml suspen (PO) E 1 g

AMOXICILLIN 250 mg tab-cap (PO) E 1 g
AMOXICILLIN 250 mg/5 ml suspen (PO) P 1 g
AMOXICILLIN 500 mg tab-cap (PO) E 1 g
AMOXICILLIN (DISPERSIBLE) 125 MG tab-cap (PO) EP 1 g
AMOXICILLIN (dispersible) 250 mg tab-cap (PO) EP 1 g
AMOXICILLIN+CLAVULANIC ACID 1000+200 mg vial (INJ) P 1 g
AMOXICILLIN+CLAVULANIC ACID 250mg+125mg tab-cap (PO) P 1 g
AMOXICILLIN+CLAVULANIC ACID 500mg+100mg vial (INJ) P 1 g
AMOXICILLIN+CLAVULANIC ACID 500mg+125mg tab-cap (PO) E 1 g
AMOXICILLIN+CLAVULANIC ACID 875mg+125mg tab-cap (PO) P 1 g
AMOXICILLIN+CLAVULANIC ACID (125+31.25 mg/5ml) suspen (PO) P 1 g
AMOXICILLIN+CLAVULANIC ACID (250+62.5 mg/5ml) suspen (PO) P 1 g
AMPICILLIN 1 g vial (INJ) E 2 g
AMPICILLIN 250 mg vial (INJ) P 2 g
AMPICILLIN 500 mg tab-cap (PO) P 2 g
AMPICILLIN 500 mg vial (INJ) E 2 g
AMPICILLIN+SULBACTAM 1000mg+500mg vial (INJ) N 2 g
CEFADROXIL 250 mg/5 ml suspen (PO) N 2 g
CEFADROXIL MONOHYDRATE 500 mg tab-cap (PO) N 2 g
CEFALEXIN 125 mg/5 ml suspen (PO) E 2 g
CEFALEXIN 125 mg/ml suspen (PO) P 2 g

WHO DEFINED

CEFALEXIN 250 mg tab-cap (PO) E 2 g
CEFALEXIN 250 mg/5 ml suspen (PO) E 2 g
CEFALEXIN 500 mg tab-cap (PO) P 2 g
CEFAZOLIN 1 g vial (INJ) E 3 g
CEFAZOLIN 500 mg ampoule (INJ) P 3 g
CEFEPIME 1 g vial (INJ) T 2 g
CEFIXIME 100 mg/5 ml suspen (PO) P 0.4 g
CEFIXIME 200 mg tab-cap (PO) P 0.4 g
CEFIXIME 400 mg tab-cap (PO) E 0.4 g
CEFOTAXIME 1 g vial (INJ) CP 4 g
CEFOTAXIME 500 mg vial (INJ) CP 4 g
CEFTAZIDIME 1 g vial (INJ) P 4 g
CEFTAZIDIME 250 mg vial (INJ) C 4 g
CEFTRIAXONE 1 g vial (INJ) E 2 g
CEFTRIAXONE 250 mg vial (INJ) E 2 g
CEFTRIAXONE 500 mg vial (INJ) P 2 g
CEFUROXIME 1.5 g vial (INJ) N 3 g
CEFUROXIME 125 mg/5 ml suspen (PO) N 0.5 g
CEFUROXIME 250 mg tab-cap (PO) N 0.5 g
CEFUROXIME 500 mg tab-cap (PO) N 0.5 g
CEFUROXIME 750 mg vial (INJ) N 3 g
CLOXACILLIN SODIUM 125 mg/5 ml suspen (PO) T 2 g
CLOXACILLIN SODIUM 250 mg tab-cap (PO) T 2 g

WHO DEFINED
CLOXACILLIN SODIUM 250 mg vial (INJ) T 2 g

CLOXACILLIN SODIUM 500 mg tab-cap (PO) T 2 g
CLOXACILLIN SODIUM 500 mg vial (INJ) T 2 g
DICLOXACILLIN 250 mg tab-cap (PO) E 2 g
DICLOXACILLIN 500 mg tab-cap (PO) N 2 g
DICLOXACILLIN 500 mg vial (INJ) P 2 g
FLUCLOXACILLIN 250 mg tab-cap (PO) N 2 g
IMIPENEM+CILASTATIN 500mg+500mg vial (INJ) C 2 g
MEROPENEM 1 g vial (INJ) N 2 g
MEROPENEM 500 mg vial (INJ) N 2 g
OXACILLIN 1 g vial (INJ) T 2 g
OXACILLIN 500 mg ampoule (INJ) N 2 g
PENICILLIN, BENZATHINE BENZYL (1.44 g of pen. G) 2.4M IU powder (INJ) E 3.6 g
PENICILLIN, BENZATHINE BENZYL (720 mg of pen. G) 1.2M IU powder (INJ) P 3.6 g
PENICILLIN, BENZYL (3 g, pen. G) 5M IU powder (INJ) E 3.6 g
PENICILLIN, BENZYL (600 mg, pen. G) 1M IU powder (INJ) E 3.6 g
PENICILLIN, PHENOXYMETHYL (pen. V) 125 mg/5 ml suspen (PO) P 2 g
PENICILLIN, PHENOXYMETHYL (pen. V) 250 mg tab-cap (PO) E 2 g
PENICILLIN, PHENOXYMETHYL (pen. V) 250 mg/5 ml syrup (PO) E 2 g
PENICILLIN, PROCAINE BENZYL (1.8 g of pen. G) 3M IU powder (INJ) E 0.6 g
PENICILLIN, PROCAINE BENZYL (2.4 g of pen. G) 4M IU powder (INJ) P 0.6 g
PENICILLIN, PROCAINE BENZYL (600 mg of pen. G) 1M IU powder (INJ) E 0.6 g
PENICILLIN, PROCAINE+BENZYL 3M IU+1M IU vial (INJ) P 0.6 g
PIPERACILLIN+TAZOBACTAM 4 g+500 mg vial (INJ) N 14 g

WHO DEFINED
6.2.2. OTHER ANTIBACTERIALS
AMIKACIN SULFATE 50 mg/ml ampoule (INJ) P 1 g

AZITHROMYCIN 200 mg/5 ml suspen (PO) E 0.3 g
AZITHROMYCIN 250 mg tab-cap (PO) E 0.3 g
AZITHROMYCIN 500 mg tab-cap (PO) E 0.3 g
CHLORAMPHENICOL 125 mg/5 ml suspen (PO) P 3 g
CHLORAMPHENICOL 250 mg tab-cap (PO) E 3 g
CHLORAMPHENICOL 5% otic drop (OTIC) P
CHLORAMPHENICOL 500 mg tab-cap (PO) P 3 g
CHLORAMPHENICOL (base) 1 g vial (INJ) E 3 g
CHLORAMPHENICOL IN OIL 250 mg/ml ampoule (INJ) E 3 g
CIPROFLOXACIN 2 mg/ml vial (INJ) P 0.5 g
CIPROFLOXACIN 250 mg tab-cap (PO) E 1 g
CIPROFLOXACIN 250 mg/5 ml suspen (PO) E 1 g
CIPROFLOXACIN 500 mg tab-cap (PO) P 1 g
CLARITHROMYCIN 125 mg/5 ml suspen (PO) N 0.5 g
CLARITHROMYCIN 250 mg tab-cap (PO) N 0.5 g
CLARITHROMYCIN 250 mg/5 ml suspen (PO) N 0.5 g
CLARITHROMYCIN 500 mg tab-cap (PO) N 0.5 g
CLINDAMYCIN 300 mg tab-cap (PO) P 1.2 g
CLINDAMYCIN (BASE) 150 mg tab-cap (PO) C 0.1 g
CLINDAMYCIN (BASE) 150 mg/ml vial (INJ) C 1.8 g
DOXYCYCLINE 100 mg tab-cap (PO) C 0.1 g

WHO DEFINED
ERYTHROMYCIN (base) 125 mg/5 ml suspen (PO) E 1 g

ERYTHROMYCIN (base) 250 mg tab-cap (PO) E 1 g
ERYTHROMYCIN (base) 250 mg/5 ml suspen (PO) P 1 g
ERYTHROMYCIN (base) 500 mg tab-cap (PO) P 1 g
ERYTHROMYCIN LACTOBIONATE 500 mg vial (INJ) E 1 g
GENTAMICIN SULFATE 10 mg/ml ampoule (INJ) E 0.24 g
GENTAMICIN SULFATE 40 mg/ml ampoule (INJ) E 0.24 g
KANAMYCIN SULFATE 1 g vial (INJ) C 1 g
METRONIDAZOLE 1 g suppos (RECT) E 2 g
METRONIDAZOLE 125 mg/5 ml syrup (PO) P 1.5 g
METRONIDAZOLE 200 mg/5 ml syrup (PO) E 1.5 g
METRONIDAZOLE 200-250 mg tab-cap (PO) E 1.5 g
METRONIDAZOLE 5 mg/ml vial (INJ) E 1.5 g
METRONIDAZOLE 500 mg pessary (VAG) P 0.5 g
Supplier Number of Prices=4 High/Low Ratio=1.23 Median Price=0.0344/pessary
METRONIDAZOLE 500 mg suppos (RECT) E 2 g
MOXIFLOXACIN 400 mg tab-cap (PO) N 0.4 g
NALIDIXIC ACID 500 mg tab-cap (PO) N 4 g
NITROFURANTOIN 100 mg tab-cap (PO) E 0.2 g
NITROFURANTOIN 25 mg/5 ml suspen (PO) P 0.2 g
NITROFURANTOIN 50 mg tab-cap (PO) P 0.2 g
NORFLOXACIN 400 mg tab-cap (PO) T 0.8 g
SPECTINOMYCIN 2 g vial (INJ) E 3 g
SULFAMETHOXAZOLE+TRIMETHOPRIM (co-trimoxazole) 100 mg+20 mg tab-cap (PO) E

WHO DEFINED

SULFAMETHOXAZOLE+TRIMETHOPRIM (co-trimoxazole) 200 mg+40 mg tab-cap (PO) P
SULFAMETHOXAZOLE+TRIMETHOPRIM (co-trimoxazole) 200+40mg/5ml suspen (PO) E
SULFAMETHOXAZOLE+TRIMETHOPRIM (co-trimoxazole) 400 mg+80 mg tab-cap (PO) E
SULFAMETHOXAZOLE+TRIMETHOPRIM (co-trimoxazole) 80+16 mg/ml ampoule (INJ) E
SULFAMETHOXAZOLE+TRIMETHOPRIM (co-trimoxazole) 800 mg+160mg tab-cap (PO) P
SULFAMETHOXAZOLE+TRIMETHOPRIM (dispersible) 100 mg+20 mg tab-cap (PO) E
TETRACYCLINE 500 mg tab-cap (PO) T 1 g
TETRACYCLINE HCL 250 mg tab-cap (PO) P 1 g
VANCOMYCIN 500 mg vial (INJ) N 2 g
6.2.3. ANTILEPROSY MEDICINES
CLOFAZIMINE (lamprene) 100 mg tab-cap (PO) E 0.1 g

CLOFAZIMINE (lamprene) 50 mg tab-cap (PO) E 0.1 g
DAPSONE 100 mg tab-cap (PO) E 50 mg
RIFAMPICIN 100 mg/5 ml syrup (PO) P 0.6 g
RIFAMPICIN 150 mg tab-cap (PO) E 0.6 g
RIFAMPICIN 600 mg tab-cap (PO) EP 0.6 g
6.2.4. ANTITUBERCULOSIS MEDICINES
AMIKACIN SULFATE 250 mg/ml vial (INJ) P 1 g

CAPREOMYCIN 0.5 g vial (INJ) CP 1 g
CAPREOMYCIN 0.75 g vial (INJ) CP 1 g
CAPREOMYCIN 1 g vial (INJ) C 1 g
CYCLOSERINE 250 mg tab-cap (PO) C 0.75 g
ETHAMBUTOL 100 mg tab-cap (PO) E 1.2 g

WHO DEFINED
ETHAMBUTOL 400 mg tab-cap (PO) E 1.2 g

ETHAMBUTOL+ISONIAZID 400mg+150 mg tab-cap (PO) E
ETHIONAMIDE 125 mg tab-cap (PO) C 0.75 g
ETHIONAMIDE 250 mg tab-cap (PO) C 0.75 g
ISONIAZID (INH) 100 mg tab-cap (PO) E 0.3 g
ISONIAZID (INH) 300 mg tab-cap (PO) E 0.3 g
ISONIAZID (INH) 50 mg/5 ml elixir (PO) E 0.3 g
ISONIAZID (INH, dispersible) 100 mg tab-cap (PO) E 0.3 g
LEVOFLOXACIN 250 mg tab-cap (PO) T 0.5 g
LEVOFLOXACIN 5 mg/ml vial (INJ) T 0.5 g
LEVOFLOXACIN 500 mg tab-cap (PO) C 0.5 g
LINEZOLID 2 mg/ml vial (INJ) C 1.2 g
LINEZOLID 600 mg tab-cap (PO) C 1.2 g
OFLOXACIN 200 mg tab-cap (PO) C 0.4 g
OFLOXACIN 400 mg tab-cap (PO) C 0.4 g
P-AMINOSALICYLIC ACID (PAS) 4 g powder (PO) C 12 g
Supplier Number of Prices=1 Price=1.3333/packet
Buyer Number of Prices=1 Price=2.7516/packet
P-AMINOSALICYLIC ACID (PAS) 60% w/w granules (PO) P
Supplier Number of Prices=1 Price=0.1249/g
P-AMINOSALICYLIC ACID (PAS) (60% w/w) 9.2 g granules (PO) P
P-AMINOSALICYLIC ACID (PAS) (for oral solution) 5.52 g powder (PO) P
PROTIONAMIDE 250 mg tab-cap (PO) C 0.75 mg
PYRAZINAMIDE 400 mg tab-cap (PO) E 1.5 g
PYRAZINAMIDE 500 mg tab-cap (PO) P 1.5 g
PYRAZINAMIDE 750 mg tab-cap (PO) EP 1.5 g
RIFABUTIN 150 mg tab-cap (PO) E 0.15 g
RIFAMP.+ISONIAZID+PYRAZIN.+ETHAMBUT. (150+75+400+275 mg) tab-cap (PO) E
RIFAMPICIN 100 mg/5 ml syrup (PO) P 0.6 g

WHO DEFINED

RIFAMPICIN 600 mg tab-cap (PO) EP 0.6 g
RIFAMPICIN+ISONIAZID 150+75 mg tab-cap (PO) E
RIFAMPICIN+ISONIAZID 150mg+150mg tab-cap (PO) E
RIFAMPICIN+ISONIAZID 300+150 mg tab-cap (PO) E 2 tab
RIFAMPICIN+ISONIAZID (dispersible) 60 mg+30 mg tab-cap (PO) E
RIFAMPICIN+ISONIAZID (dispersible) 60 mg+60 mg tab-cap (PO) E
RIFAMPICIN+ISONIAZID+ETHAMBUTOL 150+75+275mg tab-cap (PO) P
RIFAMPICIN+ISONIAZID+PYRAZINAMIDE (dispersible) 60+30+150 mg tab-cap (PO) E
STREPTOMYCIN SULFATE 1 g vial (INJ) E 1 g
TERIZIDONE 250 mg tab-cap (PO) N
6.3. ANTIFUNGAL MEDICINES
AMPHOTERICIN B 50 mg vial (INJ) E 35 mg

CLOTRIMAZOLE 1% cream (TOP) E
Supplier Number of Prices=9 High/Low Ratio=3.68 Median Price=0.0147/g
CLOTRIMAZOLE 1% cream (VAG) E 0.1 g
CLOTRIMAZOLE 100 mg pessary (VAG) E 0.1 g
Buyer Number of Prices=3 High/Low Ratio=18.67 Median Price=0.0977/pessary
FLUCONAZOLE 100 mg tab-cap (PO) P 0.2 g
FLUCONAZOLE 2 mg/ml vial (INJ) E 0.2 g
FLUCONAZOLE 50 mg tab-cap (PO) E 0.2 g

WHO DEFINED
FLUCONAZOLE 50 mg/5 ml suspen (PO) E 0.2 g

GRISEOFULVIN 125 mg tab-cap (PO) E 0.5 g
GRISEOFULVIN 250 mg tab-cap (PO) E 0.5 g
GRISEOFULVIN 500 mg tab-cap (PO) P 0.5 g
ITRACONAZOLE 100 mg tab-cap (PO) N 0.2 g
KETOCONAZOLE 200 mg tab-cap (PO) T 0.2 g
MICONAZOLE NITRATE (buccal muco-adhesive) 10 mg tab-cap (PO) N 0.2 g
NYSTATIN 100,000 IU pessary (VAG) E 0.1 mu
Buyer Number of Prices=1 Price=0.1000/pessary
NYSTATIN 100,000 IU tab-cap (PO) E 1.5 mu
NYSTATIN 100000 IU/ml suspen (PO) P 1.5 mu
NYSTATIN 500,000 IU tab-cap (PO) E 1.5 mu
6.4. ANTIVIRAL MEDICINES
ACICLOVIR 200 mg/5 ml suspen (PO) P 4 g

GANCICLOVIR 500 mg vial (INJ) N 0.5 g
VALGANCICLOVIR 450 mg tab-cap (PO) E 0.9 g
6.4.1. ANTIHERPES MEDICINES
ACICLOVIR 200 mg tab-cap (PO) E 4 g

ACICLOVIR 400 mg tab-cap (PO) P 4 g
ACICLOVIR 5% cream (TOP) N
Buyer Number of Prices=1 Price=0.0360/g
ACICLOVIR (dispersible) 200 MG tab-cap (PO) EP 4 g
ACICLOVIR (powder) 250 mg vial (INJ) E 4 g
VALACICLOVIR 500 mg tab-cap (PO) T 3 g
6.4.2. ANTIRETROVIRALS
LAMIVUDINE+STAVUDINE+NEVIRAPINE (3TC+d4T+NVP) 150+30+200mg tab-cap (PO) E

WHO DEFINED

LAMIVUDINE+STAVUDINE+NEVIRAPINE (3TC+d4T+NVP) 150+40+200mg tab-cap (PO) P
LAMIVUDINE+STAVUDINE+NEVIRAPINE (3TC+d4T+NVP) 30+6+50 mg tab-cap (PO) P
LAMIVUDINE+STAVUDINE+NEVIRAPINE (3TC+d4T+NVP) 60+12+100 mg tab-cap (PO) P
LAMIVUDINE/ZIDOVUDINE + EFAVIRENZ (2 tab l/z.+ 1 tab ef. co-pack) 150/300+600m tab-cap (PO) P
LAMIVUDINE/ZIDOVUDINE + NEVIRAPINE (1 tab l/z. + 1 tab n. co-pack) 150/300+200m tab-cap (PO) E
6.4.2.1 NUCLEOSIDE/NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS
ABACAVIR (ABC) 20 mg/ml solution (PO) E 0.6 g

ABACAVIR (ABC) 300 mg tab-cap (PO) E 0.6 g
ABACAVIR SULFATE 60 mg tab-cap (PO) P 0.6 g
ABACAVIR+LAMIVUDINE 60mg+30mg tab-cap (PO) P
ABACAVIR+LAMIVUDINE (ABC/3TC) 600 mg+300mg tab-cap (PO) P 1 tab
DIDANOSINE (chewable, dispersible) 200 mg tab-cap (PO) N 0.4 g
DIDANOSINE (ddI) 10 mg/ml powder (PO) N 0.4 g
DIDANOSINE (ddI) 200 mg tab-cap (PO) N 0.4 g
DIDANOSINE (ddI, chewable) 100 mg tab-cap (PO) N 0.4 g
DIDANOSINE (ddI, delayed-release) 125 mg tab-cap (PO) N 0.4 g
DIDANOSINE (dispersible) 400 mg tab-cap (PO) N 0.4 g
LAMIVUDINE (3TC) 10 mg/ml solution (PO) E 0.3 g

WHO DEFINED

LAMIVUDINE (3TC) 150 mg tab-cap (PO) E 0.3 g
LAMIVUDINE (3TC) 300 mg tab-cap (PO) P 0.3 g
LAMIVUDINE+STAVUDINE (3TC+d4T) 150 mg+30 mg tab-cap (PO) P
LAMIVUDINE+STAVUDINE (3TC+d4T) 150 mg+40 mg tab-cap (PO) P
LAMIVUDINE+STAVUDINE (dispersible, 3TC+d4t) 30 mg+6 mg tab-cap (PO) EP
LAMIVUDINE+STAVUDINE (tablet for oral suspension) 60+12 mg tab-cap (PO) N
LAMIVUDINE+TENOFOVIR DF (3TC+TDF) 300+300 mg tab-cap (PO) P
LAMIVUDINE+ZIDOVUDINE+ABACAVIR (150+300+300 mg) tab-cap (PO) P
LAMIVUDINE/ZIDOVUDINE+ABACAVIR (150/300+300 mg co-pack) tab-cap (PO) P
STAVUDINE (d4T) 1 mg/ml solution (PO) E 80 mg
STAVUDINE (d4T) 15 mg tab-cap (PO) E 80 mg
TENOFOVIR DF+LAMIVUDINE 300mg+300mg tab-cap (PO) P
TENOFOVIR DISOPROXIL FUMERATE (TDF) (equiv.245mg tenofovir disopro) 300 mg tab-cap (PO) E 0.245 g
ZIDOVUDINE (AZT) 100 mg tab-cap (PO) E 0.6 g
ZIDOVUDINE (AZT) 300 mg tab-cap (PO) E 0.6 g
ZIDOVUDINE (AZT) 50 mg/5 ml solution (PO) E 0.6 g
6.4.2.2 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
EFAVIRENZ (EFV) 100 mg tab-cap (PO) E 0.6 g

EFAVIRENZ (EFV) 30 mg/ml syrup (PO) P 0.6 g

WHO DEFINED

ETRAVIRINE 100 mg tab-cap (PO) N 0.4 g
NEVIRAPINE (NVP) 200 mg tab-cap (PO) E 0.4 g
NEVIRAPINE (NVP) 50 mg/5 ml suspen (PO) E 0.4 g
6.4.2.3 PROTEASE INHIBITORS
ABACAVIR+LAMIVUDINE (dispersible) 60mg+30mg tab-cap (PO) E

ATAZANAVIR 150 mg tab-cap (PO) E 0.3 g
ATAZANAVIR+RITONAVIR 300+100 mg tab-cap (PO) N
DARUNAVIR 300 mg tab-cap (PO) EP 1.2 g
EFAVIRENZ+EMTRICITABINE+TENOFOVIR DF (600+200+300 mg) tab-cap (PO) E
EFAVIRENZ+LAMIVUDINE+TENOFOVIR DISOP. (600+300+300 mg) tab-cap (PO) P
INDINAVIR (IDV) 400 mg tab-cap (PO) N 2.4 g
LAMIVUDINE+ZIDOVUDINE (3TC+AZT) 150mg+300mg tab-cap (PO) E 2 tab
LAMIVUDINE+ZIDOVUDINE (3TC+AZT) 30+60 mg tab-cap (PO) E
LAMIVUDINE+ZIDOVUDINE (dispersible) 30 mg+60 mg tab-cap (PO) E
LAMIVUDINE+ZIDOVUDINE+NEVIRAPINE (150+300+200 mg) 3TC+AZT+NVP tab-cap (PO) E
LAMIVUDINE+ZIDOVUDINE+NEVIRAPINE (3TC/AZT/NVP) 30+60+50 mg tab-cap (PO) E
LAMIVUDINE+ZIDOVUDINE+NEVIRAPINE (3TC/AZT/NVP, dispersible) 30+60+50 mg tab-cap (PO) E
LOPINAVIR+RITONAVIR (LPV/r) 100 mg+25 mg tab-cap (PO) P
LOPINAVIR+RITONAVIR (LPV/r) 133.3+33.3mg tab-cap (PO) E
LOPINAVIR+RITONAVIR (LPV/r) 200 mg+50 mg tab-cap (PO) P
LOPINAVIR+RITONAVIR (LPV/r) 80+20 mg/ml solution (PO) E
NELFINAVIR (NFV) 250 mg tab-cap (PO) E 2.25 g

WHO DEFINED

NELFINAVIR (NFV) 50 mg/g powder (PO) E 2.25 g
RITONAVIR (RTV) 100 mg tab-cap (PO) E 1.2 g
RITONAVIR (RTV) 80 mg/ml solution (PO) E 1.2 g
SAQUINAVIR (SQV) 200 mg tab-cap (PO) E 1.8 g
SAQUINAVIR (SQV) 500 mg tab-cap (PO) P 1.8 g
TENOFOVIR DF+EMTRICITABINE (TDF+FTC) 300 mg+200mg tab-cap (PO) E 1 tab
6.4.3. OTHER ANTIVIRALS
OSELTAMIVIR 75 mg tab-cap (PO) E 0.15 g

RALTEGRAVIR 400 mg tab-cap (PO) N 0.8 g
6.5.1. ANTIAMOEBIC AND ANTIGIARDIASIS MEDICINES
METRONIDAZOLE 125 mg/5 ml syrup (PO) P 1.5 g

METRONIDAZOLE 200 mg/5 ml syrup (PO) E 1.5 g
METRONIDAZOLE 5 mg/ml vial (INJ) E 1.5 g
TINIDAZOLE 500 mg tab-cap (PO) T 1.5 g
6.5.2. ANTILEISHMANIASIS MEDICINES
AMPHOTERICIN B 50 mg vial (INJ) E 35 mg

MEGLUMINE ANTIMONATE 30-45% ampoule (INJ) E 0.85 g
SODIUM STIBOGLUCONATE (10% Sb) 33% vial (INJ) E 0.85 g
6.5.3.1 ANTIMALARIAL MEDICINES, FOR CURATIVE TREATMENT
AMODIAQUINE 150-200 mg tab-cap (PO) E 0.5 g

AMODIAQUINE 50 mg/5 ml suspen (PO) P 0.5 g

WHO DEFINED

ARTEMETHER 20 mg/ml ampoule (INJ) P 120 mg
ARTEMETHER 80 mg/ml ampoule (INJ) C 120 mg
ARTEMETHER+LUMEFANTRINE 15+90mg/5ml suspen (PO) P
ARTEMETHER+LUMEFANTRINE 20 mg+120 mg tab-cap (PO) E
ARTEMETHER+LUMEFANTRINE (6 + 1 tablets co-pack) 20 mg+120 mg tab-cap (PO) E
Supplier Number of Prices=1 Price=0.6152/pack
Supplier Number of Prices=2 High/Low Ratio=1.06 Median Price=1.6802/pack
ARTEMETHER+LUMEFANTRINE (dispersible) 20 mg+120 mg tab-cap (PO) E
ARTESUNATE 60 mg vial (INJ) E
ARTESUNATE+AMODIAQUINE (12 + 12 tablets co-pack) 50 mg+153 mg tab-cap (PO) E
ARTESUNATE+AMODIAQUINE (3 fixed dose combo tabs) 100mg+270mg tab-cap (PO) P
Supplier Number of Prices=3 High/Low Ratio=1.79 Median Price=0.9280/treatmen
ARTESUNATE+AMODIAQUINE (3 fixed dose combo tabs) 25mg+67.5mg tab-cap (PO) P
ARTESUNATE+AMODIAQUINE (3 fixed dose combo tabs) 50 mg+135 mg tab-cap (PO) P
Supplier Number of Prices=1 Price=0.6363/treatmen
ARTESUNATE+AMODIAQUINE (6 fixed-dose combo tabs) 100mg+270mg tab-cap (PO) P
ARTESUNATE+AMODIAQUINE (FDC) 50 mg+153 mg tab-cap (PO) P
ARTESUNATE+SULFADOXINE/PYRIMETHAMINE (6 tab artes.+3 tab SP co-pack) 100+500/25mg tab-cap (PO) E
CHLOROQUINE (BASE) 100 mg tab-cap (PO) E 0.5 g
CHLOROQUINE (BASE) 50 mg/5 ml syrup (PO) E 0.5 g
DIHYDROARTEMISININ + PIPERAQUINE 40 + 320 mg tab-cap (PO) N
DOXYCYCLINE 100 mg tab-cap (PO) C 0.1 g
HYDROXYCHLOROQUINE 300 mg tab-cap (PO) N 0.516 g
HYDROXYCHLOROQUINE SULFATE 200 mg tab-cap (PO) N 0.516 g
MEFLOQUINE 250 mg tab-cap (PO) E 1 g

WHO DEFINED

PRIMAQUINE (base) 15 mg tab-cap (PO) E 15 mg
QUININE DIHYDROCHLORIDE 100 mg/5 ml syrup (PO) P 1.5 g
QUININE DIHYDROCHLORIDE 125-150mg/ml ampoule (INJ) P 0.3 g
QUININE DIHYDROCHLORIDE 250-300mg/ml ampoule (INJ) E 0.3 g
QUININE HYDROCHLORIDE 300 mg/ml ampoule (INJ) P 1.5 g
QUININE SULFATE 100 mg/5 ml syrup (PO) P 1.5 g
QUININE SULFATE 200-250 mg tab-cap (PO) P 0.3 g
QUININE SULFATE 300 mg tab-cap (PO) E 0.3 g
QUININE SULFATE 50 mg/5 ml syrup (PO) EP 1.5 g
QUININE SULFATE 500 mg tab-cap (PO) P 0.3 g
SULFADOXINE+PYRIMETHAMINE 500 mg+25 mg tab-cap (PO) C
SULFADOXINE+PYRIMETHAMINE (250 mg+12.5 mg/5 ml) 250+12mg/5ml suspen (PO) CP 75 mg
SULPHAMETOPYRAZINE-PYRIMETHAMINE 500+25 mg tab-cap (PO) N 75 mg
TETRACYCLINE HCL 250 mg tab-cap (PO) P 1 g
6.5.3.2 ANTIMALARIAL MEDICINES, FOR PROPHYLAXIS
ATOVAQUONE+PROGUANIL 250mg+100mg tab-cap (PO) N 4 tab

CHLOROQUINE (BASE) 50 mg/5 ml syrup (PO) E 0.5 g
HYDROXYCHLOROQUINE 300 mg tab-cap (PO) N 0.516 g
MEFLOQUINE 250 mg tab-cap (PO) E 1 g
PROGUANIL 100 mg tab-cap (PO) E 0.2 g

WHO DEFINED
6.5.4. ANTI-PNEUMOCYSTOSIS AND ANTITOXOPLASMOSIS MEDICINES
SULFADIAZINE 500 mg tab-cap (PO) E 0.6 g

7. ANTIMIGRAINE MEDICINES
PROPRANOLOL HCL 40 mg tab-cap (PO) E 0.16 g

7.1. FOR TREATMENT OF ACUTE MIGRAINE ATTACK

ERGOTAMINE+CAFFEINE 1+100 mg tab-cap (PO) N
7.2. FOR MIGRAINE PROPHYLAXIS
PROPRANOLOL HCL 10 mg tab-cap (PO) P 0.16 g

8.1. IMMUNOSUPPRESSIVE MEDICINES
AZATHIOPRINE 50 mg tab-cap (PO) C 0.15 g

CICLOSPORIN 100 mg tab-cap (PO) P 0.25 g
CICLOSPORIN 100 mg/ml solution (PO) CP 0.25 g
CICLOSPORIN 25 mg tab-cap (PO) C 0.25 g
MYCOPHENOLATE MOFETIL 250 mg tab-cap (PO) N 2 g
TACROLIMUS 1 mg tab-cap (PO) N 5 mg
8.2. CYTOTOXIC AND ADJUVANT MEDICINES
ALLOPURINOL 100 mg tab-cap (PO) E 0.4 g


WHO DEFINED
ALLOPURINOL 300 mg tab-cap (PO) C 0.4 g

ASPARAGINASE 1,000 IU/ml ampoule (INJ) P
ASPARAGINASE 10,000 IU/ml vial (INJ) C
BLEOMYCIN 15 IU vial (INJ) C
CALCIUM FOLINATE 15 mg tab-cap (PO) C 60 mg
CALCIUM FOLINATE 50 mg vial (INJ) P 60 mg
CAPECITABINE 150 mg tab-cap (PO) C
CAPECITABINE 500 mg tab-cap (PO) C
CARBOPLATIN 150 mg vial (INJ) C
CARBOPLATIN 450 mg vial (INJ) C
CHLORAMBUCIL 2 mg tab-cap (PO) C
CISPLATIN 1 mg/ml vial (INJ) C
CISPLATIN 10 mg vial (INJ) C
CISPLATIN 50 mg vial (INJ) C
CYCLOPHOSPHAMIDE 1 g vial (INJ) P
CYCLOPHOSPHAMIDE 200 mg vial (INJ) P
CYCLOPHOSPHAMIDE 50 mg tab-cap (PO) P
CYCLOPHOSPHAMIDE 500 mg vial (INJ) C
CYTARABINE 100 mg vial (INJ) C
CYTARABINE 500 mg vial (INJ) C
DACARBAZINE 200 mg vial (INJ) P
DACTINOMYCIN 500 mcg vial (INJ) C
DAUNORUBICIN 20 mg vial (INJ) CP
DOCETAXEL 20 mg vial (INJ) C
DOCETAXEL 40 mg vial (INJ) C
DOCETAXEL 80 mg vial (INJ) CP
DOXORUBICIN HCL 10 mg vial (INJ) C

WHO DEFINED
DOXORUBICIN HCL 50 mg vial (INJ) C

EPIRUBICIN 10 mg vial (INJ) N
EPIRUBICIN 50 mg vial (INJ) N
ETOPOSIDE 20 mg/ml vial (INJ) C
FILGRASTIM 300 mcg/ml vial (INJ) C 0.35 mg
FILGRASTIM 480mcg/0.8ml syringe (INJ) C 0.35 mg
Buyer Number of Prices=1 Price=62.8625/syringe
FILGRASTIM 480mcg/1.6ml vial (INJ) C 0.35 mg
FLUDARABINE PHOSPHATE 50 mg vial (INJ) C
FLUOROURACIL 25 mg/ml vial (INJ) P
FLUOROURACIL 50 mg/ml ampoule (INJ) C
FLUTAMIDE 250 mg tab-cap (PO) N 0.75 g
GEMCITABINE 1 g vial (INJ) C
GEMCITABINE 200 mg vial (INJ) C
HYDROXYCARBAMIDE (hydroxyurea) 500 mg tab-cap (PO) C
IDARUBICIN 10 mg vial (INJ) N
IDARUBICIN 5 mg vial (INJ) N
IFOSFAMIDE 1 g vial (INJ) C
IFOSFAMIDE 2 g vial (INJ) C
IFOSFAMIDE 500 mg vial (INJ) C
IMATINIB 100 mg tab-cap (PO) C
IMATINIB 400 mg tab-cap (PO) C
MELPHALAN 2 mg tab-cap (PO) N
MELPHALAN 50 mg vial (INJ) N
MERCAPTOPURINE 50 mg tab-cap (PO) C
MESNA 100 mg/ml ampoule (INJ) C
MESNA 400 mg ampoule (INJ) CP
METHOTREXATE SODIUM 2.5 mg tab-cap (PO) C 2.5 mg
METHOTREXATE SODIUM 25 mg/ml vial (INJ) P

WHO DEFINED

MITOMYCIN 5 mg vial (INJ) N
OXALIPLATIN 100 mg vial (INJ) C
OXALIPLATIN 50 mg vial (INJ) C
PACLITAXEL 100 mg vial (INJ) CP
PACLITAXEL 6 mg/ml vial (INJ) C
RITUXIMAB 10 mg/ml ampoule (INJ) C
TEMOZOLOMIDE 100 mg tab-cap (PO) N
THALIDOMIDE 100 mg tab-cap (PO) N 0.1 g
TIOGUANINE 40 mg tab-cap (PO) C
TRASTUZUMAB 440 mg vial (INJ) N
VINBLASTINE 10 mg vial (INJ) C
VINCRISTINE 1 mg vial (INJ) C
VINORELBINE 10 mg/1 ml vial (INJ) C
VINORELBINE 50 mg/5 ml vial (INJ) C
8.3. HORMONES AND ANTIHORMONES
ANASTROZOLE 1 mg tab-cap (PO) C 1 mg

BICALUTAMIDE 50 mg tab-cap (PO) C 50 mg
CYPROTERONE ACETATE 50 mg tab-cap (PO) N 0.1 g
HYDROCORTISONE (sodium succinate) 100 mg vial (INJ) E 30 mg
LETROZOLE 2.5 mg tab-cap (PO) N 2.5 mg
METHYLPREDNISOLONE (sodium succinate) 1 g vial (INJ) CP 20 mg
METHYLPREDNISOLONE (sodium succinate) 500 mg vial (INJ) CP 20 mg
PREDNISOLONE 1 mg tab-cap (PO) P

WHO DEFINED

PREDNISOLONE (BASE) 15 mg/5 ml syrup (PO) P 10 mg
TAMOXIFEN CITRATE 10 mg tab-cap (PO) C 20 mg
TAMOXIFEN CITRATE 20 mg tab-cap (PO) C 20 mg
9. ANTIPARKINSONISM MEDICINES
BENZATROPINE MESILATE 1 mg/ml ampoule (INJ) N 2 mg

BENZATROPINE MESILATE 2 mg tab-cap (PO) N 2 mg
BIPERIDEN 2 mg tab-cap (PO) E 10 mg
BROMOCRIPTINE MESILATE 2.5 mg tab-cap (PO) N 40 mg
LEVODOPA+CARBIDOPA 100+25 mg tab-cap (PO) P 0.6 g
LEVODOPA+CARBIDOPA 250+25 mg tab-cap (PO) E 0.6 g
TRIHEXYPHENIDYL (benzhexol) 2 mg tab-cap (PO) T 10 mg
TRIHEXYPHENIDYL (benzhexol) 5 mg tab-cap (PO) T 10 mg
10.1. ANTI-ANAEMIA MEDICINES
EPOETIN ALPHA 2000 IU vial (INJ) N

EPOETIN ALPHA 4000 IU vial (INJ) N
EPOETIN BETA 50,000 IU vial (INJ) N
FERROUS SALT 20 mg/ml suspen (PO) P 0.2 g
FERROUS SALT 40 mg/ml solution (PO) P 0.2 g
FERROUS SALT (iron=60-65 mg) 200 mg tab-cap (PO) E 0.2 g
FERROUS SALT+FOLIC ACID (iron=60 mg) 200 mg+0.4mg tab-cap (PO) E 0.2 g
FERROUS SALT+FOLIC ACID (iron=60 mg) 200+0.25 mg tab-cap (PO) P 0.2 g
FERROUS SULFATE 125 mg/ml drops (PO) EP 0.2 g

WHO DEFINED

FOLIC ACID 1 mg tab-cap (PO) E 0.4 mg
FOLIC ACID 5 mg tab-cap (PO) E 0.4 mg
IRON DEXTRAN 50 mg/ml ampoule (INJ) N 0.1 g
VITAMIN B12 (cyanocobalamin) 1 mg/ml ampoule (INJ) N 0.02 mg
10.2. MEDICINES AFFECTING COAGULATION

CLOPIDOGREL BISULFATE 75 mg tab-cap (PO) E 75 mg
ENOXAPARIN 100 mg syringe (INJ) E 2 tu
Buyer Number of Prices=1 Price=4.0318/syringe
Buyer Number of Prices=2 High/Low Ratio=2.16 Median Price=3.2100/syringe
HEPARIN 1000 IU/ml ampoule (INJ) C 10 tu
HEPARIN 5000 IU/ml ampoule (INJ) C 10 tu
PROTAMINE SULFATE 10 mg/ml ampoule (INJ) C
TRANEXAMIC ACID 100 mg/ml ampoule (INJ) E 2 g
VITAMIN K1 (phytomenadione) 1 mg/ml ampoule (INJ) P 20 mg
VITAMIN K1 (phytomenadione) 10 mg tab-cap (PO) E 20 mg
VITAMIN K1 (phytomenadione) 10 mg/ml ampoule (INJ) E 20 mg
WARFARIN SODIUM 1 mg tab-cap (PO) C 7.5 mg
WARFARIN SODIUM 3 mg tab-cap (PO) P 7.5 mg

WHO DEFINED
10.3 OTHER MEDICINES FOR HAEMOGLOBINOPATHIES
DEFEROXAMINE MESILATE 500 mg ampoule (INJ) E

HYDROXYCARBAMIDE (hydroxyurea) 500 mg tab-cap (PO) C
11.2. PLASMA-DERIVED MEDICINES
ALBUMIN, HUMAN NORMAL 20-25% vial (INJ) N

11.2.2. BLOOD COAGULATION FACTORS
FACTOR VIIA 100,000 U vial (INJ) N 6 tu

FACTOR VIII 1000 IU vial (INJ) C 500 u
11.3. PLASMA SUBSTITUTES
DEXTRAN 70 6% IN SOD. CHLORIDE 0.9% solution (IV) E

POLYGELINE 3.5% solution (INJ) N
12.1. ANTIANGINAL MEDICINES
AMLODIPINE 10 mg tab-cap (PO) N 5 mg

AMLODIPINE 5 mg tab-cap (PO) T 5 mg
ATENOLOL 100 mg tab-cap (PO) E 75 mg
BISOPROLOL 5 mg tab-cap (PO) E 10 mg
CARVEDILOL 12.5 mg tab-cap (PO) T 37.5 mg
CARVEDILOL 25 mg tab-cap (PO) T 37.5 mg
DILTIAZEM HCL 60 mg tab-cap (PO) N 0.24 g
GLYCERYL TRINITRATE 0.4 mg/dose nasal spr (N/T) EP
Buyer Number of Prices=1 Price=0.0298/dose
GLYCERYL TRINITRATE (nitroglycerin) 0.5 mg tab-cap (SL) E 5 mg

WHO DEFINED
GLYCERYL TRINITRATE (nitroglycerin) 5 mg/ml ampoule (INJ) P

ISOSORBIDE DINITRATE 10 mg tab-cap (PO) P 60 mg
ISOSORBIDE DINITRATE 20 mg tab-cap (PO) P 60 mg
ISOSORBIDE DINITRATE 5 mg tab-cap (SL) E 20 mg
ISOSORBIDE DINITRATE 5 mg tab-cap (PO) E 60 mg
ISOSORBIDE DINITRATE 5 mg tab-cap (SL) E 20 mg
ISOSORBIDE MONONITRATE 20 mg tab-cap (PO) N 40 mg
METOPROLOL 100 mg tab-cap (PO) E 0.15 g
NIFEDIPINE 10 mg tab-cap (PO) E 30 mg
NIFEDIPINE (sustained-release) 10 mg tab-cap (PO) T 30 mg
VERAPAMIL HCL (slow-release) 240 mg tab-cap (PO) P 0.24 g
12.2. ANTIARRHYTHMIC MEDICINES
ADENOSINE 3 mg/ml ampoule (INJ) N 15 mg

AMIODARONE 200 mg tab-cap (PO) C 0.2 g
AMIODARONE 50 mg/ml vial (INJ) C 0.2 g
LIDOCAINE HCL 2% vial (INJ) E 3 g
PROPRANOLOL 1 mg/ml ampoule (INJ) P 0.16 g

WHO DEFINED

QUINIDINE SULFATE 200 mg tab-cap (PO) N 1.2 g
VERAPAMIL HCL 2.5 mg/ml vial (INJ) E 0.24 g
VERAPAMIL HCL 40 mg tab-cap (PO) E 0.24 g
12.3. ANTIHYPERTENSIVE MEDICINES

BENDROFLUMETHIAZIDE 5 mg tab-cap (PO) T 2.5 mg
CAPTOPRIL 12.5 mg tab-cap (PO) T 50 mg
CAPTOPRIL 25 mg tab-cap (PO) T 50 mg
CARVEDILOL 6.25 mg tab-cap (PO) N 37.5 mg
DILTIAZEM HCL 60 mg tab-cap (PO) N 0.24 g
DOXAZOSIN 4 mg tab-cap (PO) N 4 mg
ENALAPRIL 10 mg tab-cap (PO) P 10 mg
HYDRALAZINE 20 mg ampoule (INJ) N 0.1 g
Supplier Number of Prices=10 High/Low Ratio=9.51 Median Price=4.6717/ampoule
Buyer Number of Prices=4 High/Low Ratio=8.22 Median Price=4.1600/ampoule
HYDRALAZINE 25 mg tab-cap (PO) N 0.1 g

WHO DEFINED
HYDRALAZINE 50 mg tab-cap (PO) N 0.1 g

HYDROCHLOROTHIAZIDE 12.5 mg tab-cap (PO) E 25 mg
HYDROCHLOROTHIAZIDE 25 mg tab-cap (PO) E 25 mg
IRBESARTAN 150 mg tab-cap (PO) N 0.15 g
LABETALOL 5 mg/ml ampoule (INJ) N 0.6 g
LISINOPRIL 10 mg tab-cap (PO) T 10 mg
LISINOPRIL 20 mg tab-cap (PO) T 10 mg
LISINOPRIL 5 mg tab-cap (PO) N 10 mg
LOSARTAN 50 mg tab-cap (PO) N 50 mg
METHYLDOPA 250 mg tab-cap (PO) E 1 g
METHYLDOPA 500 mg tab-cap (PO) P 1 g
MINOXIDIL 10 mg tab-cap (PO) N 20 mg
NIMODIPINE 30 mg tab-cap (PO) T 0.3 g
TAMSULOSIN 0.4 mg tab-cap (PO) N 0.4 mg
12.4. MEDICINES USED IN HEART FAILURE


WHO DEFINED

CAPTOPRIL 12.5 mg tab-cap (PO) T 50 mg
DIGOXIN 0.05 mg/ml solution (PO) E 0.25 mg
DIGOXIN 0.125 mg tab-cap (PO) P 0.25 mg
DIGOXIN 0.25 mg tab-cap (PO) E 0.25 mg
DIGOXIN 0.25 mg/ml ampoule (INJ) E 0.25 mg
DOBUTAMINE 12.5 mg/ml vial (INJ) N 0.5 g
DOPAMINE HCL 40 mg/ml ampoule (INJ) C 0.5 g
FUROSEMIDE 10 mg/ml ampoule (INJ) E 40 mg
FUROSEMIDE 40 mg tab-cap (PO) E 40 mg
NOREPINEPHRINE 1 mg/ml vial (INJ) N 6 mg
12.5. ANTITHROMBOTIC MEDICINES

STREPTOKINASE (powder) 1,500,000 IU vial (INJ) C 1.5 mu

WHO DEFINED
12.6. LIPID-LOWERING AGENTS
ATORVASTATIN 10 mg tab-cap (PO) N 20 mg

ATORVASTATIN 20 mg tab-cap (PO) T 20 mg
ATORVASTATIN 40 mg tab-cap (PO) N 20 mg
GEMFIBROZIL 600 mg tab-cap (PO) N 1.2 g
LOVASTATIN 20 mg tab-cap (PO) T 45 mg
SIMVASTATIN 10 mg tab-cap (PO) E 30 mg
SIMVASTATIN 20 mg tab-cap (PO) T 30 mg
13. DERMATOLOGICAL MEDICINES (TOPICAL)
CAMPHOR 10% ointment (TOP) N

CLOBETASOL PROPRIONATE 0.05% cream (TOP) N
13.1. ANTIFUNGAL MEDICINES (DERMATOLOGICAL)
BENZOIC & SALICYLIC ACID (whitfield's) 6% + 3% ointment (TOP) N

CLOTRIMAZOLE 1% cream (TOP) E
KETOCONAZOLE 2% cream (TOP) N
MICONAZOLE 25 mg/ml oral gel (PO) P 0.2 g
MICONAZOLE NITRATE 2% cream (TOP) E
NYSTATIN 100,000 IU/g cream (TOP) P
NYSTATIN 100,000 IU/g ointment (TOP) P
TERBINAFINE 1% cream (TOP) E
13.2. ANTI-INFECTIVE MEDICINES (DERMATOLOGICAL)
CHLORHEXIDINE 1% cream (TOP) P

FUSIDIC ACID 2% cream (TOP) N

WHO DEFINED
GENTIAN VIOLET (methylrosanilinium chloride) powder (TOP) N

MUPIROCIN 2% cream (TOP) E
MUPIROCIN 2% ointment (TOP) E
NEOMYCIN+BACITRACIN 5mg+500IU/g ointment (TOP) N
NITROFURAZONE 0.2% ointment (TOP) N
POTASSIUM PERMANGANATE powder (TOP) E
SILVER SULFADIAZINE 1% cream (TOP) E
TETRACYCLINE 3% ointment (TOP) P
TETRACYCLINE HCL 1% ointment (TOP) P
13.3. ANTI-INFLAMMATORY AND ANTIPRURITIC MEDICINES
BETAMETHASONE VALERATE 0.1% cream (TOP) E

BETAMETHASONE VALERATE 0.1% ointment (TOP) E
CALAMINE lotion (TOP) E
FLUOCINOLONE 0.025% cream (TOP) N
HYDROCORTISONE 1% cream (TOP) E
HYDROCORTISONE 1% ointment (TOP) E
13.5. SCABICIDES AND PEDICULICIDES
ICHTHAMMOL 20% ointment (TOP) N

PERMETHRIN 5% cream (TOP) E
14.1. OPHTHALMIC MEDICINES (DIAGNOSTIC)
FLUORESCEIN 100 mg/ml ampoule (INJ) EP

FLUORESCEIN SODIUM opht strp (OPHT) P
Supplier Number of Prices=4 High/Low Ratio=2.61 Median Price=0.0854/each
Buyer Number of Prices=1 Price=0.1522/each
TROPICAMIDE 0.5% opht drop (OPHT) E
TROPICAMIDE 1% opht drop (OPHT) P

WHO DEFINED
14.2. RADIOCONTRAST MEDIA
AMIDOTRIZOATE 76% ampoule (INJ) P

BARIUM SULFATE powder (PO) P
Supplier Number of Prices=1 Price=37.8000/kg
Buyer Number of Prices=1 Price=79.3269/kg
IOHEXOL 350 mg/ml vial (INJ) E
SODIUM AMIDOTRIZOATE (meglumine diatrizoate) 76% vial (INJ) E
15.1. ANTISEPTICS
CETRIMIDE+CHLORHEXIDINE GLUCONATE 15%+1.5% solution (TOP) P

CHLORHEXIDINE GLUCONATE 20% solution (TOP) P
CHLORHEXIDINE GLUCONATE 5% solution (TOP) E
CHLORHEXIDINE SURGICAL SCRUB 4% liquid (TOP) P
HYDROGEN PEROXIDE 3% solution (TOP) N
HYDROGEN PEROXIDE 6% solution (TOP) N
POVIDONE IODINE 10% ointment (TOP) T
POVIDONE IODINE 10% solution (TOP) E
POVIDONE IODINE (Scrub) 7.5% liquid (TOP) P
15.2. DISINFECTANTS
ALCOHOL (ethanol) 95-96% liquid (TOP) N

ALCOHOL, DENATURED 70% liquid (TOP) N
ALCOHOL, DENATURED 95-96% liquid (TOP) N
ALCOHOL, ISOPROPYL 70% liquid (TOP) N
CHLORAMINE 500 mg tab-cap (TOP) N
CHLOROXYLENOL 4.8% solution (N/A) E
GLUTARALDEHYDE 2% solution (TOP) E

WHO DEFINED
16. DIURETICS
BENDROFLUMETHIAZIDE 2.5 mg tab-cap (PO) T 2.5 mg

BENDROFLUMETHIAZIDE 5 mg tab-cap (PO) T 2.5 mg
CHLORTHALIDONE 50 mg tab-cap (PO) N 25 mg
FUROSEMIDE 10 mg/ml ampoule (INJ) E 40 mg
FUROSEMIDE 10 mg/ml solution (PO) P 40 mg
FUROSEMIDE 40 mg tab-cap (PO) E 40 mg
HYDROCHLOROTHIAZIDE+TRIAMTERENE 25 mg+50 mg tab-cap (PO) N
MANNITOL 20% solution (IV) C
SPIRONOLACTONE 100 mg tab-cap (PO) CP 75 mg
SPIRONOLACTONE 25 mg tab-cap (PO) C 75 mg
17. GASTROINTESTINAL MEDICINES
GLYCERIN 1 g suppos (RECT) N

LOPERAMIDE HCL 2 mg tab-cap (PO) E 10 mg
OCTREOTIDE 0.1 mg/ml ampoule (INJ) N 0.7 mg
17.1. ANTIULCER MEDICINES
ALUMINIUM HYDR.+ MAGNESIUM HYDR. 250+120 mg tab-cap (PO) P

ALUMINIUM HYDROXIDE 500 mg tab-cap (PO) N 3 g
ALUMINIUM HYDROXIDE (chewable) 500 mg tab-cap (PO) N 3 g
CIMETIDINE 100 mg/ml vial (INJ) T 0.8 g

WHO DEFINED

CIMETIDINE 200 mg tab-cap (PO) T 0.8 g
CIMETIDINE 400 mg tab-cap (PO) T 0.8 g
FAMOTIDINE 20 mg tab-cap (PO) T 40 mg
FAMOTIDINE 40 mg tab-cap (PO) T 40 mg
MAGNESIUM TRISILICATE COMPOUND (chewable) tab-cap (PO) T
OMEPRAZOLE 10 mg tab-cap (PO) E 20 mg
OMEPRAZOLE 20 mg tab-cap (PO) E 20 mg
OMEPRAZOLE 40 mg vial (INJ) E 20 mg
RANITIDINE 150 mg tab-cap (PO) E 0.3 g
RANITIDINE 25 mg/ml ampoule (INJ) E 0.3 g
RANITIDINE 300 mg tab-cap (PO) P 0.3 mg
17.2. ANTIEMETIC MEDICINES

DIMENHYDRINATE 50 mg tab-cap (PO) N
DIMENHYDRINATE 50 mg/ml vial (INJ) N
GRANISETRON 1 mg/ml ampoule (INJ) N 3 mg
METOCLOPRAMIDE HCL 10 mg tab-cap (PO) E 30 mg
METOCLOPRAMIDE HCL 4 mg/ml drops (PO) P 30 mg
METOCLOPRAMIDE HCL 5 mg/5 ml syrup (PO) E 30 mg
METOCLOPRAMIDE HCL 5 mg/ml ampoule (INJ) E 30 mg
ONDANSETRON 2 mg/ml ampoule (INJ) E 16 mg

WHO DEFINED

17.3. ANTI-INFLAMMATORY MEDICINES
ANTIHAEMORRHOIDAL ointment (RECT) E

ANTIHAEMORRHOIDAL suppos (RECT) E
SULFASALAZINE 500 mg tab-cap (PO) C 2 g
17.4. LAXATIVES
BISACODYL 10 mg suppos (RECT) N 10 mg

BISACODYL 5 mg tab-cap (PO) N 10 mg
MAGNESIUM SULFATE powder (PO) N
SENNA (sennosides) 7.5 mg tab-cap (PO) E 15 mg
17.5.1. ORAL REHYDRATION
ORAL REHYDRATION SALTS (ORS) 1 PKT/1 l powder (PO) E

Supplier Number of Prices=10 High/Low Ratio=2.01 Median Price=0.1068/packet
Buyer Number of Prices=21 High/Low Ratio=6.67 Median Price=0.0500/packet
ORAL REHYDRATION SALTS (ORS) 1 pkt/500 ml powder (PO) E
ORS+ZINC CO-PACK (1-lt packet ORS+1 tab Zinc) 1 ORS+20 mg each (PO) EP
Buyer Number of Prices=3 High/Low Ratio=1.90 Median Price=0.5800/each
ORS+ZINC CO-PACK (2 1-lt ORS Packets+1 tab Zinc) 2 ORS+20 mg each (PO) EP
Buyer Number of Prices=3 High/Low Ratio=2.09 Median Price=0.8000/each
ORS+ZINC CO-PACK (2 1-lt ORS+10 tabs Zinc) 2 ORS+20 mg each (PO) EP
ORS+ZINC CO-PACK (4 500ml packets+10 tabs Zinc) 4 ORS+20 mg each (PO) EP
Supplier Number of Prices=1 Price=0.5040/each
17.5.2. MEDICINES FOR DIARRHOEA IN CHILDREN
ZINC SULFATE 10 mg/5 ml syrup (PO) E 0.6 g

ZINC SULFATE 20 mg tab-cap (PO) E
ZINC SULFATE 20 mg/5 ml syrup (PO) EP 0.6 g
ZINC SULFATE (dispersible) 10 mg tab-cap (PO) EP 0.6 g
ZINC SULFATE (dispersible) 20 mg tab-cap (PO) P 0.6 g

WHO DEFINED
18. HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES
ALENDRONATE 10 mg tab-cap (PO) N

DANAZOL 200 mg tab-cap (PO) N 0.6 g
HUMAN MENOPAUSAL GONADOTROPHIN 75 IU vial (INJ) N 30 u
18.1. ADRENAL HORMONES AND SYNTHETIC SUBSTITUTES
HYDROCORTISONE 10 mg tab-cap (PO) E 30 mg

18.3.1. ORAL HORMONAL CONTRACEPTIVES
ETHINYLESTRADIOL+DESOGESTREL 0.03+0.15mg tab-cap (PO) N

Supplier Number of Prices=1 Price=0.7245/cycle
ETHINYLESTRADIOL+LEVONORGESTREL 0.03+0.15 mg tab-cap (PO) E
Supplier Number of Prices=5 High/Low Ratio=3.63 Median Price=0.5138/cycle
Buyer Number of Prices=3 High/Low Ratio=10.17 Median Price=0.2167/cycle
ETHINYLESTRADIOL+NORGESTREL 0.05+0.5 mg tab-cap (PO) N
Buyer Number of Prices=1 Price=0.2741/cycle
LEVONORGESTREL 0.03 mg tab-cap (PO) E
Supplier Number of Prices=2 High/Low Ratio=1.80 Median Price=0.4409/cycle
Buyer Number of Prices=2 High/Low Ratio=6.25 Median Price=0.8062/cycle
LEVONORGESTREL 0.75 mg tab-cap (PO) E
LEVONORGESTREL 1.5 mg tab-cap (PO) E 1.5 mg
LYNESTRENOL 0.5 mg tab-cap (PO) N
Supplier Number of Prices=1 Price=0.4305/cycle
18.3.2. INJECTABLE HORMONAL CONTRACEPTIVES
MEDROXYPROGESTERONE ACETATE 150 mg/ml vial (INJ) E 1.67 mg

NORETHISTERONE 200 mg/ml ampoule (INJ) E
NORETHISTERONE+ESTRADIOL CYPIONATE (in oil) 50mg+5mg/ml vial (INJ) N
18.3.3. INTRAUTERINE DEVICES
IUD (COPPER) iud (VAG) E

Supplier Number of Prices=4 High/Low Ratio=6.09 Median Price=1.0891/iud
Buyer Number of Prices=1 Price=3.0000/iud
IUD (LEVONORGESTREL) 52 mg iud (VAG) EP
18.3.4. BARRIER METHODS
CONDOM, FEMALE condom (N/A) P

Supplier Number of Prices=4 High/Low Ratio=1.92 Median Price=0.7421/condom
CONDOMS (LUBRICATED) condom (N/A) E
Supplier Number of Prices=8 High/Low Ratio=2.73 Median Price=0.0341/condom

WHO DEFINED
18.3.5. IMPLANTABLE CONTRACEPTIVES
ETONOGESTREL 68 mg/rod rod (SC) N 68 mcg

Supplier Number of Prices=2 High/Low Ratio=1.49 Median Price=11.1075/rod
Buyer Number of Prices=1 Price=10.0172/rod
LEVONORGESTREL 75 mg/rod rod (SC) E
Supplier Number of Prices=2 High/Low Ratio=1.49 Median Price=5.5538/set
Buyer Number of Prices=1 Price=4.7920/set
18.4. ESTROGENS
ESTROGENS, CONJUGATED 0.625 mg tab-cap (PO) N 0.625 mg

18.5. INSULINS AND OTHER MEDICINES USED FOR DIABETES
CHLORPROPAMIDE 250 mg tab-cap (PO) T 0.375 g

GLIBENCLAMIDE 5 mg tab-cap (PO) N 10 mg
GLICLAZIDE 80 mg tab-cap (PO) E 0.16 g
GLICLAZIDE (slow-release) 30 mg tab-cap (PO) E 60 mg
GLIMEPIRIDE 2 mg tab-cap (PO) N 2 mg
GLIMEPIRIDE 4 mg tab-cap (PO) N 2 mg
INSULIN, ISOPHANE (NPH) 100 IU/ml vial (SC) E 40 iu
INSULIN, ISOPHANE (NPH) 40 IU/ml vial (SC) E 40 iu
INSULIN, NEUT. SOL/ISOPHANE 30/70 (human, mixtard) 100 IU/ml vial (SC) P 40 u
INSULIN, NEUTRAL SOLUBLE (REGULAR) 100 IU/ml vial (SC) E 40 iu
INSULIN, NEUTRAL SOLUBLE (REGULAR) 40 IU/ml vial (SC) E 40 iu
INSULIN, ZINC SUSP (LENTE) 100 IU/ml vial (SC) E 40 iu
METFORMIN HCL 500 mg tab-cap (PO) C 2 g
METFORMIN HCL 850 mg tab-cap (PO) CP 2 g
18.6. OVULATION INDUCERS
CLOMIFENE 50 mg tab-cap (PO) C 9 mg

HUMAN CHORIONIC GONADOTROPHIN 5000 IU ampoule (INJ) N 250 u

WHO DEFINED
18.7. PROGESTOGENS
MEDROXYPROGESTERONE 10 mg tab-cap (PO) EP 5 mg

MEDROXYPROGESTERONE 5 mg tab-cap (PO) C 5 mg
NORETHISTERONE 5 mg tab-cap (PO) E 5 mg
18.8. THYROID HORMONES AND ANTITHYROID MEDICINES
CARBIMAZOLE 5 mg tab-cap (PO) N 15 mg

LEVOTHYROXINE 100 mcg tab-cap (PO) E 0.15 mg
LEVOTHYROXINE 200 mcg tab-cap (PO) P 0.15 mg
LEVOTHYROXINE 50 mcg tab-cap (PO) E 0.15 mg
PROPYLTHIOURACIL 50 mg tab-cap (PO) C 0.1 g
19.1. DIAGNOSTIC AGENTS
TUBERCULIN (PPD) 5 IU vial (INJ) E

19.2. SERA AND IMMUNOGLOBULINS
ANTIVENOM SERUM vial (INJ) E

IMMUNOGLOBULIN, ANTI-HEPATITIS B 200 U ampoule (INJ) N
IMMUNOGLOBULIN, ANTI-TETANUS (Human) 250 IU vial (INJ) P
IMMUNOGLOBULIN, VARICELLA ZOSTER (human) 125 IU/ml vial (INJ) N
TETANUS ANTITOXIN 1500 IU ampoule (INJ) N
19.3. VACCINES
VACCINE, BCG (dried) powder (INJ) E

VACCINE, DIPHTHERIA-TETANUS vial (INJ) E
Buyer Number of Prices=2 High/Low Ratio=7.81 Median Price=0.5593/dose
VACCINE, HEPATITIS B vial (INJ) E
VACCINE, HPV vial (INJ) N
VACCINE, INFLUENZA 0.5 ml ampoule (INJ) E
VACCINE, MEASLES vial (INJ) E

WHO DEFINED
VACCINE, MEASLES-MUMPS-RUBELLA vial (INJ) E

VACCINE, MENINGOCOCCAL vial (INJ) E
Supplier Number of Prices=1 Price=3.2340/dose
VACCINE, PENTAVALENT (tetanus,dip,pertus,polio,Hib) vial (INJ) EP
VACCINE, PNEUMOCOCCAL vial (INJ) E
VACCINE, POLIO (ORAL) vial (PO) E
VACCINE, RABIES vial (INJ) E
VACCINE, ROTAVIRUS vial (PO) E
VACCINE, TETANUS TOXOID vial (INJ) E
VACCINE, TYPHOID vial (INJ) E
VACCINE, YELLOW FEVER vial (INJ) E
20. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS
ATRACURIUM 10 mg/ml ampoule (INJ) N

NEOSTIGMINE METHYLSULFATE 0.5 mg/ml ampoule (INJ) E 60 mg
NEOSTIGMINE METHYLSULFATE 2.5 mg/ml ampoule (INJ) E
PANCURONIUM BROMIDE 2 mg/ml ampoule (INJ) N
PYRIDOSTIGMINE BROMIDE 60 mg tab-cap (PO) C 0.18 g
ROCURONIUM BROMIDE 50 mg/5 ml vial (INJ) N
SUXAMETHONIUM CL (succinylcholine) 20 mg/ml vial (INJ) P
SUXAMETHONIUM CL (succinylcholine) 50 mg/ml ampoule (INJ) E
VECURONIUM 4 mg vial (INJ) P
21. OPHTHALMOLOGICAL PREPARATIONS
CROMOGLICIC ACID (sodium cromoglicate) 2% opht drop (OPHT) N

21.1. OPHTHALMOLOGICAL ANTI-INFECTIVE AGENTS
ACICLOVIR 3% opht oint (OPHT) N


WHO DEFINED

CHLORAMPHENICOL 0.5% opht drop (OPHT) P
CHLORAMPHENICOL 1% opht oint (OPHT) P
CHLORAMPHENICOL+DEXAMETHASONE 0.5%+0.1% opht drop (OPHT) N
CIPROFLOXACIN 3 mg/ml opht drop (OPHT) P
GENTAMICIN (base) 0.3% opht drop (OPHT) E
NATAMYCIN 50 mg/ml opht drop (OPHT) N
OFLOXACIN 0.3% opht drop (OPHT) E
SULFACETAMIDE SODIUM 10% opht drop (OPHT) N
TETRACYCLINE HCL 1% opht oint (OPHT) E
21.2. OPHTHALMOLOGICAL ANTI-INFLAMMATORY AGENTS
BETAMETHASONE (opht/otic) 0.1% opht drop (OPHT) P

DEXAMETHASONE 0.1% opht drop (OPHT) P
DICLOFENAC SODIUM 0.1% opht drop (OPHT) N
HYDROCORTISONE 1% opht drop (OPHT) P
PREDNISOLONE 1% opht drop (OPHT) P
21.3. OPHTHALMOLOGICAL LOCAL ANAESTHETICS
OXYBUPROCAINE 0.4% opht drop (OPHT) N

PROPARACAINE 0.5% opht drop (OPHT) T
TETRACAINE 0.5% opht drop (OPHT) E
21.4. MIOTICS AND ANTIGLAUCOMA MEDICINES
ACETAZOLAMIDE 250 mg tab-cap (PO) E 0.75 g

DORZOLAMIDE CHLORHYDRATE 2% opht drop (OPHT) N 0.3 ml
LATANOPROST 0.005% opht drop (OPHT) E 0.1 ml
PILOCARPINE 1% opht drop (OPHT) P 0.4 ml

WHO DEFINED

PILOCARPINE 2% opht drop (OPHT) E 0.4 ml
PILOCARPINE 4% opht drop (OPHT) E 0.4 ml
TIMOLOL MALEATE 0.25% opht drop (OPHT) E 0.2 ml
TIMOLOL MALEATE 0.5% opht drop (OPHT) E 0.2 ml
21.5. MYDRIATICS
ATROPINE SULFATE 1% opht drop (OPHT) E

CYCLOPENTOLATE 1% opht drop (OPHT) N
TROPICAMIDE 1% opht drop (OPHT) P
21.6. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)
BEVACIZUMAB 25 mg/ml vial (INJ) C

22.1. OXYTOCICS
ERGOMETRINE MALEATE 0.2 mg tab-cap (PO) N 0.2 mg

ERGOMETRINE MALEATE 0.2 mg/ml ampoule (INJ) E 0.2 mg
ERGOMETRINE MALEATE 0.5 mg tab-cap (PO) N 0.2 mg
ERGOMETRINE MALEATE 0.5 mg/ml ampoule (INJ) P 0.2 mg
METHYLERGOMETRINE MALEATE 0.2 mg/ml ampoule (INJ) T 0.2 mg
MISOPROSTOL 100 mcg tab-cap (PO) P 0.8 mg
MISOPROSTOL 200 mcg tab-cap (PO) E 0.8 mg
OXYTOCIN 10 IU ampoule (INJ) E 15 u
OXYTOCIN 5 IU ampoule (INJ) P 15 u
22.2. ANTIOXYTOCICS (TOCOLYTICS)


WHO DEFINED
NIFEDIPINE 20 mg tab-cap (PO) EP 30 mg

SALBUTAMOL 0.5 mg/ml ampoule (INJ) E 12 mg
SALBUTAMOL 4 mg tab-cap (PO) E 12 mg
23. PERITONEAL DIALYSIS SOLUTION
DIALYSIS SOL. PERITONEAL W/ DEXTROSE 1.5% solution (IV) C

24. MEDICINES FOR MENTAL AND BEHAVIORAL DISORDERS

FLUPHENAZINE DECANOATE 25 mg/ml ampoule (INJ) E 1 mg
IMIPRAMINE HCL 25 mg tab-cap (PO) T 0.1 g
LITHIUM CARBONATE 300 mg tab-cap (PO) E 24 mmol
24.1. MEDICINES USED IN PSYCHOTIC DISORDERS
CHLORPROMAZINE HCL 100 mg tab-cap (PO) C 0.3 g

CHLORPROMAZINE HCL 25 mg/ml ampoule (INJ) C 0.1 g
CLOZAPINE 100 mg tab-cap (PO) C 0.3 g
CLOZAPINE 25 mg tab-cap (PO) C 0.3 g
HALOPERIDOL 0.5 mg tab-cap (PO) E 8 mg
HALOPERIDOL 1.5-2 mg tab-cap (PO) E 8 mg
HALOPERIDOL 10 mg tab-cap (PO) P 8 mg
HALOPERIDOL 2 mg/ml syrup (PO) E 8 mg
HALOPERIDOL 5 mg tab-cap (PO) E 8 mg
HALOPERIDOL 5 mg/ml ampoule (INJ) E 3.3 mg

WHO DEFINED

OLANZAPINE 10 mg tab-cap (PO) N 10 mg
OLANZAPINE 5 mg tab-cap (PO) N 10 mg
PROCHLORPERAZINE 5 mg tab-cap (PO) T 0.1 g
RISPERIDONE 0.5 mg tab-cap (PO) E 5 mg
RISPERIDONE 1 mg tab-cap (PO) E 5 mg
RISPERIDONE 1 mg/ml solution (PO) EP 5 mg
TRIFLUOPERAZINE 5 mg tab-cap (PO) T 20 mg
24.2. MEDICINES USED IN MOOD DISORDERS
CARBAMAZEPINE 200 mg tab-cap (PO) E 1 g

CARBAMAZEPINE (sustained-release) 200 mg tab-cap (PO) E 1 g
IMIPRAMINE HCL 10 mg tab-cap (PO) T 0.1 g
METHYLPHENIDATE HYDROCHLORIDE (IC) 10 mg tab-cap (PO) N 30 mg
VALPROIC ACID (slow release) 200 mg tab-cap (PO) P 1.5 g
24.2.1. MEDICINES USED IN DEPRESSIVE DISORDERS
AMITRIPTYLINE 25 mg tab-cap (PO) E 75 mg

FLUOXETINE 20 mg tab-cap (PO) E 20 mg
SERTRALINE 50 mg tab-cap (PO) N 50 mg
VENLAFAXINE 75 mg tab-cap (PO) N 0.1 g
24.2.2. MEDICINES USED IN BIPOLAR DISORDERS
SODIUM VALPROATE 500 mg tab-cap (PO) E 1.5 g

VALPROIC ACID 500 mg tab-cap (PO) E 1.5 g

WHO DEFINED
24.3. MEDICINES FOR ANXIETY DISORDERS
ALPRAZOLAM 0.25 mg tab-cap (PO) N 1 mg

ALPRAZOLAM 0.5 mg tab-cap (PO) T 1 mg
24.4. MEDICINES USED FOR OBSESSIVE COMPULSIVE DISORDERS
CLOMIPRAMINE 25 mg tab-cap (PO) E 0.1 g

24.5. MEDICINES FOR DISORDERS DUE TO PSYCHOACTIVE SUBSTANCE USE
METHADONE (IC) 5 mg tab-cap (PO) CP 25 mg

25. MEDICINES ACTING ON THE RESPIRATORY TRACT
AMINOPHYLLINE 100 mg tab-cap (PO) N 0.6 g

AMINOPHYLLINE 25 mg/ml ampoule (INJ) N 0.6 g
COUGH PREPARATION syrup (PO) N
DIPHENHYDRAMINE 25 mg tab-cap (PO) T 0.3 g
EPHEDRINE 0.5% nasal (NASA) P
EPHEDRINE HCL 30 mg tab-cap (PO) C 50 mg
EPHEDRINE SULFATE 50 mg/ml ampoule (INJ) P 50 mg
NOSCAPINE 15 mg tab-cap (PO) N 0.125 g
THEOPHYLLINE (sustained-release) 200 mg tab-cap (PO) N 0.4 g
25.1 ANTIASTHMATIC AND MEDICINES FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
BECLOMETASONE 100 mcg/dose inhaler (INH) P 0.8 mg

Supplier Number of Prices=2 High/Low Ratio=7.01 Median Price=0.0453/dose

WHO DEFINED

BECLOMETASONE 250 mcg/dose inhaler (INH) E 0.8 mg
BECLOMETASONE 50 mcg nasal (N/T) E 0.4 mg
BECLOMETASONE 50 mcg/dose inhaler (INH) E 0.8 mg
BUDESONIDE 100 mcg/dose inhaler (PO) E 0.8 mg
IPRATROPIUM BROMIDE 20 mcg/dose inhaler (INH) E 0.12 mg
IPRATROPIUM BROMIDE 250 mcg/ml respsol (INH) P 0.12 mg
SALBUTAMOL 0.2% respsol (INH) P 10 mg
SALBUTAMOL 0.5 mg/ml ampoule (INJ) E 12 mg
SALBUTAMOL 0.5% respsol (INH) E 10 mg
SALBUTAMOL 100 mcg/dose inhaler (INH) E 0.8 mg
SALBUTAMOL 2 mg/5 ml syrup (PO) E 12 mg
SALMETEROL+FLUTICASONE (25+250 mcg/dose) inhaler (INH) N
26.1. ORAL SOLUTIONS CORRECTING WATER, ELECTROLYTE, & ACID-BASE DISTURBANCES
ORAL REHYDRATION SALTS (ORS) 1 PKT/1 l powder (PO) E

Supplier Number of Prices=10 High/Low Ratio=2.01 Median Price=0.1068/packet
Buyer Number of Prices=21 High/Low Ratio=6.67 Median Price=0.0500/packet
POTASSIUM CHLORIDE (KCL, 20 mEq/15 ml) 10% vial (INJ) P 3 g
26.2. PARENTERAL SOLUTIONS CORRECTING WATER, ELECTROLYTE, & ACID-BASE DISTURBANCES
DEXTROSE 10% IN WATER solution (IV) E

DEXTROSE 2.5% IN SOD. CHLORIDE 0.45% solution (IV) P
DEXTROSE 4.3-5% IN WATER solution (IV) E
DEXTROSE 5% IN SODIUM CHLORIDE 0.45% solution (IV) P

WHO DEFINED

DEXTROSE 5% IN SODIUM CHLORIDE 0.9% solution (IV) P
DEXTROSE 5% IN WATER solution (IV) E
DEXTROSE 50% IN WATER (hypertonic) solution (IV) E
POTASSIUM CHLORIDE 15% vial (INJ) P 3 g
SODIUM BICARBONATE 8.4% solution (INJ) T
SODIUM CHLORIDE IN WATER 0.45% solution (IV) P
SODIUM CHLORIDE IN WATER (normal saline) 0.9% solution (IV) E
SODIUM LACTATE COMPOUND (Ringer's/Hartmann's sol.) solution (IV) E
26.3. MISCELLANEOUS SOLUTIONS
WATER FOR INJECTION 10 ml ampoule (INJ) E

WATER FOR INJECTION 100 ml vial (INJ) P
WATER FOR INJECTION 5 ml ampoule (INJ) E
27. VITAMINS AND MINERALS
CALCIUM GLUCONATE 100 mg/ml ampoule (INJ) E 3 g

CALCIUM LACTATE 250-300 mg tab-cap (PO) P 2 g
POTASSIUM CHLORIDE 600 mg tab-cap (PO) P 3 g
POTASSIUM CHLORIDE (sustained-release) 600 mg tab-cap (PO) P 3 g
VITAMIN A (Retinol (10,000 IU)) 3 mg tab-cap (PO) E 50 tu
VITAMIN A (Retinol (25,000 IU)) 7.5 mg tab-cap (PO) P 50 tu

WHO DEFINED

VITAMIN B COMPLEX ampoule (INJ) N
VITAMIN B COMPLEX syrup (PO) N
VITAMIN B COMPLEX tab-cap (PO) N
VITAMIN B1 (thiamine HCl) 100 mg tab-cap (PO) P 50 mg
VITAMIN B1 (thiamine HCl) 100 mg/ml ampoule (INJ) P 50 mg
VITAMIN B1 (thiamine HCl) 50 mg tab-cap (PO) E 50 mg
VITAMIN B12 (cyanocobalamin) 1 mg/ml ampoule (INJ) N 0.02 mg
VITAMIN B6 (pyridoxine) 25 mg tab-cap (PO) E 0.16 g
VITAMIN B6 (pyridoxine) 50 mg tab-cap (PO) P 0.16 g
VITAMIN B6 (pyridoxine) 50 mg/ml ampoule (INJ) P 0.16 g
VITAMIN C (ascorbic acid) 100 mg tab-cap (PO) P 0.2 g
VITAMIN D (alfacalcidol) 0.25 mcg tab-cap (PO) T 1 mcg
VITAMIN D3 (chloecalciferol) 10,000 IU/ml drops (PO) N
VITAMIN, MULTI syrup (PO) N
VITAMIN, MULTI tab-cap (PO) N
VITAMIN, MULTI (pediatric) drops (PO) N
VITAMIN, MULTI + IRON tab-cap (PO) N
VITAMIN, MULTI + MINERALS tab-cap (PO) N
28. EAR, NOSE AND THROAT MEDICINES IN CHILDREN

XYLOMETAZOLINE 0.05% nasal (N/T) E 0.8 mg

WHO DEFINED
29.2. MEDICINES ADMINISTERED TO THE MOTHER
BETAMETHASONE 4 mg/ml ampoule (INJ) N 1.5 mg

30.1. MEDICINES USED TO TREAT GOUT
ALLOPURINOL 100 mg tab-cap (PO) E 0.4 g

ALLOPURINOL 300 mg tab-cap (PO) C 0.4 g
COLCHICINE 0.5-0.6 mg tab-cap (PO) N 1 mg
30.2. DISEASE-MODIFYING AGENTS USED IN RHEUMATOID DISORDERS (DMARDS)
AZATHIOPRINE 50 mg tab-cap (PO) C 0.15 g

HYDROXYCHLOROQUINE SULFATE 200 mg tab-cap (PO) N 0.516 g
METHOTREXATE SODIUM 2.5 mg tab-cap (PO) C 2.5 mg
PENICILLAMINE 250 mg tab-cap (PO) C 0.5 g
SULFASALAZINE 500 mg tab-cap (PO) C 2 g
30.3. JUVENILE JOINT DISEASES

UA ITEMS UNCLASSIFIED ON WHO ESSENTIAL MEDICINES LIST
BALANCED SALT SOLUTION solution (OPHT) N

BALANCED SALT SOLUTION solution (TOP) N
CETIRIZINE 10 mg tab-cap (PO) N 10 mg
CETIRIZINE 5 mg/5 ml syrup (PO) N 10 mg

WHO DEFINED

CHLORAMPHENICOL 10 mcg disc (DIAG) N
DETERMINE CHASE BUFFER vial (N/A) N
DICLOFENAC 1% ointment (TOP) N
ERYTHROMYCIN 15 mcg disc (DIAG) N
FORMALDEHYDE 40% liquid (N/A) N
GENTAMICIN 10 mcg disc (DIAG) N
HYOSCINE BUTYLBROMIDE 10 mg tab-cap (PO) N 60 mg
HYOSCINE BUTYLBROMIDE 10 mg/ml ampoule (INJ) N 60 mg
HYOSCINE BUTYLBROMIDE 20 mg tab-cap (PO) N 60 mg
HYPROMELLOSE 0.3% opht drop (OPHT) N
LANCET, BLOOD (sterile, disposible) each (DIAG) N
LUBRICATING JELLY ointment (TOP) N
MOSQUITO NET, 1-PERSON, LLIN (70 x 180 x 150 cm) net (N/A) N
MOSQUITO NET, 2-PERSON, IMPREGNATED (130 x 180 x 150 cm) net (N/A) N
MOSQUITO NET, 2-PERSON, LLIN (130 x 180 x 150 cm) net (N/A) N
MOSQUITO NET, FAMILY, IMPREGNATED (190 x 180 x 150 cm) net (N/A) N
MOSQUITO NET, FAMILY, LLIN (190 x 180 x 150 cm) net (N/A) N
MOSQUITO NET, FAMILY, NON-IMPREG. (190 x 180 x 150 cm) net (N/A) N
MOSQUITO NET, IMPREGNATED (100 x 180 x 150 cm) net (N/A) N
MOSQUITO NET, IMPREGNATED (160 x 180 x 150 cm) net (N/A) N
MOSQUITO NET, LLIN (160 x 180 x 150 cm) net (N/A) N
OXACILLIN 1 mcg disc (N/A) N
OXYBUTYNIN 5 mg tab-cap (PO) N 15 mg
PARAFFIN, LIQUID (mineral oil) liquid (TOP) N
PARAFFIN, WHITE SOFT ointment (TOP) N

WHO DEFINED
PERMETHRIN (for mosquito net treatment) 10% solution (N/A) N

PREDNISONE 20 mg tab-cap (PO) N 10 mg
SODIUM DICHLOROISOCYANURATE (NaDCC) 1.67 g tab-cap (N/A) N
SODIUM DICHLOROISOCYANURATE (NaDCC) 8.5 mg tab-cap (N/A) N
TEST, BLOODGROUP ANTI-A, MONOCLONAL test (DIAG) N
TEST, BLOODGROUP ANTI-A/B, MONOCLONAL test (DIAG) N
TEST, BLOODGROUP, ANTI-B, MONOCLONAL test (DIAG) N
TEST, BLOODGROUP, ANTI-D, MONOCLONAL test (DIAG) N
TEST, BRUCELLA MELITENSIS ANTIGEN (rapid) test (DIAG) N
Buyer Number of Prices=1 Price=0.1897/test
TEST, GLUCOSE IN URINE test (DIAG) N
Supplier Number of Prices=2 High/Low Ratio=1.88 Median Price=0.0626/strip
Buyer Number of Prices=1 Price=0.0702/strip
TEST, GLUCOSE METER (On Call Plus) each (DIAG) N
TEST, GLUCOSE METER (SD Check Gold) each (DIAG) N
TEST, GLUCOSE METER STRIPS (for On Call Plus) test (DIAG) N
TEST, GLUCOSE METER STRIPS (for SD Check Gold) each (DIAG) N
TEST, HEPATITIS B HBSAG ELISA (version 3) test (DIAG) N
Supplier Number of Prices=1 Price=1.9970/test
TEST, HEPATITIS B, HBSAG, DETERMINE test (DIAG) N
TEST, HEPATITIS BSAG test (DIAG) N
Supplier Number of Prices=4 High/Low Ratio=5.99 Median Price=0.6720/test
TEST, HEPATITIS C ELISA test (DIAG) N
TEST, HEPATITIS C, HCVSCAN (TM) (Rapid test) test (DIAG) N
TEST, HIV 1+2 INSTANTCHEK (TM) test (DIAG) N
TEST, HIV 1+2 SD BIOLINE 3.0 (TM) test (DIAG) N
TEST, HIV 1+2 STAT PAK (TM) test (DIAG) N
TEST, HIV 1+2+O AG/AB MUREX (TM) test (DIAG) N
TEST, HIV 1+2, INTEC test (DIAG) N
TEST, HIV, CAPILLUS HIV-1/2 (TM) test (DIAG) N

WHO DEFINED
TEST, HIV, DETERMINE HIV-1/2 (TM) test (DIAG) N

Buyer Number of Prices=2 High/Low Ratio=1.18 Median Price=1.0699/test
TEST, HIV, UNIGOLD I/II (TM) test (DIAG) N
TEST, MALARIA P. FALCIPARUM (Paracheck) test (DIAG) N
TEST, MALARIA, P. FALCIPARUM (First Response Ag rapid test) test (DIAG) N
TEST, MALARIA, P. FALCIPARUM (Visitect) test (DIAG) N
TEST, MALARIA, P. FALCIPARUM+P. PAN (First Response Ag rapid test) test (DIAG) N
TEST, MALARIA, P. FALCIPARUM/P. OVALE test (DIAG) N
TEST, MALARIA, P.FALCIPARUM, P.VIVAX test (DIAG) N
TEST, MALARIA, SD-BIOLINE test (DIAG) N
TEST, PREGNANCY (urine) test (DIAG) N
Buyer Number of Prices=3 High/Low Ratio=1.90 Median Price=0.0690/test
TEST, SYPHILIS (RPR Fortress) test (DIAG) N
TEST, SYPHILIS (VDRL Carbon Antigen Fortress) bott (DIAG) N
TEST, SYPHILIS DETERMINE (TM) test (DIAG) N
TEST, SYPHILIS RPR (TM) test (DIAG) N
TEST, SYPHILIS SD BIOLINE 3.0 (TM) (rapid test) test (DIAG) N
TEST, URINE GLUCOSE/PROTEIN STRIP test (DIAG) N
UROGRAPHIN 76% solution (INJ) N
VDRL CARBON ANTIGEN (vd24) solution (N/A) N
ZINC OXIDE 10% ointment (TOP) N
ZOLEDRONIC ACID 4 mg/5 ml vial (INJ) N

List III: Price Comparison Forms
Lista III: Formularios para la

Comparación de Precios
Liste III : Formulaires pour la

Comparaison des Prix
List III: Price Comparison Form (Supplier Prices Only)
COUNTRY:______________ PHARMACEUTICAL SUPPLY UNIT:_________________________ PRICE PAID FOR PERIOD:_________ TO _________

CURRENCY USED:________ EXCHANGE RATE WITH US$:_______
WHO PACK PACK UNIT MEDIAN INT. SUPPLIER
ITEM DESCRIPTION EML SIZE PRICE PRICE UNIT PRICE (US$)
Abacavir (Abc) 20 mg/ml Solution E __________ ___________ _________/ml 0.0406/ml
Abacavir (Abc) 300 mg Tab-Cap E __________ ___________ _________/tab-cap 0.2199/tab-cap
Abacavir+lamivudine (Abc/3tc) 600 mg+300mg Tab-Cap P __________ ___________ _________/tab-cap 0.5157/tab-cap
Abacavir+lamivudine 60mg+30mg Tab-Cap P __________ ___________ _________/tab-cap 0.0700/tab-cap
Acetazolamide 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0287/tab-cap
Acetylsalicylic Acid 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0020/tab-cap
Acetylsalicylic Acid 75 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0140/tab-cap
Aciclovir 5% Cream N __________ ___________ _________/g 0.3942/g
Aciclovir 3% Opht Oint N __________ ___________ _________/g 3.2758/g
Aciclovir (Dispersible) 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0475/tab-cap
Aciclovir 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0457/tab-cap
Aciclovir 400 mg Tab-Cap P __________ ___________ _________/tab-cap 0.1040/tab-cap
Albendazole 100 mg/5 ml Suspen P __________ ___________ _________/ml 0.0106/ml
Albendazole (Chewable) 200 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0182/tab-cap
Albendazole 200 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0169/tab-cap
Albendazole (Chewable) 400 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0248/tab-cap
Alcohol (Ethanol) 95-96% Liquid N __________ ___________ _________/ml 0.0231/ml
WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on the list
SP-1 International Drug Price Indicator Guide, 2014


Alcohol, Denatured 70% Liquid N __________ ___________ _________/ml 0.0050/ml
Alcohol, Denatured 95-96% Liquid N __________ ___________ _________/ml 0.0050/ml
Allopurinol 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0581/tab-cap
Aluminium Hydr.+ Magnesium Hydr. 250+120 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0056/tab-cap
Aluminium Hydroxide (Chewable) 500 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0061/tab-cap
Aluminium Hydroxide 500 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0058/tab-cap
Amidotrizoate 76% Ampoule P __________ ___________ _________/ml 0.2744/ml
Amikacin Sulfate 250 mg/ml Vial P __________ ___________ _________/ml 0.7578/ml
Aminophylline 25 mg/ml Ampoule N __________ ___________ _________/ml 0.0268/ml
Aminophylline 100 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0062/tab-cap
Amitriptyline 25 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0072/tab-cap
Amlodipine 10 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0765/tab-cap
Amlodipine 5 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0252/tab-cap
Amodiaquine 150-200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0140/tab-cap
Amoxicillin 125 mg/5 ml Suspen E __________ ___________ _________/ml 0.0054/ml
Amoxicillin 250 mg/5 ml Suspen P __________ ___________ _________/ml 0.0068/ml
Amoxicillin (Dispersible) 125 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0167/tab-cap
Amoxicillin 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0184/tab-cap
Amoxicillin+clavulanic Acid (125+31.25 Mg/5ml) Suspen P __________ ___________ _________/ml 0.0323/ml


Amoxicillin+clavulanic Acid 250mg+125mg Tab-Cap P __________ ___________ _________/tab-cap 0.1350/tab-cap
Amoxicillin+clavulanic Acid 500mg+125mg Tab-Cap E __________ ___________ _________/tab-cap 0.2000/tab-cap
Amoxicillin+clavulanic Acid 1000+200 mg Vial P __________ ___________ _________/vial 3.3265/vial
Amphotericin B 50 mg Vial E __________ ___________ _________/vial 7.0000/vial
Ampicillin 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0407/tab-cap
Ampicillin 1 g Vial E __________ ___________ _________/vial 0.1700/vial
Ampicillin 250 mg Vial P __________ ___________ _________/vial 0.1232/vial
Ampicillin 500 mg Vial E __________ ___________ _________/vial 0.1264/vial
Antihaemorrhoidal Ointment E __________ ___________ _________/g 0.0658/g
Antihaemorrhoidal Suppos E __________ ___________ _________/supp 0.1469/supp
Antivenom Serum Vial E __________ ___________ _________/vial 51.6320/vial
Artemether 20 mg/ml Ampoule P __________ ___________ _________/ml 0.6600/ml
Artemether 80 mg/ml Ampoule C __________ ___________ _________/ml 1.0900/ml
Artemether+lumefantrine 15+90mg/5ml Suspen P __________ ___________ _________/ml 0.0708/ml
Artemether+lumefantrine 20 mg+120 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1703/tab-cap
Artemether+lumefantrine (6 + 1 Tablets Co-Pack) 20 mg+120 mg E __________ ___________ _________/pack 0.6152/pack

Tab-Cap

Tab-Cap

Tab-Cap

Tab-Cap


Artemether+lumefantrine (Dispersible) 20 mg+120 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0942/tab-cap
Artesunate 60 mg Vial E __________ ___________ _________/vial 2.3022/vial
Artesunate+amodiaquine (3 Fixed Dose Combo Tabs) 100mg+270mg P __________ ___________ _________/treatmen 0.9280/treatmen
Tab-Cap
Artesunate+amodiaquine (6 Fixed-Dose Combo Tabs) 100mg+270mg P __________ ___________ _________/treatmen 1.5000/treatmen

Tab-Cap
Artesunate+amodiaquine (3 Fixed Dose Combo Tabs) 25mg+67.5mg P __________ ___________ _________/treatmen 0.3906/treatmen
Tab-Cap
Artesunate+amodiaquine (3 Fixed Dose Combo Tabs) 50 mg+135 mg P __________ ___________ _________/treatmen 0.6363/treatmen
Tab-Cap
Artesunate+amodiaquine (12 + 12 Tablets Co-Pack) 50 mg+153 mg E __________ ___________ _________/pack 1.0380/pack

Tab-Cap
Artesunate+amodiaquine (Fdc) 50 mg+153 mg Tab-Cap P __________ ___________ _________/tab-cap 0.2434/tab-cap

Tab-Cap

Tab-Cap
Artesunate+sulfadoxine/pyrimethamine (6 Tab Artes.+3 Tab Sp Co- E __________ ___________ _________/pack 1.9284/pack

Pack) 100+500/25mg Tab-Cap
Atazanavir+ritonavir 300+100 mg Tab-Cap N __________ ___________ _________/tab-cap 0.7105/tab-cap
Atenolol 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0243/tab-cap
Atorvastatin 10 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0762/tab-cap
Atorvastatin 20 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0552/tab-cap
Atovaquone+proguanil 250mg+100mg Tab-Cap N __________ ___________ _________/tab-cap 3.1742/tab-cap
Atropine Sulfate 1 mg/ml Ampoule E __________ ___________ _________/ml 0.1435/ml
Atropine Sulfate 1% Opht Drop E __________ ___________ _________/ml 0.3173/ml
Azathioprine 50 mg Tab-Cap C __________ ___________ _________/tab-cap 0.1910/tab-cap
Azithromycin 200 mg/5 ml Suspen E __________ ___________ _________/ml 0.0580/ml


Azithromycin 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1619/tab-cap
Barium Sulfate Powder P __________ ___________ _________/kg 37.8000/kg
Beclometasone 100 mcg/dose Inhaler P __________ ___________ _________/dose 0.0453/dose
Beclometasone 50 mcg/dose Inhaler E __________ ___________ _________/dose 0.0152/dose
Bendroflumethiazide 5 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0057/tab-cap
Benzoic & Salicylic Acid (Whitfield's) 6% + 3% Ointment N __________ ___________ _________/g 0.0114/g
Benzyl Benzoate 25% Lotion E __________ ___________ _________/ml 0.0044/ml
Benzyl Benzoate (Concentrated) 90% Solution P __________ ___________ _________/ml 0.0108/ml
Betamethasone Valerate 0.1% Cream E __________ ___________ _________/g 0.0396/g
Betamethasone Valerate 0.1% Ointment E __________ ___________ _________/g 0.0175/g
Biperiden 2 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0512/tab-cap
Bisacodyl 10 mg Suppos N __________ ___________ _________/supp 0.1667/supp
Bisacodyl 5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0114/tab-cap
Bleomycin 15 iu Vial C __________ ___________ _________/vial 28.5078/vial
Bromocriptine Mesilate 2.5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1717/tab-cap
Budesonide 200 mcg/dose Inhaler E __________ ___________ _________/dose 0.0333/dose
Bupivacaine Hcl 0.5% Ampoule E __________ ___________ _________/ml 0.0868/ml
Bupivacaine Hcl + Dextrose 0.5% + 8% Ampoule E __________ ___________ _________/ml 0.2494/ml
Calamine Lotion E __________ ___________ _________/ml 0.0063/ml
Calcium Gluconate 100 mg/ml Ampoule E __________ ___________ _________/ml 0.0227/ml


Calcium Lactate 250-300 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0150/tab-cap
Camphor 10% Ointment N __________ ___________ _________/g 0.0216/g
Capreomycin 0.5 g Vial C __________ ___________ _________/vial 2.9900/vial
Capreomycin 0.75 g Vial C __________ ___________ _________/vial 3.9900/vial
Capreomycin 1 g Vial C __________ ___________ _________/vial 6.2500/vial
Captopril 25 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0139/tab-cap
Carbamazepine 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0194/tab-cap
Carbimazole 5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0246/tab-cap
Carvedilol 6.25 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0336/tab-cap
Cefalexin 125 mg/5 ml Suspen E __________ ___________ _________/ml 0.0180/ml
Cefalexin 125 mg/ml Suspen P __________ ___________ _________/ml 0.0060/ml
Cefalexin 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0617/tab-cap
Cefalexin 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0801/tab-cap
Cefixime 100 mg/5 ml Suspen P __________ ___________ _________/ml 0.0467/ml
Cefixime 200 mg Tab-Cap P __________ ___________ _________/tab-cap 0.1829/tab-cap
Cefixime 400 mg Tab-Cap E __________ ___________ _________/tab-cap 0.2750/tab-cap
Cefotaxime 1 g Vial C __________ ___________ _________/vial 2.5548/vial
Ceftazidime 1 g Vial P __________ ___________ _________/vial 1.7472/vial
Ceftazidime 250 mg Vial C __________ ___________ _________/vial 1.6128/vial
Ceftriaxone 1 g Vial E __________ ___________ _________/vial 0.7470/vial


Ceftriaxone 250 mg Vial E __________ ___________ _________/vial 0.5152/vial
Ceftriaxone 500 mg Vial P __________ ___________ _________/vial 0.7660/vial
Cefuroxime 125 mg/5 ml Suspen N __________ ___________ _________/ml 0.0573/ml
Cefuroxime 250 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1333/tab-cap
Cefuroxime 750 mg Vial N __________ ___________ _________/vial 1.6698/vial
Cetirizine 5 mg/5 ml Syrup N __________ ___________ _________/ml 0.0063/ml
Cetirizine 10 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0126/tab-cap
Cetrimide+chlorhexidine Gluconate 15%+1.5% Solution P __________ ___________ _________/ml 0.0046/ml
Charcoal, Activated 125 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0161/tab-cap
Chloramine 500 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0155/tab-cap
Chloramphenicol 10 mcg Disc N __________ ___________ _________/each 0.0888/each
Chloramphenicol 0.5% Opht Drop P __________ ___________ _________/ml 0.0697/ml
Chloramphenicol 1% Opht Oint P __________ ___________ _________/g 0.0495/g
Chloramphenicol 5% Otic Drop P __________ ___________ _________/ml 0.0224/ml
Chloramphenicol 125 mg/5 ml Suspen P __________ ___________ _________/ml 0.0097/ml
Chloramphenicol 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0255/tab-cap
Chloramphenicol (Base) 1 g Vial E __________ ___________ _________/vial 0.5008/vial
Chloramphenicol In Oil 250 mg/ml Ampoule E __________ ___________ _________/ml 0.3301/ml
Chloramphenicol+dexamethasone 0.5%+0.1% Opht Drop N __________ ___________ _________/ml 0.1164/ml
Chlorhexidine 1% Cream P __________ ___________ _________/g 0.0336/g


Chlorhexidine Gluconate 20% Solution P __________ ___________ _________/ml 0.0106/ml
Chlorhexidine Gluconate 5% Solution E __________ ___________ _________/ml 0.0042/ml
Chlorhexidine Surgical Scrub 4% Liquid P __________ ___________ _________/ml 0.0051/ml
Chloroquine (base) 50 mg/5 ml Syrup E __________ ___________ _________/ml 0.0146/ml
Chloroquine (base) 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0084/tab-cap
Chloroxylenol 4.8% Solution E __________ ___________ _________/ml 0.0036/ml
Chlorphenamine Maleate 10 mg/ml Ampoule E __________ ___________ _________/ml 0.1477/ml
Chlorphenamine Maleate 2 mg/5 ml Elixir P __________ ___________ _________/ml 0.0005/ml
Chlorphenamine Maleate 4 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0016/tab-cap
Chlorpromazine Hcl 25 mg/ml Ampoule C __________ ___________ _________/ml 0.1263/ml
Chlorpromazine Hcl 100 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0163/tab-cap
Chlorpropamide 250 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0263/tab-cap
Cimetidine 200 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0113/tab-cap
Cimetidine 100 mg/ml Vial T __________ ___________ _________/ml 0.2050/ml
Ciprofloxacin 3 mg/ml Opht Drop P __________ ___________ _________/ml 0.0917/ml
Ciprofloxacin 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0213/tab-cap
Ciprofloxacin 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0430/tab-cap


Ciprofloxacin 2 mg/ml Vial P __________ ___________ _________/ml 0.0100/ml
Cisplatin 1 mg/ml Vial C __________ ___________ _________/ml 0.2778/ml
Clarithromycin 125 mg/5 ml Suspen N __________ ___________ _________/ml 0.0528/ml
Clarithromycin 250 mg Tab-Cap N __________ ___________ _________/tab-cap 0.2864/tab-cap
Clindamycin 300 mg Tab-Cap P __________ ___________ _________/tab-cap 0.1000/tab-cap
Clindamycin (base) 150 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0833/tab-cap
Clofazimine (Lamprene) 100 mg Tab-Cap E __________ ___________ _________/tab-cap 1.2672/tab-cap
Clofazimine (Lamprene) 50 mg Tab-Cap E __________ ___________ _________/tab-cap 0.6670/tab-cap
Clomifene 50 mg Tab-Cap C __________ ___________ _________/tab-cap 0.3080/tab-cap
Clomipramine 25 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0283/tab-cap
Clotrimazole 1% Cream E __________ ___________ _________/g 0.0147/g
Clotrimazole 100 mg Pessary E __________ ___________ _________/pessary 0.1462/pessary
Cloxacillin Sodium 125 mg/5 ml Suspen T __________ ___________ _________/ml 0.0085/ml
Cloxacillin Sodium 250 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0220/tab-cap
Cloxacillin Sodium 500 mg Vial T __________ ___________ _________/vial 0.2339/vial
Codeine (Ic) 30 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0712/tab-cap
Condom, Female Condom P __________ ___________ _________/condom 0.7421/condom
Condoms (lubricated) Condom E __________ ___________ _________/condom 0.0341/condom


Cough Preparation Syrup N __________ ___________ _________/ml 0.0063/ml
Cromoglicic Acid (Sodium Cromoglicate) 2% Opht Drop N __________ ___________ _________/ml 0.1690/ml
Cyclopentolate 1% Opht Drop N __________ ___________ _________/ml 2.8772/ml
Cyclophosphamide 1 g Vial P __________ ___________ _________/vial 2.3100/vial
Cyclophosphamide 200 mg Vial P __________ ___________ _________/vial 2.3100/vial
Cyclophosphamide 500 mg Vial C __________ ___________ _________/vial 11.3691/vial
Cycloserine 250 mg Tab-Cap C __________ ___________ _________/tab-cap 0.3800/tab-cap
Dapsone 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0142/tab-cap
Darunavir 300 mg Tab-Cap E __________ ___________ _________/tab-cap 0.5633/tab-cap
Determine Chase Buffer Vial N __________ ___________ _________/ml 4.0839/ml
Dexamethasone 4 mg/ml Ampoule E __________ ___________ _________/ml 0.1661/ml
Dexamethasone 5 mg/ml Ampoule P __________ ___________ _________/ml 0.1077/ml
Dexamethasone 0.1% Opht Drop P __________ ___________ _________/ml 0.1138/ml
Dexamethasone 0.5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0080/tab-cap
Dextran 70 6% In Sod. Chloride 0.9% Solution E __________ ___________ _________/ml 0.0101/ml
Dextrose 10% In Water Solution E __________ ___________ _________/ml 0.0013/ml
Dextrose 2.5% In Sod. Chloride 0.45% Solution P __________ ___________ _________/ml 0.0018/ml
Dextrose 4.3-5% In Water Solution E __________ ___________ _________/ml 0.0009/ml
Dextrose 5% In Sodium Chloride 0.9% Solution P __________ ___________ _________/ml 0.0009/ml
Dextrose 50% In Water (Hypertonic) Solution E __________ ___________ _________/ml 0.0180/ml


Diazepam (Ic) 5 mg/ml Ampoule E __________ ___________ _________/ml 0.0666/ml
Diazepam (Ic) 5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0086/tab-cap
Diclofenac 1% Ointment N __________ ___________ _________/g 0.0171/g
Diclofenac 100 mg Suppos N __________ ___________ _________/supp 0.1152/supp
Diclofenac Sodium 25 mg/ml Ampoule N __________ ___________ _________/ml 0.0353/ml
Diclofenac Sodium 25 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0056/tab-cap
Didanosine (Ddi) 10 mg/ml Powder N __________ ___________ _________/g 6.6098/g
Didanosine (Ddi, Chewable) 100 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1351/tab-cap
Didanosine (Ddi, Delayed-Release) 125 mg Tab-Cap N __________ ___________ _________/tab-cap 0.2975/tab-cap
Didanosine (Chewable, Dispersible) 200 mg Tab-Cap N __________ ___________ _________/tab-cap 0.2392/tab-cap
Didanosine (Ddi) 200 mg Tab-Cap N __________ ___________ _________/tab-cap 0.4463/tab-cap
Diethylcarbamazine Citrate 50 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0057/tab-cap
Digoxin 0.25 mg/ml Ampoule E __________ ___________ _________/ml 0.1044/ml
Digoxin 0.25 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0121/tab-cap


Dihydroartemisinin + Piperaquine 40 + 320 mg Tab-Cap N __________ ___________ _________/tab-cap 0.4009/tab-cap
Dihydrocodeine (Ic) 30 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0812/tab-cap
Dobutamine 12.5 mg/ml Vial N __________ ___________ _________/ml 0.1450/ml
Dopamine Hcl 40 mg/ml Ampoule C __________ ___________ _________/ml 0.0839/ml
Doxorubicin Hcl 10 mg Vial C __________ ___________ _________/vial 13.4755/vial
Doxycycline 100 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0141/tab-cap
Efavirenz (Efv) 30 mg/ml Syrup P __________ ___________ _________/ml 0.0989/ml
Efavirenz (Efv) 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1540/tab-cap
Efavirenz+emtricitabine+tenofovir Df (600+200+300 Mg) Tab-Cap E __________ ___________ _________/tab-cap 0.3791/tab-cap
Efavirenz+lamivudine+tenofovir Disop. (600+300+300 Mg) Tab-Cap P __________ ___________ _________/tab-cap 0.3857/tab-cap
Enalapril 10 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0268/tab-cap
Ephedrine 30 mg/ml Vial P __________ ___________ _________/ml 0.8891/ml
Ephedrine Hcl 30 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0123/tab-cap
Ephedrine Sulfate 50 mg/ml Ampoule P __________ ___________ _________/ml 1.1347/ml
Epinephrine (Adrenaline) 1 mg/ml Ampoule E __________ ___________ _________/ml 0.3339/ml
Ergometrine Maleate 0.2 mg/ml Ampoule E __________ ___________ _________/ml 0.1155/ml


Ergometrine Maleate 0.5 mg/ml Ampoule P __________ ___________ _________/ml 0.2826/ml
Ergometrine Maleate 0.2 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0129/tab-cap
Ergometrine Maleate 0.5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0119/tab-cap
Ergotamine+caffeine 1+100 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1210/tab-cap
Erythromycin 15 mcg Disc N __________ ___________ _________/each 0.0888/each
Erythromycin (Base) 125 mg/5 ml Suspen E __________ ___________ _________/ml 0.0113/ml
Erythromycin (Base) 250 mg/5 ml Suspen P __________ ___________ _________/ml 0.0497/ml
Erythromycin (Base) 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0391/tab-cap
Erythromycin (Base) 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0802/tab-cap
Ethambutol 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0360/tab-cap
Ethambutol+isoniazid 400mg+150 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0288/tab-cap
Ethinylestradiol+desogestrel 0.03+0.15mg Tab-Cap N __________ ___________ _________/cycle 0.7245/cycle
Ethinylestradiol+levonorgestrel 0.03+0.15 mg Tab-Cap E __________ ___________ _________/cycle 0.5138/cycle
Ethionamide 125 mg Tab-Cap C __________ ___________ _________/tab-cap 0.1118/tab-cap
Ethosuximide 250 mg Tab-Cap C __________ ___________ _________/tab-cap 0.1845/tab-cap
Etonogestrel 68 mg/rod Rod N __________ ___________ _________/rod 11.1075/rod
Fentanyl Citrate (Ic) 50 mcg/ml Vial N __________ ___________ _________/ml 0.4828/ml
Ferrous Salt 40 mg/ml Solution P __________ ___________ _________/ml 0.0471/ml
Ferrous Salt 20 mg/ml Suspen P __________ ___________ _________/ml 0.0168/ml


Ferrous Salt (Iron=60-65 Mg) 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0029/tab-cap
Ferrous Salt+folic Acid (Iron=60 Mg) 200 mg+0.4mg Tab-Cap E __________ ___________ _________/tab-cap 0.0031/tab-cap
Ferrous Salt+folic Acid (Iron=60 Mg) 200+0.25 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0027/tab-cap
Flucloxacillin 250 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0616/tab-cap
Fluconazole 50 mg/5 ml Suspen E __________ ___________ _________/ml 0.0182/ml
Fluconazole 100 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0472/tab-cap
Fluconazole 50 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0285/tab-cap
Fluconazole 2 mg/ml Vial E __________ ___________ _________/ml 0.0216/ml
Fluorescein Sodium Opht Strp P __________ ___________ _________/each 0.0854/each
Fluorouracil 25 mg/ml Vial P __________ ___________ _________/ml 1.1392/ml
Fluphenazine Decanoate 25 mg/ml Ampoule E __________ ___________ _________/ml 0.8268/ml
Folic Acid 1 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0029/tab-cap
Formaldehyde 40% Liquid N __________ ___________ _________/ml 0.0073/ml
Furosemide 10 mg/ml Ampoule E __________ ___________ _________/ml 0.0571/ml
Furosemide 40 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0067/tab-cap
Gentamicin 10 mcg Disc N __________ ___________ _________/each 0.0990/each
Gentamicin (Base) 0.3% Opht Drop E __________ ___________ _________/ml 0.1156/ml
Gentamicin Sulfate 10 mg/ml Ampoule E __________ ___________ _________/ml 0.0943/ml


Gentian Violet (Methylrosanilinium Chloride) Powder N __________ ___________ _________/g 0.1236/g
Glibenclamide 5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0068/tab-cap
Gliclazide 80 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0591/tab-cap
Glutaraldehyde 2% Solution E __________ ___________ _________/ml 0.0028/ml
Glycerin 2 g Suppos N __________ ___________ _________/supp 0.2800/supp
Glyceryl Trinitrate (Nitroglycerin) 0.5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0946/tab-cap
Griseofulvin 125 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0205/tab-cap
Griseofulvin 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0612/tab-cap
Haloperidol 5 mg/ml Ampoule E __________ ___________ _________/ml 0.2897/ml
Haloperidol 2 mg/ml Syrup E __________ ___________ _________/ml 0.1243/ml
Haloperidol 1.5-2 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0239/tab-cap
Haloperidol 5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0069/tab-cap
Halothane Liquid E __________ ___________ _________/ml 0.1250/ml
Heparin 1000 iu/ml Ampoule C __________ ___________ _________/ml 0.9768/ml
Hydralazine 20 mg Ampoule N __________ ___________ _________/ampoule 4.6717/ampoule
Hydralazine 25 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0378/tab-cap
Hydrochlorothiazide 25 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0043/tab-cap


Hydrocortisone 1% Cream E __________ ___________ _________/g 0.0399/g
Hydrocortisone 1% Ointment E __________ ___________ _________/g 0.0472/g
Hydrocortisone 1% Opht Drop P __________ ___________ _________/ml 0.0988/ml
Hydrocortisone (Sodium Succinate) 100 mg Vial E __________ ___________ _________/vial 0.5332/vial
Hydrogen Peroxide 3% Solution N __________ ___________ _________/ml 0.0023/ml
Hyoscine Butylbromide 10 mg/ml Ampoule N __________ ___________ _________/ml 0.2719/ml
Hyoscine Butylbromide 20 mg/ml Ampoule E __________ ___________ _________/ml 0.2057/ml
Hyoscine Butylbromide 10 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0317/tab-cap
Ibuprofen 100 mg/5 ml Suspen P __________ ___________ _________/ml 0.0075/ml
Ibuprofen 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0069/tab-cap
Ichthammol 20% Ointment N __________ ___________ _________/g 0.0374/g
Imipenem+cilastatin 500mg+500mg Vial C __________ ___________ _________/vial 10.6400/vial
Indinavir (Idv) 400 mg Tab-Cap N __________ ___________ _________/tab-cap 0.2917/tab-cap
Indometacin 25 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0047/tab-cap
Insulin, Isophane (Nph) 100 iu/ml Vial E __________ ___________ _________/ml 0.8834/ml
Insulin, Neut. Sol/isophane 30/70 (Human, Mixtard) 100 iu/ml P __________ ___________ _________/ml 0.4334/ml
Vial
Insulin, Neutral Soluble (Regular) 100 iu/ml Vial E __________ ___________ _________/ml 0.8834/ml


Insulin, Zinc Susp (Lente) 100 iu/ml Vial E __________ ___________ _________/ml 1.1140/ml
Iron Dextran 50 mg/ml Ampoule N __________ ___________ _________/ml 0.2471/ml
Isoflurane Liquid E __________ ___________ _________/ml 0.1693/ml
Isoniazid (Inh, Dispersible) 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0093/tab-cap
Isoniazid (Inh) 300 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0253/tab-cap
Isosorbide Dinitrate 10 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0724/tab-cap
Isosorbide Dinitrate 5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0340/tab-cap
Itraconazole 100 mg Tab-Cap N __________ ___________ _________/tab-cap 0.2778/tab-cap
Iud (copper) Iud E __________ ___________ _________/iud 1.0891/iud
Kanamycin Sulfate 1 g Vial C __________ ___________ _________/vial 1.0923/vial
Ketamine 50 mg/ml Vial E __________ ___________ _________/ml 0.1171/ml
Ketoconazole 200 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0630/tab-cap
Lamivudine (3tc) 10 mg/ml Solution E __________ ___________ _________/ml 0.0086/ml
Lamivudine (3tc) 150 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0423/tab-cap
Lamivudine+stavudine (3tc+d4t) 150 mg+30 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0730/tab-cap
Lamivudine+stavudine (3tc+d4t) 150 mg+40 mg Tab-Cap P __________ ___________ _________/tab-cap 0.1584/tab-cap
Lamivudine+stavudine (Dispersible, 3tc+d4t) 30 mg+6 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0332/tab-cap
Lamivudine+stavudine (Tablet For Oral Suspension) 60+12 mg Tab- N __________ ___________ _________/tab-cap 0.0577/tab-cap
Cap
Lamivudine+stavudine+nevirapine (3tc+d4t+nvp) 150+30+200mg Tab- E __________ ___________ _________/tab-cap 0.1260/tab-cap

Cap
Lamivudine+stavudine+nevirapine (3tc+d4t+nvp) 150+40+200mg Tab- P __________ ___________ _________/tab-cap 0.2949/tab-cap

Cap
Lamivudine+stavudine+nevirapine (3tc+d4t+nvp) 30+6+50 mg Tab- P __________ ___________ _________/tab-cap 0.0399/tab-cap

Cap


Lamivudine+stavudine+nevirapine (3tc+d4t+nvp) 60+12+100 mg Tab- P __________ ___________ _________/tab-cap 0.0752/tab-cap

Cap
Lamivudine+tenofovir Df (3tc+tdf) 300+300 mg Tab-Cap P __________ ___________ _________/tab-cap 0.1759/tab-cap
Lamivudine+zidovudine (3tc+azt) 150mg+300mg Tab-Cap E __________ ___________ _________/tab-cap 0.1318/tab-cap
Lamivudine+zidovudine (Dispersible) 30 mg+60 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0417/tab-cap
Lamivudine+zidovudine (3tc+azt) 30+60 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0362/tab-cap
Lamivudine+zidovudine+abacavir (150+300+300 Mg) Tab-Cap P __________ ___________ _________/tab-cap 0.4410/tab-cap
Lamivudine+zidovudine+nevirapine (3tc/azt/nvp) 30+60+50 mg Tab- E __________ ___________ _________/tab-cap 0.0643/tab-cap

Cap
Lamivudine+zidovudine+nevirapine (3tc/azt/nvp, Dispersible) E __________ ___________ _________/tab-cap 0.0653/tab-cap

30+60+50 mg Tab-Cap
Lamivudine+zidovudine+nevirapine (150+300+200 Mg) 3tc+azt+nvp E __________ ___________ _________/tab-cap 0.1423/tab-cap

Tab-Cap
Lamivudine/zidovudine + Efavirenz (2 Tab L/z.+ 1 Tab Ef. Co- P __________ ___________ _________/tab-cap 0.1811/tab-cap
Pack) 150/300+600m Tab-Cap
Lamivudine/zidovudine + Nevirapine (1 Tab L/z. + 1 Tab N. Co- E __________ ___________ _________/tab-cap 0.1446/tab-cap
Pack) 150/300+200m Tab-Cap
Lamivudine/zidovudine+abacavir (150/300+300 Mg Co-Pack) Tab-Cap P __________ ___________ _________/tab-cap 0.3894/tab-cap
Lancet, Blood (Sterile, Disposible) Each N __________ ___________ _________/each 0.0171/each
Levamisole 50 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0062/tab-cap
Levodopa+carbidopa 250+25 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1617/tab-cap
Levofloxacin 250 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0841/tab-cap
Levofloxacin 500 mg Tab-Cap C __________ ___________ _________/tab-cap 0.1042/tab-cap
Levofloxacin 5 mg/ml Vial T __________ ___________ _________/ml 0.0167/ml
Levonorgestrel 75 mg/rod Rod E __________ ___________ _________/set 5.5538/set
Levonorgestrel 0.03 mg Tab-Cap E __________ ___________ _________/cycle 0.4409/cycle
Levonorgestrel 0.75 mg Tab-Cap E __________ ___________ _________/tab-cap 0.2341/tab-cap


Levothyroxine 100 mcg Tab-Cap E __________ ___________ _________/tab-cap 0.1783/tab-cap
Lidocaine Hcl 1% Vial E __________ ___________ _________/ml 0.0250/ml
Lidocaine Hcl + Epinephrine Dental 2%+1:80000 Crtdgs E __________ ___________ _________/ml 0.2639/ml
Lidocaine Hcl 5% (in Dextrose 7.5%) Vial E __________ ___________ _________/ml 0.1641/ml
Linezolid 600 mg Tab-Cap C __________ ___________ _________/tab-cap 6.9000/tab-cap
Lisinopril 10 mg Tab-Cap T __________ ___________ _________/tab-cap 0.1340/tab-cap
Lisinopril 5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0900/tab-cap
Loperamide Hcl 2 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0092/tab-cap
Lopinavir+ritonavir (Lpv/r) 80+20 mg/ml Solution E __________ ___________ _________/ml 0.1079/ml
Lopinavir+ritonavir (Lpv/r) 100 mg+25 mg Tab-Cap P __________ ___________ _________/tab-cap 0.1040/tab-cap
Lopinavir+ritonavir (Lpv/r) 133.3+33.3mg Tab-Cap E __________ ___________ _________/tab-cap 0.2398/tab-cap
Loratadine 10 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0492/tab-cap
Losartan 50 mg Tab-Cap N __________ ___________ _________/tab-cap 0.2443/tab-cap
Lubricating Jelly Ointment N __________ ___________ _________/g 0.0305/g
Lynestrenol 0.5 mg Tab-Cap N __________ ___________ _________/cycle 0.4305/cycle
Magnesium Sulfate 50% Vial E __________ ___________ _________/ml 0.1323/ml
Magnesium Trisilicate Compound (Chewable) Tab-Cap T __________ ___________ _________/tab-cap 0.0040/tab-cap
Mannitol 20% Solution C __________ ___________ _________/ml 0.0066/ml


Mebendazole 100 mg/5 ml Suspen P __________ ___________ _________/ml 0.0197/ml
Mebendazole (Chewable) 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0067/tab-cap
Mebendazole 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0079/tab-cap
Mebendazole (Chewable) 500 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0334/tab-cap
Medroxyprogesterone Acetate 150 mg/ml Vial E __________ ___________ _________/ml 0.7472/ml
Mefenamic Acid 250 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0074/tab-cap
Mefloquine 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.8990/tab-cap
Meloxicam 7.5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0146/tab-cap
Meropenem 1 g Vial N __________ ___________ _________/vial 7.3440/vial
Metformin Hcl 500 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0169/tab-cap
Methotrexate Sodium 2.5 mg Tab-Cap C __________ ___________ _________/tab-cap 0.1914/tab-cap
Methotrexate Sodium 25 mg/ml Vial P __________ ___________ _________/ml 3.0350/ml
Methyldopa 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0313/tab-cap
Methylergometrine Maleate 0.2 mg/ml Ampoule T __________ ___________ _________/ml 0.1860/ml
Methylprednisolone Acetate 40 mg Vial N __________ ___________ _________/vial 3.8640/vial
Metoclopramide Hcl 5 mg/ml Ampoule E __________ ___________ _________/ml 0.0762/ml
Metoclopramide Hcl 4 mg/ml Drops P __________ ___________ _________/ml 0.0982/ml
Metoclopramide Hcl 10 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0063/tab-cap
Metronidazole 500 mg Pessary P __________ ___________ _________/pessary 0.0344/pessary


Metronidazole 1 g Suppos E __________ ___________ _________/supp 0.4300/supp
Metronidazole 125 mg/5 ml Syrup P __________ ___________ _________/ml 0.0069/ml
Metronidazole 200 mg/5 ml Syrup E __________ ___________ _________/ml 0.0080/ml
Metronidazole 200-250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0064/tab-cap
Metronidazole 5 mg/ml Vial E __________ ___________ _________/ml 0.0050/ml
Miconazole Nitrate 2% Cream E __________ ___________ _________/g 0.0138/g
Miconazole Nitrate (Buccal Muco-Adhesive) 10 mg Tab-Cap N __________ ___________ _________/tab-cap 0.2491/tab-cap
Misoprostol 100 mcg Tab-Cap P __________ ___________ _________/tab-cap 0.2046/tab-cap
Misoprostol 200 mcg Tab-Cap E __________ ___________ _________/tab-cap 0.3461/tab-cap
Morphine Sulfate (Ic) 10 mg/ml Ampoule E __________ ___________ _________/ml 0.6089/ml
Morphine Sulfate (Ic) 10 mg Tab-Cap E __________ ___________ _________/tab-cap 0.9302/tab-cap
Morphine Sulfate (Ic, Sustained-Release) 30 mg Tab-Cap P __________ ___________ _________/tab-cap 0.5163/tab-cap
Mosquito Net, 1-Person, Llin (70 X 180 X 150 Cm) Net N __________ ___________ _________/each 6.1654/each
Mosquito Net, 2-Person, Impregnated (130 X 180 X 150 Cm) Net N __________ ___________ _________/each 5.3940/each
Mosquito Net, 2-Person, Llin (130 X 180 X 150 Cm) Net N __________ ___________ _________/each 3.4036/each
Mosquito Net, Family, Impregnated (190 X 180 X 150 Cm) Net N __________ ___________ _________/each 5.3430/each
Mosquito Net, Family, Llin (190 X 180 X 150 Cm) Net N __________ ___________ _________/each 6.9000/each
Mosquito Net, Family, Non-Impreg. (190 X 180 X 150 Cm) Net N __________ ___________ _________/each 1.1400/each
Mosquito Net, Impregnated (100 X 180 X 150 Cm) Net N __________ ___________ _________/each 4.4850/each
Mosquito Net, Impregnated (160 X 180 X 150 Cm) Net N __________ ___________ _________/each 5.4600/each


Mosquito Net, Llin (160 X 180 X 150 Cm) Net N __________ ___________ _________/each 5.0879/each
Moxifloxacin 400 mg Tab-Cap N __________ ___________ _________/tab-cap 0.6451/tab-cap
Mupirocin 2% Cream E __________ ___________ _________/g 0.1351/g
Nalidixic Acid 500 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0425/tab-cap
Naloxone Hcl 0.4 mg/ml Ampoule E __________ ___________ _________/ml 1.1307/ml
Naproxen 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0322/tab-cap
Nelfinavir (Nfv) 50 mg/g Powder E __________ ___________ _________/g 0.2956/g
Nelfinavir (Nfv) 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.5196/tab-cap
Neomycin+bacitracin 5mg+500iu/g Ointment N __________ ___________ _________/g 0.0414/g
Neostigmine Methylsulfate 0.5 mg/ml Ampoule E __________ ___________ _________/ml 0.1743/ml
Nevirapine (Nvp) 50 mg/5 ml Suspen E __________ ___________ _________/ml 0.0101/ml
Nevirapine (Nvp) 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1051/tab-cap
Niclosamide (Chewable) 500 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0290/tab-cap
Niclosamide 500 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0607/tab-cap
Nifedipine (Sustained-Release) 10 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0142/tab-cap
Nifedipine 10 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0130/tab-cap
Nitrofurantoin 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0123/tab-cap
Norethisterone 200 mg/ml Ampoule E __________ ___________ _________/ml 1.6542/ml


Norethisterone 5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0738/tab-cap
Norethisterone+estradiol Cypionate (In Oil) 50mg+5mg/ml Vial N __________ ___________ _________/ml 1.9740/ml
Norfloxacin 400 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0261/tab-cap
Noscapine 15 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0294/tab-cap
Nystatin 100,000 iu/g Cream P __________ ___________ _________/g 0.0231/g
Nystatin 100,000 iu/g Ointment P __________ ___________ _________/g 0.0337/g
Nystatin 100,000 iu Pessary E __________ ___________ _________/pessary 0.0405/pessary
Nystatin 100000 iu/ml Suspen P __________ ___________ _________/ml 0.0360/ml
Nystatin 100,000 iu Tab-Cap E __________ ___________ _________/tab-cap 0.0319/tab-cap
Ofloxacin 200 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0580/tab-cap
Ofloxacin 400 mg Tab-Cap C __________ ___________ _________/tab-cap 0.1090/tab-cap
Omeprazole 20 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0180/tab-cap
Ondansetron 2 mg/ml Ampoule E __________ ___________ _________/ml 0.6321/ml
Ondansetron 4 mg Tab-Cap E __________ ___________ _________/tab-cap 0.5311/tab-cap
Oral Rehydration Salts (Ors) 1 pkt/1 l Powder E __________ ___________ _________/packet 0.1068/packet
Oral Rehydration Salts (Ors) 1 pkt/500 ml Powder E __________ ___________ _________/packet 0.0532/packet
Ors+zinc Co-Pack (4 500ml Packets+10 Tabs Zinc) 4 ors+20 mg E __________ ___________ _________/each 0.5040/each
Each
Oxacillin 1 mcg Disc N __________ ___________ _________/each 0.1980/each
Oxytocin 10 iu Ampoule E __________ ___________ _________/ml 0.1750/ml
Oxytocin 5 iu Ampoule P __________ ___________ _________/ml 0.2640/ml


P-Aminosalicylic Acid (pas) 60% w/w Granules P __________ ___________ _________/g 0.1249/g
P-Aminosalicylic Acid (pas) (60% W/w) 9.2 g Granules P __________ ___________ _________/packet 1.1500/packet
P-Aminosalicylic Acid (pas) 4 g Powder C __________ ___________ _________/packet 1.3333/packet
P-Aminosalicylic Acid (pas) (For Oral Solution) 5.52 g Powder P __________ ___________ _________/packet 1.3700/packet
Paclitaxel 6 mg/ml Vial C __________ ___________ _________/ml 164.1376/ml
Pancuronium Bromide 2 mg/ml Ampoule N __________ ___________ _________/ml 0.4657/ml
Paracetamol 100 mg Suppos E __________ ___________ _________/supp 0.0700/supp
Paracetamol 125 mg Suppos P __________ ___________ _________/supp 0.0956/supp
Paracetamol 120 mg/5 ml Suspen P __________ ___________ _________/ml 0.0054/ml
Paracetamol 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0020/tab-cap
Paraffin, Liquid (Mineral Oil) Liquid N __________ ___________ _________/ml 0.0030/ml
Paraffin, White Soft Ointment N __________ ___________ _________/g 0.0075/g
Penicillin, Benzathine Benzyl (720 Mg Of Pen. G) 1.2m iu Powder P __________ ___________ _________/vial 0.1278/vial
Penicillin, Benzathine Benzyl (1.44 G Of Pen. G) 2.4m iu Powder E __________ ___________ _________/vial 0.2635/vial
Penicillin, Benzyl (600 Mg, Pen. G) 1m iu Powder E __________ ___________ _________/vial 0.0757/vial
Penicillin, Benzyl (3 G, Pen. G) 5m iu Powder E __________ ___________ _________/vial 0.2223/vial
Penicillin, Phenoxymethyl (Pen. V) 125 mg/5 ml Suspen P __________ ___________ _________/ml 0.0100/ml
Penicillin, Phenoxymethyl (Pen. V) 250 mg/5 ml Syrup E __________ ___________ _________/ml 0.0149/ml
Penicillin, Phenoxymethyl (Pen. V) 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0172/tab-cap


Penicillin, Procaine Benzyl (600 Mg Of Pen. G) 1m iu Powder E __________ ___________ _________/vial 0.0980/vial
Penicillin, Procaine Benzyl (1.8 G Of Pen. G) 3m iu Powder E __________ ___________ _________/vial 0.2164/vial
Penicillin, Procaine Benzyl (2.4 G Of Pen. G) 4m iu Powder P __________ ___________ _________/vial 0.2606/vial
Penicillin, Procaine+benzyl 3m iu+1m iu Vial P __________ ___________ _________/vial 0.2987/vial
Pentazocine (Ic) 30 mg/ml Ampoule N __________ ___________ _________/ml 0.2032/ml
Permethrin 1% Lotion E __________ ___________ _________/ml 0.0275/ml
Permethrin 2.5% Ointment P __________ ___________ _________/g 0.0416/g
Permethrin (For Mosquito Net Treatment) 10% Solution N __________ ___________ _________/ml 0.1631/ml
Pethidine Hcl (Ic) 50 mg/ml Ampoule E __________ ___________ _________/ml 0.3847/ml
Phenobarbital (Ic) 100 mg/ml Ampoule P __________ ___________ _________/ml 1.1160/ml
Phenobarbital (Ic) 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0094/tab-cap
Phenobarbital (Ic) 50-60 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0087/tab-cap
Phenobarbital (Ic) 200 mg/ml Vial E __________ ___________ _________/ml 5.0012/ml
Phenytoin 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0100/tab-cap
Pilocarpine 2% Opht Drop E __________ ___________ _________/ml 0.3428/ml
Polygeline 3.5% Solution N __________ ___________ _________/ml 0.0097/ml
Potassium Chloride (Sustained-Release) 600 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0500/tab-cap
Potassium Chloride (Kcl, 20 Meq/15 Ml) 10% Vial P __________ ___________ _________/ml 0.0439/ml
Potassium Chloride 15% Vial P __________ ___________ _________/ml 0.1053/ml
Povidone Iodine 10% Ointment T __________ ___________ _________/g 0.0627/g


Povidone Iodine 10% Solution E __________ ___________ _________/ml 0.0087/ml
Praziquantel 600 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1199/tab-cap
Prednisolone 1% Opht Drop P __________ ___________ _________/ml 0.0887/ml
Prednisolone 5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0117/tab-cap
Primaquine (Base) 15 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0220/tab-cap
Proguanil 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0489/tab-cap
Promethazine Hcl 25 mg/ml Ampoule T __________ ___________ _________/ml 0.0949/ml
Promethazine Hcl 5 mg/5 ml Suspen T __________ ___________ _________/ml 0.0054/ml
Promethazine Hcl 25 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0053/tab-cap
Propofol 10 mg/ml Vial E __________ ___________ _________/ml 0.2424/ml
Propranolol Hcl 40 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0075/tab-cap
Protamine Sulfate 10 mg/ml Ampoule C __________ ___________ _________/ml 2.0338/ml
Protionamide 250 mg Tab-Cap C __________ ___________ _________/tab-cap 0.1293/tab-cap
Pyrazinamide 400 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0276/tab-cap
Pyrazinamide 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0336/tab-cap
Pyrazinamide 750 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0461/tab-cap
Quinine Dihydrochloride 125-150mg/ml Ampoule P __________ ___________ _________/ml 0.2430/ml
Quinine Dihydrochloride 250-300mg/ml Ampoule E __________ ___________ _________/ml 0.1419/ml
Quinine Dihydrochloride 100 mg/5 ml Syrup P __________ ___________ _________/ml 0.0446/ml
Quinine Hydrochloride 300 mg/ml Ampoule P __________ ___________ _________/ml 0.1200/ml
Quinine Sulfate 100 mg/5 ml Syrup P __________ ___________ _________/ml 0.0112/ml


Quinine Sulfate 50 mg/5 ml Syrup E __________ ___________ _________/ml 0.0086/ml
Quinine Sulfate 200-250 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0398/tab-cap
Quinine Sulfate 300 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0638/tab-cap
Quinine Sulfate 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0645/tab-cap
Ranitidine 25 mg/ml Ampoule E __________ ___________ _________/ml 0.1376/ml
Ranitidine 150 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0364/tab-cap
Ranitidine 300 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0329/tab-cap
Rifabutin 150 mg Tab-Cap E __________ ___________ _________/tab-cap 1.0000/tab-cap
Rifamp.+isoniazid+pyrazin.+ethambut. (150+75+400+275 Mg) Tab- E __________ ___________ _________/tab-cap 0.0614/tab-cap

Cap
Rifampicin+isoniazid 150+75 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0409/tab-cap
Rifampicin+isoniazid 150mg+150mg Tab-Cap E __________ ___________ _________/tab-cap 0.0343/tab-cap
Rifampicin+isoniazid (Dispersible) 60 mg+30 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0175/tab-cap
Rifampicin+isoniazid+ethambutol 150+75+275mg Tab-Cap P __________ ___________ _________/tab-cap 0.0729/tab-cap
Rifampicin+isoniazid+pyrazinamide (Dispersible) 60+30+150 mg E __________ ___________ _________/tab-cap 0.0255/tab-cap

Tab-Cap
Ritonavir (Rtv) 80 mg/ml Solution E __________ ___________ _________/ml 0.0959/ml
Ritonavir (Rtv) 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1199/tab-cap
Salbutamol 0.5 mg/ml Ampoule E __________ ___________ _________/ml 0.0870/ml
Salbutamol 100 mcg/dose Inhaler E __________ ___________ _________/dose 0.0105/dose
Salbutamol 0.2% Respsol P __________ ___________ _________/ml 0.1456/ml


Salbutamol 0.5% Respsol E __________ ___________ _________/ml 0.1667/ml
Salbutamol 2 mg/5 ml Syrup E __________ ___________ _________/ml 0.0078/ml
Salbutamol 2 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0026/tab-cap
Saquinavir (Sqv) 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.4042/tab-cap
Senna (Sennosides) 7.5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0112/tab-cap
Silver Sulfadiazine 1% Cream E __________ ___________ _________/g 0.0206/g
Simvastatin 20 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0531/tab-cap
Sodium Bicarbonate 8.4% Solution T __________ ___________ _________/ml 0.0440/ml
Sodium Chloride In Water (Normal Saline) 0.9% Solution E __________ ___________ _________/ml 0.0010/ml
Sodium Dichloroisocyanurate (Nadcc) 1.67 g Tab-Cap N __________ ___________ _________/tab-cap 0.0618/tab-cap
Sodium Dichloroisocyanurate (Nadcc) 8.5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0295/tab-cap
Sodium Lactate Compound (Ringer's/hartmann's Sol.) Solution E __________ ___________ _________/ml 0.0011/ml
Sodium Stibogluconate (10% Sb) 33% Vial E __________ ___________ _________/ml 0.3218/ml
Sodium Valproate 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0704/tab-cap
Spectinomycin 2 g Vial E __________ ___________ _________/vial 4.8000/vial
Spironolactone 25 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0432/tab-cap
Stavudine (D4t) 1 mg/ml Solution E __________ ___________ _________/ml 0.0066/ml
Stavudine (D4t) 15 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0231/tab-cap


Streptomycin Sulfate 1 g Vial E __________ ___________ _________/vial 0.5127/vial
Sulfadiazine 500 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0529/tab-cap
Sulfadoxine+pyrimethamine 500 mg+25 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0373/tab-cap
Sulfamethoxazole+trimethoprim (Co-Trimoxazole) 80+16 mg/ml E __________ ___________ _________/ml 0.4723/ml

Ampoule
Sulfamethoxazole+trimethoprim (Co-Trimoxazole) 200+40mg/5ml E __________ ___________ _________/ml 0.0050/ml

Suspen
Sulfamethoxazole+trimethoprim (Dispersible) 100 mg+20 mg Tab- E __________ ___________ _________/tab-cap 0.0085/tab-cap

Cap
Sulfamethoxazole+trimethoprim (Co-Trimoxazole) 100 mg+20 mg E __________ ___________ _________/tab-cap 0.0051/tab-cap

Tab-Cap
Sulfamethoxazole+trimethoprim (Co-Trimoxazole) 200 mg+40 mg P __________ ___________ _________/tab-cap 0.0133/tab-cap

Tab-Cap

Tab-Cap
Sulfamethoxazole+trimethoprim (Co-Trimoxazole) 800 mg+160mg P __________ ___________ _________/tab-cap 0.0250/tab-cap

Tab-Cap
Suxamethonium Cl (Succinylcholine) 50 mg/ml Ampoule E __________ ___________ _________/ml 0.5292/ml
Tamoxifen Citrate 10 mg Tab-Cap C __________ ___________ _________/tab-cap 0.1783/tab-cap
Tenofovir Df+emtricitabine (Tdf+ftc) 300 mg+200mg Tab-Cap E __________ ___________ _________/tab-cap 0.2029/tab-cap
Tenofovir Df+lamivudine 300mg+300mg Tab-Cap P __________ ___________ _________/tab-cap 0.1631/tab-cap
Tenofovir Disoproxil Fumerate (tdf) (Equiv.245mg Tenofovir E __________ ___________ _________/tab-cap 0.1335/tab-cap
Disopro) 300 mg Tab-Cap
Terizidone 250 mg Tab-Cap N __________ ___________ _________/tab-cap 1.6660/tab-cap
Test, Bloodgroup Anti-A, Monoclonal Test N __________ ___________ _________/ml 0.2750/ml
Test, Bloodgroup Anti-A/b, Monoclonal Test N __________ ___________ _________/ml 0.4035/ml
Test, Bloodgroup, Anti-B, Monoclonal Test N __________ ___________ _________/ml 0.2750/ml


Test, Bloodgroup, Anti-D, Monoclonal Test N __________ ___________ _________/ml 0.5210/ml
Test, Glucose In Urine Test N __________ ___________ _________/strip 0.0626/strip
Test, Glucose Meter (Sd Check Gold) Each N __________ ___________ _________/each 53.8583/each
Test, Glucose Meter (On Call Plus) Each N __________ ___________ _________/each 19.3530/each
Test, Glucose Meter Strips (For Sd Check Gold) Each N __________ ___________ _________/each 0.3793/each
Test, Glucose Meter Strips (For On Call Plus) Test N __________ ___________ _________/strip 0.3042/strip
Test, Hepatitis B Hbsag Elisa (Version 3) Test N __________ ___________ _________/test 1.9970/test
Test, Hepatitis B, Hbsag, Determine Test N __________ ___________ _________/test 1.6730/test
Test, Hepatitis Bsag Test N __________ ___________ _________/test 0.6720/test
Test, Hepatitis C Elisa Test N __________ ___________ _________/test 3.3638/test
Test, Hepatitis C, Hcvscan (tm) (Rapid Test) Test N __________ ___________ _________/test 2.8492/test
Test, Hiv 1+2 Instantchek (tm) Test N __________ ___________ _________/test 1.8755/test
Test, Hiv 1+2 Sd Bioline 3.0 (tm) Test N __________ ___________ _________/test 1.6800/test
Test, Hiv 1+2 Stat Pak (tm) Test N __________ ___________ _________/test 2.7854/test
Test, Hiv 1+2+o Ag/ab Murex (tm) Test N __________ ___________ _________/test 2.7061/test
Test, Hiv 1+2, Intec Test N __________ ___________ _________/test 0.5916/test
Test, Hiv, Capillus Hiv-1/2 (tm) Test N __________ ___________ _________/test 2.6441/test
Test, Hiv, Determine Hiv-1/2 (tm) Test N __________ ___________ _________/test 1.2000/test
Test, Hiv, Unigold I/ii (tm) Test N __________ ___________ _________/test 3.1779/test
Test, Malaria P. Falciparum (Paracheck) Test N __________ ___________ _________/test 0.8915/test
Test, Malaria, P. Falciparum (Visitect) Test N __________ ___________ _________/test 1.7126/test


Test, Malaria, P. Falciparum (First Response Ag Rapid Test) N __________ ___________ _________/test 0.6752/test
Test
Test, Malaria, P. Falciparum+p. Pan (First Response Ag Rapid N __________ ___________ _________/test 0.9947/test
Test) Test
Test, Malaria, P. Falciparum/p. Ovale Test N __________ ___________ _________/test 0.6160/test
Test, Malaria, P.falciparum, P.vivax Test N __________ ___________ _________/test 1.0614/test
Test, Malaria, Sd-Bioline Test N __________ ___________ _________/test 1.0036/test
Test, Pregnancy (Urine) Test N __________ ___________ _________/test 0.0900/test
Test, Syphilis (Vdrl Carbon Antigen Fortress) Bott N __________ ___________ _________/ml 1.9032/ml
Test, Syphilis (Rpr Fortress) Test N __________ ___________ _________/test 0.1506/test
Test, Syphilis Determine (tm) Test N __________ ___________ _________/test 1.7500/test
Test, Syphilis Rpr (tm) Test N __________ ___________ _________/test 0.1250/test
Test, Syphilis Sd Bioline 3.0 (tm) (Rapid Test) Test N __________ ___________ _________/test 0.9987/test
Test, Urine Glucose/protein Strip Test N __________ ___________ _________/strip 0.0430/strip
Tetanus Antitoxin 1500 iu Ampoule N __________ ___________ _________/ampoule 1.2500/ampoule
Tetracaine 0.5% Opht Drop E __________ ___________ _________/ml 0.1514/ml
Tetracycline 3% Ointment P __________ ___________ _________/g 0.0457/g
Tetracycline Hcl 1% Ointment P __________ ___________ _________/g 0.0512/g
Tetracycline Hcl 1% Opht Oint E __________ ___________ _________/g 0.0514/g
Tetracycline Hcl 250 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0150/tab-cap
Thiopental Sodium 1 g Vial E __________ ___________ _________/vial 2.3797/vial
Thiopental Sodium 500 mg Vial E __________ ___________ _________/vial 1.8190/vial
Tiabendazole (Chewable) 500 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0617/tab-cap


Tiabendazole 500 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1066/tab-cap
Timolol Maleate 0.25% Opht Drop E __________ ___________ _________/ml 0.1986/ml
Tinidazole 500 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0397/tab-cap
Tramadol Hydrochloride 100 mg/ml Ampoule E __________ ___________ _________/ml 0.0559/ml
Tramadol Hydrochloride 100 mg/ml Solution N __________ ___________ _________/ml 0.2059/ml
Tramadol Hydrochloride 50 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0450/tab-cap
Trifluoperazine 5 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0165/tab-cap
Trihexyphenidyl (Benzhexol) 5 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0316/tab-cap
Tropicamide 0.5% Opht Drop E __________ ___________ _________/ml 0.1356/ml
Tropicamide 1% Opht Drop P __________ ___________ _________/ml 0.6850/ml
Vaccine, Hepatitis B Vial E __________ ___________ _________/vial 7.6024/vial
Vaccine, Meningococcal Vial E __________ ___________ _________/dose 3.2340/dose
Vaccine, Rabies Vial E __________ ___________ _________/vial 10.6380/vial
Vaccine, Rotavirus Vial E __________ ___________ _________/dose 20.6640/dose
Vaccine, Tetanus Toxoid Vial E __________ ___________ _________/dose 0.1764/dose
Vaccine, Typhoid Vial E __________ ___________ _________/dose 4.4352/dose
Vaccine, Yellow Fever Vial E __________ ___________ _________/dose 4.2900/dose
Valproic Acid 150 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0822/tab-cap
Vdrl Carbon Antigen (Vd24) Solution N __________ ___________ _________/ml 2.8050/ml


Vecuronium 4 mg Vial P __________ ___________ _________/vial 2.2283/vial
Verapamil Hcl 40 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0427/tab-cap
Vincristine 1 mg Vial C __________ ___________ _________/vial 13.1252/vial
Vitamin A (Retinol (50,000 Iu)) 15 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0181/tab-cap
Vitamin B Complex Ampoule N __________ ___________ _________/ml 0.1357/ml
Vitamin B Complex Syrup N __________ ___________ _________/ml 0.0056/ml
Vitamin B Complex Tab-Cap N __________ ___________ _________/tab-cap 0.0032/tab-cap
Vitamin B1 (Thiamine Hcl) 50 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0067/tab-cap
Vitamin B12 (Cyanocobalamin) 1 mg/ml Ampoule N __________ ___________ _________/ml 0.3192/ml
Vitamin B6 (Pyridoxine) 50 mg/ml Ampoule P __________ ___________ _________/ml 0.0139/ml
Vitamin B6 (Pyridoxine) 50 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0105/tab-cap
Vitamin C (Ascorbic Acid) 100 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0055/tab-cap
Vitamin K1 (Phytomenadione) 1 mg/ml Ampoule P __________ ___________ _________/ml 0.3738/ml
Vitamin K1 (Phytomenadione) 10 mg/ml Ampoule E __________ ___________ _________/ml 0.2335/ml
Vitamin, Multi Syrup N __________ ___________ _________/ml 0.0081/ml
Vitamin, Multi Tab-Cap N __________ ___________ _________/tab-cap 0.0069/tab-cap
Warfarin Sodium 1 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0420/tab-cap


Water For Injection 10 ml Ampoule E __________ ___________ _________/ampoule 0.0498/ampoule
Water For Injection 100 ml Vial P __________ ___________ _________/vial 0.3696/vial
Xylometazoline 0.05% Nasal E __________ ___________ _________/ml 0.0747/ml
Zidovudine (Azt) 50 mg/5 ml Solution E __________ ___________ _________/ml 0.0100/ml
Zidovudine (Azt) 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0586/tab-cap
Zinc Oxide 10% Ointment N __________ ___________ _________/g 0.0120/g
Zinc Sulfate (Dispersible) 20 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0230/tab-cap
Zinc Sulfate 20 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0273/tab-cap

List III: Price Comparison Form (Buyer Prices Only)
COUNTRY:______________ PHARMACEUTICAL SUPPLY UNIT:_________________________ PRICE PAID FOR PERIOD:_________ TO _________

CURRENCY USED:________ EXCHANGE RATE WITH US$:_______
WHO PACK PACK UNIT MEDIAN INT. BUYER
Abacavir (Abc) 20 mg/ml Solution E __________ ___________ _________/ml 0.0197/ml
Abacavir (Abc) 300 mg Tab-Cap E __________ ___________ _________/tab-cap 0.2342/tab-cap
Abacavir Sulfate 60 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0943/tab-cap
Abacavir+lamivudine (Abc/3tc) 600 mg+300mg Tab-Cap P __________ ___________ _________/tab-cap 0.5074/tab-cap
Abacavir+lamivudine (Dispersible) 60mg+30mg Tab-Cap E __________ ___________ _________/tab-cap 0.0917/tab-cap
Acetazolamide 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0330/tab-cap
Acetylsalicylic Acid 75 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0074/tab-cap
Aciclovir 5% Cream N __________ ___________ _________/g 0.0360/g
Aciclovir 3% Opht Oint N __________ ___________ _________/g 2.7292/g
Aciclovir 200 mg/5 ml Suspen P __________ ___________ _________/ml 0.1664/ml
Aciclovir (Dispersible) 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0352/tab-cap
Aciclovir 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0459/tab-cap
Aciclovir 400 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0392/tab-cap
Aciclovir (Powder) 250 mg Vial E __________ ___________ _________/vial 5.6372/vial
Adenosine 3 mg/ml Ampoule N __________ ___________ _________/ml 2.5816/ml


Albumin, Human Normal 20-25% Vial N __________ ___________ _________/ml 0.5632/ml
Alcohol (Ethanol) 95-96% Liquid N __________ ___________ _________/ml 0.0040/ml
Alcohol, Isopropyl 70% Liquid N __________ ___________ _________/ml 0.0014/ml
Alendronate 10 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0606/tab-cap
Allopurinol 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0273/tab-cap
Allopurinol 300 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0545/tab-cap
Alprazolam 0.25 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0084/tab-cap
Alprazolam 0.5 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0672/tab-cap
Aluminium Hydr.+ Magnesium Hydr. 250+120 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0039/tab-cap
Aluminium Hydroxide 500 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0120/tab-cap
Amikacin Sulfate 50 mg/ml Ampoule P __________ ___________ _________/ml 0.2393/ml
Amikacin Sulfate 250 mg/ml Vial P __________ ___________ _________/ml 0.1908/ml
Aminophylline 25 mg/ml Ampoule N __________ ___________ _________/ml 0.0480/ml
Aminophylline 100 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0058/tab-cap
Amiodarone 200 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0711/tab-cap
Amiodarone 50 mg/ml Vial C __________ ___________ _________/ml 0.4431/ml
Amitriptyline 10 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0226/tab-cap
Amitriptyline 25 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0288/tab-cap
Amitriptyline 50 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0330/tab-cap
Amlodipine 10 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0102/tab-cap


Amlodipine 5 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0094/tab-cap
Amodiaquine 50 mg/5 ml Suspen P __________ ___________ _________/ml 0.0086/ml
Amodiaquine 150-200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0121/tab-cap
Amoxicillin 125 mg/5 ml Suspen E __________ ___________ _________/ml 0.0090/ml
Amoxicillin 250 mg/5 ml Suspen P __________ ___________ _________/ml 0.0063/ml
Amoxicillin+clavulanic Acid 500mg+125mg Tab-Cap E __________ ___________ _________/tab-cap 0.1529/tab-cap
Amoxicillin+clavulanic Acid 1000+200 mg Vial P __________ ___________ _________/vial 1.3700/vial
Amoxicillin+clavulanic Acid 500mg+100mg Vial P __________ ___________ _________/vial 1.5027/vial
Amphotericin B 50 mg Vial E __________ ___________ _________/vial 14.1045/vial
Ampicillin 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0200/tab-cap
Ampicillin 1 g Vial E __________ ___________ _________/vial 0.2720/vial
Ampicillin 250 mg Vial P __________ ___________ _________/vial 0.5294/vial
Ampicillin 500 mg Vial E __________ ___________ _________/vial 0.3313/vial
Ampicillin+sulbactam 1000mg+500mg Vial N __________ ___________ _________/vial 0.6358/vial


Anastrozole 1 mg Tab-Cap C __________ ___________ _________/tab-cap 0.5457/tab-cap
Antihaemorrhoidal Suppos E __________ ___________ _________/supp 0.4700/supp
Antivenom Serum Vial E __________ ___________ _________/vial 20.3700/vial
Artemether+lumefantrine 20 mg+120 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1472/tab-cap
Asparaginase 1,000 iu/ml Ampoule P __________ ___________ _________/ml 4.2000/ml
Asparaginase 10,000 iu/ml Vial C __________ ___________ _________/ml 14.7075/ml
Atazanavir 150 mg Tab-Cap E __________ ___________ _________/tab-cap 0.2622/tab-cap
Atorvastatin 20 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0439/tab-cap
Atracurium 10 mg/ml Ampoule N __________ ___________ _________/ml 0.7120/ml
Atropine Sulfate 0.25 mg/ml Ampoule P __________ ___________ _________/ml 0.0671/ml
Atropine Sulfate 0.5 mg/ml Ampoule P __________ ___________ _________/ml 0.1588/ml
Atropine Sulfate 1 mg/ml Ampoule E __________ ___________ _________/ml 0.1067/ml
Atropine Sulfate 1% Opht Drop E __________ ___________ _________/ml 0.6150/ml
Azathioprine 50 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0848/tab-cap
Azithromycin 200 mg/5 ml Suspen E __________ ___________ _________/ml 0.0177/ml


Balanced Salt Solution Solution N __________ ___________ _________/ml 0.1253/ml
Balanced Salt Solution Solution N __________ ___________ _________/ml 0.0299/ml
Barium Sulfate Powder P __________ ___________ _________/kg 79.3269/kg
Beclometasone 100 mcg/dose Inhaler P __________ ___________ _________/dose 0.0160/dose
Beclometasone 50 mcg Nasal E __________ ___________ _________/dose 0.0127/dose
Bendroflumethiazide 2.5 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0071/tab-cap
Bendroflumethiazide 5 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0114/tab-cap
Benzatropine Mesilate 1 mg/ml Ampoule N __________ ___________ _________/ml 2.6500/ml
Benzatropine Mesilate 2 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0346/tab-cap
Benzoic & Salicylic Acid (Whitfield's) 6% + 3% Ointment N __________ ___________ _________/g 0.0095/g
Benzyl Benzoate 25% Lotion E __________ ___________ _________/ml 0.0031/ml
Betamethasone 4 mg/ml Ampoule N __________ ___________ _________/ml 0.7276/ml
Betamethasone (Opht/otic) 0.1% Opht Drop P __________ ___________ _________/ml 0.1860/ml
Betamethasone Valerate 0.1% Cream E __________ ___________ _________/g 0.0516/g
Betamethasone Valerate 0.1% Ointment E __________ ___________ _________/g 0.0687/g
Bevacizumab 25 mg/ml Vial C __________ ___________ _________/ml 159.6350/ml
Bicalutamide 50 mg Tab-Cap C __________ ___________ _________/tab-cap 0.3981/tab-cap
Biperiden 2 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0101/tab-cap
Bisacodyl 10 mg Suppos N __________ ___________ _________/supp 0.1022/supp


Bisacodyl 5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0193/tab-cap
Bisoprolol 5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0660/tab-cap
Bleomycin 15 iu Vial C __________ ___________ _________/vial 16.7150/vial
Bromocriptine Mesilate 2.5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.2024/tab-cap
Bupivacaine Hcl + Dextrose 0.5% + 8% Ampoule E __________ ___________ _________/ml 0.0800/ml
Bupivacaine Hcl + Epinephrine (0.5% + 1:200,000) Vial N __________ ___________ _________/ml 0.0793/ml
Calamine Lotion E __________ ___________ _________/ml 0.0051/ml
Calcium Folinate 15 mg Tab-Cap C __________ ___________ _________/tab-cap 1.3307/tab-cap
Calcium Folinate 50 mg Vial P __________ ___________ _________/vial 2.3861/vial
Calcium Gluconate 100 mg/ml Ampoule E __________ ___________ _________/ml 0.0431/ml
Calcium Lactate 250-300 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0168/tab-cap
Capecitabine 150 mg Tab-Cap C __________ ___________ _________/tab-cap 0.5194/tab-cap
Capecitabine 500 mg Tab-Cap C __________ ___________ _________/tab-cap 1.4212/tab-cap
Capreomycin 1 g Vial C __________ ___________ _________/vial 8.3870/vial
Captopril 12.5 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0175/tab-cap


Carbamazepine 100 mg/5 ml Suspen E __________ ___________ _________/ml 0.0339/ml
Carbamazepine (Sustained-Release) 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1970/tab-cap
Carbamazepine 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0223/tab-cap
Carbimazole 5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0534/tab-cap
Carboplatin 150 mg Vial C __________ ___________ _________/vial 13.5103/vial
Carboplatin 450 mg Vial C __________ ___________ _________/vial 35.3500/vial
Carvedilol 12.5 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0317/tab-cap
Carvedilol 25 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0448/tab-cap
Carvedilol 6.25 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0300/tab-cap
Cefadroxil 250 mg/5 ml Suspen N __________ ___________ _________/ml 0.0181/ml
Cefadroxil Monohydrate 500 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0696/tab-cap
Cefalexin 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0470/tab-cap
Cefalexin 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0621/tab-cap
Cefazolin 500 mg Ampoule P __________ ___________ _________/vial 0.5412/vial
Cefazolin 1 g Vial E __________ ___________ _________/vial 0.4342/vial
Cefepime 1 g Vial T __________ ___________ _________/vial 1.6796/vial
Cefixime 200 mg Tab-Cap P __________ ___________ _________/tab-cap 0.2106/tab-cap
Cefixime 400 mg Tab-Cap E __________ ___________ _________/tab-cap 1.3371/tab-cap
Cefotaxime 1 g Vial C __________ ___________ _________/vial 0.8323/vial


Cefotaxime 500 mg Vial C __________ ___________ _________/vial 0.6004/vial
Ceftazidime 1 g Vial P __________ ___________ _________/vial 1.1100/vial
Ceftriaxone 1 g Vial E __________ ___________ _________/vial 0.4192/vial
Ceftriaxone 250 mg Vial E __________ ___________ _________/vial 0.5726/vial
Ceftriaxone 500 mg Vial P __________ ___________ _________/vial 0.4610/vial
Cefuroxime 125 mg/5 ml Suspen N __________ ___________ _________/ml 0.0532/ml
Cefuroxime 1.5 g Vial N __________ ___________ _________/vial 2.4997/vial
Cefuroxime 750 mg Vial N __________ ___________ _________/vial 1.5775/vial
Cetirizine 5 mg/5 ml Syrup N __________ ___________ _________/ml 0.0049/ml
Cetirizine 10 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0086/tab-cap
Cetrimide+chlorhexidine Gluconate 15%+1.5% Solution P __________ ___________ _________/ml 0.0038/ml
Chlorambucil 2 mg Tab-Cap C __________ ___________ _________/tab-cap 1.2433/tab-cap
Chloramphenicol 0.5% Opht Drop P __________ ___________ _________/ml 0.0241/ml
Chloramphenicol 1% Opht Oint P __________ ___________ _________/g 0.2956/g
Chloramphenicol 5% Otic Drop P __________ ___________ _________/ml 0.1544/ml
Chloramphenicol 125 mg/5 ml Suspen P __________ ___________ _________/ml 0.0102/ml
Chloramphenicol 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0455/tab-cap
Chloramphenicol 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0455/tab-cap
Chloramphenicol (Base) 1 g Vial E __________ ___________ _________/vial 0.4830/vial


Chloramphenicol+dexamethasone 0.5%+0.1% Opht Drop N __________ ___________ _________/ml 0.2042/ml
Chlorhexidine Gluconate 5% Solution E __________ ___________ _________/ml 0.0041/ml
Chlorhexidine Surgical Scrub 4% Liquid P __________ ___________ _________/ml 0.0059/ml
Chloroquine (base) 50 mg/5 ml Syrup E __________ ___________ _________/ml 0.0240/ml
Chloroxylenol 4.8% Solution E __________ ___________ _________/ml 0.0062/ml
Chlorphenamine Maleate 10 mg/ml Ampoule E __________ ___________ _________/ml 0.1424/ml
Chlorphenamine Maleate 2 mg/5 ml Elixir P __________ ___________ _________/ml 0.0047/ml
Chlorphenamine Maleate 4 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0034/tab-cap
Chlorpromazine Hcl 25 mg/ml Ampoule C __________ ___________ _________/ml 0.1380/ml
Chlorpropamide 250 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0367/tab-cap
Chlorthalidone 50 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0375/tab-cap
Ciclosporin 100 mg/ml Solution C __________ ___________ _________/ml 1.5669/ml
Ciclosporin 100 mg Tab-Cap P __________ ___________ _________/tab-cap 1.4207/tab-cap
Ciclosporin 25 mg Tab-Cap C __________ ___________ _________/tab-cap 0.3555/tab-cap
Ciprofloxacin 3 mg/ml Opht Drop P __________ ___________ _________/ml 0.2437/ml


Ciprofloxacin 250 mg/5 ml Suspen E __________ ___________ _________/ml 0.1410/ml
Ciprofloxacin 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0395/tab-cap
Ciprofloxacin 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0379/tab-cap
Ciprofloxacin 2 mg/ml Vial P __________ ___________ _________/ml 0.0105/ml
Cisatracurium 2 mg/ml Ampoule N __________ ___________ _________/ml 1.4160/ml
Cisplatin 1 mg/ml Vial C __________ ___________ _________/ml 0.3497/ml
Cisplatin 10 mg Vial C __________ ___________ _________/ml 0.1710/ml
Cisplatin 50 mg Vial C __________ ___________ _________/vial 6.7713/vial
Citalopram 20 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1400/tab-cap
Clarithromycin 250 mg/5 ml Suspen N __________ ___________ _________/ml 0.0431/ml
Clindamycin 300 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0700/tab-cap
Clindamycin (base) 150 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0816/tab-cap
Clindamycin (base) 150 mg/ml Vial C __________ ___________ _________/ml 0.0830/ml
Clobetasol Proprionate 0.05% Cream N __________ ___________ _________/g 0.0462/g
Clomifene 50 mg Tab-Cap C __________ ___________ _________/tab-cap 0.2717/tab-cap
Clomipramine 25 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0538/tab-cap
Clonazepam 2.5 mg/ml Drops N __________ ___________ _________/ml 0.4589/ml
Clonazepam 0.5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0326/tab-cap
Clonazepam 2 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0326/tab-cap


Clopidogrel Bisulfate 75 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0775/tab-cap
Cloxacillin Sodium 125 mg/5 ml Suspen T __________ ___________ _________/ml 0.0079/ml
Clozapine 100 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0994/tab-cap
Clozapine 25 mg Tab-Cap C __________ ___________ _________/tab-cap 0.1055/tab-cap
Codeine (Ic) 30 mg Tab-Cap E __________ ___________ _________/tab-cap 0.2889/tab-cap
Colchicine 0.5-0.6 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0360/tab-cap
Cough Preparation Syrup N __________ ___________ _________/ml 0.0059/ml
Cyclopentolate 1% Opht Drop N __________ ___________ _________/ml 0.3337/ml
Cyclophosphamide 50 mg Tab-Cap P __________ ___________ _________/tab-cap 0.3000/tab-cap
Cyclophosphamide 1 g Vial P __________ ___________ _________/vial 10.1261/vial
Cyclophosphamide 500 mg Vial C __________ ___________ _________/vial 6.3952/vial
Cycloserine 250 mg Tab-Cap C __________ ___________ _________/tab-cap 0.4887/tab-cap
Cyproterone Acetate 50 mg Tab-Cap N __________ ___________ _________/tab-cap 0.2271/tab-cap


Cytarabine 100 mg Vial C __________ ___________ _________/vial 4.2004/vial
Cytarabine 500 mg Vial C __________ ___________ _________/vial 5.3864/vial
Dacarbazine 200 mg Vial P __________ ___________ _________/vial 12.8428/vial
Dactinomycin 500 mcg Vial C __________ ___________ _________/vial 24.7330/vial
Danazol 200 mg Tab-Cap N __________ ___________ _________/tab-cap 0.9402/tab-cap
Dapsone 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.2500/tab-cap
Darunavir 300 mg Tab-Cap E __________ ___________ _________/tab-cap 0.5475/tab-cap
Daunorubicin 20 mg Vial C __________ ___________ _________/vial 21.4896/vial
Deferoxamine Mesilate 500 mg Ampoule E __________ ___________ _________/ampoule 6.7579/ampoule
Determine Chase Buffer Vial N __________ ___________ _________/ml 0.0328/ml
Dexamethasone 4 mg/ml Ampoule E __________ ___________ _________/ml 0.1695/ml
Dexamethasone 5 mg/ml Ampoule P __________ ___________ _________/ml 0.0825/ml
Dexamethasone 0.1% Opht Drop P __________ ___________ _________/ml 0.2206/ml
Dexamethasone 0.5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0300/tab-cap
Dextrose 50% In Water (Hypertonic) Solution E __________ ___________ _________/ml 0.0082/ml
Dialysis Sol. Peritoneal W/ Dextrose 1.5% Solution C __________ ___________ _________/ml 0.0036/ml
Diazepam (Ic) 5 mg/ml Ampoule E __________ ___________ _________/ml 0.0876/ml


Diclofenac 1% Ointment N __________ ___________ _________/g 0.0070/g
Diclofenac 12.5 mg Suppos N __________ ___________ _________/supp 0.2300/supp
Diclofenac 1.8 mg/ml Suspen N __________ ___________ _________/ml 0.0063/ml
Diclofenac Sodium 25 mg/ml Ampoule N __________ ___________ _________/ml 0.0345/ml
Diclofenac Sodium 0.1% Opht Drop N __________ ___________ _________/ml 0.1759/ml
Diclofenac Sodium (Sustained-Release) 75 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0153/tab-cap
Dicloxacillin 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0640/tab-cap
Dicloxacillin 500 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0600/tab-cap
Dicloxacillin 500 mg Vial P __________ ___________ _________/vial 1.0700/vial
Didanosine (Dispersible) 400 mg Tab-Cap N __________ ___________ _________/tab-cap 2.2386/tab-cap
Digoxin 0.25 mg/ml Ampoule E __________ ___________ _________/ml 0.3788/ml


Digoxin 0.05 mg/ml Solution E __________ ___________ _________/ml 0.1127/ml
Digoxin 0.125 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0318/tab-cap
Digoxin 0.25 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0482/tab-cap
Diltiazem Hcl 60 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0599/tab-cap
Dimenhydrinate 50 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0100/tab-cap
Dimenhydrinate 50 mg/ml Vial N __________ ___________ _________/ml 0.2130/ml
Diphenhydramine 25 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0100/tab-cap
Dobutamine 12.5 mg/ml Vial N __________ ___________ _________/ml 0.0848/ml
Docetaxel 20 mg Vial C __________ ___________ _________/vial 10.8300/vial
Dopamine Hcl 40 mg/ml Ampoule C __________ ___________ _________/ml 0.0625/ml
Dorzolamide Chlorhydrate 2% Opht Drop N __________ ___________ _________/ml 1.5340/ml
Doxazosin 4 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0913/tab-cap
Doxycycline 100 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0191/tab-cap
Droperidol 2.5 mg/ml Ampoule N __________ ___________ _________/ml 0.5350/ml


Efavirenz+emtricitabine+tenofovir Df (600+200+300 Mg) Tab-Cap E __________ ___________ _________/tab-cap 0.4151/tab-cap
Enoxaparin 100 mg Syringe E __________ ___________ _________/syringe 4.0318/syringe
Ephedrine 0.5% Nasal P __________ ___________ _________/ml 0.0329/ml
Ephedrine 30 mg/ml Vial P __________ ___________ _________/ml 0.9750/ml
Ephedrine Hcl 30 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0066/tab-cap
Ephedrine Sulfate 50 mg/ml Ampoule P __________ ___________ _________/ml 1.9501/ml
Epinephrine (Adrenaline) 1 mg/ml Ampoule E __________ ___________ _________/ml 0.2531/ml
Epirubicin 10 mg Vial N __________ ___________ _________/vial 7.2300/vial
Epirubicin 50 mg Vial N __________ ___________ _________/vial 42.0000/vial
Epoetin Alpha 2000 iu Vial N __________ ___________ _________/vial 1.8440/vial
Epoetin Alpha 4000 iu Vial N __________ ___________ _________/vial 6.5629/vial
Epoetin Beta 50,000 iu Vial N __________ ___________ _________/vial 149.6000/vial
Ergometrine Maleate 0.2 mg/ml Ampoule E __________ ___________ _________/ml 0.2777/ml
Ergometrine Maleate 0.5 mg/ml Ampoule P __________ ___________ _________/ml 0.6345/ml


Ergotamine+caffeine 1+100 mg Tab-Cap N __________ ___________ _________/tab-cap 0.2688/tab-cap
Erythromycin (Base) 125 mg/5 ml Suspen E __________ ___________ _________/ml 0.0092/ml
Erythromycin (Base) 250 mg/5 ml Suspen P __________ ___________ _________/ml 0.0141/ml
Erythromycin (Base) 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0428/tab-cap
Erythromycin (Base) 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0738/tab-cap
Erythromycin Lactobionate 500 mg Vial E __________ ___________ _________/vial 16.8150/vial
Estrogens, Conjugated 0.625 mg Tab-Cap N __________ ___________ _________/tab-cap 0.2281/tab-cap
Ether, Anaesthetic Solution E __________ ___________ _________/ml 0.0094/ml
Ethinylestradiol+levonorgestrel 0.03+0.15 mg Tab-Cap E __________ ___________ _________/cycle 0.2167/cycle
Ethinylestradiol+norgestrel 0.05+0.5 mg Tab-Cap N __________ ___________ _________/cycle 0.2741/cycle
Etomidate 2 mg/ml Ampoule N __________ ___________ _________/ml 0.3655/ml
Etonogestrel 68 mg/rod Rod N __________ ___________ _________/rod 10.0172/rod
Etoposide 20 mg/ml Vial C __________ ___________ _________/ml 0.7800/ml
Etravirine 100 mg Tab-Cap N __________ ___________ _________/tab-cap 0.2981/tab-cap
Factor Viia 100,000 u Vial N __________ ___________ _________/vial 1154.8958/vial
Factor Viii 1000 iu Vial C __________ ___________ _________/vial 238.9703/vial
Famotidine 20 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0062/tab-cap


Famotidine 40 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0217/tab-cap
Fentanyl Citrate (Ic) 50 mcg/ml Vial N __________ ___________ _________/ml 0.3675/ml
Ferrous Salt 20 mg/ml Suspen P __________ ___________ _________/ml 0.0944/ml
Ferrous Salt (Iron=60-65 Mg) 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0109/tab-cap
Ferrous Salt+folic Acid (Iron=60 Mg) 200 mg+0.4mg Tab-Cap E __________ ___________ _________/tab-cap 0.0340/tab-cap
Ferrous Salt+folic Acid (Iron=60 Mg) 200+0.25 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0052/tab-cap
Ferrous Sulfate 125 mg/ml Drops E __________ ___________ _________/ml 0.0167/ml
Filgrastim 480mcg/0.8ml Syringe C __________ ___________ _________/syringe 62.8625/syringe
Filgrastim 300 mcg/ml Vial C __________ ___________ _________/ml 3.9523/ml
Filgrastim 480mcg/1.6ml Vial C __________ ___________ _________/vial 94.6576/vial
Flucloxacillin 250 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0415/tab-cap
Fluconazole 50 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0565/tab-cap
Fluconazole 2 mg/ml Vial E __________ ___________ _________/ml 0.0463/ml
Fludarabine Phosphate 50 mg Vial C __________ ___________ _________/vial 54.2553/vial
Flumazenil 0.1 mg/ml Vial N __________ ___________ _________/ml 1.4565/ml
Fluocinolone 0.025% Cream N __________ ___________ _________/g 0.0813/g
Fluorescein 100 mg/ml Ampoule E __________ ___________ _________/ml 2.4498/ml
Fluorescein Sodium Opht Strp P __________ ___________ _________/each 0.1522/each
Fluorouracil 50 mg/ml Ampoule C __________ ___________ _________/ml 0.2839/ml


Fluoxetine 20 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0168/tab-cap
Fluphenazine Decanoate 25 mg/ml Ampoule E __________ ___________ _________/ml 1.7279/ml
Flutamide 250 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0990/tab-cap
Formaldehyde 40% Liquid N __________ ___________ _________/ml 0.0070/ml
Furosemide 10 mg/ml Ampoule E __________ ___________ _________/ml 0.0742/ml
Furosemide 10 mg/ml Solution P __________ ___________ _________/ml 0.2009/ml
Furosemide 40 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0083/tab-cap
Fusidic Acid 2% Cream N __________ ___________ _________/g 0.1302/g
Gabapentin 100 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1282/tab-cap
Ganciclovir 500 mg Vial N __________ ___________ _________/vial 48.0000/vial
Gemcitabine 1 g Vial C __________ ___________ _________/vial 25.8472/vial
Gemcitabine 200 mg Vial C __________ ___________ _________/vial 16.6145/vial
Gemfibrozil 600 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1000/tab-cap
Gentamicin (Base) 0.3% Opht Drop E __________ ___________ _________/ml 0.1870/ml
Gentian Violet (Methylrosanilinium Chloride) Powder N __________ ___________ _________/g 0.0208/g


Glibenclamide 5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0083/tab-cap
Gliclazide (Slow-Release) 30 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0350/tab-cap
Gliclazide 80 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0455/tab-cap
Glimepiride 2 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0400/tab-cap
Glimepiride 4 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0469/tab-cap
Glucagon 1 mg Vial N __________ ___________ _________/vial 25.7458/vial
Glutaraldehyde 2% Solution E __________ ___________ _________/ml 0.0074/ml
Glyceryl Trinitrate (Nitroglycerin) 5 mg/ml Ampoule P __________ ___________ _________/ml 0.7436/ml
Glyceryl Trinitrate 0.4 mg/dose Nasal Spr E __________ ___________ _________/dose 0.0298/dose
Glyceryl Trinitrate (Nitroglycerin) 0.5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1634/tab-cap
Granisetron 1 mg/ml Ampoule N __________ ___________ _________/ml 6.5000/ml
Granisetron 1 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1582/tab-cap
Griseofulvin 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.1201/tab-cap
Haloperidol 5 mg/ml Ampoule E __________ ___________ _________/ml 0.4723/ml
Haloperidol 2 mg/ml Syrup E __________ ___________ _________/ml 0.0311/ml
Haloperidol 0.5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0894/tab-cap
Haloperidol 1.5-2 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0260/tab-cap


Haloperidol 10 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0155/tab-cap
Haloperidol 5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0200/tab-cap
Halothane Liquid E __________ ___________ _________/ml 0.1855/ml
Human Chorionic Gonadotrophin 5000 iu Ampoule N __________ ___________ _________/ampoule 11.8309/ampoule
Human Menopausal Gonadotrophin 75 iu Vial N __________ ___________ _________/vial 17.5000/vial
Hydralazine 20 mg Ampoule N __________ ___________ _________/ampoule 4.1600/ampoule
Hydrochlorothiazide 12.5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0087/tab-cap
Hydrochlorothiazide+triamterene 25 mg+50 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0210/tab-cap
Hydrocortisone 1% Cream E __________ ___________ _________/g 0.0529/g
Hydrocortisone 1% Ointment E __________ ___________ _________/g 0.1003/g
Hydrocortisone 10 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0903/tab-cap
Hydrocortisone (Sodium Succinate) 100 mg Vial E __________ ___________ _________/vial 0.5517/vial
Hydroxycarbamide (Hydroxyurea) 500 mg Tab-Cap C __________ ___________ _________/tab-cap 0.1180/tab-cap
Hydroxychloroquine 300 mg Tab-Cap N __________ ___________ _________/tab-cap 0.3532/tab-cap


Hydroxychloroquine Sulfate 200 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1240/tab-cap
Hydroxyzine 10 mg/5 ml Syrup N __________ ___________ _________/ml 0.0093/ml
Hydroxyzine 25 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0073/tab-cap
Hyoscine Butylbromide 10 mg/ml Ampoule N __________ ___________ _________/ml 0.1207/ml
Hyoscine Butylbromide 20 mg/ml Ampoule E __________ ___________ _________/ml 0.1835/ml
Hypromellose 0.3% Opht Drop N __________ ___________ _________/ml 0.1170/ml
Ibuprofen 100 mg/5 ml Suspen P __________ ___________ _________/ml 0.0107/ml
Idarubicin 10 mg Vial N __________ ___________ _________/vial 83.0288/vial
Idarubicin 5 mg Vial N __________ ___________ _________/vial 140.0000/vial
Ifosfamide 1 g Vial C __________ ___________ _________/vial 8.5950/vial
Ifosfamide 2 g Vial C __________ ___________ _________/vial 39.0245/vial
Ifosfamide 500 mg Vial C __________ ___________ _________/vial 25.0054/vial
Imatinib 100 mg Tab-Cap C __________ ___________ _________/tab-cap 0.7446/tab-cap
Imatinib 400 mg Tab-Cap C __________ ___________ _________/tab-cap 28.1493/tab-cap
Imipenem+cilastatin 500mg+500mg Vial C __________ ___________ _________/vial 5.1105/vial
Imipramine Hcl 10 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0217/tab-cap
Imipramine Hcl 25 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0309/tab-cap


Immunoglobulin, Anti-Hepatitis B 200 u Ampoule N __________ ___________ _________/ampoule 32.7200/ampoule
Immunoglobulin, Anti-Tetanus (Human) 250 iu Vial P __________ ___________ _________/ml 29.2800/ml
Immunoglobulin, Varicella Zoster (Human) 125 iu/ml Vial N __________ ___________ _________/vial 125.6500/vial
Indometacin 100 mg Suppos N __________ ___________ _________/supp 0.0995/supp
Indometacin 25 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0076/tab-cap
Insulin, Neut. Sol/isophane 30/70 (Human, Mixtard) 100 iu/ml P __________ ___________ _________/ml 0.3603/ml
Vial
Iohexol 350 mg/ml Vial E __________ ___________ _________/ml 0.2198/ml
Ipratropium Bromide 20 mcg/dose Inhaler E __________ ___________ _________/dose 0.0328/dose
Ipratropium Bromide 250 mcg/ml Respsol P __________ ___________ _________/ml 0.4086/ml
Irbesartan 150 mg Tab-Cap N __________ ___________ _________/tab-cap 0.2400/tab-cap
Iron Dextran 50 mg/ml Ampoule N __________ ___________ _________/ml 1.4261/ml
Isoflurane Liquid E __________ ___________ _________/ml 0.2182/ml
Isoniazid (Inh) 50 mg/5 ml Elixir E __________ ___________ _________/ml 0.0319/ml


Isosorbide Mononitrate 20 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1769/tab-cap
Itraconazole 100 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1606/tab-cap
Iud (copper) Iud E __________ ___________ _________/iud 3.0000/iud
Iud (levonorgestrel) 52 mg Iud E __________ ___________ _________/each 122.4600/each
Kanamycin Sulfate 1 g Vial C __________ ___________ _________/vial 1.1851/vial
Ketamine 10 mg/ml Vial P __________ ___________ _________/ml 0.2206/ml
Ketamine 50 mg/ml Vial E __________ ___________ _________/ml 0.1654/ml
Ketoconazole 2% Cream N __________ ___________ _________/g 0.0354/g
Ketoconazole 200 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0421/tab-cap
Labetalol 5 mg/ml Ampoule N __________ ___________ _________/ml 0.1170/ml
Lactulose 3.35 g/5 ml Solution E __________ ___________ _________/ml 0.0118/ml
Lamivudine (3tc) 10 mg/ml Solution E __________ ___________ _________/ml 0.0099/ml
Lamivudine (3tc) 150 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0569/tab-cap
Lamivudine (3tc) 300 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0587/tab-cap
Lamivudine+stavudine+nevirapine (3tc+d4t+nvp) 150+30+200mg Tab- E __________ ___________ _________/tab-cap 0.1533/tab-cap

Cap
Lamivudine+zidovudine (3tc+azt) 150mg+300mg Tab-Cap E __________ ___________ _________/tab-cap 0.1412/tab-cap
Lamivudine+zidovudine (Dispersible) 30 mg+60 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0471/tab-cap
Lamivudine+zidovudine+abacavir (150+300+300 Mg) Tab-Cap P __________ ___________ _________/tab-cap 0.4486/tab-cap
Lamivudine+zidovudine+nevirapine (150+300+200 Mg) 3tc+azt+nvp E __________ ___________ _________/tab-cap 0.3157/tab-cap

Tab-Cap


Lamotrigine 100 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0385/tab-cap
Latanoprost 0.005% Opht Drop E __________ ___________ _________/ml 0.8965/ml
Letrozole 2.5 mg Tab-Cap N __________ ___________ _________/tab-cap 3.5300/tab-cap
Levamisole 40 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0157/tab-cap
Levamisole 50 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0106/tab-cap
Levodopa+carbidopa 100+25 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0780/tab-cap
Levodopa+carbidopa 250+25 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1000/tab-cap
Levofloxacin 250 mg Tab-Cap T __________ ___________ _________/tab-cap 0.2357/tab-cap
Levofloxacin 500 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0867/tab-cap
Levofloxacin 5 mg/ml Vial T __________ ___________ _________/ml 0.0087/ml
Levonorgestrel 75 mg/rod Rod E __________ ___________ _________/set 4.7920/set
Levonorgestrel 0.03 mg Tab-Cap E __________ ___________ _________/cycle 0.8062/cycle
Levothyroxine 200 mcg Tab-Cap P __________ ___________ _________/tab-cap 0.0200/tab-cap
Lidocaine Hcl 2% Gel E __________ ___________ _________/g 0.1639/g


Lidocaine Hcl + Epinephrine Dental 2%+1:80000 Crtdgs E __________ ___________ _________/ml 0.2334/ml
Lidocaine Hcl 5% (in Dextrose 7.5%) Vial E __________ ___________ _________/ml 3.6800/ml
Lidocaine+epinephrine 1%+1:100000 Vial P __________ ___________ _________/ml 0.0973/ml
Lidocaine+epinephrine 2%+1:100000 Vial P __________ ___________ _________/ml 0.0424/ml
Linezolid 2 mg/ml Vial C __________ ___________ _________/ml 0.1035/ml
Lisinopril 5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0600/tab-cap
Lithium Carbonate 300 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0410/tab-cap
Loperamide Hcl 2 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0275/tab-cap
Lopinavir+ritonavir (Lpv/r) 80+20 mg/ml Solution E __________ ___________ _________/ml 0.0846/ml
Loratadine 5 mg/5 ml Syrup N __________ ___________ _________/ml 0.0073/ml
Loratadine 10 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0110/tab-cap
Lorazepam 1 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0815/tab-cap
Lorazepam 2 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0085/tab-cap
Losartan 50 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0202/tab-cap
Lovastatin 20 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0156/tab-cap
Lubricating Jelly Ointment N __________ ___________ _________/g 0.0145/g
Magnesium Sulfate Powder N __________ ___________ _________/g 0.0015/g


Magnesium Trisilicate Compound (Chewable) Tab-Cap T __________ ___________ _________/tab-cap 0.0053/tab-cap
Mannitol 20% Solution C __________ ___________ _________/ml 0.0057/ml
Mebendazole 100 mg/5 ml Suspen P __________ ___________ _________/ml 0.0103/ml
Medroxyprogesterone 10 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1997/tab-cap
Medroxyprogesterone 5 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0888/tab-cap
Medroxyprogesterone Acetate 150 mg/ml Vial E __________ ___________ _________/ml 0.7912/ml
Meglumine Antimonate 30-45% Ampoule E __________ ___________ _________/ml 0.8640/ml
Melphalan 2 mg Tab-Cap N __________ ___________ _________/tab-cap 1.7313/tab-cap
Melphalan 50 mg Vial N __________ ___________ _________/vial 47.1707/vial
Mercaptopurine 50 mg Tab-Cap C __________ ___________ _________/tab-cap 1.9430/tab-cap
Meropenem 1 g Vial N __________ ___________ _________/vial 9.2550/vial
Meropenem 500 mg Vial N __________ ___________ _________/vial 6.7545/vial
Mesna 100 mg/ml Ampoule C __________ ___________ _________/ml 0.4800/ml
Mesna 400 mg Ampoule C __________ ___________ _________/ampoule 3.4976/ampoule


Methadone (Ic) 5 mg Tab-Cap C __________ ___________ _________/tab-cap 5.0000/tab-cap
Methotrexate Sodium 2.5 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0690/tab-cap
Methotrexate Sodium 25 mg/ml Vial P __________ ___________ _________/ml 2.9775/ml
Methyldopa 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0436/tab-cap
Methyldopa 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.1200/tab-cap
Methylphenidate Hydrochloride (Ic) 10 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0543/tab-cap
Methylprednisolone (Sodium Succinate) 1 g Vial C __________ ___________ _________/vial 12.6473/vial
Methylprednisolone (Sodium Succinate) 500 mg Vial C __________ ___________ _________/vial 5.8527/vial
Methylprednisolone Acetate 40 mg Vial N __________ ___________ _________/vial 1.5590/vial
Metoclopramide Hcl 5 mg/ml Ampoule E __________ ___________ _________/ml 0.0497/ml
Metoclopramide Hcl 5 mg/5 ml Syrup E __________ ___________ _________/ml 0.0083/ml
Metoclopramide Hcl 10 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0174/tab-cap
Metoprolol 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0200/tab-cap
Metronidazole 1 g Suppos E __________ ___________ _________/supp 0.6624/supp
Metronidazole 500 mg Suppos E __________ ___________ _________/supp 0.2054/supp
Metronidazole 200 mg/5 ml Syrup E __________ ___________ _________/ml 0.0069/ml
Metronidazole 5 mg/ml Vial E __________ ___________ _________/ml 0.0045/ml
Miconazole 25 mg/ml Oral Gel P __________ ___________ _________/g 0.0991/g


Miconazole Nitrate 2% Cream E __________ ___________ _________/g 0.0077/g
Midazolam (Ic) 1 mg/ml Ampoule E __________ ___________ _________/ml 0.0614/ml
Midazolam (Ic) 5 mg/ml Ampoule E __________ ___________ _________/ml 0.2200/ml
Midazolam 15 mg Tab-Cap E __________ ___________ _________/tab-cap 0.2922/tab-cap
Minoxidil 10 mg Tab-Cap N __________ ___________ _________/tab-cap 0.4696/tab-cap
Misoprostol 200 mcg Tab-Cap E __________ ___________ _________/tab-cap 0.2269/tab-cap
Mitomycin 5 mg Vial N __________ ___________ _________/vial 21.5000/vial
Morphine (Ic, Sustained-Release) 10 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1513/tab-cap
Morphine Sulfate (Ic) 10 mg/ml Ampoule E __________ ___________ _________/ml 1.0630/ml
Morphine Sulfate (Ic) 15 mg/ml Ampoule P __________ ___________ _________/ml 0.6180/ml
Morphine Sulfate (Slow Release) 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.8054/tab-cap
Morphine Sulfate (Ic, Sustained-Release) 30 mg Tab-Cap P __________ ___________ _________/tab-cap 0.4400/tab-cap
Morphine Sulfate (Slow Release) 60 mg Tab-Cap E __________ ___________ _________/tab-cap 0.5103/tab-cap
Moxifloxacin 400 mg Tab-Cap N __________ ___________ _________/tab-cap 1.6423/tab-cap
Mupirocin 2% Cream E __________ ___________ _________/g 0.1448/g
Mupirocin 2% Ointment E __________ ___________ _________/g 0.1673/g
Mycophenolate Mofetil 250 mg Tab-Cap N __________ ___________ _________/tab-cap 0.3521/tab-cap
Nalbufine Chlorhydrate 10 mg/ml Vial N __________ ___________ _________/ml 0.9800/ml
Nalidixic Acid 500 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1215/tab-cap
Naloxone Hcl 0.4 mg/ml Ampoule E __________ ___________ _________/ml 0.7039/ml
Naloxone Hcl 0.02 mg/ml Vial P __________ ___________ _________/ml 0.1903/ml


Naproxen 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0557/tab-cap
Naproxen 500 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0873/tab-cap
Natamycin 50 mg/ml Opht Drop N __________ ___________ _________/ml 4.8903/ml
Nelfinavir (Nfv) 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.8000/tab-cap
Nevirapine (Nvp) 50 mg/5 ml Suspen E __________ ___________ _________/ml 0.0054/ml
Nevirapine (Nvp) 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0487/tab-cap
Nimodipine 30 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0285/tab-cap
Nitrofurantoin 25 mg/5 ml Suspen P __________ ___________ _________/ml 0.0084/ml
Nitrofurantoin 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0720/tab-cap
Nitrofurantoin 50 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0285/tab-cap
Nitrofurazone 0.2% Ointment N __________ ___________ _________/g 0.0391/g
Norepinephrine 1 mg/ml Vial N __________ ___________ _________/ml 0.2093/ml
Norethisterone 200 mg/ml Ampoule E __________ ___________ _________/ml 4.5131/ml
Norethisterone 5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1996/tab-cap
Norethisterone+estradiol Cypionate (In Oil) 50mg+5mg/ml Vial N __________ ___________ _________/ml 4.3900/ml


Nystatin 100,000 iu/g Ointment P __________ ___________ _________/g 0.0992/g
Nystatin 100,000 iu Pessary E __________ ___________ _________/pessary 0.1000/pessary
Nystatin 100000 iu/ml Suspen P __________ ___________ _________/ml 0.0346/ml
Octreotide 0.1 mg/ml Ampoule N __________ ___________ _________/ml 9.7690/ml
Ofloxacin 0.3% Opht Drop E __________ ___________ _________/ml 0.3090/ml
Olanzapine 10 mg Tab-Cap N __________ ___________ _________/tab-cap 0.4300/tab-cap
Olanzapine 5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1200/tab-cap
Omeprazole 40 mg Vial E __________ ___________ _________/vial 0.4534/vial
Ondansetron 2 mg/ml Ampoule E __________ ___________ _________/ml 0.1771/ml
Oral Rehydration Salts (Ors) 1 pkt/1 l Powder E __________ ___________ _________/packet 0.0500/packet
Ors+zinc Co-Pack (1-Lt Packet Ors+1 Tab Zinc) 1 ors+20 mg Each E __________ ___________ _________/each 0.5800/each
Ors+zinc Co-Pack (2 1-Lt Ors Packets+1 Tab Zinc) 2 ors+20 mg E __________ ___________ _________/each 0.8000/each
Each
Ors+zinc Co-Pack (2 1-Lt Ors+10 Tabs Zinc) 2 ors+20 mg Each E __________ ___________ _________/each 0.4500/each
Oseltamivir 75 mg Tab-Cap E __________ ___________ _________/tab-cap 2.1330/tab-cap
Oxacillin 500 mg Ampoule N __________ ___________ _________/vial 0.2049/vial
Oxacillin 1 g Vial T __________ ___________ _________/vial 0.6472/vial


Oxaliplatin 100 mg Vial C __________ ___________ _________/vial 59.0858/vial
Oxaliplatin 50 mg Vial C __________ ___________ _________/vial 37.5858/vial
Oxybuprocaine 0.4% Opht Drop N __________ ___________ _________/ml 0.3953/ml
Oxybutynin 5 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0819/tab-cap
Oxytocin 10 iu Ampoule E __________ ___________ _________/ml 0.1252/ml
Oxytocin 5 iu Ampoule P __________ ___________ _________/ml 0.4946/ml
P-Aminosalicylic Acid (pas) 4 g Powder C __________ ___________ _________/packet 2.7516/packet
Paclitaxel 100 mg Vial C __________ ___________ _________/vial 10.2734/vial
Paclitaxel 6 mg/ml Vial C __________ ___________ _________/ml 0.9491/ml
Pancuronium Bromide 2 mg/ml Ampoule N __________ ___________ _________/ml 0.6727/ml
Paracetamol 100 mg/ml Suspen P __________ ___________ _________/ml 0.0231/ml
Paracetamol 120 mg/5 ml Suspen P __________ ___________ _________/ml 0.0042/ml
Paraffin, Liquid (Mineral Oil) Liquid N __________ ___________ _________/ml 0.0089/ml
Paraffin, White Soft Ointment N __________ ___________ _________/g 0.0029/g
Penicillamine 250 mg Tab-Cap C __________ ___________ _________/tab-cap 0.4381/tab-cap
Penicillin, Benzathine Benzyl (720 Mg Of Pen. G) 1.2m iu Powder P __________ ___________ _________/vial 0.2155/vial
Penicillin, Benzathine Benzyl (1.44 G Of Pen. G) 2.4m iu Powder E __________ ___________ _________/vial 0.2760/vial


Penicillin, Benzyl (600 Mg, Pen. G) 1m iu Powder E __________ ___________ _________/vial 0.3238/vial
Penicillin, Benzyl (3 G, Pen. G) 5m iu Powder E __________ ___________ _________/vial 0.6800/vial
Penicillin, Phenoxymethyl (Pen. V) 125 mg/5 ml Suspen P __________ ___________ _________/ml 0.0069/ml
Penicillin, Phenoxymethyl (Pen. V) 250 mg/5 ml Syrup E __________ ___________ _________/ml 0.0071/ml
Penicillin, Phenoxymethyl (Pen. V) 250 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0200/tab-cap
Penicillin, Procaine Benzyl (600 Mg Of Pen. G) 1m iu Powder E __________ ___________ _________/vial 0.1801/vial
Penicillin, Procaine Benzyl (2.4 G Of Pen. G) 4m iu Powder P __________ ___________ _________/vial 0.2330/vial
Pentazocine (Ic) 30 mg/ml Ampoule N __________ ___________ _________/ml 0.1485/ml
Permethrin 5% Cream E __________ ___________ _________/g 0.0355/g
Pethidine (Ic) 50 mg Tab-Cap E __________ ___________ _________/tab-cap 0.2734/tab-cap
Pethidine Hcl (Ic) 50 mg/ml Ampoule E __________ ___________ _________/ml 0.2634/ml
Phenobarbital (Ic) 100 mg/ml Ampoule P __________ ___________ _________/ml 1.0080/ml
Phenobarbital (Ic) 15 mg/5 ml Elixir E __________ ___________ _________/ml 0.0762/ml
Phenobarbital (Ic) 20 mg/5 ml Elixir P __________ ___________ _________/ml 0.0043/ml
Phenobarbital (Ic) 50-60 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0472/tab-cap
Phenobarbital (Ic) 200 mg/ml Vial E __________ ___________ _________/ml 3.2830/ml
Phenytoin 50 mg/ml Ampoule E __________ ___________ _________/ml 0.3866/ml
Phenytoin 125 mg/5 ml Suspen P __________ ___________ _________/ml 0.0279/ml
Phenytoin 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0359/tab-cap


Pilocarpine 1% Opht Drop P __________ ___________ _________/ml 0.2280/ml
Piperacillin+tazobactam 4 g+500 mg Vial N __________ ___________ _________/vial 4.1276/vial
Piroxicam 20 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0252/tab-cap
Polygeline 3.5% Solution N __________ ___________ _________/ml 0.0239/ml
Potassium Chloride (Sustained-Release) 600 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0385/tab-cap
Potassium Chloride 600 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0987/tab-cap
Potassium Chloride 15% Vial P __________ ___________ _________/ml 0.0224/ml
Potassium Permanganate Powder E __________ ___________ _________/g 0.0106/g
Povidone Iodine (Scrub) 7.5% Liquid P __________ ___________ _________/ml 0.0107/ml
Povidone Iodine 10% Ointment T __________ ___________ _________/g 0.0133/g
Povidone Iodine 10% Solution E __________ ___________ _________/ml 0.0059/ml
Praziquantel 600 mg Tab-Cap E __________ ___________ _________/tab-cap 0.3174/tab-cap
Prednisolone 1% Opht Drop P __________ ___________ _________/ml 0.3796/ml
Prednisolone 1 mg Tab-Cap P __________ ___________ _________/tab-cap 0.1000/tab-cap
Prednisolone (base) 15 mg/5 ml Syrup P __________ ___________ _________/ml 0.0305/ml
Prednisone 20 mg Tab-Cap N __________ ___________ _________/tab-cap 2.8256/tab-cap
Prednisone 5 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0100/tab-cap


Prednisone 50 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0837/tab-cap
Primaquine (Base) 15 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0554/tab-cap
Prochlorperazine 5 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0200/tab-cap
Proguanil 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.2520/tab-cap
Promethazine Hcl 25 mg/ml Ampoule T __________ ___________ _________/ml 0.2493/ml
Promethazine Hcl 5 mg/5 ml Suspen T __________ ___________ _________/ml 0.0055/ml
Promethazine Hcl 25 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0043/tab-cap
Proparacaine 0.5% Opht Drop T __________ ___________ _________/ml 0.3420/ml
Propofol 10 mg/ml Vial E __________ ___________ _________/ml 0.0708/ml
Propranolol 1 mg/ml Ampoule P __________ ___________ _________/ml 10.8000/ml
Propranolol Hcl 10 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0246/tab-cap
Propranolol Hcl 40 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0106/tab-cap
Propranolol Hcl 80 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0795/tab-cap
Propylthiouracil 50 mg Tab-Cap C __________ ___________ _________/tab-cap 0.0604/tab-cap
Protamine Sulfate 10 mg/ml Ampoule C __________ ___________ _________/ml 1.4811/ml
Pyrazinamide 500 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0429/tab-cap
Pyridostigmine Bromide 60 mg Tab-Cap C __________ ___________ _________/tab-cap 0.2820/tab-cap
Quinidine Sulfate 200 mg Tab-Cap N __________ ___________ _________/tab-cap 0.3500/tab-cap
Quinine Dihydrochloride 250-300mg/ml Ampoule E __________ ___________ _________/ml 0.4987/ml
Quinine Sulfate 300 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0911/tab-cap
Raltegravir 400 mg Tab-Cap N __________ ___________ _________/tab-cap 0.8364/tab-cap


Ranitidine 25 mg/ml Ampoule E __________ ___________ _________/ml 0.1736/ml
Ranitidine 150 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0204/tab-cap
Ranitidine 300 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0194/tab-cap
Rifamp.+isoniazid+pyrazin.+ethambut. (150+75+400+275 Mg) Tab- E __________ ___________ _________/tab-cap 0.0756/tab-cap

Cap
Rifampicin 100 mg/5 ml Syrup P __________ ___________ _________/ml 0.1386/ml
Rifampicin 150 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0841/tab-cap
Risperidone 1 mg/ml Solution E __________ ___________ _________/ml 0.5978/ml
Risperidone 0.5 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0182/tab-cap
Risperidone 1 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0268/tab-cap
Ritonavir (Rtv) 80 mg/ml Solution E __________ ___________ _________/ml 0.0630/ml
Ritonavir (Rtv) 100 mg Tab-Cap E __________ ___________ _________/tab-cap 0.1288/tab-cap
Rituximab 10 mg/ml Ampoule C __________ ___________ _________/ml 15.9293/ml
Rocuronium Bromide 50 mg/5 ml Vial N __________ ___________ _________/ml 0.6595/ml
Salbutamol 0.5 mg/ml Ampoule E __________ ___________ _________/ml 1.9830/ml


Salbutamol 100 mcg/dose Inhaler E __________ ___________ _________/dose 0.0078/dose
Salbutamol 0.5% Respsol E __________ ___________ _________/ml 0.0470/ml
Salbutamol 2 mg/5 ml Syrup E __________ ___________ _________/ml 0.0037/ml
Salmeterol+fluticasone (25+250 Mcg/dose) Inhaler N __________ ___________ _________/dose 0.0568/dose
Saquinavir (Sqv) 200 mg Tab-Cap E __________ ___________ _________/tab-cap 0.2440/tab-cap
Saquinavir (Sqv) 500 mg Tab-Cap P __________ ___________ _________/tab-cap 1.1308/tab-cap
Sertraline 50 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0382/tab-cap
Sevoflurane Solution N __________ ___________ _________/ml 0.4105/ml
Silver Sulfadiazine 1% Cream E __________ ___________ _________/g 0.0247/g
Simvastatin 10 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0658/tab-cap
Simvastatin 20 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0245/tab-cap
Sodium Amidotrizoate (Meglumine Diatrizoate) 76% Vial E __________ ___________ _________/ml 0.4725/ml
Sodium Bicarbonate 8.4% Solution T __________ ___________ _________/ml 0.0140/ml
Sodium Chloride In Water 0.45% Solution P __________ ___________ _________/ml 0.0011/ml
Sodium Chloride In Water (Normal Saline) 0.9% Solution E __________ ___________ _________/ml 0.0010/ml
Sodium Dichloroisocyanurate (Nadcc) 1.67 g Tab-Cap N __________ ___________ _________/tab-cap 0.0445/tab-cap
Sodium Lactate Compound (Ringer's/hartmann's Sol.) Solution E __________ ___________ _________/ml 0.0007/ml
Sodium Valproate 250 mg/5 ml Suspen N __________ ___________ _________/ml 0.0447/ml


Stavudine (D4t) 1 mg/ml Solution E __________ ___________ _________/ml 0.0062/ml
Streptokinase (Powder) 1,500,000 iu Vial C __________ ___________ _________/vial 50.0850/vial
Streptomycin Sulfate 1 g Vial E __________ ___________ _________/vial 4.3910/vial
Sulfacetamide Sodium 10% Opht Drop N __________ ___________ _________/ml 0.2946/ml
Sulfadoxine+pyrimethamine (250 Mg+12.5 Mg/5 Ml) 250+12mg/5ml C __________ ___________ _________/ml 0.0782/ml
Suspen
Sulfadoxine+pyrimethamine 500 mg+25 mg Tab-Cap C __________ ___________ _________/tab-cap 0.1060/tab-cap
Sulfamethoxazole+trimethoprim (Co-Trimoxazole) 80+16 mg/ml E __________ ___________ _________/ml 0.0501/ml

Ampoule
Sulfamethoxazole+trimethoprim (Co-Trimoxazole) 200+40mg/5ml E __________ ___________ _________/ml 0.0048/ml

Suspen

Tab-Cap
Sulfamethoxazole+trimethoprim (Co-Trimoxazole) 800 mg+160mg P __________ ___________ _________/tab-cap 0.0274/tab-cap

Tab-Cap
Sulfasalazine 500 mg Tab-Cap C __________ ___________ _________/tab-cap 0.1673/tab-cap
Sulphametopyrazine-Pyrimethamine 500+25 mg Tab-Cap N __________ ___________ _________/tab-cap 0.2156/tab-cap
Suxamethonium Cl (Succinylcholine) 50 mg/ml Ampoule E __________ ___________ _________/ml 0.4485/ml
Suxamethonium Cl (Succinylcholine) 20 mg/ml Vial P __________ ___________ _________/ml 0.4067/ml
Tacrolimus 1 mg Tab-Cap N __________ ___________ _________/tab-cap 0.9307/tab-cap


Tamsulosin 0.4 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0471/tab-cap
Temozolomide 100 mg Tab-Cap N __________ ___________ _________/tab-cap 46.4240/tab-cap
Tenofovir Df+emtricitabine (Tdf+ftc) 300 mg+200mg Tab-Cap E __________ ___________ _________/tab-cap 0.2251/tab-cap
Tenofovir Df+lamivudine 300mg+300mg Tab-Cap P __________ ___________ _________/tab-cap 0.2178/tab-cap
Tenofovir Disoproxil Fumerate (tdf) (Equiv.245mg Tenofovir E __________ ___________ _________/tab-cap 0.5411/tab-cap
Disopro) 300 mg Tab-Cap
Tenoxicam 20 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0692/tab-cap
Terbinafine 1% Cream E __________ ___________ _________/g 0.1100/g
Terizidone 250 mg Tab-Cap N __________ ___________ _________/tab-cap 0.7117/tab-cap
Test, Bloodgroup Anti-A, Monoclonal Test N __________ ___________ _________/ml 0.1853/ml
Test, Bloodgroup Anti-A/b, Monoclonal Test N __________ ___________ _________/ml 0.2651/ml
Test, Bloodgroup, Anti-B, Monoclonal Test N __________ ___________ _________/ml 0.1853/ml
Test, Bloodgroup, Anti-D, Monoclonal Test N __________ ___________ _________/ml 0.3307/ml
Test, Brucella Melitensis Antigen (Rapid) Test N __________ ___________ _________/test 0.1897/test
Test, Glucose In Urine Test N __________ ___________ _________/strip 0.0702/strip
Test, Hepatitis B, Hbsag, Determine Test N __________ ___________ _________/test 1.2854/test
Test, Hepatitis Bsag Test N __________ ___________ _________/test 0.5313/test
Test, Hepatitis C, Hcvscan (tm) (Rapid Test) Test N __________ ___________ _________/test 2.6333/test
Test, Hiv, Capillus Hiv-1/2 (tm) Test N __________ ___________ _________/test 0.9828/test
Test, Hiv, Determine Hiv-1/2 (tm) Test N __________ ___________ _________/test 1.0699/test
Test, Hiv, Unigold I/ii (tm) Test N __________ ___________ _________/test 3.3696/test
Test, Malaria, P. Falciparum (First Response Ag Rapid Test) N __________ ___________ _________/test 0.6203/test
Test


Test, Pregnancy (Urine) Test N __________ ___________ _________/test 0.0690/test
Tetracycline 500 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0360/tab-cap
Tetracycline Hcl 1% Opht Oint E __________ ___________ _________/g 0.0690/g
Tetracycline Hcl 250 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0128/tab-cap
Thalidomide 100 mg Tab-Cap N __________ ___________ _________/tab-cap 0.4168/tab-cap
Theophylline (Sustained-Release) 200 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0240/tab-cap
Thiopental Sodium 1 g Vial E __________ ___________ _________/vial 2.0300/vial
Thiopental Sodium 500 mg Vial E __________ ___________ _________/vial 1.3750/vial
Tinidazole 500 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0675/tab-cap
Tioguanine 40 mg Tab-Cap C __________ ___________ _________/tab-cap 7.0688/tab-cap
Topiramate 100 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0546/tab-cap
Topiramate 25 mg Tab-Cap N __________ ___________ _________/tab-cap 0.0243/tab-cap
Tramadol Hydrochloride 100 mg/ml Solution N __________ ___________ _________/ml 0.0766/ml
Tramadol Hydrochloride 50 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0218/tab-cap
Tranexamic Acid 100 mg/ml Ampoule E __________ ___________ _________/ml 1.1599/ml
Trastuzumab 440 mg Vial N __________ ___________ _________/vial 1877.3550/vial
Triamcinolone Acetonide 10 mg/ml Ampoule N __________ ___________ _________/ml 0.9628/ml
Trifluoperazine 5 mg Tab-Cap T __________ ___________ _________/tab-cap 0.0815/tab-cap


Tropicamide 0.5% Opht Drop E __________ ___________ _________/ml 0.3740/ml
Tropicamide 1% Opht Drop P __________ ___________ _________/ml 0.2914/ml
Tuberculin (Ppd) 5 iu Vial E __________ ___________ _________/dose 0.2180/dose
Urographin 76% Solution N __________ ___________ _________/ml 4.9140/ml
Vaccine, Bcg (Dried) Powder E __________ ___________ _________/dose 0.1564/dose
Vaccine, Diphtheria-Tetanus Vial E __________ ___________ _________/dose 0.5593/dose
Vaccine, Hepatitis B Vial E __________ ___________ _________/vial 1.1209/vial
Vaccine, Hpv Vial N __________ ___________ _________/ml 94.5000/ml
Vaccine, Influenza 0.5 ml Ampoule E __________ ___________ _________/vial 5.2592/vial
Vaccine, Measles Vial E __________ ___________ _________/dose 0.7016/dose
Vaccine, Measles-Mumps-Rubella Vial E __________ ___________ _________/dose 0.2370/dose
Vaccine, Meningococcal Vial E __________ ___________ _________/dose 10.7708/dose
Vaccine, Pentavalent (Tetanus,dip,pertus,polio,hib) Vial E __________ ___________ _________/dose 15.4111/dose
Vaccine, Pneumococcal Vial E __________ ___________ _________/dose 16.9838/dose
Vaccine, Polio (Oral) Vial E __________ ___________ _________/dose 0.2465/dose
Vaccine, Rabies Vial E __________ ___________ _________/vial 15.6334/vial
Vaccine, Rotavirus Vial E __________ ___________ _________/dose 6.9614/dose
Vaccine, Tetanus Toxoid Vial E __________ ___________ _________/dose 0.6526/dose
Vaccine, Yellow Fever Vial E __________ ___________ _________/dose 21.2817/dose


Valaciclovir 500 mg Tab-Cap T __________ ___________ _________/tab-cap 0.6250/tab-cap
Valganciclovir 450 mg Tab-Cap E __________ ___________ _________/tab-cap 20.5755/tab-cap
Valproic Acid (Sodium Valproate) 200 mg/5 ml Syrup E __________ ___________ _________/ml 0.0333/ml
Valproic Acid (Slow Release) 200 mg Tab-Cap P __________ ___________ _________/tab-cap 0.1755/tab-cap
Valproic Acid 500 mg Tab-Cap E __________ ___________ _________/tab-cap 0.3100/tab-cap
Vancomycin 500 mg Vial N __________ ___________ _________/vial 1.7500/vial
Vecuronium 4 mg Vial P __________ ___________ _________/vial 0.8512/vial
Venlafaxine 75 mg Tab-Cap N __________ ___________ _________/tab-cap 0.1425/tab-cap
Verapamil Hcl (Slow-Release) 240 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0879/tab-cap
Verapamil Hcl 2.5 mg/ml Vial E __________ ___________ _________/ml 1.4905/ml
Vinblastine 10 mg Vial C __________ ___________ _________/vial 15.5750/vial
Vincristine 1 mg Vial C __________ ___________ _________/vial 3.2783/vial
Vinorelbine 10 mg/1 ml Vial C __________ ___________ _________/vial 8.6146/vial
Vinorelbine 50 mg/5 ml Vial C __________ ___________ _________/vial 30.4579/vial
Vitamin A (Retinol (25,000 Iu)) 7.5 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0390/tab-cap
Vitamin B Complex Ampoule N __________ ___________ _________/ml 0.0669/ml


Vitamin B Complex Syrup N __________ ___________ _________/ml 0.0037/ml
Vitamin B Complex Tab-Cap N __________ ___________ _________/tab-cap 0.0052/tab-cap
Vitamin B1 (Thiamine Hcl) 100 mg/ml Ampoule P __________ ___________ _________/ml 0.2170/ml
Vitamin B1 (Thiamine Hcl) 100 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0221/tab-cap
Vitamin B12 (Cyanocobalamin) 1 mg/ml Ampoule N __________ ___________ _________/ml 0.6915/ml
Vitamin B6 (Pyridoxine) 50 mg/ml Ampoule P __________ ___________ _________/ml 0.4384/ml
Vitamin B6 (Pyridoxine) 25 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0059/tab-cap
Vitamin B6 (Pyridoxine) 50 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0179/tab-cap
Vitamin D (Alfacalcidol) 0.25 mcg Tab-Cap T __________ ___________ _________/tab-cap 0.3407/tab-cap
Vitamin D3 (Chloecalciferol) 10,000 iu/ml Drops N __________ ___________ _________/ml 0.0713/ml
Vitamin K1 (Phytomenadione) 10 mg/ml Ampoule E __________ ___________ _________/ml 0.3612/ml
Vitamin K1 (Phytomenadione) 10 mg Tab-Cap E __________ ___________ _________/tab-cap 0.2702/tab-cap
Vitamin, Multi (Pediatric) Drops N __________ ___________ _________/ml 0.0274/ml
Vitamin, Multi Syrup N __________ ___________ _________/ml 0.0101/ml
Vitamin, Multi Tab-Cap N __________ ___________ _________/tab-cap 0.0166/tab-cap
Vitamin, Multi + Iron Tab-Cap N __________ ___________ _________/tab-cap 0.0575/tab-cap
Vitamin, Multi + Minerals Tab-Cap N __________ ___________ _________/tab-cap 0.0200/tab-cap


Warfarin Sodium 3 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0336/tab-cap
Water For Injection 100 ml Vial P __________ ___________ _________/vial 0.8500/vial
Zidovudine (Azt) 50 mg/5 ml Solution E __________ ___________ _________/ml 0.0103/ml
Zinc Sulfate 10 mg/5 ml Syrup E __________ ___________ _________/ml 0.0019/ml
Zinc Sulfate 20 mg/5 ml Syrup E __________ ___________ _________/ml 0.0025/ml
Zinc Sulfate (Dispersible) 10 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0072/tab-cap
Zinc Sulfate (Dispersible) 20 mg Tab-Cap P __________ ___________ _________/tab-cap 0.0110/tab-cap
Zinc Sulfate 20 mg Tab-Cap E __________ ___________ _________/tab-cap 0.0452/tab-cap
Zoledronic Acid 4 mg/5 ml Vial N __________ ___________ _________/vial 29.3800/vial

ANNEXES
List of Synonyms
Synonym Name as Listed in the Guide
acetaminophen paracetamol
adrenaline epinephrine
ascorbic acid vitamin C
aspirin acetylsalicylic acid
AZT zidovudine
bendrofluazide bendroflumethiazide
benzathine penicillin penicillin, benzathine benzyl
benzhexol trihexyphenidyl
benztropine benzatropine
benzyl penicillin penicillin, benzyl
butylscopolamine bromide hyoscine butylbromide
carbon absorbent charcoal, activated
chlorpheniramine chlorphenamine
cholecalciferol vitamin D-3
cyanocobalamin vitamin B-12
doxorubicin4.Epi epirubicin
ergocalciferol vitamin D
ethanol alcohol
Factor VIII antihemophilic factor
frusemide furosemide
gammabenzene hexachloride lindane
glucose dextrose
haemaccel polygeline
Hartmann’s Solution sodium lactate compound
hydroxycobalamin vitamin B-12
hydroxyurea hydroxycarbamide
INH isoniazid
insulin, short-acting (Actrapid) insulin, neutral soluble (regular)
insulin, intermediate-acting (Insulatard) insulin, isophane (NPH)
ipecac syrup ipecacuanha syrup
IZS insulin, zinc suspension (lente)
NPH insulin insulin, isophane (NPH)
lignocaine lidocaine
nitroglycerin glyceryl trinitrate
normal saline sodium chloride 0.9%
penicillin G benzathine penicillin, benzathine benzyl
penicillin G sodium penicillin, benzyl
penicillin VK penicillin, phenoxymethyl
penicillin V potassium penicillin, phenoxymethyl
phenobarbitone phenobarbital
phenoxymethyl penicillin penicillin, phenoxymethyl
phytomenadione vitamin K-1
povidone PVP iodine
procaine penicillin penicillin, procaine benzyl
pyridoxine vitamin B-6
retinol vitamin A
Synonym Name as Listed in the Guide
Ringer’s lactate sodium lactate compound
sodium cromoglycate cromoglicic acid
stiloboestrol diethylstilbestrol
succinylcholine suxamethonium
sulfamethoxazole & trimethoprim co-trimoxazole (smz/tmp)
thiamine vitamin B-1
thiopentone thiopental sodium
thyroxine sodium levothyroxine sodium
vitamin B12a hydroxocobalamin

WHO EML Therapeutic Categories, April 2015
1. Anaesthetics inhibitors
1.1. General anaesthetics and oxygen 6.4.4.2.5. Other antivirals
1.1.1. Inhalational medicines 6.5. Antiprotozoal medicines
1.1.2. Injectable medicines 6.5.1. Antiamoebic and antigiardiasis
1.2. Local anaesthetics medicines
1.3. Preoperative medication and sedation for 6.5.2. Antileishmaniasis medicines
short-term procedures 6.5.3. Antimalarial medicines
2. Medicines for pain and palliative care 6.5.3.1. For curative treatment
2.1. Non-opioids & nonsteroidal anti-inflam- 6.5.3.2. For prophylaxis
matory medicines (NSAIMs) 6.5.4. Anti-pneumocystosis and
2.2. Opioid analgesics antitoxoplasmosis medicines
2.3. Medicines for other common symptoms in 6.5.5. Antitrypanosomal medicines
palliative care 6.5.5.1. African trypanosomiasis
3. Antiallergics and medicines used in anaphy- 6.5.5.2. American trypanosomiasis
laxis 7. Antimigraine medicines
4. Antidotes and other substances used in 7.1. For treatment of acute attack
poisonings 7.2. For prophylaxis
4.1. Non-specific 8. Antineoplastic and immunosuppressives
4.2. Specific 8.1. Immunosuppressive medicines
5. Anticonvulsants/Antiepileptics 8.2 Cytotoxic and adjuvant medicines
6. Anti-infective medicines 8.3. Hormones and antihormones
6.1. Anthelminthics 9. Antiparkinsonism medicines
6.1.1. Intestinal anthelminthics 10. Medicines affecting the blood
6.1.2. Antifilarials 10.1. Antianaemia medicines
6.1.3. Antischistosomals and antitrematode 10.2. Medicines affecting coagulation
medicines 10.3. Other medicines for haemoglobinopathies
6.2. Antibacterials 11. Blood products and plasma substitutes of
6.2.1. Beta lactam medicines human origin
6.2.2. Other antibacterials 11.1. Blood and blood components
6.2.3. Antileprosy medicines 11.2. Plasma-derived medicines
6.2.4. Antituberculosis medicines 11.2.1. Human immunoglobulins
6.3. Antifungal medicines 11.2.2. Blood coagulation factors
6.4. Antiviral medicines 11.3. Plasma substitutes
6.4.1. Antiherpes medicines 12. Cardiovascular medicines
6.4.2. Antiretrovirals 12.1. Antianginal medicines
6.4.2.1. Nucleoside/nucleotide reverse 12.2. Antiarrhythmic medicines
transcriptase inhibitors 12.3. Antihypertensive medicines
6.4.2.2. Non-nucleoside reverse tran- 12.4. Medicines used in heart failure
scriptase inhibitors 12.5. Antithrombotic medicines
6.4.2.3. Protease inhibitors 12.6. Lipid-lowering agents
6.4.3. Other antivirals 13. Dermatological medicines (topical)
6.4.4. Antihepatitis medicines 13.1. Antifungal medicines
6.4.4.1. Medicines for hepatitis B 13.2. Anti-infective medicines
6.4.4.1.1 Nucleoside/Nucleotide reverse 13.3. Anti-inflammatory and antipruritic
transcriptase inhibitors medicines
6.4.4.2. Medicines for hepatitis C 13.4. Medicines affecting skin differentiation
6.4.4.2.1. Nucleotide polymerase inhibitors and proliferation
6.4.4.2.2. Protease inhibitors 13.5. Scabicides and pediculicides
6.4.4.2.3. NS5A inhibitors 14. Diagnostic agents
6.4.4.2.4. Non-nucleoside polymerase 14.1. Ophthalmic medicines
WHO Therapeutic Categories

14.2. Radiocontrast media 21.2. Anti-inflammatory agents
15. Disinfectants and antiseptics 21.3. Local anaesthetics
15.1. Antiseptics 21.4. Miotics and antiglaucoma medicines
15.2. Disinfectants 21.5. Mydriatics
16. Diuretics 21.6. Anti-vascular endothelial growth factor
17. Gastrointestinal medicines (VEGF)
17.1. Antiulcer medicines 22. Oxytocics and antioxytocics
17.2. Antiemetic medicines 22.1. Oxytocics
17.3. Anti-inflammatory medicines 22.2. Antioxytocics (tocolytics)
17.4. Laxatives 23. Peritoneal dialysis solution
17.5. Medicines used in diarrhoea 24. Medicines for mental and behavioral
17.5.1. Oral rehydration disorders
17.5.2. Medicines for diarrhoea in children 24.1. Medicines used in psychotic disorders
18. Hormones, other endocrine medicines and 24.2. Medicines used in mood disorders
contraceptives 24.2.1. Medicines used in depressive disorders
18.1. Adrenal hormones and synthetic substi- 24.2.2. Medicines used in bipolar disorders
tutes 24.3. Medicines for anxiety disorders
18.2. Androgens 24.4. Medicines used for obsessive compulsive
18.3. Contraceptives disorders
18.3.1. Oral hormonal contraceptives 24.5. Medicines for disorders due to
18.3.2. Injectable hormonal contraceptives psychoactive substance use
18.3.3. Intrauterine devices 25. Medicines acting on the respiratory tract
18.3.4. Barrier methods 25.1. Antiasthmatic and medicines for chronic
18.3.5. Implantable contraceptives obstructive pulmonary disease
18.4. Estrogens 26. Solutions correcting water, electrolyte, and
18.5. Insulins and other medicines used for acid-base disturbances
diabetes 26.1. Oral
18.6. Ovulation inducers 26.2. Parenteral
18.7. Progestogens 26.3. Miscellaneous
18.8. Thyroid hormones and antithyroid 27. Vitamins and minerals
medicines 28. Ear, nose and throat conditions in children
19. Immunologicals 29. Specific medicines for neonatal care
19.1. Diagnostic agents 29.1. Medicines administered to the neonate
19.2. Sera and immunoglobulins 29.2. Medicines administered to the mother
19.3. Vaccines 30. Medicines for diseases of joints
20. Muscle relaxants (peripherally acting) and 30.1. Medicines used to treat gout
cholinesterase inhibitors 30.2. Disease-modifying agents used in rheu
21. Ophthalmological preparations matic disorders (DMARDs)
21.1. Anti-infective agents 30.3. Juvenile joint diseases
Source: WHO Model List of Essential Medicines 19th edition (revised April 2015), from http://
www.who.int/medicines/publications/essentialmedicines/en/index.html

OMS LME Categorías Terapéuticas, Abril 2015
1. Anestésicos 6.4.4.2.2. Inhibidores de proteasa
1.1. Anestésicos generales y oxígeno 6.4.4.2.3. Inhibidores NS5A
1.1.1. Medicamentos inhalados 6.4.4.2.4. Inhibidores no nucleosídicos de
1.1.2. Medicamentos inyectables polimerasa
1.2. Anestésicos locales 6.4.4.2.5. Otros antivíricos
1.3. Medicación preoperatoria y sedación 6.5. Antiprotozoarios
para procedimientos breves 6.5.1. Antiamebianos y antigiardiásicos
2. Medicamentos para dolor y cuidado 6.5.2. Antileishmaniásicos
paliativo 6.5.3 Antipalúdicos
2.1. Analgésicos no opiáceos y 6.5.3.1. Para tratamiento curativo
antiiflamatorios no esteoideos (AINE) 6.5.3.2. Para profilaxis
2.2. Analgésicos opiáceos 6.5.4. Antipneumocistósicos y
2.3. Medicamentos para otros síntomas antitoxoplasmósicos
comunes en cuidado paliativo 6.5.5 Antitripanosomiásicos
3. Antialérgicos y medicamentos utilizados en 6.5.5.1 Tripanosomiasis africana
la anafilaxia 6.5.5.2 Tripanosomiasis americana
4. Antídotos y otras sustancias usadas en 7. Antimigrañosos (antijaquecosos)
intoxicaciones 7.1. Para el tratamiento de la crisis aguda
4.1. Inespecíficos 7.2. Para profilaxis
4.2. Específicos 8. Antineoplásicos y inmunodepresores
5. Anticonvulsivantes/antiepilépticos 8.1. Inmunodepresores
6. Antiinfecciosos 8.2. Citotóxicos y medicamentos adyuvantes
6.1. Antihelmínticos 8.3. Hormonas y antihormonas
6.1.1. Antihelmínticos intestinales 9. Antiparkinsonianos
6.1.2. Antifilariásicos 10. Medicamentos con efectos en la sangre
6.1.3. Antiesquistosomiásicos y 10.1. Antianémicos
antitrematódicos 10.2. Medicamentos con efectos en la
6.2. Antibacterianos coagulación
6.2.1. Betalactámicos 10.3. Otros medicamentos para
6.2.2. Otros antibacterianos hemoglobinopatías
6.2.3. Antileprosos 11. Productos sanguineos y sustitutos del
6.2.4. Antituberculosos plasma de origen humano
6.3. Antifúngicos 11.1. Sangre y componentes sanguíneos
6.4. Antivíricos 11.2. Medicamentos derivados del plasma
6.4.1. Antiherpéticos 11.2.1. Inmunoglobulinas humanas
6.4.2. Antirretrovíricos 11.2.2. Factores de coagulación sanguíneos
6.4.2.1. Inhibidores nucleosídicos de la 11.3. Sucedáneos del plasma
transcriptasa inversa 12. Medicamentos cardiovasculares
6.4.2.2. Inhibidores no nucleosídicos de la 12.1. Antianginosos
transcriptasa inversa 12.2. Antiarrítmicos
6.4.2.3. Inhibidores de la proteasa 12.3. Antihipertensivos
6.4.3. Otros antivíricos 12.4. Medicamentos utilizados en la
6.4.4. Medicamentos anti-hepatitis insuficiencia cardiaca
6.4.4.1. Medicamentos anti-hepatitis B 12.5. Antitrombóticos
6.4.4.1.1 Inhibidores nucleosídicos/ 12.6. Agentes hipolipemiantes
nucleótidos de la transcriptasa 13. Medicamentos dermatológicos (tópicos)
reversa 13.1. Antifúngicos
6.4.4.2. Medicamentos anti-hepatitis C 13.2. Antiinfecciosos
6.4.4.2.1. Inhibidores de polimerasa de 13.3. Antiinflamatorios y antipruriginosos
nucleotidos 13.4. Medicamentos que afectan a la diferencia-
OMS Categorías Terapéuticas

ción cutánea y la proliferación 21.5. Midriáticos
13.5. Escabicidas y pediculicida 21.6. Terapia antiangiogenesis (anti-VEGF)
14. Agentes de diagnóstico 22. Oxitócicos y antioxitócicos
14.1. Medicamentos oftálmicos 22.1. Oxitócicos
14.2. Medios de contraste radiológico 22.2. Antioxitócicos
15. Desinfectantes y antisépticos 23. Solución de diálisis peritoneal
15.1. Antisépticos 24. Medicamentos para trastornos mentales y
15.2. Desinfectantes del comportamiento
16. Diuréticos 24.1. Medicamentos usados en los trastornos
17. Medicamentos gastrointestinales psicóticos
17.1. Antiulcerosos 24.2. Medicamentos usados en los trastornos
17.2. Antieméticos del humor
17.3. Antiinflamatorios 24.2.1. Medicamentos usados en los trastornos
17.4. Laxantes depresivos
17.5. Medicamentos usados en la diarrea 24.2.2. Medicamentos usados en los trastornos
17.5.1. Rehidratación oral bipolares
17.5.2. Antidiarreicos para uso pediátrico 24.3. Medicamentos usados en los trastornos
18. Hormonas, otros medicamentos endocrinos de la ansiedad
y anticonceptivos 24.4. Medicamentos usados en los trastornos
18.1. Hormonas suprarrenales y sucedáneos obsesivo-compulsivos
sintéticos 24.5 Medicamentos para desordenes debidos
18.2. Andrógenos al uso de substancias psicoactivas
18.3. Anticonceptivos 25. Medicamentos que actúan en las vías
18.3.1. Anticonceptivos hormonales orales respiratorias
18.3.2. Anticonceptivos hormonales 25.1. Antiasmáticos y medicamentos utilizados
inyectables en la neumopatía obstructiva crónica
18.3.3. Dispositivos intrauterinos 26. Soluciones correctoras de los trastornos
18.3.4. Métodos de barrera hidroelectrolíticos y del equilibria
18.3.5 Anticonceptivos implantables ácidobásico
18.4. Estrógenos 26.1. Orales
18.5. Insulinas y antidiabéticos 26.2. Parenterales
18.6. Inductores de la ovulación 26.3. Diversas
18.7. Progestágenos 27. Vitaminas y sustancias minerales
18.8. Hormonas tiroideas y antitiroideos 28. Medicamentos de oido, nariz, y garganta en
19. Productos inmunológicos niños
19.1. Agentes de diagnóstico 29. Medicamentos específicos para cuidado
19.2. Sueros e inmunoglobulinas neonatal
19.3. Vacunas 29.1. Medicamentos administrados al neonato
20. Miorrelajantes (de acción periférica) e 29.2. Medicamentos administrados a la madre
inhibidores de la colinesterasa 30. Medicamentos para enfermedades de
21. Preparaciones oftalmológicas articulaciones
21.1. Antiinfecciosos 30.1. Antigotosos
21.2. Antiinflamatorios 30.2. Antirreumáticos modificadores de la
21.3. Anestésicos locales enfermedad (ARME)
21.4. Mióticos y antiglaucomatosos 30.3. Enfermedades articulares juveniles
Fuente: La 19o Lista Modelo de Medicamentos Esenciales de la OMS (revisada abril 2015), de http://
www.who.int/medicines/publications/essentialmedicines/en/index.html
Indicateur de Prix internationaux des Médicaments 2014

OMS LME Catégories Thérapeutiques, Avril 2015
1. Anesthésiques 6.4.4.2.1. Inhibiteurs de la polymérase
1.1. Anesthésiques généraux et oxygène nucléotidique
1.1.1. Médicaments inhalables 6.4.4.2.2. Inhibiteurs des protéases
1.1.2. Médicaments injectables 6.4.4.2.3. Inhibiteurs de NS5A
1.2. Anesthésiques locaux 6.4.4.2.4. Inhibiteurs non nucléosidiques de
1.3. Premédication anesthésique et sédation polymérase
pour interventions de courte durée 6.4.4.2.5. Autres antiviraux
2. Médicaments pour la douleur et les soins 6.5. Antiprotozoaires
palliatifs 6.5.1. Antiamibiens et antigiardiens
2.1 Analgésiques non opioïdes et anti- 6.5.2. Antileishmaniens
inflammatoires non stéroïdiens 6.5.3. Antipaludiques
2.2. Analgésiques opioïdes 6.5.3.1. Traitement curatif
2.3. Médicaments pour les autres symptômes 6.5.3.2. Prophylaxie
communs des soins palliatifs 6.5.4. Médicaments contre la pneumocytose et
3. Antiallergiques et anti-anaphylactiques la toxoplasmose
4. Antidotes et autres substances utilisées 6.5.5. Trypanocides
pour le traitement des intoxications 6.5.5.1. Trypanosomiase africaine
4.1. Non spécifiques 6.5.5.2. Trypanosomiase américaine
4.2. Spécifiques 7. Antimigraineux
5. Anticonvulsivants/ anti-epileptiques 7.1. Traitement de la crise
6. Anti-infectieux 7.2. Prophylaxie
6.1. Antihelminthiques 8. Antinéoplasiques et immunosuppresseurs
6.1.1. Médicaments contre les helminthes 8.1. Immunosuppresseurs
intestinaux 8.2. Cytotoxiques et médicaments adjuvants
6.1.2. Antifilariens 8.3. Hormones and antihormones
6.1.3. Schistosomicides (antibilharziens) et 9. Antiparkinsoniens
antitrématodes 10. Médicaments utilises en hematologie
6.2. Antibactériens 10.1. Antianémiques
6.2.1. Bêta-lactamines 10.2. Médicaments de l’hémostase
6.2.2. Autres antibactériens 10.3. Autres médicaments pour le traitement
6.2.3. Antilépreux des hémoglobinopathies
6.2.4. Antituberculeux 11. Sang et succédanés du plasma d’origine
6.3. Antifongiques humaine
6.4. Antiviraux 11.1. Sang et composants du sang
6.4.1. Antiherpétiques 11.2. Médicaments dérivés du plasma humain
6.4.2. Antirétroviraux 11.2.1. Immunoglobulines humaines
6.4.2.1. Inhibiteurs nucléosidiques/ 11.2.2 Facteurs de coagulation de sang
nucléotidiques de la trancriptase 11.3. Substituts du plasma
inverse 12. Médicaments utilises en cardio-angeiologie
6.4.2.2. Inhibiteurs non-nucléosidiques de 12.1. Antiangioreux
la transcriptase inverse 12.2. Antiarythmiques
6.4.2.3. Inhibiteurs des protéases 12.3. Antihypertenseurs
6.4.3. Autres antiviraux 12.4. Médicaments de l’insuffisance cardiaque
6.4.4. Médicaments contre les hépatites 12.5. Antithrombotiques
6.4.4.1. Médicaments contre l’hépatite B 12.6. Hypolipémiants
6.4.4.1.1 Inhibiteurs nucléosidiques/ 13. Médicaments utilises en dermatologie
nucléotidiques de la transcriptase (topiques)
inverse 13.1. Antifongiques
6.4.4.2. Médicaments contre l’hépatite C 13.2. Anti-infectieux
OMS Catégories Thérapeutiques

13.3. Anti-inflammatoires et antiprurigineux 21.2. Anti-inflammatoires
13.4. Médicaments de la différenciation et de la 21.3. Anesthésiques locaux
prolifération cutanées 21.4. Myotiques et antiglaucomateux
13.5. Scabicides et pédiculocides 21.5. Mydriatiques
14. Produits de diagnostic 21.6. Facteur de croissance de l'endothélium
14.1. En ophthalmologie vasculaire (VGEF)
14.2. Produits de contraste 22. Ocytociques et anti-ocytociques
15. Désinfectants et antiseptiques 22.1. Ocytociques
15.1. Antiseptiques 22.2. Anti-ocytociques (tocolytiques)
15.2. Désinfectants 23. Solutions pour dialyse péritonéale
16. Diurétiques 24. Medicaments des desordres mentaux et
17. Médicaments indiques en gastroenterologie comportementaux
17.1. Antiulcèreux 24.1. Antipsychotiques
17.2. Antiémétiques 24.2. Médicaments des troubles de l’humeur
17.3. Anti-inflammatoires 24.2.1. Antidépresseurs
17.4. Laxatifs 24.2.2. Normothymiques
17.5. Antidiarrhéiques 24.3. Anxiolytiques
17.5.1. Réhydratation orale 24.4. Médicaments des troubles obsessionnels
17.5.2. Antidiarrhéiques à usage pédiatrique compulsifs
18. Hormones, autres médicaments indiques en 24.5. Médicaments des troubles liés à l'usage
endocrinologie et contraceptifs de substances psychoactives
18.1. Hormones surrénaliennes et corticoïdes 25. Médicaments indiques en pneumologie
de synthèse 25.1. Antiasthmatiques et traitement des
18.2. Androgènes bronchopneumopathies chroniques
18.3. Contraceptifs obstructives
18.3.1. Contraceptifs hormonaux oraux 26. Correction des troubles hydro-
18.3.2 Contraceptifs hormonaux injectables électrolytiques et acido-basiques
18.3.3. Dispositifs intra-utérins 26.1. Voie orale
18.3.4. Contraception locale 26.2. Voie parentérale
18.3.5. Contraceptifs implantables 26.3. Divers
18.4. Estrogènes 27. Vitamines et elements minéraux
18.5. Insulines et autres antidiabétiques 28. Médicaments de l’oreille, du nez et de la
18.6. Inductueurs de l’ovulation gorge chez l’enfant
18.7. Progestatifs 29. Medicaments propres aux soins neonatals
18.8. Hormones thyroïdiennes et 29.1. Médicaments pour le nouveau-né
antithyroïdiens 29.2. Médicaments pour la mère
19. Preparations pour l’immunologie 30. Médicaments pour les maladies des
19.1. Produits de diagnostic articulations
19.2. Sérums et immunoglobulines 30.1. Antigoutteux
19.3. Vaccins 30.2. Médicaments utilises pour le traitement
20. Myorelaxants (périphériques) et inhibiteurs de fond des affections rhumatismales
de la cholinesterase 30.3. Maladies juvéniles des articulations
21. Préparations pour l’ophtalmologie
21.1. Anti-infectieux
Source: La 19e liste modèle OMS des médicaments essentiels (revue en avril 2015) de http://www.who.int/
medicines/publications/essentialmedicines/en/index.html.
Indicateur de Prix internationaux des Médicaments 2014

About Management Sciences for Health
Management Sciences for Health (MSH) is an international nonprofit organization, dedicated
to closing the gap between what is known about the overwhelming public health challenges
facing many nations and what is done to address those challenges.
Since 1971, MSH has worked in more than 150 countries with policymakers, health profession-
als, and health care consumers to improve the quality, availability, and affordability of health
services. We work with governments, donors, nongovernmental organizations, and health
agencies to respond to priority health problems such as HIV & AIDS, tuberculosis, malaria,
maternal-child health, and reproductive health. Our publications and electronic products
augment our assistance in these technical areas.
MSH’s staff of more than 2,400 from over 70 nations work in its Medford, Massachusetts,
headquarters; offices in the Washington, DC, area; and more than 50 country offices. Through
technical assistance, research, training, and systems development, MSH is committed to
making a lasting difference in global health.
For more information about Management Sciences for Health, please visit our website at
www.msh.org.
About the MSH Center for Pharmaceutical
Management
MSH has more than 30 years of experience in establishing, managing, and evaluating pharma-
ceutical sector activities in developing countries. In 1983, the MSH Drug Management Program
(DMP) was established in recognition of the key role that pharmaceuticals play in delivering
high-quality health care in developing countries.
In 2001, the DMP was restructured as the Center for Pharmaceutical Management (CPM). The
center, building on the work of the DMP, remains committed to providing high-quality techni-
cal assistance and training in pharmaceutical management worldwide.
The key to MSH’s success in providing technical assistance in pharmaceutical management is
our proven ability to work closely with both senior- and operations-level personnel in develop-
ing countries, while maintaining strong working relationships with the many international
agencies and donors sponsoring our work. These donors include USAID, WHO, PAHO,
UNICEF, Danida, the World Bank, and foundations such as the Bill & Melinda Gates Founda-
tion and the Rockefeller Foundation.
CPM has nearly 700 staff members working out of its primary office in the Washington, D.C.,
area and other locations worldwide, together with a roster of more than 50 expert consultants,
who are available as required. For more information on CPM, please contact:
Management Sciences for Health
Center for Pharmaceutical Management
4301 N. Fairfax Drive, Suite 400
Arlington, VA 22203 USA
Telephone: 703.524.6575
Fax: 703.524.7898
E-mail: cpm@msh.org
Acerca de Management Sciences for Health
Management Sciences for Health (MSH) es una organización privada sin fines de lucro
dedicada a cerrar la brecha entre lo que se sabe acerca de los retos de salud pública de muchas
naciones y lo que se hace por resolverlos.
Desde 1971, MSH ha trabajado en más de 150 países, con personal de políticas, profesionales de
salud y consumidores de servicios de atención de salud para mejorar la calidad, la disponi-
bilidad y la accesibilidad financiera de los servicios de salud. Trabajamos con los gobiernos, los
donantes, las organizaciones no gubernamentales, y las agencias de salud para responder a los
problemas prioritarios de salud como el VIH & SIDA, la tuberculosis, el paludismo, la
supervivencia maternal-infantil y la salud reproductiva. Nuestros productos electrónicos y
publicaciones complementan nuestra asistencia en estas áreas técnicas.
El cuadro de MSH que suma más de 2400 personas de más de 70 naciones trabaja en su sede en
Cambridge, Massachusetts, oficinas en los alrededores de Washington, DC y más de 50 oficinas
en el terreno. A través de sus investigaciones, asistencia técnica, capacitación y desarrollo de
sistemas, MSH se compromete a hacer una diferencia duradera en la salud global.
Para más información sobre Management Sciences for Health, por favor visite nuestro sitio
web, www.msh.org.
Acerca del Centro de Gestión Farmacéutica de
MSH
MSH tiene más de 30 años de experiencia en el desarrollo, gerencia y evaluación de las
actividades del sector farmacéutico en los países en desarrollo. En 1983 creó su programa de
gestión farmacéutica (Drug Management Program, o DMP), por reconocer el papel esencial de los
medicamentos en proporcionar atención médica de calidad en los países en desarrollo.
En 2001 DMP se transformó en el actual Centro de Gestión Farmacéutica (Center for Pharmaceuti-
cal Management, o CPM), que continúa la labor iniciada por DMP a nivel mundial y su
dedicación a proporcionar asistencia técnica y capacitación de alta calidad sobre este tema.
El éxito de MSH en su asistencia técnica sobre la gestión farmacéutica, se debe a su demostrada
capacidad para colaborar estrechamente—tanto con el personal de alto nivel, como con el
personal operativo en los países en desarrollo—y mantener una sólida relación de trabajo con
las diversas organizaciones internacionales y donantes que patrocinan sus actividades. Estos
donantes incluyen USAID, OMS, OPS, UNICEF, Danida, el Banco Mundial y fundaciones como
la Bill & Melinda Gates y la Rockefeller.
CPM tiene cerca de 700 personas asignadas en su oficina principal en el área metropolitana de
Washington, D.C., y en otros lugares por todo el mundo, y cuenta con una lista de más de 50
consultores especializados, que prestan sus servicios cuando estos son necesarios. Para más
información sobre CPM, por favor comuníquese con:

Arlington, VA 22203 EE.UU.
Teléfono: 703.524.6575
Fax: 703.524.7898
Correo electrónico: cpm@msh.org
A propos de Management Sciences for Health
Management Sciences for Health (MSH) est une organisation internationale à but non lucratif,
qui cherche à combler l’écart entre ce que l’on connaît des énormes défis de santé publique qui
confrontent de nombreuses nations et ce que l’on fait pour les adresser.
Depuis 1971, MSH a travaillé dans plus de 150 pays avec des décideurs, des professionnels de la
santé et des clients des services de santé pour améliorer la qualité et la disponibilité des services
de santé, et pour en réduire le coût. Nous collaborons avec les gouvernements, les bailleurs au
fonds, les organisations non gouvernementales, et les agences de santé pour répondre aux
problèmes prioritaires de santé, tels que le VIH & SIDA, la tuberculose, le paludisme, la santé
maternel-enfantine, et la santé de la reproduction. Nos publications et nos produits
électroniques sont une forme supplémentaire d’assistance dans ces domaines techniques.
MSH emploie plus de 2400 personnes provenant de plus de 70 nations ; MSH a son siège à
Cambridge, dans le Massachusetts, et des bureaux dans les environs de Washington DC ainsi
que dans plus de 50 pays. En fournissant assistance technique, recherche, formation, et en
développant des systèmes, MSH s’engage à faire une différence durable dans la santé mondiale.
Pour plus d’information sur Management Sciences for Health, veuillez consulter notre site Web
à www.msh.org.
A propos du Centre MSH pour la Gestion des
Médicaments
MSH a plus de 30 années d’expérience en ce qui concerne la mise sur pied, la gestion et
l’évaluation d’activités du secteur pharmaceutique dans des pays en développement. En 1983,
le Programme de Gestion des Médicaments (DMP) de MSH était créé au regard de l’importance
cruciale que détiennent les produits pharmaceutiques dans la prestation de soins de santé de
qualité dans des pays en développement.
En 2001, le DMP était restructuré donnant naissance au Centre pour la Gestion des Médica-
ments (CPM). Le Centre, fidèle aux travaux du DMP, reste engagé à fournir une assistance
technique et formation de qualité en matière de gestion pharmaceutique dans le monde entier.
MSH sait apporter une assistance technique efficace en matière de gestion pharmaceutique car
nous sommes capables de travailler en étroite collaboration avec les cadres supérieurs et
opérationnels dans des pays en développement tout en maintenant de relations fortes de travail
avec les nombreuses organisations internationales et bailleurs de fonds parrainant nos activités.
Ces bailleurs comprennent l’USAID, l’OMS, l’OPS, l’UNICEF, Danida, la Banque mondiale et
des fondations telles que la Fondation Bill & Melinda Gates et la Fondation Rockefeller.
CPM compte-t-il près de 700 membres de personnel travaillant à partir de ses bureaux
principaux dans la région de Washington, DC, et d’autres endroits mondials de pair avec un
groupe de plus de 50 consultants hautement spécialisés intervenant de manière ponctuelle.
Pour plus d’information sur CPM, veuillez contacter :

Arlington, VA 22203 États-Unis
Téléphone : 703.524.6575
Fax : 703.524.7898
Courrier électronique : cpm@msh.org
2014 Edition ISBN 0-913723-05-3
International Drug Price Indicator Guide

MSH’s International Drug Price Indicator Guide provides an indication of drug prices
on the international market. Updated annually, this Guide contains a spectrum of prices from
drug suppliers and procurement agencies based on their current price lists. It also contains
prices obtained from international development organizations and government agencies.
Comparative price information is important for getting the best price, and this
is an essential reference for anyone involved in the procurement of pharmaceuticals.
The 2014 edition of the International Drug Price Indicator Guide was produced with the World
Health Organization.
The Guide is also available on MSH’s Electronic Resource Center at

http://erc.msh.org/priceguide.
“As a health economist working on drug policy issues, I find the

MSH International Drug Price Indicator Guide invaluable…”
— Research Fellow, London School of Hygiene & Tropical Medicine
“This Guide has become an indispensable tool in our efforts here

to promote rational drug use.”
— Physician, National Drug Information Center, College of Medicine, the Philippines
Managing Drug Supply:

Managing Access to Medicines and other Health Technologies
Third Edition
Working with authors from around the world, MSH has revised its seminal
publication on global pharmaceutical management. Its 52 updated chapters
provide an overview and specific suggestions for effectively managing
pharmaceutical systems. The publication includes six new chapters on
pharmacovigilance, traditional medicines, intellectual property, and other
cutting-edge topics. MDS-3 is available on CD-ROM and online at www.msh.org.
200 Rivers Edge Drive • Medford, MA 02155 USA

Phone: 617.250.9500 • Fax: 617.250.9090 • Web site: www.msh.org

Proguanil PDF

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Proguanil PDF

Uploaded by

Copyright:

Available Formats

2014 Edition

INTERNATIONAL DRUG PRICE

GUIA INTERNACIONAL DE INDICADORES DE

INDICATEUR DE PRIX INTERNATIONAUX

Management Sciences for Health Phone: 617.250.9500

Center for Pharmaceutical Management Phone: 703.524.6575

Cover design by Joe Meiring

PLEASE NOTE: Explanatory FAVOR DE NOTAR: Notas NOTE: Le texte explicatif

HOW TO USE THE GUIDE ................................................................................................................................................ E-5

INFORMATION YOU SHOULD KNOW ......................................................................................................... E-6

LIST OF PRICE SOURCES ...................................................................................................................................... E-9

CONTACT INFORMATION............................................................................................................................ E-15

FORMAT OF THE PRICE LISTS ....................................................................................................................... E-23

HOW TO ANALYZE AND COMPARE YOUR PRICES.......................................................................... E-33

Contents/Contenido/Table des Matières vii

LIST II: PRODUCTS SORTED BY THERAPEUTIC CATEGORY ................................... T-1

ABOUT MANAGEMENT SCIENCES FOR HEALTH

viii International Drug Price Indicator Guide 2014

x International Drug Price Indicator Guide 2014

E-4 International Drug Price Indicator Guide 2014

How to Use the Guide E-5

E-6 International Drug Price Indicator Guide 2014

Information You Should Know E-7

E-8 International Drug Price Indicator Guide 2014

List of Price Sources

International Drug Price Indicator Guide 2014

The Supply Chain Management System project delivers essential lifesaving

List of Price Sources

International Drug Price Indicator Guide 2014

DDP, The Clinton Health Access Initiative contributed price

The Democratic Republic of Congo Integrated Health

List of Price Sources

International Drug Price Indicator Guide 2014

Action Medeor International Healthcare

Contact Information E-15

Botswana Public Procurement and Asset Disposal Board

Telephone: 267 360 2000

Caja Costarricense de Seguro Social—CCSS (“Costa Rica Social Security—CRSS”)

Clinton Health Access Initiative

E-16 International Drug Price Indicator Guide 2014

Dominican Republic PROMESE/CAL

Global TB Drug Facility (GDF)

Contact Information E-17

Medical Export Group, BV

Medical Stores Department (MSD)

E-18 International Drug Price Indicator Guide 2014

Mission for Essential Drugs and Supplies (MEDS)

Namibia Central Medical Stores

Organisation of Eastern Caribbean States Pharmaceutical Procurement Service

Contact Information E-19

South Africa Department of Health

Sudan National Health Insurance Fund

Telephone: 249 1 837 47618

Supply Chain Management System (SCMS)

E-20 International Drug Price Indicator Guide 2014

Telephone: 503 2248-8800

United Nations Population Fund (UNFPA)

Contact Information E-21

Format of the Price Lists E-23

E-24 International Drug Price Indicator Guide 2014

Package Price (US$)

Unit Price (US$)

Format of the Price Lists E-25